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Chapter 5. Systematic Review Results by
Biomarker Classifications
5.1 Markers of Absorption and Permeability:
Overview
Tests of gut permeability and of absorption often overlap in concept, and are frequently
performed simultaneously. For this reason, it is appropriate to provide background in tandem.
Proper functioning of the intestine depends on sufficient absorptive surface area and
maintaining the barrier function and structural integrity of the lining of this organ. Absorptive
surface is a function of individual villous surface area, as depicted in the photos below [3], and
of gut length, which is probably not compromised in post-natally-acquired enteropathic
syndromes. Absorption depends on the ability of various cellular mechanisms to assimilate
nutrients from food that is ingested, using processes that rely on specialized pumps, pathways,
and degradation. Integrity reflects
sieve size, and presumably passive
diffusion of large molecules across
non-intact epithelia. To varying
extents, these functionalities are
hindered in EED, celiac disease, and
small bowel Crohn’s disease, among
other disorders.
To perform its functions, the
Microvilli of the small bowel, as seen with a magifying lens
[3]. Normal finger-like projections are presented in the top
panel. Enteropathy is characterized by flattened villi (bottom
panel). Reproduced from Gut, Booth, C.C., Vol. 5, p. 46,
1964 with permission from BMJ Publishing Group Ltd.
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intestinal epithelium utilizes a layer of

highly specialized columnar epithelial cells connected by the apical junctional complex of tight
junctions and adherens junctions. Theoretically, specific molecules can be chosen strategically
to interrogate these various attributes. For example, breaches in integrity that enable passive
diffusion into the host could be measured by ingesting a substance that is not found in the diet,
and measuring its concentration in the blood or urine. Another detection strategy would be to
use a molecule that is easily absorbed in health and disease, but where absorption is limited
only by mucosal surface availability, and, similarly, measure this tracer in urine and blood. The
optimal challenge substances would resist digestion in the gut, be nontoxic, and be easily
measured. Ideally, one attribute (surface area) can and should be measured in parallel with the
other (specific uptake). Lastly, it might be difficult to separate one function (i.e., permeability)
from the other (absorption); therefore these two processes are discussed in tandem in this
section.

5.1.1 Sugars as Tracers of Intestinal Function
Historically, sugars have served well as tracers of intestinal function. These substances
are nontoxic, easily detected in blood or urine, and, most importantly, neither made, nor
degraded, by the host, so their presence in the body reflects gut uptake. Most of these sugars
are assayed after ingestion of a load. Some of these sugars are “endomolecular,” i.e.,
consumed as part of a normal diet, but most are “xenomolecular,” i.e., foreign to natural diets,
not metabolically necessary for the host, and absorbed without the benefit of specific
transporters. Because they are foreign to the human diet, their use as a marker of intestinal
function requires administration of a load to assay presence in body fluids. Moreover, depending
on their size and the physiology of their assimilation, these sugars can be used to probe either
amalgamated function, or specific processes or lesions (see Table 13).
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Table 13. Sugar probes.

Sugar

Molecular
weight

D-xylose

150.13

Lactose

Lactulose

1

Molecular structure

Endo- vs.
Xeno1
molecular

Primary function
assessed when found
in blood and/or urine /
Other comments

Chemical (IUPAC) name

Formula

[174]

D-xylose

HOCH2
(CH
(OH))3CHO

Xenomolecular

Measure of small bowel
(perhaps primarily
jejunal) absorptive
capacity. Sugar
synthesized by wood.

342.3

[175]

β-D-galactopyranosyl-(1→4)D-glucose

C12H22O11

Endomolecular

Measure of small bowel
permeability, although
might also reflect lactase
deficiency.

342.30

[176]

4-0-β-D-galactopyranosyl-Dfructofuranose

C12H22-011

Xenomolecular

Measure of small bowel
permeability. Usually
normalized to mannitol.

We use the term xenomolecular for probes that would not be ingested in a normal dietary environment, while endomolecular probes are common
and/or necessary dietary constituents. Therefore, endomolecular probes or their breakdown products are typical constituents in body analytes.

Table 13. Sugar probes.

Sugar

Molecular
weight

Mannitol

182.17

Rhamnose 164.16

Sucralose

Sucrose

Molecular structure

Primary function
assessed when found
in blood and/or urine /
Other comments

Chemical (IUPAC) name

Formula

[177]

(2R,3R,4R,5R)-Hexan1,2,3,4,5,6-hexol

C6H14O6

Xenomolecular

Measure of total small
bowel absorptive
capacity.

[178]

2R,3R,4R,5R,6S)-6methyloxane-2,3,4,5-tetrol

C6H12O5 ·
H2O

Xenomolecular

Has been used in lieu of
mannitol as a measure of
total small bowel
absorptive capacity.

[179]

1,6-Dichloro-1,6-dideoxy-β-Dfructofuranosyl-4-chloro-4deoxy-α-D-galactopyranoside

C12H19-Cl3O8

Xenomolecular

Measure of colonic
permeability. Active
R
ingredient in Splenda .

[180]

Structural α-D-glucopyranosyl(1→2)-β-D-fructofuranoside

C12H22-O11

Endomolecular

Measure of gastric
permeability.

397.64

342.30

Endo- vs.
Xeno1
molecular

An early sugar that was employed as an indicator of intestinal function was D-xylose
[181, 182], a pentose, which remains a standard for single sugar absorption testing worldwide.
Humans do not synthesize D-xylose isomerase. Following an enteral challenge, the molecule is
eliminated intact by renal clearance, after circulating in the blood. It is largely passively
absorbed in the small bowel. The mechanism of clearance is glomerular filtration without
demonstrated tubular reabsorption or renal tubular excretion. Hence, uptake of D-xylose can be
assayed by seeking the peak in the serum or by collecting urine for assay. The assay for Dxylose currently relies on isotopic or photometric assays [183]. Its main limitation is that a single
sugar cannot differentiate loss of absorptive function from loss of absorptive area (e.g., due to
shortened bowel length). Other single sugars that indicate absorptive function include mannitol
and rhamnose. Sugars that are not absorbed by an intact healthy gastrointestinal tract better
reflect porosity including lactose and lactulose in the small intestine, sucrose in the stomach,
and sucralose in the large intestine.
The second class of sugar absorption tests utilizes two sugars. One sugar reflects total
small bowel absorptive capacity, and is most often mannitol or, occasionally, rhamnose. This
"denominator" sugar requires no specific uptake mechanisms or host attributes except for
available surface area. The “numerator” sugar in these dual tests is most often lactulose
although lactose, sucrose, and sucralose have also been used. These large molecules enter the
host by passive diffusion in the presence of alterations of the integrity of the small bowel
(lactulose and lactose), stomach (sucrose), or colon (sucralose).
Dual sugar tests have additional advantages. A single molecule might be affected by
factors that are not related to the permeability process, e.g., rates of gastric emptying and
intestinal transit, bacterial degradation, or the sufficiency of urine collection. In contrast, a ratio
of excretion of two molecules is not susceptible to these factors, because such processes act on
both molecules similarly, and the ratio is the key retained metric. However, absolute values
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might be low in these situations, and dynamic ranges for uptake are not well established.
Finally, in adults, some data suggest that the use of hyperosmolar fluids (i.e., lactulose and
mannitol) might affect absorption via solvent drag [184]. For purposes of comparison, the four
grams of lactulose and one gram of mannitol dissolved in five milliliters of water, a commonly
employed formulation [185] produces a solution that is 4,629 mOsm/kg as compared to normal
plasma osmolality of 270-285 mOsm/kg.
Variations on the challenge and recover motif used in the classic sugar absorption
studies warrant discussion. Some studies use indirect assessments of uptake. For example,
non-absorbed D-xylose can be metabolized by microbes in the bacteria-rich colon, and possibly
also in small bowel bacterial overgrowth, and measured as exhaled carbon dioxide.
We reviewed 36 studies that assessed small intestinal absorption or permeability using
sugars as absorbed probes. Three studies measured lactose, an endomolecular sugar, either in
the serum (n=1) or urine (n=2) among breastfeeding children. Of the 36 studies, 35 assessed
malabsorption/permeability deficits by administering xenomolecular sugar challenges using
lactulose, mannitol, rhamnose, or xylose (including one study each that also measured serum
and urinary lactose). We reviewed five studies that reported xenomolecular probe results
of single-only sugar tests, and 30 studies that reported results of dual sugar tests. The dual
sugar tests included urinary L:M (n=25 studies), urinary or serum L:R (n=5), and urinary
lactose:lactulose (n=1). The single sugar assay was used in six studies: urinary lactose (n=1)
and D-xylose (two using serum measures, one using urine as a substrate, and two in which the
body fluid from which the sugar was measured was not reported).

5.1.2 Endomolecular Nutrients as Tracers of Intestinal Function
Essential nutrients that are absorbed by healthy small intestine provide another
opportunity to assess gut absorptive function. These types of marker assessments can provide
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especially valuable information regarding the role of derangement of gut function among
children with nutrient deficiencies, i.e., how much of the deficiency is because of lack of intake
rather than malabsorption. Since these molecules are naturally found in body analytes, load
administration requires tagging such as with the use of radiolabeled molecules, quantification of
which can then be assessed in breath, blood, urine, and/or stool as surrogate markers of
absorptive capacity. We reviewed six studies that utilized such methodologies including
assessments of zinc (n=3), lipid (n=2) and iron (n=1) absorption.
We present in Evidence Tables 1 and 2 data from publications that utilized markers of
absorption and permeability, respectively. Evidence Table 1 depicts data related to the
systematic review from the articles that reported results of markers that were principally related
to absorptive functions (such as D-xylose and fecal fat). Evidence Table 2 contains data on
markers related to porosity or permeability. However, tests of gut permeability are often
assessed simultaneously with markers of absorption. For example, the lactulose:mannitol ratio
(L:M) and lactulose:rhamnose ratio (L:R) are often described as tests of permeability; however,
by their nature they do include measures of absorption (via mannitol and rhamnose,
respectively). For this reason, we present markers of permeability with or without concomitant
assessment of absorption in Evidence Table 2. We identified 44 publications that assessed
small intestinal absorption (13 studies) or permeability (primarily, sometimes also with some
assessment of absorption based on dual sugar testing; 31 studies) in children in resource-poor
settings.

5.2 Markers of Absorption
Data regarding markers of absorption are presented in Evidence Table 1.
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Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest
2002
Dini E et al.

Location and
Target Population

Caracas, Venezuela Case-control

6 mo-9 yr olds with
recruited from an
Sudan III and
outpatient nutrition
steatocrit in the
center and welldetection of fecal fat nourished controls.
in malnourished
children
Fecal fat by four
different testing
methods as a
marker of
malabsorption
among children with
varying nutritional
status and wellnourished controls

Design and
Sample Size

n=129;
n=99 cases:
• 30 with
subclinical
malnutrition
• 34 with mild
malnutrition
• 30 with
moderate
malnutrition
• 5 with severe
malnutrition
n=30 controls

Biomarker

Results

Stool Test:
Fecal fat, by method:
• Sudan III
classic
• Sudan III
modified
• Steatocrit
classic
• Steatocrit acid

Conclusion

Proportions testing positive for A majority of children
fecal fat ranged from 33%-41% studied tested negative
overall, depending on test
for fecal fat.
method used.
The highest percent
The proportion testing positive testing positive was in
varied by nutritional status
those with severe
across testing methods:
malnutrition, followed by
those with subclinical• 80%-100% of severely
malnourished subjects had a moderate malnutrition.
Controls had the lowest
positive test
• Similar proportions of subjects percent testing positive.
Each subject
underwent testing for with subclinical, mild or
moderate malnutrition tested Subjects with enteric
all four methods.
parasites or those
positive, ranging from 30%experiencing diarrhea at
47%
time of testing excreted
• 13%-27% of controls tested
fat significantly more
positive
These differences appeared to often than uninfected
children without
be significant, but statistical
diarrhea, although the
comparison results were not
magnitude of difference
entirely clear.
was not reported.
Fecal fat did not vary based on
There was some
quantity of fat intake.
variation between the
different testing
By all four methods, a high
methods, for example
percentage of children with
parasites tested positive (~60%) their relationship with a
history of diarrhea in the
compared to children without
year prior to testing.
parasites (25%).
Associations were observed
between infection with Giardia
lamblia or Blastocystis hominis
and fecal fat (p<0.05); this held
true across diagnostic methods.
The presence of diarrhea at time
of testing was positively
associated with fecal fat by all
test methods (p<0.02 for all
except steatocrit classic,

Comments
Spanish language
article.
Control recruitment
strategy was not
well described.
Proportions positive
for fecal fat by
history of diarrhea
(current or
previous) were not
provided.
Authors reported
percent agreement
between tests but
did not report
results of statistical
testing of these
estimates.
Test results varied
by subject
characteristics;
however,
assessments
adjusting for
potential
confounding were
not reported.

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

There was a high
prevalence (100%) of
abnormal D-xylose
results among HIVinfected children,
regardless of diarrhea
status.

Portuguese
language article.

p=0.06).
The relationship between fecal
fat and history of diarrhea in the
year prior to testing varied by
test method:
• Sudan III classic: p=0.134
• Sudan III modified: p<0.001
• Steatocrit classic: p=0.14
• Steatocrit acid: p=0.015

2006

Sao Paulo, Brazil

Cohort

n=11;
5 mo-12 yr old
(median 24 mo) HIVn=5 patients with
Functional,
infected subjects
current or recent
microbiological and recruited from a
morphological
hospital and clinic. episode of
diarrhea
intestinal findings
among human
All subjects had
n=6 patients with
immunodeficiency
some degree of
no diarrhea in the
virus infected
protein-energy
30 days
children
malnutrition.
preceding
enrollment
Small intestinal and
rectal biopsy to
assess morphology
and D-xylose as a
marker of
malabsorption
among HIV-infected
children
Leite CA et al.

Blood Test:
D-xylose
(9 tested)

Agreement between all four
methods was 72%. Agreement
between at least three was
91.5%.
100% had low D-xylose
absorption:
• Mean: 15.6 mg/dL
• SD: 5
• Range: 8.9-24.4
• Median: 14.2

D-xylose <25 mg/dL
was defined as
Biopsy of small
indicative of
intestine by tethered
malabsorption. This
capsule or
Small intestinal biopsy:
value is higher than
endoscopy:
• 100% had some degree of
what some
All patients also had
Histopathology
villous atrophy based on a I-IV cellular infiltration of the references have
grading system:
noted as a cut-point
(10 tested)
lamina propria and
[186]
varying degrees of
• Grade I: 3
Investigators used
villous atrophy.
• Grade I/II: 2
Rectal biopsy:
a well-articulated
• Grade II: 1
Histopathology
There
was
no
correlation
system of grading
• Grade II/III: 1
between
D-xylose
and
villous atrophy.
(6 tested)
• Grade III/IV: 1
degree
of
villous
atrophy
• 2 samples were too
Results were not
on biopsy.
superficial to assess
presented by
• Intraepithelial lymphocytes
diarrhea status,
were increased in half of the
perhaps due to
biopsies.
small sample size.
• Lymphocytic and
polymorphonuclear (PMN)
infiltration of the lamina
propria were present in 10/10
and 7/10 biopsies,
respectively.

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Rectal biopsy:
• 100% had normal architecture
Lymphocytic and PMN infiltration
were present in 6/6 and 4/6,
respectively.
2005
Lima, Peru
RCT
Urine Test:
Mean zinc parameters (SD) at Despite a reduction in
Zinc excretion to
initial assessment:
FAZ with increasing
measure fractional • FAZ:
López de Romaña D 3-4 yr olds residing n=41;
fortification, TAZ
absorption of zinc
et al.
in a poor community (31 completed
increased as more zinc
• Group 1: 0.34 (0.11)
(FAZ) and total
at the periphery of both initial and
was consumed and with
• Group 2: 0.24 (0.05)
absorbed zinc (TAZ)
follow-up
Longitudinal
Lima with stunting
increasing
• Group 3: 0.13 (0.04)
absorption assay following
measurements of
and moderate
concentrations of zinc
• TAZ (mg/d):
radiolabeled zinc
at 2 mo)
zinc absorption in
anemia as a
fortification.
• Group 1: 0.71 (0.18)
administration
Peruvian children
surrogate risk factor
• Group 2: 1.11 (0.21)
Authors speculate that
consuming wheat
for zinc deficiency. Group 1:
• Group 3: 1.34 (0.47)
n=14 received
reduction in FAZ with
products fortified
wheat flour with
increasing fortification
with iron only or iron
Neither mean FAZ nor TAZ
iron fortification
could be due to factors
and 1 of 2 amounts
changed significantly at
only
of zinc
subsequent assessments in any such as saturation
(10 completed
kinetics.
treatment group.
follow-up)
Zinc absorption
Authors described a
among stunted,
In both the initial and
Group 2:
anemic children
subsequent assays, mean TAZ unexpected finding:
n=12 received
subjects consuming
receiving zinc as
from zinc-fortified meals
wheat flour with
more zinc from the zincwell as iron and/or
increased with increasing
iron and 3mg
fortified breakfast
iron/zinc-fortified
amounts of fortification (p<
zinc/100g flour
foods
0.001). However mean FAZ was and lunch meals
(9 completed
inversely related to zinc intake absorbed less zinc from
follow-up)
the unfortified
from these meals (p<0.001).
dinners during the initial
Group 3:
absorption assay.
Non-fortified dinner FAZ and
n=15 wheat flour
TAZ were significantly lower in
with iron and 9mg
the group receiving the most
zinc/100g flour
zinc-supplementation at the
(12 completed
initial assay (p=0.015 and
follow-up)
p=0.012, respectively) despite
no difference in zinc intakes
from the unfortified dinner by
treatment group. This
relationship between groups was
not observed at the second
assay; however, a significant
decrease of 16% in mean FAZ

Comments

Intestinal function
could play a role in
zinc (or other
micronutrient)
absorption; such
factors were not
explored in this
study.
The principal aim of
this study was to
determine
appropriate extent
of zinc fortification
of a staple food in a
specific community;
we present only
results relevant to
this review.

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

and TAZ from the unfortified
dinners was observed between
initial and subsequent assays
(p<0.001).

2002

Blantyre, Malawi

Case-series

n=10
2–5 yr olds (mean
age 43.6 mo, SD
Zinc homeostasis in 7.7) from rural area
Malawian children
attending
consuming a high- immunization clinic.
phytate, maizebased diet
There was a high
prevalence of
Zinc absorption in a stunting and low
sample of 10
plasma zinc in this
asymptomatic
series.
children
Manary ML et al.

Mean plasma zinc
concentrations did not differ
between treatment groups
throughout the study period. The
proportion with low fasting
plasma zinc concentrations
(<65μg/dL) was lower at the end
of the study (3.3% vs. 20.5%
initially, p=0.046).
Stool Test:
Mean (SD):
EFZ was higher than
Authors note that
Endogenous fecal • FAZ: 0.24 (0.04)
would be expected for a the lack of
zinc (EFZ)
• TAZ (mg/d): 1.30 (0.33)
zinc deficient cohort, and comparable
• EFZ (mg/d): 1.15 (0.33)
EFZ was not correlated data from children
with TAZ as would have of the age range in
Urine Test:
Language in the discussion
this study limits
been expected. While
Zinc excretion to
section strongly suggests, but
data interpretation.
high-phytate diets
measure fractional does not explicitly state, that
They also provide
leading to poor zinc
absorption (FAZ)
TAZ and EFZ were not
absorption might explain results per body
and total absorption correlated. Correlation analysis these findings, the
weight due to
(TAZ) following
for these parameters was not
presumed
authors note that in a
radiolabeled zinc
reported.
previous study (among a relationship; validity
administration
somewhat older age
of such measures
has not been
group) there were no
established.
differences in EFZ
among children
consuming high- or low- Authors comment
phytate diets [187]. They that the methods
note that such
used for calculating
absorption
perturbations in EFZ
have also been reported measures are
sensitive and
in children with
accurate, but quite
enteropathy due to
cystic fibrosis [188] and difficult to conduct,
especially among
suggest that a similar
process could be going children.
on in these Malawian
children due to TE.

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest
2001

Location and
Target Population

Design and
Sample Size

New Delhi,
India

Case-series

n=94;
(38 with repeat
0-15 yr old
biopsies)
Tropical sprue in
gastroenterology
north Indian children clinic patients with
<5 yr old: n=44
PD.
D-xylose and
duodenal biopsy as Those with abnormal
morphology on
markers of TS
biopsy, abnormal Dxylose test, and
clinical response to
antibiotics were
diagnosed as having
TS.
Mittal SK et al.

Those with abnormal
morphology and
response to glutenfree diet were
diagnosed with CD.
We include data on
these subjects for
comparative
reasons.

2002

Hermosillo, Sonora, Case-control
Mexico
n=13;
Moya-Camarena SY
3-6 yr olds in a
et al.
<5 yr old:
periurban setting
Effects of
attending preschool n=5
asymptomatic
centers meeting
Giardia intestinalis inclusion criteria of n=7
infection on
no GI symptoms, no asymptomatic
carbohydrate
antibiotics in the
cases infected
1

D-xylose results were expressed as % of dose administered.

Biomarker

Results

Conclusion

Comments

Duodenal biopsy,
36 (38.3%) were diagnosed with More than half of the GI Biopsy results were
method not specified: TS including 14/44 (31.8%) who clinic patients with PD
not provided for
Histopathology
were under 5 years of age.
patients without TS
had some degree of
or CD.
villous atrophy.
18 (19.1%) were diagnosed with
Blood Tests:
CD.
More than one-third and It was unclear if
there were patients
almost one-fifth of
• Hemoglobin
Degree of villous atrophy among subjects were diagnosed with abnormal D• D-xylose*
TS vs. CD patients:
with TS and CD,
xylose and
• Mild in 8/36 (22.2%) vs. 0
histology who did
respectively.
• Moderate in 23/36 (63.9%) vs.
not respond to
* Not specified
4/18
(22.2%)
By
study
diagnostic
antibiotic therapy
whether from urine or
•
Severe
in
5/36
(13.9%)
vs.
and therefore were
definition,
all
TS
patients
serum, and units of
improved with treatment. not diagnosed with
14/18 (77.8%)
measurement not
Among those who had TS.
provided.
Mean hemoglobin concentration repeat biopsies, almost
(range) among TS patients was three-quarters showed Cut-off points used
8.3 g/dL (5.5-11) and did not
to define abnormal
normalization of
differ from values of those with histology, while 23% had D-xylose tests were
CD.
partial improvement and not provided.
1 patient had worsened
Among the 22 TS patients,
pathology.
repeat biopsies showed:
• 16 with normalization
• 5 with improvement
• 1 worsened despite marked
clinical improvement

Breath Tests*:
• Lactose HBT
• D-Xylose HBT**

Urine Test:
,1
D-xylose**

* Reported as parts

The D-xylose test was abnormal
in all TS patients by diagnostic
definition.
Mean lactose HBT (SE):
• Cases pre-treatment: 3.6
(0.75) ppm
• Cases post-treatment: -0.85
(0.75) ppm (p<0.05 compared
to pre-treatment)
• Controls: 0.19 (0.81) ppm
(p<0.05 compared to pretreatment cases)

Lactose HBT
concentrations were
normal according to
established cut-points
among all subjects.

Statistical methods
might not have
been adequate to
account for intrasubject correlation
when comparing
However, lactose HBT the same group of
was significantly higher subjects (cases)
among cases compared before and after
to controls and there
treatment.

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest
absorption in wellnourished Mexican
children

Location and
Target Population

Design and
Sample Size

preceding 3 wk, and only with G.
intestinalis
no SBBO by
lactulose HBT and
n=6 controls
Indican test.
without Giardia

Biomarker

Results

Conclusion

per million (ppm)
Mean xylose HBT (SE):
was also a significant
post-substrate
• Cases pre-treatment: 2.2
decrease in lactose HBT
ingestion after
(0.69) ppm for infected group among cases after
• Cases post-treatment: -4.16 treatment. The clinical
subtraction of
Lactose hydrogen
(0.69) ppm (p<0.05 compared relevance of such mildly
baseline, prebreath test (HBT) as
to pre-treatment)
elevated HBT results in
substrate H2
concentrations. A
• Controls: 1.13 (0.74) ppm (NS asymptomatically
a marker of lactose
Cases were
positive HBT is
compared to pre-treatment
absorption, and
infected children is
evaluated before considered to be a
cases)
xylose breath test
unclear.
and urinary excretion
and 3 wk after
rise of >20ppm in
as markers of xylose
treatment with
breath H2 above
Mean urinary excretion of xylose Results did not
tinidazole. Post- baseline H2
(SE) among cases pre-treatment demonstrate xylose
absorption in welltreatment stools concentration.
and post- treatment was 34% (3) malabsorption by either
nourished children
were verified for
and 46% (11), respectively (NS), urinary or breath
with asymptomatic
absence of
** Investigators did well above cut-offs indicative of measures among any
giardiasis and nonparasites.
not specify the xylose malabsorption.
infected controls
group. While urinary
enantiomer used,
results did not differ
however test
before and after
functionality
treatment, case xylose
characteristics lead
HBT was significantly
us to assume that it
lower after treatment;
was the dextrorotary
again the clinical
(D) enantiomer.
significance of such
results is not apparent.
2002
Kingston, Jamaica Case-series
Stool Tests:
Median total stool excretion of High concentrations of
13
13
C in phase 1 was 9% (range:
C (compared to
• Total and
13
n=24
1%-29%) and did not vary
Murphy JL et al.
5-23 mo olds
healthy UK children)
fractionated C
between TG groups.
admitted to the
[190] were observed in
following
13
Maldigestion and
Tropical Metabolism Subjects were
ingestion of one Median C excretion dropped half of the subjects at
13
33%-99% in phase 2 and 86%- admission, reflecting
malabsorption of
Research Unit of the divided into 3
of three C
groups of 8
95% in phase 3 compared to
dietary lipid during University of the
impaired digestion or
labeled
children, each
severe childhood
West Indies with
absorption.
triglycerides (TG): phase 1 (p<0.05 each).
malnutrition
severe malnutrition. group receiving a trilaurin, triolein,
different labeled
Over the study period, there
The differences in stool
or trilinolein*
13
13
Stool recovery of
triglyceride.
were significant associations
C were wide but not as
• C stool assay
between total lipid and the
extreme as in a previous
radiolabeled
following
13
Data were
amount of C labeled TGs in
study by same
products as markers
administration of
collected in three labeled fatty acid
stool for some groups, but not
investigators (also
of lipid digestion and
13
separate phases
examined in this review)
absorption, and bile
C glycocholate** for others.
as described
using a different TG
salt deconjugation
13
above in JL
Median C in TG and FA was (tripalmitin) substrate
as a marker of
Murphy et al.
similar across TG groups in all [149].
SBBO among
* To assess fat
children with severe
2001 [149].
excretion as a % of phases. 13C FA recovery was

Comments

Investigators
wished to exclude
children with SBBO.
As such, inclusion
criteria restricted
participants to
those with
adequate
production of H2
following ingestion
of lactulose and
with minimal urinary
indoxyl sulfate
excretion. The
number of children
excluded due to
failure to meet
these criteria was
not reported.

Authors state that
the study was not
powered to
compare the
different TGs, but
they contend that
medium chain
trilaurin did not
appear to be
processed
differently than the
longer chain TGs
triolein and
trilinolein.
Authors did not
describe the
method used to
assign subjects to

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest
malnutrition

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

dose administered.
Also assessed
13
proportion of C in
triglyceride (TG) and
fatty acid (FA)
fractions to
distinguish excretion
caused impaired
digestion (presence
of TG) vs. poor
absorption (presence
of FA).

similar and reduced by ~2/3
13
compared to Phase 1. C TG
was not detectable in Phases 2
or 3. Statistical comparisons
between phases were not
reported.

13

different TG groups.

C excretion did not
significantly differ
between TG groups and
declined with improving
clinical course.

While it was noted
that some subjects
had positive stool
cultures, details
Similar to their previous were not provided
13
C after radiolabeled
study, significantly more on the nature of the
13
glycocholate administration was C in stool was
enteric infections.
detected in stool at quantities
recovered as FA than
considered to be in excess of
TG, reflecting impaired
the 7% recovery of dose
absorption over poor
administered upper limit of
lipid digestion/
** To assess bile salt normal in U.S. adults in [189]:
hydrolysis. Unlike in their
previous study, there
deconjugation in the • Phase 1: 13/24 (54%)
• Phase 2: 5/24 (20.8%)
was evidence of SBBO
bowel caused by
Phase 3: 3/24 (12.5%)
as measured postSBBO; conducted
13
ingestion of C
after the TG
glycocholate.
assessment and a 3
day washout period.
2001
Kingston, Jamaica Case-series
Stool Tests:
Mean fecal fat (SD):
Mean fecal fat was not Statistical methods
• Phase 1: 2.4 g/day (3.6) or
elevated compared to
might be
• Fecal fat*
7-23 mo olds with
n=8
Murphy JL et al.
5.9% (9.4) of dietary lipid
published norms [191, inappropriate for a
• Total and
13
malnutrition admitted
intake
192], during any study small sample.
fractionated C
Gastrointestinal
to the University of
• Phase 2: 1.7 (0.9) g/day, or
phase.
assay after
Data were
All subjects were
handling and
the West Indies.
3.3% (2.4) of intake
administration of
metabolic disposal of
collected in three 13C tripalmitin
• Phase 3: 0.9 (0.6) g/day, or
There was wide variation treated with
13
C-labelled
separate phases
in fecal fat at
antibiotics including
1.4% (0.7) of intake
(TP)**
13
(each lasting 9
•
Differences
between
phases
metronidazole for
tripalmitin during
presentation,
and
wide
• C assay after
13
days):
C
presumptive SBBO;
were
not
statistically
rehabilitation from
variations
in
stool
administration of
1. Within 48 hours 13C glycocholate
across subjects. Authors this might have
significant.
childhood
of admission
indicate that this is the affected GCA
malnutrition
(GCA)***
13
2. During early
Total excretion of C in stool
first such assessment in testing.
also varied widely across
Fecal fat, stool
rehabilitation
malnourished children;
Breath Tests:
13
3. During late
patients (0%-44%) and did not previous studies on
recovery of
• CO2 after
differ between study phases.
healthy children from the
rehabilitation
radiolabeled
administration of
13
UK demonstrated
products, and breath
C glycocholate
13
Correlation
between
fecal
fat
average excretion of 6%
tests as markers of
(GCA)*** or C
13
and
C
(r=0.48;
p<0.05)
was
[190].
lipid digestion and
TP****
observed.
absorption and bile
The majority of excreted
salt deconjugation
* In 72 hour stool
13
C was in the form of
as a marker of
collection (measured Lack of lipid digestion and
FA rather than TG.
SBBO among
as total grams and as absorption were assessed by

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
children with severe
malnutrition

Design and
Sample Size

Biomarker
% of dietary fat
intake).

Results

measuring TG and FA fractions,
13
respectively. Mean C TG
recovery (SD) (% of
administered dose), number of
** To assess fat
excretion as a % of patients excreting TG:
dose administered. • Phase 1: 0.7% (1.6), n=3
• Phase 2: 0.9% (2.8), n=1
Also assessed
13
proportion of C in • Phase 3: no recovery from
triglyceride (TG) and
any subjects, differences
fatty acid (FA)
between phases were NS
fractions to
13
distinguish excretion C FA fraction in stool declined
caused by impaired during rehabilitation.
13
digestion (presence Mean C FA recovery (SD):
• Phase 1: 6.0% (7.3)
of TG) vs. poor
absorption (presence • Phase 2: 4.8% (3.7)
• Phase 3: 3.3% (3.8),
of FA).
differences between phases
were NS
*** To assess bile
salt deconjugation in
the bowel caused by Mean FA values were ~9x (NS),
5x (p<0.001), and 3x (p<0.05)
SBBO; conducted
higher than mean TG values in
after the TG
assessment and a 3 Phases 1, 2, and 3, respectively.
day washout period.
Following administration of
13
**** Expressed as a labeled TP, absorbed C label
by breath analysis was ~5%
percentage of
absorbed label (dose (range 0%-21.2%) and similar
administered - label across study phases.
recovered in stool) to
assess oxidation for Following the administration of
acute energy needs. labeled GCA, there was either
13
no or minimal recovery of C in
13
stool and CO2 on breath (as %
of dose administered) in all
phases.

Conclusion
Authors interpreted this
to reflect failure of lipid
absorption in the face of
adequate digestion/
hydrolysis. Each form
(FA and TG) was found
in decreasing values as
the study phases
progressed, suggesting
improved digestion and
absorption, although
results did not differ
significantly.
Fecal fat was correlated
with concentrations of
13
C in stool.
There was no evidence
of SBBO or bile acid
malabsorption.
13

CO2 excretion following
13
administration of C TP
was minimal, suggesting
a propensity for
deposition in adipose
tissues rather than
oxidation for immediate
energy needs. The
authors report that this
breath test has not been
widely used, but that
healthy UK children
have breath excretion
values from 15%-43%
[190], compared to a
mean of 5% and range
0%-21% in this cohort;
the latter findings were
more similar to results
from kwashiorkor
13
patients where Clabeled oleic acid was

Comments

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

2000

Sao Paulo, Brazil

Case-control

Nichols B et al.

Cases were children n=33;
(mean age 9.9 mo,
SD 8.1) hospitalized n=24 cases
with malnutrition
refractory to dietary n=9 controls
rehabilitation.

Contribution of
villous atrophy to
reduced intestinal
maltase in infants
with malnutrition
Jejunal biopsy,
maltase activity, and
enzyme messenger
RNAs among
malnourished and
well-nourished
children. Assessed
association between
maltase and villous
atrophy and other
mucosal intestinal
markers indicative of
loss of enterocytes
and enterocytic
function.

Controls were
children (mean age
3.6 mo, SD 1.0) with
HAZ and WAZ
scores >-2 and
normal intestinal
mucosa on biopsy,
hospitalized for
Kasai procedure for
biliary atresia.

Subjects were
matched on
height and
weight; ages
differed within
matched sets.

Biomarker

Results

Conclusion

Comments

used as substrate [193].
Mean villous atrophy score (SD): The malnourished
Tissue from
• Cases: 2.6 (0.8)
children had significantly patients requiring
• Controls: 1.2 (0.5), p=0.006) greater villous atrophy
intestinal resection
as part of their
than the younger
WAZ score was correlated with controls.
biliary atresia
villous atrophy (r=0.65, p- value
management
not reported).
Among the subset tested provides an
for mRNA messages,
opportunity to
13/25 [sic] cases and 0/5
maltase activity as well assess presumably
controls had subnormal (defined as the mRNA
“normal” intestinal
as <94U/g protein) of maltase
architecture.
abundances for MGA,
activity; mean maltase was 34% villin and SGLT were
However, unless
lower among cases (p=0.11).
significantly correlated they mocked up ex
vivo mucosal
Maltase activity did not appear with case status and
to decrease with WAZ score
biopsies in these
were correlated with
(further details not provided).
controls, resections
villous atrophy.
will have lower
However, in sub-analyses
While maltase deficiency proportions of
among those samples with an
has been reported in
villous to
adequate β-actin, a
submucosa tissue
malnutrition in other
housekeeping gene message, studies, authors assert compared to cases’
(n=10 cases, n=9 controls),
samples derived
that these are the first
cases’ findings expressed as a results that directly
from mucosal
mean percent of controls' (SD) support the hypothesis biopsies. While this
included:
probably doesn’t
that reductions in
• Villous length (reciprocal of
maltase activity are due affect histology, it
atrophy score): 38.9 (41.6),
to villous atrophy. This might affect
enterocyte
p=0.004
study also nicely
• Maltase activity: 37.1 (23.2), correlates mRNA
functional assays
p=0.001
relative abundance with and mRNA
• MGA mRNA: 45.1 (36.4),
determination, as
function.
transmural tissue
p=0.016
• Villin mRNA: 52.5 (22.6),
will bring in more
diverse populations
p=0.003
• SGLT mRNA: 66.6 (23.1),
of cells; only some
* Mucosal atrophy
of them might have
p=0.057
was scored on a
• β-actin: 88.2 (15.8), p=0.189
transcripts of
scale of 1 (absence
interest. However,
of atrophy compared
Both villous length and maltase
the bias is likely in a
to an organ donor) to
activity in a subset of cases
direction that would
4 (similar to children
were less than 40% of control
reduce effect size.
with active CD).
values.

Jejunal capsule
biopsy:
• Histopathology*
• Maltase activity
• Intestinal
messenger RNA
(mRNA)
abundances:
• Maltaseglucoamylase
(MGA)
• Sucraseisomaltase (SI)
• Villin, a
structural
protein
expressed
only in
enterocytes
• Sodiumactivated
luminal
glucosegalactose
transporter 1
(SGLT), a
functional
protein
expressed
only in
enterocytes
• β-actin

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker
Histology among
controls was on
surgically resected
tissue.

Results

Conclusion

It was unclear if
control inclusion
criteria included
absence of atrophy
or if all potential
controls lacked
atrophy.

MGA, villin, and SGLT mRNA
abundances were correlated
with villous atrophy score
(r=0.73), (r=0.76), and (r=0.54),
respectively (p-values not
1
reported) .
MGA mRNA abundance was
correlated with maltase activity
(r=0.32).

2001

Florianopolis, Brazil Cross-sectional

Blood Test:
D-xylose

18 mo-14 yr old HIV- n=104
infected children with
Intestinal absorption GI and non-GI

Prevalence of an abnormal Dxylose result was 7.7%.

Perin NM et al.

1

Villin and SGLT1 were assessed as a ratio with housekeeper gene β-actin.

Mean D-xylose (SD, range):
42.8mg/dL (14.4mg/dL, 16-73

Comments

Statistical methods
might not have
adequately taken
into account the
small sample size
and matching
scheme.

D-xylose showed
substantial variation
across individuals.

Subsets of subjects
were investigated
for various tests.
For example, 10
cases had mRNA
analyses based on
β-actin adequacy.
Another instance of
selected testing
was the subset of
22 and 15 cases
that had WAZ score
to histology and
mRNA correlation
analyses,
respectively.
Rationale for subset
selection was not
thoroughly
described.
Portuguese
language article.
D-xylose <25 mg/dL
was defined as

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
of D-xylose in
symptoms of HIV
children infected with infection recruited
the human
from a pediatric
immunodeficiency
AIDS center.
virus

Design and
Sample Size

Conclusion

Comments
indicative of
malabsorption.

D-xylose was not associated
with age.
Of the 8 children with abnormal
results, 1 had diarrhea. Of 19
with diarrhea, 1 had an
abnormal result.

2002

Chandigarh, India

Poddar U et al.

n=47
18 mo-14 yr olds
with PD, FTT, or
pallor from a hospital
pediatric
gastroenterology
unit.

Duodenal biopsy, Dxylose, and fecal fat
in children with
symptoms of CD but
normal mucosal
biopsy results

Results
mg/dL)

D-xylose as a
marker of intestinal
absorption among
HIV-infected children
with and without GI
symptoms

Celiac disease in
India: Are they true
cases of celiac
disease?

Biomarker

Subjects with normal
crypt:villous ratio on
biopsy were of
interest for this
review.

Case-control

Of those with abnormal results,
50% had Cryptosporidium
infection. Of the 33 subjects with
Cryptosporidium infection, 4 had
abnormal D-xylose results.
Endoscopic duodenal 38% had chronic inflammatory Among controls with
biopsy:
cell infiltrates in the lamina
normal mucosal
Histopathology
propria.
architecture by biopsy,
more than one-third had
55% had abnormal D-xylose
PD.
Stool Tests:
concentrations.
D-xylose and fecal fat
• Fecal fat*
20% had abnormal fecal fat test. might not correlate well
• D-xylose**
with duodenal biopsy
No results beyond proportion
results.
positive were reported for any of
* In 72-hour stool
the above markers.
collection.
** Not specified
whether from urine or
serum, and units of
measurement not
provided.

Relationships
between fecal fat,
D-xylose and
biopsy results were
not reported.
While 38% of
controls had PD,
results for the
markers studied
were not stratified
by PD for this
group.
Seven children with
biopsies consistent
with CD did not
respond to glutenfree diet and were
excluded from the
study.
Cut-off points used
to define abnormal
D-xylose tests were
not provided.

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Study Outcomes of
Diagnostic Interest
2004

Location and
Target Population

Design and
Sample Size

Dhaka, Bangladesh Case-control

Biomarker

Results

Blood Test:
Iron (absorption
test)

2-5 yr old apparently n=25:
healthy children from
Helicobacter pylori a periurban setting, n=13 cases
infected with H.
infection, iron
screened for iron
pylori
deficiency and H.
absorption, and
pylori.
gastric acid
n=12 controls not
secretion in
infected with H.
Bangladeshi children
pylori
Iron absorption
among children with
iron deficiency
anemia with and
without H. pylori
infection
2006
Xi-Chou (town) &
Cross-sectional Stool Test:
Endogenous fecal
Yun-Nan (province),
zinc (EFZ)
n=43
Sheng XY et al.
China
Sarker SA et al.

19-25 mo olds
Major variables of
zinc homeostasis in recruited from a
remote small town
Chinese toddlers
and 2 surrounding
Differences in zinc rural villages.
absorption in healthy
toddlers with a high 48% of children had
prevalence of zinc plasma zinc
concentrations below
deficiency.
2.5th percentile.
Dietary zinc intake
was low.

Conclusion

Comments

Mean iron absorption from
ferrous (Fe) sulfate and Fe
fumarate:
• Uninfected children: 15.6%
and 5.4%, (p<0.001)
• Infected children before
treatment: 19.7% and 5.3%,
(p<0.0001)
• Infected children after
treatment: 22.5% and 6.4%,
(p<0.0001)
• H. pylori treatment did not
significantly affect absorption
(Fe sulfate or fumarate),
p=0.3

Iron absorption from Fe
fumarate was
significantly lower than
from Fe sulfate.

Data on iron
absorption among
2-5 yr olds are
limited, making
comparison of
results from this
study setting
difficult.

Mean (SD):
• FAZ: 0.35 (0.12)
• AZ (mg/d): 0.63 (0.24)
• EFZ (mg/d): 0.67 (0.23)

Zinc absorption was
lower than physiologic
requirements and EFZ
was higher than
expected.

1

Results do not support
the hypothesis that H.
pylori infection
influences absorption of
water-soluble (Fe
sulfate) or non-watersoluble (Fe fumarate)
iron compounds.

Urine Test:
The quantity of absorbed zinc
Zinc excretion to
was lower than physiologic
The authors note that
measure fractional requirements.
the results are difficult to
absorption of zinc
explain and specifically
(FAZ) and total
There was no statistically
state that they do not
absorbed zinc (TAZ) significant difference in any
think (though without
following
laboratory value between the
clear justification) that
radiolabeled zinc
town and village groups.
enteropathy is prevalent
administration
in the population and
Zinc absorption was ~80% of
therefore could not be a
estimated physiologic
contributing factor.
requirement and equivalent to
the amount of endogenous zinc
There was a high
excreted via the intestine; it was
prevalence of
expected that absorbed zinc
stunting among the
would exceed excreted zinc
subjects.
[144, 187, 194, 195]
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects.
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s.
1

Geometric mean.

Evidence Table 1. Markers of absorption.
Biomarkers in bold are primarily markers of malabsorption.
Reference and
Location and
Design and
Study Outcomes of
Biomarker
Results
Conclusion
Target Population
Sample Size
Diagnostic Interest
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting.

Comments

Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval,
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins,
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G,
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score),
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s)

Thirteen studies used markers of intestinal absorption among children in resourcelimited settings. The range of markers included urinary, breath and serum markers of sugar
absorption, fecal fat as a marker of lipid absorption, measures of endomolecular absorption, and
presence of messenger RNAs in intestinal tissue as markers of intestinal surface area, and, by
inference, absorptive capacity.

5.2.1 D-Xylose
While single molecule tests have disadvantages compared with dual molecule tests, as
discussed above, the D-xylose test has been commonly used to assess malabsorption in
developing settings. There has been further criticism of this test, including its potential hepatic
metabolism of the sugar [196] and jejunal absorption [197].
D-Xylose was the most commonly reported measure of small bowel absorption in the
literature that we reviewed and was employed in five studies. It was assessed either in serum
(n=2) [136, 152] or urine (n=1) [147], although in two studies the substrate from which D-xylose
was measured was not reported [146, 155]. Although one of these reports did not specify the
xylose enantiomer [147], test functionality characteristics led us to assume it was the
dextrorotary (D) enantiomer, as was used in the other studies. This study, in addition to
assessment of urinary excretion of the sugar, also measured hydrogen excretion in breath
before and after administration of the xylose. Three of the studies [136, 146, 147] provided
demographic information stratified by age group and together included 58 children under five
years of age. However, none of the studies presented D-xylose data by age group. Overall, the
five studies included D-xylose results for 267 children up to the age of 14 years.
Two of the studies investigated the association of D-xylose with degree of villous atrophy
on biopsy. One of these studies performed D-xylose tests in children with symptoms of celiac
disease and normal architecture on duodenal biopsy, although approximately one-third had
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chronic inflammatory cell infiltrates in the lamina propria [155]. This publication reported
abnormal D-xylose results in 55% of these subjects (but did not provide information on the
range of normal and abnormal concentrations, sampling site, or units of measure of D-xylose).
Their results suggested that the D-xylose test might not correlate well with intestinal
histopathology, especially crypt:villous architecture. The other study was among HIV-infected
children with protein-energy malnutrition in Brazil [136]. All subjects’ tissue had cellular
infiltration of the lamina propria and varying degrees of villous atrophy on biopsy, and all
subjects also had abnormally low D-xylose absorption (based on authors’ reported cutoff value
of <25 mg/dL). However, there was no correlation between the proportion of serum D-xylose
absorption and the degree of villous atrophy on biopsy.
Another Brazilian study used the same definition of normal range for serum D-xylose
among HIV-infected children with and without gastrointestinal symptoms. Eight percent of the
children had D-xylose below the “normal” range in their blood following challenge [152]. The
authors also examined the relationships between D-xylose absorption and history of diarrhea
and Cryptosporidium infection. Of the eight children with abnormal D-xylose, one had diarrhea,
and of 19 subjects with diarrhea, one had an abnormal result for D-xylose. Among subjects with
abnormal results, 50% had Cryptosporidium infection, and of the 33 with Cryptosporidium
infection (many of whom did not have diarrhea), four had an abnormal D-xylose test. They did
not report statistical testing of association, but these clinical factors do not appear to be
associated with D-xylose absorption in this cohort.
Moya-Camarena et al. performed urinary D-xylose and xylose breath hydrogen tests in
well-nourished children with asymptomatic Giardia intestinalis infection and healthy controls
recruited from preschool centers [147]. Results did not demonstrate any disturbance in urinary
xylose absorption among infected cases or healthy controls. Urinary results did not differ before
and after treatment for Giardia. Breath hydrogen levels decreased significantly with treatment,
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indicating improvement. The clinical and physiologic implications of this difference, in the face of
hydrogen breath test results well within the range of normal, are not apparent. The investigators
did not report on the relationship between breath and urinary D-xylose results.
Finally, Mittal et al. used the D-xylose absorption test as part of their diagnostic criteria
for tropical sprue among gastroenterology clinic patients presenting with persistent diarrhea. By
definition, all of the children had abnormal xylose absorption results; however, information about
the D-xylose dose, units of measure, cutoff point for normal, and even the identity of the
sampled fluid (urine or serum) were not provided [146].
Methods of test performance and cutoff points were often not described adequately to
enable comparing results across studies. For example, in two instances D-xylose abnormal cut
points were specifically defined as <25 mg/dL [136, 152], This is higher than some references
suggest as a cutoff point among infants and children [186]. Insufficient data were reported in
these two studies for readers to assess how the proportion of those with D-xylose malabsorption
might have shifted with differing cut points. In two other studies D-xylose results were only
reported as normal or abnormal without defining a cutoff point [146, 155].

5.2.2 Endomolecular Challenge Absorption Tests
Six studies assessed absorption after administering labelled endomolecules (zinc (n=3),
iron (n=1), and lipids (n=2)). These investigations rely on challenge with the molecule of interest,
which is generally a stable isotope, and measure urinary excretion as an indicator of absorption,
or fecal excretion, as an indicator of non-absorption. When examining stool, it is important to
note that the fecal concentration could potentially represent uptake and subsequent excretion by
the host. In one Peruvian study, there appeared to be saturation kinetics at high doses of zinc,
and zinc dosing early in the day was related to diminished absorption of this divalent cation from
unfortified foods later in the day [141]. Manary et al. identified an unexpectedly high fractional
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excretion of the challenge zinc in children in Malawi [144]. In China, Sheng et al. demonstrated
unexpectedly high fractional excretion of zinc in stool, and inferred diminished uptake of this
nutrient, but also speculated that their population of children were not suffering from enteropathy
[164]. Murphy et al. used 13C labeled triglycerides (TG) as trilaurin, triolein, or trilinolein, and
determined that in a group of Jamaican children, many of whom had bacterial overgrowth, the
uptake of challenge lipids was impaired, but that the defect was not related to impaired intestinal
lipolysis [148] Earlier, Murphy et al. demonstrated that during acute malnutrition, there is
impaired lipid uptake from the gut, and that this defect improved during rehabilitation [149].
Unlike in the cohort in their later study, small bowel bacterial overgrowth was not an issue in this
cohort. Sarker et al. studied labeled iron uptake in children with and without Helicobacter pylori
infection, and found no evidence for diminished uptake among the infected children [163].
Similarly, treatment of the H. pylori infection did not improve uptake. They inferred that this
gastric infection did not play a role in diminished uptake of iron by children in Bangladesh, but
did note that there are limited data on the physiology of normal iron uptake in children in the age
group studied (2-5 year olds).

5.2.3 Enterocyte-specific Proteins
Nichols et al. assessed intestinal tissue markers of digestion (see Evidence Table 3) as
well as two markers of absorption: intestinal messenger RNA (mRNA) abundances of villin and
sodium-activated luminal glucose-galactose transporter 1 transcripts [53]. These are structural
proteins expressed only in enterocytes. mRNAs for these proteins are found in reduced
quantities if intestinal surface area is diminished and hence reflect absorptive capacity. Nichols
et al. compared the mRNA abundances in intestinal biopsies of children with refractory
malnutrition to values found in controls that were neither stunted nor wasted, and found a
reduction of more than 50% in mRNA abundances for both proteins among cases. It is
important to note that the controls were children with biliary atresia who, as part of their
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management for the condition, underwent intestinal resection. Without having performed an ex
vivo mucosal biopsy in the control subjects, it is not possible to rule out a lower ratio of villous to
submucosa tissue present in resected tissue which might affect mRNA determinations, as
transmural tissue can be expected to contain a more diverse population of cells, only some of
which might contain the transcripts of interest. However, the bias, if any, is likely in the direction
that would reduce effect size.

5.2.4 Fecal Fat
Data on fecal fat was reported in three studies as a marker of malabsorption, including
one study that measured the fat by four different methods, with a high degree of consistency in
results across techniques [116]. That study, conducted among children with varying nutritional
status in Venezuela, and another study conducted in India among children with symptoms
consistent with and being evaluated for celiac disease [155], reported results as percent of
subjects that tested positive while another study of severely malnourished Jamaican children
[149] presented results as mean fecal fat excretion in grams per day and as percent of intake;
hence, the results of this third study could not be compared to the other two. Positive results
among the Venezuelan children varied from 13-27% (depending on laboratory method) among
well-nourished children to 80-100% (again, depending on method) among the most severely
malnourished children [116], while the Indian study detected fat in the stools of 20% of the
children [155].
The Jamaican study found the fecal fat results to correlate with recovery of radiolabeled
lipids in the stool after administration of 13C tripalmitin. The Indian study found that 55% of
subjects with symptoms of celiac disease but a negative serologic evaluation for that disorder
had abnormal D-xylose absorption (although the authors did not report the units of measure,
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cutoff point of normal-abnormal results, or whether or not they measured the sugar in the urine
or serum) and 20% had abnormal fecal fat results; correlation testing was not reported.

5.2.5 Summary of Markers of Absorption
The assessed markers demonstrated normal and abnormal enteric function, depending
on the marker and the study. The proportion of abnormal urinary D-xylose excretion results
ranged from none among well-nourished children with asymptomatic Giardia intestinalis
infection and healthy controls [147] to 100% among HIV-infected children in Brazil with proteinenergy malnutrition [136]. Endomolecular markers also yielded varying results in different study
populations. Apparent malabsorption was observed based on lipid uptake in a cohort of
Jamaican children, some of whom had small bowel bacterial overgrowth [149]. In contrast, a
study of iron uptake among children with and without Helicobacter pylori infection found no
evidence of impaired absorption [163]. Malnourished children had reduced absorptive capacity
relative to controls as inferred from reduced abundance of messenger RNA in biopsies for
enterocyte-specific proteins [53]. Similarly malnourished children showed absorptive
derangement by fecal fat test, with a notably higher proportion of positive tests than among wellnourished children [116].
Two of the fecal fat studies were the only ones that assessed more than one marker that
is primarily a measure of absorptive capacity. The Jamaican study was the only one that
reported testing for correlation between these tests of absorption [149]. Several studies
compared the relationship of markers of absorption to biopsy. D-xylose [136, 146, 155] and
fecal fat [155] corresponded poorly with histopathology. The papers suggested that there was
only a short interval between the performance of these tests and the biopsies, but the exact
length of time was not provided. Abundance of messenger RNA for two enterocyte-specific
proteins, villin and sodium-activated luminal glucose-galactose transporter 1, did correlate with
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villous atrophy in a study examining biopsy-derived markers [53]. None of the studies compared
markers of absorption to other types of markers of enteric dysfunction (i.e., other than to biopsy
or other measures of absorptive function).
Only one study reported data on an absorption marker in relation to the presence of
diarrhea, finding no apparent association with D-xylose absorption, although this was not
analyzed statistically [152]. None of the studies examined the association between absorption
markers and growth outcomes. A Peruvian study was the only one to report an absorption
marker as a clinical endpoint of an intervention trial, in this case a randomized, controlled trial of
zinc supplementation [141]. It was also the only study to measure intra-individual longitudinal
change outside of the context of intervention or convalescence. These investigators assessed
zinc absorption longitudinally in controls without zinc supplementation and observed no change
in absorption of this pentose sugar.
These absorption tests showed a range of logistical challenges for deployment in
resource-limited settings. When methods were described, the D-xylose test was conducted by
colorimetric or spectrophotometric means, whereas the tests of endomolecules involved more
complex laboratory methods and the intestinal tissue markers, requiring biopsy, were most
technically complicated and invasive. The D-xylose studies generally did not cite reference
standards or compare their results to those from other studies. Two studies compared their fecal
fat results to those in other published studies [116, 149]. One of these studies also conducted a
lipid breath test and compared results to those previously published [149]. All of the zinc
absorption studies discussed results in relation to expected values based on reference indices
and other studies of zinc homeostasis [141, 144, 164]. In the iron absorption study, authors
cited a lack of data available in the literature for subjects of similar age for comparison [163].
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5.3 Markers of Permeability
Data regarding markers of permeability are presented in Evidence Table 2. As discussed
above, many of the tests that assess permeability also entail a test component that assesses
absorptive function.
Thirty-one studies assessed markers of intestinal permeability. All but one of these
included assessments of dual sugar tests as either lactulose:mannitol (L:M) (n=25) or
lactulose:rhamnose (L:R) (n=5); the other reported measures of lactose in the urine as
lactose:creatinine. Two studies reporting L:M test results also reported other markers of
permeability, either urinary lactose and lactose:lactulose or plasma endotoxin and IgG
endotoxin-core antibody.
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Evidence Table 2. Markers of permeability.
This category includes markers with dual assessment of absorption and permeability. Biomarkers in bold are primarily markers of permeability (with or without dual
assessment of absorption).
Reference and Study
Location and
Design and
Outcomes of
Biomarker
Results
Conclusion
Comments
Target Population Sample Size
Diagnostic Interest
2004
Keneba, Gambia Cohort
Stool Test:
Mean neopterin concentration was L:M and mean fecal Study population
Neopterin
negatively correlated with long-term neopterin
might have some
2 mo olds from
n=72
height (r=-0.29, p<0.009) and weight concentration were overlap with that of
Campbell DI et al.
(r=-0.36, p<0.007) gain, but not with not correlated.
Campbell et al. also
rural area followed
Urine Tests:
giardiasis.
included in this
Intestinal inflammation until 15 mo of age. Subjects were
1
evaluated with
review [110].
Mean L:M in the
measured by fecal
• Lactulose
2
twice-weekly
Mean L:M (CI): 0.31 (0.26, 0.34).
Gambian children
neopterin in Gambian
• Mannitol
questionnaire to • L:M
was substantially
children with
determine
Mean excretion of lactulose (CI):
higher than normal
enteropathy:
diarrhea
0.20 (0.18, 0.23).
values in children in
association with
growth failure, Giardia
morbidity, clinic
the UK. These high
lamblia, and intestinal
assessments of
Mean excretion of mannitol (CI): 3.0 L:M ratios appear to
growth, and
(2.8, 3.2).
be driven by
permeability
screening
mannitol excretion.
Fecal neopterin and
laboratory tests
Mean L:M was negatively correlated
every 2 mo.
with long-term height gain (r value
L:M as markers of
not provided, p<0.0001), but was not
intestinal inflammation
correlated with presence of Giardia.
and permeability,
respectively, and their
L:M and fecal neopterin were not
correlation with growth
status and Giardia
correlated (p=0.11).
recovery in the stool
2003
Keneba, The
Cohort
Urine Tests:
At 8 wk of age:
Mean L:M ratios
Presence of malaria
4
3
Gambia
• Mean L:M: 0.169 (CI: 0.145,
were elevated at 8 parasites was
• Lactulose
n=71
Campbell DI et al.
0.198; range: 0.058-0.657)
weeks of age, and assessed by blood
(53 tested)
•
Mean
lactulose
recovery:
0.202
All 2-11 mo olds
more than doubled smear at each
• Mannitol
study visit; the only
(SD=0.159;
range:
0.009-0.640)
were recruited
Growth faltering in
in the first year of
(52 tested)
•
Mean
mannitol
recovery:
3.80
parameter
rural Gambian infants from this rural
life.
• L:M
associated with
(SD=2.35; range: 0.52-8.58)
village and
is associated with
(52 tested)
malaria was CRP.
Many markers of
followed up to 14
impaired small
L:M more than doubled between 12 inflammation and
mo of age.
intestinal barrier
wk-1 yr of age (r=0.44, p<0.001) and endotoxin release
Authors did not
function, leading to
Blood tests:
was driven by both increasing
report investigating
were significantly
endotoxemia and
• Albumin
lactulose
(r=0.18,
p<0.001)
and
relationships
correlated
with
L:M
systemic inflammation
• CBC
decreasing
mannitol
(r=-0.14,
between certain
and
lactulose
• C-reactive
p<0.01)
excretion
with
age.
serum parameters
recovery.
L:M as a marker of
protein (CRP)
1

Lactulose and mannitol results were expressed as % of dose administered.
Type of mean not specified.
3
For lactulose and mannitol results, excretion measurement was not specified.
4
Geometric mean.
2

Evidence Table 2. Markers of permeability.
Reference and Study
Location and
Design and
Outcomes of
Target Population Sample Size
Diagnostic Interest
intestinal permeability
and its relationship
with various
inflammatory markers
and endotoxin

Biomarker

Results

Conclusion

• IgA
• IgM
• IgG
• Plasma endotoxin
• IgG endotoxin-core
antibody

WAZ and HAZ scores were
negatively correlated with L:M (r=0.41, p<0.001), and primarily driven
by lactulose excretion (r=-0.39,
p<0.001).

Poor growth was
significantly
correlated with L:M
ratios, primarily due
to lactulose
excretion.

Laboratory values were consistent
with chronic, low level
immunostimulation:
• 50% of platelet and 39% of
leukocyte counts were elevated,
especially mean lymphocyte
counts which were almost twice
expected values [198].
1
• While the mean CRP was within
the normal range, 25% of values
were above the upper limit of
normal (5 mg/L), and 17% were
>10 mg/L [198].
• Mean IgG, IgA and IgM
concentrations were near normal
at 8 wk of age, but increased
rapidly; all three were elevated
above expected values in all other
age groups [198, 199]
2
• Mean free plasma endotoxin
concentration was twice the upper
limit of normal [200] and IgG
endotoxin-core antibody
concentrations were also elevated
[198]
• However, mean albumin
concentrations (and
concentrations within SD) were
generally within normal range
[198].
L:M was correlated with
IgG and IgA (r=0.41 and 0.41,
1
2

Geometric mean.
Geometric mean.

Comments
(blood counts, CRP
concentrations) and
L:M.
Authors postulate
that while general
markers of
inflammation
cannot
be specifically
ascribed to a gut
source, endotoxin
and its related core
antibody are
potentially a direct
measure of
intestinal
inflammation due to
gut gram negatives
as a primary source
of endotoxin
release among
subjects without
sources of extraintestinal gram
negative infection.
Study population
might have overlap
with that of
Campbell et al.
2004 also included
in this review [15].

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

Comments

respectively, p<0.001), and IgM
(r=0.28, p<0.02).
IgG and IgA were also correlated
with lactulose recovery (r=0.26 and
0.25, respectively, p<0.02).
IgG endotoxin core antibody
concentration was correlated with
L:M and driven by lactulose
recovery, (r=0.35, p<0.005 for both).
Endotoxin concentrations were
correlated with lactulose recovery
(r=0.36, p<0.02) only.
2003
Fajara and
Case-control
Endoscopic
Crypt-hyperplasia and villous
All Gambian
Sibanar, The
small bowel biopsy, atrophy were observed among all
subjects had
n=40 cases:
site not specified:
Gambian subjects, and the degree of evidence of
Campbell DI et al.
Gambia
• Group 1: n=4
• Histopathology
histopathology did not differ among enteropathy with
• Group 2: n=11 • Morphometric
cases with differing nutritional status, crypt-hyperplasia
6 mo-3 yr old
Chronic T cellnor was there a correlation with
(7 with diarrhea) assessment by
mediated enteropathy hospital- and
and villous atrophy,
computer analysis* diarrhea.
clinic-based cases • Group 3: n=25
in rural west African
and mean IELs >2
• Intestinal tissue
(18 with
children: relationship from rural
SD above UK
1
IEL means were ~3-fold higher in norms, independent
cytokines and
diarrhea)
with nutritional status communities.
immune markers: Gambian than UK children.
and small bowel
of nutritional status
n=34 with case
Case groups
function
and diarrhea history.
• CD-3
tissue samples
Median CD3, CD4, CD8, CD19, and
based on
• CD-4
CD25 cell counts were significantly Elevation of cellsufficient for
differences in
• CD-8
L:M as a marker of
higher (2-5x higher) among each
cytokine
mediated intestinal
nutritional status:
• CD-19
case
group
compared
to
the
UK
intestinal permeability, 1. WAZ score >-2, immunomarkers and
• CD-25
controls.
with GI
small bowl biopsy with
reactivity tests:
mucosal
• HLA-DR
complaints other • Group 1: n=3
assessment of
proinflammatory
• Perforin
than diarrhea
• Group 2: n=8
IEL, γδ, syndecan-1, HLA-DR, and cytokines was
intestinal immune
• γδ T-cell
2. Grade I protein • Group 3: n=23
perforin were detected among the
markers, and
present across the 3
receptor
Gambian children in varying degrees Gambian groups,
energy
computerized
• Syndecan-1
but were not reported for UK
malnutrition
morphometric analysis
variably correlated
• TNF-α
controls. Syndecan, CD3, and CD8 with nutritional
(PEM) (WAZ
among rural Gambian
• IFN-γ
displayed a gradient proportional to status.
score -2 to -4)
children with differing
•
TGF-β
malnutrition severity.
degrees of malnutrition and
• IL-10
and compared to wellL:M ratios were
unresponsive to
All Gambian groups showed higher elevated in all
nourished UK children
nutritional
supplements,
lamina propria cytokineGambian groups,
1

These figures are presumed to represent IEL means; however, this was not explicitly stated.

Statistical
methodology was
not sufficiently
detailed to
determine what was
compared (e.g. type
of central tendency
measure and
variance
calculations for L:M
not stated).
Duration of diarrhea
not specified, but
assumed to be
persistent.
Mucosal
lymphocyte
densities, cytokine
immuno-reactivity,
and L:M results
were not stratified
by history of
diarrhea.

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size
with or without
diarrhea
3. Grade II PEM
(WAZ score <-4)
with or without
diarrhea

Biomarker

Results

Conclusion

Urine Tests:
2
• Lactulose
• Mannitol
• L:M

immunoreactive mononuclear cell
2
density (~200-450/mm ) than UK
2
controls (30-80/mm ).

without apparent
correlation to host
nutritional status.

Among subjects with elevated
cytokines, similar densities were
seen for both pro-inflammatory (IFN* Biopsy involved
γ and TNF-α) and putative regulatory
morphometric
(IL-10 and TGF-β) cytokines.
assessment by
computer analysis of Epithelial expression of TGF-β was
villous height, crypt also enhanced compared to UK
controls, but subjects with poorer
depth, villous:crypt
nutritional status had lower densities
ratio, and
of mucosal TGF-β+ cells, with
intraepithelial
median densities of 420 and 250
lymphocyte (IEL)
2
cells/mm in the grade I and grade II
density (per 100
PEM groups, respectively.
epithelial cells).

Controls from UK*
who were well
nourished children
with GI complaints
other than diarrhea
and with normal
endoscopy results
were also studied.

* UK subjects are
presented in this
table due to
comparisons of
interest made in
the review.
However we do
not include these
subjects in the
sample size for
this review.

2002
Campbell DI et al.
Age-related
association of small
1

Keneba, The
Gambia and
surrounding
villages
2-60 yr olds

1

L:M values :
• Group 1: 0.53 (0.4-1.3)
• Group 2: 0.47 (0.02-2.20)
• Group 3: 0.73 (0.14-2.2)
• Not assessed among the UK
controls
Nutritional status was not associated
with L:M, recoveries of lactulose or
mannitol.

Cohort
n=162;
<5 yr old:
n=26

Urine Tests:
2
• Lactulose
• Mannitol
• L:M

L:M was correlated with mucosal B
lymphocyte density (r=0.57, p<0.05),
IEL (r=0.51, p<0.02), and perforin+
IEL (r=-0.64, p<0.03).
3
Mean L:M (SE) in 2-5 yr old group: Mean L:M in
0.353 (0.022).
asymptomatic 2 to 5
yr olds was high and
Mean lactulose and mannitol %
decreased
recovery was ~0.45 and ~0.65,
significantly with
respectively.
increasing age, but

Not clearly indicated if these figures represent mean (CI) or another measure of central tendency.
Lactulose and mannitol results were expressed as % of dose administered.
3
Type of mean not specified.
2

Comments

Subjects were free
from diarrhea
symptoms for at
least one week
prior to urinary
assessments.

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest
intestinal mucosal
enteropathy with
nutritional status in
rural Gambian children

Location and
Design and
Target Population Sample Size
randomly selected (23 were refrom rural
assessed)
communities.

L:M and urinary
lactulose and mannitol
recovery as a marker
of intestinal
permeability and its
association with
nutritional status at
varying ages. Also
assessed correlation
of change in L:M with
nutritional status at 3.5
mo re-visit.

Biomarker

Results

L:M was highest in 2-5 yr age group
and decreased with increasing age
(up to age 20) (p<0.001), but never
fell within referenced UK normal
ranges [201].

In contrast, although mannitol
excretion slightly decreased with
age, this trend did not reach
statistical significance. In fact,
excretion proportions were at all
times ½ - ⅓ of expected UK values
[201].

There was a small improvement in
mean L:M (SE) between the two
study time points from 0.198 (0.018)
to 0.172 (0.010) (p=0.026 for change
in L:M), driven by an improvement in
mannitol recovery with no change in
lactulose excretion.
Indices of intestinal permeability
within subjects showed a high

Reported results were adjusted for age, sex, and visit.

never fell within
expected range of
values.

Comments

The authors sought
correlation between
the mean L:M of the
two visits and
Among all age
groups, L:M showed ∆BMIZ, ∆HAZ and
∆WAZ scores, but
significant intraMost of the improvement in L:M was subject correlation statistical
driven by a reduction in lactulose
calculations were
between tests
excretion (p<0.001), which fell within conducted 3.5
not provided.
expected UK ranges by age 10 yr. months apart.

L:M was inversely correlated with
1
HAZ score (r=-0.31, p<0.001), but
not with WAZ or body mass index
(BMI) Z- scores. The correlation with
HAZ score was mainly due to the
higher lactulose excretion in subjects
with poorer HAZ scores (r=-0.22,
p=0.001) and held across all age
groups.

1

Conclusion

Among all age
groups, L:M was
significantly
inversely correlated
with HAZ score,
primarily driven by
lactulose excretion.

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

Comments

degree of correlation between the
two visits:
• Lactulose: r=0.55, p<0.001
• Mannitol: r=0.24, p<0.05
• L:M: r=0.66, p<0.001

2003
Chen P et al.
Association of vitamin
A and zinc status with
altered intestinal
permeability: analyses
of cohort data from
northeastern Brazil
L:M as a marker of
intestinal permeability
pre- and post-vitamin
A and zinc
supplementation
among children with
history of PD or low
WAZ score

1
2

Goncalves Dias
Cohort
favela in Fortaleza,
Brazil
n=75 with presupplement L:M
2-97 mo olds
and retinol
recruited from an concentrations
urban shantytown. measured:
• 51 with presupplement
circulating zinc
concentrations
measured
• 20 with postintervention*
longitudinal
follow-up of
subset with
history of PD or
low WAZ score

Urine Tests:
1
• Lactulose
• Mannitol
• L:M

For lactulose and mannitol results, excretion measurement was not specified.
Type of mean not specified.

Change in measures between visits
(analysis not stratified by age):
• Mean L:M (SD):
• Visit 1: -1.62 (0.66)
• Visit 2: -1.76 (0.55),
(p=0.026)
• Mean mannitol recovery (SD):
• Visit 1: 5.25 (2.69)
• Visit 2: 6.28 (3.03),
(p=0.006)
• Mean lactulose recovery (SD):
• Visit 1: 0.28 (0.20)
• Visit 2: 0.29 (0.18),
NS (p-value not specified)
Baseline mean (SD):
2
• L:M : 0.29 (0.16)
• Lactulose: 0.54 (0.29)
• Mannitol: 2.07 (0.88)

Supplementation of Longitudinal data
vitamin A and zinc were not reported
stratifying on
resulted in
underlying condition
significant
improvements in L:M (i.e. PD history vs.
L:M was not correlated with age. L:M among the cohort of WAZ score).
was inversely correlated with retinol children with a
(r=-0.55, p<0.0005), including after history of PD or low Follow-up data on
L:M were not
WAZ score who
adjustment for zinc concentration
provided for the
received postand stratification on retinol
children with normal
supplementation
concentrations.
assessment. Less WAZ score or no
Retinol was correlated with mannitol than one-third of the history of PD.
(r=0.28, p=0.017) and lactulose (r=- subjects had postUnclear how long
intervention L:M
0.22, p<0.063) excretion.
after
assessments.
supplementation
Lactulose, mannitol and their
the L:M testing was
combined ratio were not correlated
done.
with zinc concentrations.

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

* These subjects
received a single
oral dose of
vitamin A and a 2wk course of daily
zinc supplements.

2007

Keneba, The
Gambia

RCT

Urine Test:
L:M

n=197
Subjects recruited
at birth from rural n=99 received
Effectiveness of an
high dose vitamin
early supplementation community. Age
scheme of high-dose range during study A protocol
was 0-12 mo.
vitamin A versus
n=98 received
standard WHO
standard dose
protocol in Gambian
vitamin A protocol
mothers and infants: a
randomised controlled
trial
Darboe MK et al.

L:M as a marker of
intestinal epithelial
integrity among infants
receiving high-dose
vitamin A or standard
vitamin A protocol
2001
Durban,
South Africa
Filteau SM et al.
Pregnant, HIVThe effect of antenatal infected women
vitamin A and (beta)- between 28-32 wk
carotene
gestation recruited
supplementation on
from antenatal
gut integrity of infants clinic. Infants were
1

RCT
n=238
n=119 received
vitamin A
supplements
(26 with HIV
infection)

Conclusion

L:M improved after supplementation
for the cohort of 20 children followed
longitudinally with PD or low WAZ
score:
L:M mean (SD):
• Pre-treatment: 0.28 (0.12)
• Post-treatment: 0.19 (0.07)
However, lactulose and mannitol
excretion did not change
significantly.
1
Mean L:M and proportion with
values >0.30 among those receiving
standard doses of vitamin A, by age:
• 2 mo: 0.195, 12%
• 5 mo: 0.197, 13%
• 7 mo: 0.212, 22%
• 9 mo: 0.286, 30%
• 12 mo: 0.322, 34%

Comments
Postsupplementation
L:M results in the
text of the
publication differed
somewhat from
what was reported
in the publication
table.

L:M values rose by
~50% from age 2
mo to 1 yr and were
not affected by
dosing of vitamin A.

The L:M normal
cutoff was defined
higher than for most
other L:M studies,
as 0.30. This was
derived from the
mean plus 2 SD
from a study of UK
infants [202].

Mean L:M differed between the two
groups only at 7 mo (0.276 in highdose vitamin A group, p=0.014),
although there was no difference in
percentages with L:M >0.30.

Urine Tests:
2
• Lactulose
• Mannitol
• L:M

Subjects tested:
• 1 wk:
• Treatment:

Geometric mean.
For lactulose and mannitol results, excretion measurement was not specified.
3
Geometric mean.
2

Results

3

Mean L:M (CI) at 1 wk among
Mean L:M overall
Specific sugar
infants without reports of illness was was within normal
excretion was
0.12 (0.08, 0.17). L:M did not change range. However,
normalized to
with increasing age and did not
urinary creatinine to
mean L:M for
significantly increase with reported placebo-treated,
control for variation
morbidity.
HIV-infected infants in renal function.
by 14 weeks was
While a history of ever having been significantly elevated
breastfed was an important
to almost 0.5.

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest
of HIV-infected South
African women
L:M as a marker of
intestinal permeability
among infants of HIVinfected mothers
enrolled in a vitamin A
trial

Location and
Design and
Target Population Sample Size
followed until 14
wk of age.

Biomarker

Results

Conclusion

n=104
contributor to L:M at 1 wk (ΔR =0.22,
n=119 received
• Placebo: n=104 p=0.008), a significant effect was not While HIV infection
1
placebo
seen at 6 and 14 weeks . Current
did not affect
• 6 wk:
(29 with HIV
feeding
status
had
a
modest
effect
mannitol excretion, it
• Treatment:
2
infection)
on
L:M
only
at
14
wk
(ΔR
=0.06,
was associated with
n=100
p=0.04).
increased lactulose
• Placebo: n=105
excretion.
• 14 wk:
Treatment
Birth
weight
contributed
significantly
• Treatment: n=99
2
involved maternal
• Placebo: n=95 at 1 wk (ΔR =0.07, p=0.02), but
vitamin A
current weight did not contribute
supplements
significantly to L:M at any time point.
during pregnancy
and at delivery.
HIV infection status by 14 wk was
the major factor contributing to L:M
2
at 6 wk (ΔR =0.22, p=0.008) and 14
2
wk (ΔR =0.21, p=0.01).
2

Maternal HIV viral load during
pregnancy was not consistently
significantly correlated with infant
L:M. Maternal lymphocyte counts
and plasma retinol concentrations
were not associated with infant L:M.
While maternal vitamin A
supplementation had no effect on
L:M of uninfected infants, it
appeared to prevent the increase in
2
L:M of HIV-infected infants :
Mean L:M (CI):
• Uninfected:
• Vitamin A group: 0.11 (0.08,
0.15)
• Placebo group: 0.09 (0.06,
0.12)
• HIV-infected:
• Vitamin A group: 0.17 (0.13,
0.23)
• Placebo group: 0.50 (0.37,
0.68)
1
2

Reported results were adjusted for confounding variables, unless otherwise noted.
Reported results were adjusted for confounding variables included an interaction with HIV infection.

Comments

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

Comments

A high baseline
prevalence of
abnormal L:M was
observed, with no
change after
intervention.

Difficult to interpret
sucrose tests
because there are
limited data on
laboratory values
for these tests in
young children.

Mannitol was not affected by vitamin
A. HIV infection was not consistently
significantly associated with mannitol
across age groups.

2005

Urine Tests:
2
• Lactulose
n=164;
Galpin L et al.
36-60 mo olds
• Mannitol
recruited from a
• Sucrose (SUC)
Effect of Lactobacillus rural community, n=81 received
• L:M
GG on intestinal
excluding children Lactobacillus GG • SUC:L
integrity in Malawian with severe acute (80 completed the
study)
children at risk of
malnutrition or
tropical enteropathy
severe chronic
n=83 received
illnesses.
placebo
L:M and sucrose:
(81 completed the
lactulose ratio (SUC:L) Subjects were
as markers of
considered at risk study)
intestinal and gastric for EED due to
permeability,
residence in a
respectively, in
location with high Subjects received
30-days of
asymptomatic children prevalence of
Lactobacillus GG
presumed at risk of
EED.
or placebo. Only
EED
Presumed that if the 161 subjects
SBBO is etiology who completed
for EED, treatment the study had
with Lactobacillus repeat testing.
will result in
improved gut
integrity.
2008
Dhamrai Upazila, RCT
Urine Test:
Bangladesh
1

Mwenye, Malawi

RCT

P-values are from reported results that were adjusted for confounding variables.
Lactulose, mannitol, and sucrose results were expressed as % of dose administered.
3
Arithmetic mean.
2

Lactulose also did not consistently
differ between treatment groups or
by HIV-status, although vitamin A
prevention of increase in lactulose
among HIV-infected infants neared
1
significance at 14 wk (p=0.058) .
At enrollment:
• 73% had L:M >0.10
• 40% had L:M >0.20
3
• Mean L:M (SD):
• Treatment: 0.18 (0.16)
• Placebo: 0.22 (0.20)
• Mean lactulose (SD) in treatment
group: 0.25 (0.17)
• Mean mannitol (SD) in treatment
group: 8.0 (4.5)
• Mean SUC:L (SD):
• Treatment: 0.58 (0.64)
• Placebo: 0.60 (0.64)

High mannitol
excretion (relative to
UK norms) drove the
abnormal L:M.

There was little
effect on SUC:L with
intervention; sucrose
Mean excretion of sucrose (SD)
excretion increased
increased from 0.057 (0.042) to
in both treatment
0.078 (0.058) in the treatment group and control groups.
(p=0.01), but similar results were
observed in the placebo group.
Otherwise there were no changes in
lactulose, mannitol, L:M, or SUC:L
after treatment or placebo.

1

Mean L:M (SD) at baseline was
High L:M ratios
0.18 (0.24) in treatment groups, with overall with

High L:M ratios
were defined as

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest
Goto R et al.

Location and
Design and
Target Population Sample Size

3-15 mo olds from
Impact of anti-Giardia a rural area were
and anthelminthic
enrolled and
treatment on infant
followed in a 9-mo
growth and intestinal trial.
permeability in rural
Bangladesh: a
There was a high
randomised doubleprevalence of
blind controlled study malnutrition in the
study population.
L:M as a marker of
intestinal permeability,
IgG as a marker of
chronic immune
stimulation, and α-1acid glycoprotein as an
acute phase reactant
among children
undergoing antiparasitic presumptive
treatment vs. placebo.
Also assessed
markers’ associations
with growth
parameters.

n=222*

Biomarker
• L:M

Results

Conclusion

no significant difference in placebo substantial seasonal
group or in testing post-intervention. and within-infant
n=75 received
variability.
anti-Giardia and Blood Tests:
Proportion with elevated L:M at any
anthelminthic
study time point varied between
Interventions did not
• α-1-acid
treatment
impact L:M or serum
glycoprotein (AGP) 58%-74%. >57% consistently
elevated L:M ratios.
immune markers.
• IgG
n=59 received
• Albumin
anti-Giardia
Seasonal variation in L:M was
There was
treatment only
observed (p <0.001), with highest
improvement in
mean values in the monsoon
weight with better
n=88 received
season.
L:M values, the
placebo
degree to which this
L:M was associated with ∆WAZ and occurred was not
∆WHZ scores at 24 weeks (p=0.001 reported.
* Those who fully
and p<0.001, respectively, point
participated and
estimates not provided.)
for whom data
were analyzed
Serum immune marker values were
are included in
similar in all groups and did not
this review.
change substantially with
interventions.

Comments
greater than the
upper CI for UK
infants.
Same study
population as
reported by this
group in another
study also included
in this review [123].

AGP concentrations were negatively
associated with ∆WAZ score at 24
weeks (p=0.004, point estimate not
provided), and were associated with
∆WHZ score at 12 weeks but not at
24 weeks.
2
2008
Dhamrai Upazila, Longitudinal data Urine Test:
Mean L:M: 0.15
Mean L:M was
Helminthiasis
Bangladesh
extracted from an L:M
elevated. L:M was prevalence was
RCT [122].
L:M showed a decreasing trend with not associated with very low; testing for
Goto R et al.
age (p=0.003), and was associated any of the tested
association with
3-15 mo olds from
Impact of intestinal
Blood Tests:
with female gender (p=0.004), HAZ serum markers of
markers was not
a rural area were n=298
score (p=0.039), and WAZ score
permeability,
enrolled and
inflammation or with performed.
• α-1-acid
inflammation status
followed in a 9-mo
glycoprotein (AGP) (p=0.019), but not with giardiasis or giardiasis.
and parasitic infections trial.
Urine and blood • IgG
any of the serum immune markers.
Giardiasis was
on infant growth
samples were
IgG
rose
with
defined as
• Albumin
IgG, AGP, and albumin were
increasing age at the presence of a
faltering in rural
There was a high collected every 3 • Hemoglobin
Giardia-specific IgM
mo and
associated with giardiasis, but
rate expected
Bangladesh
prevalence of
1
2

Geometric mean.
Geometric mean.

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

malnutrition in the
L:M as a marker of
study population.
intestinal permeability,
IgG as a marker of
chronic immune
stimulation, and α-1acid glycoprotein as an
acute phase reactant.
Also assessed
laboratory values’
associations with
giardiasis and growth
parameters.

anthropometric
measurements
were collected
monthly.

2002

Kathmandu, Nepal Cross-sectional

Goto R et al.

0-5 yr olds (mean n=210
age 3.8 yr) from
two urban squatter
settlements.

Poor intestinal
permeability in mildly
stunted Nepali
children: Associations
with weaning practices
and Giardia lamblia
infection

37% and 33% of
subjects were
stunted and
underweight,
respectively.

Biomarker

hemoglobin was not.

Urine Tests:
1
• Lactulose
• Mannitol
2
• Lactose
(168 tested)
• L:M
(158 tested)
• Lactose:lactulose
ratio
(157 tested)

Comments
response.
Same study
population as
reported by this
group in another
study also included
in this review [122].

Cut-off values
representing
elevated
concentrations
have not been
determined for
AGP. UK norms for
10 mo olds-adults
are 0.88 g/L mean
(0.21 SD) [204].
L:M:
L:M ratios were high Low lactase activity
overall.
was defined as
• 92% had values >UK norms
3
lactose:lactulose
• Mean L:M (SD, range): 0.26 (0.21,
ratio >0.4.
Wide individual
0.04-1.71).
• Giardia-infected versus uninfected variation was
Specific L:M data
observed in L:M
means: 0.43 vs. 0.25, p=0.014
by WAZ and HAZ
ratios.
scores were not
The duration of ingestion of solid
L:M was associated reported, although
foods (with or without concurrent
authors state that
breastfeeding) was not associated with giardiasis but
L:M was not
not
helminthiasis.
with L:M in multivariate analysis.
associated with
Urinary lactose
“growth status.”
L:M was correlated with longer
concentrations and
duration of breastfeeding (r=0.27,
p<0.019). Specifically, children who lactose:lactulose
breastfed for >2 yr had higher L:M ratios were
significantly higher in
ratios than children who breastfed
for shorter times (data not provided). breastfed subjects
than in those that
were not breastfed,
L:M was not associated with:
IgG was not associated with growth
parameters. Albumin was associated
with HAZ score only (p=0.016). AGP
was inversely associated with HAZ
(p=0.011) and WAZ (p=0.005)
scores.

Lactulose and mannitol results were expressed as % of dose administered.
Lactose results were expressed in mg/L.
3
Geometric mean.
2

Conclusion

(compared to UK
norms) [199] but at
Mean circulating albumin
higher
concentration was normal for age
concentrations
[203]. Compared to UK age-matched across all ages.
reference [199], rate of rise in IgG
with increasing age was similar, but
concentrations were consistently
~3g/L higher.

L:M as a marker of
intestinal permeability,
and assessment of
association with
giardiasis,
helminthiasis,
nutritional practices,
and growth status.
1

Results

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

• History of diarrhea in the week
preceding testing
• Helminthiasis
• Age
• WAZ or HAZ scores

despite similar
intestinal
permeability values.

Comments

There were some
unexpected findings:
the duration of
Lactulose excretion ranged from
breastfeeding, and
0.02–15.00. Mannitol excretion
not the timing of
ranged from 0.5–15.00.
introduction of solid
foods, was
47% showed low lactase activity.
Lactose values and lactose:lactulose correlated with L:M,
2
ratios decreased with age (R =28%, and the correlation
p<0.0001), but were not associated was direct, not
with sex, ethnicity, and location nor inverse. Authors
speculate that this
were they associated with L:M.
could be due to
1
higher mean age of
Mean urinary lactose
their cohort
concentrations (mg/L) by feeding
compared to another
mode:
study that
• Breastfed: 172.5
demonstrated
• Non-breastfed: 44.5, p<0.0001
beneficial effect of
corrected for infant age
duration of
2
breastfeeding on
Mean lactose:lactulose ratio by
reduced L:M in
feeding mode:
Guatemala [205].
• Breastfed: 2.76
• Non-breastfed: 0.31,
p<0.0001 corrected for infant age

2000

Darwin, Australia

Haase A et al.

Cases were >4 mo n=264;
olds admitted to
n=150 cases with Urine Test:
Royal Darwin

Dual sugar
1

Geometric mean.
Geometric mean.
3
Geometric mean.
2

Case-control

Blood Test:
L:R

Mean L:M by feeding mode:
• Breastfed: 0.23
Non-breastfed: 0.28, non-significant,
p-value not specified
Among the subset with both blood
and urine specimens:
• Urine L:R:
3
• Mean (CI):
• Cases: 12.4 (9.3, 16.5)

Children with
diarrhea had
significantly higher
L:R ratios by both
blood and urine

Authors used data
from non-diarrheal
controls from their
clinical practice to
derive cut-points for

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest
permeability testing in
diarrheal disease

Location and
Design and
Target Population Sample Size

Hospital with
AD
diarrhea. Controls
n=114 controls
were patients
Lactulose:rhamnose admitted with non- with no diarrhea
ratio (L:R) as a marker GI illness.
of intestinal
permeability in children More than 75% of
with or without
cases and controls
diarrhea. Also directly were Aboriginal.
compared blood and
urine methods of L:R
testing in a subset of
subjects.

1

Geometric mean.
Geometric mean.
3
Geometric mean.
2

Biomarker

Results

L:R

• Controls: 6.7 (5.0, 8.8),
p=0.004
• Distribution across ratios:
• Low: n=31
• Intermediate: n=9
• High: n=9
• Blood L:R:
1
• Mean (CI):
• Cases: 9.4 (6.7, 13.1)
• Controls: 5.9 (4.4, 7.8),
p=0.04
• Distribution across ratios:
• Low: n=27
• Intermediate: n=11
• High: n=11

Conclusion

Comments

testing compared
L:R ratios used in
with controls without this study:
GI illness.
• Blood L:R:
Among cases:
• Low= <7
There was
• 24 had both blood
• Intermediate=
substantial
and urine L:R
7-12.5
agreement between
• 98 had blood L:R
• High= >12.5
urine and blood L:R • Urinary L:R:
only
tests in the same
• 28 had urine L:R
• Low= <10
subjects.
only
• Intermediate=
10-18
Urine has been an
Among controls:
• High= >18
established
• 25 had both blood
substrate for sugar
and urine L:R
Controls were
excretion
• 36 had blood L:R
significantly older
assessment as an
only
than the cases, but
indication of
• 53 had urine L:R
authors suggest
Among subjects with only urine
intestinal
only
that age differences
tested:
permeability.
2
do not impact L:R
Mean urine L:R (CI):
However, timed
A total of 49 subjects
test performance.
• Cases: 15.7 (12.6, 19.6)
collection of urine is
were tested with both
• Controls: 6.7 (5.7, 8.0), p<0.0001 not a trivial task,
blood and urine L:R
Numbers of
especially among
methods to allow
subjects do not
Among subjects with only blood
female children, and
direct comparison of
always match up
tested:
contamination with
values.
3
(e.g. numerator in
Mean blood L:R (CI):
stool is problematic,
test failure rate
• Cases: 12.8 (10.3, 16.0)
especially in children
calculations does
• Controls: 3.7 (2.8, 4.9), p<0.0001 with diarrhea.
not match other
However, the much
such reported
Even though blood L:R was
lower concentrations
numbers).
consistently lower than urine L:R by of probe sugars in
a geometric mean (CI) of 1.09 (1.02, blood compared to
Analyses of those
1.16), there was strong correlation urine had posed a
subjects who had
between L:R ratios in blood and
challenge to
both blood and
urine as measured by:
sensitive detection in
urine testing were
• Concordance correlation coefficient blood. High
conducted on
performance liquid
for agreement (CI) of 0.76 (0.64,
combined cases
chromatography
0.88)
and controls.
• Kappa statistic (CI) of 0.71 (0.51, (HPLC) methods, as Analyses of those

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

Comments

0.92) (when L:R ratios are divided
into 3 ordered categories)
• Sensitivity and specificity of blood
tests of 81% (25/31) and 89%
(16/18), respectively, when using
the urine testing as the standard.

used in this study,
now provide a more
sensitive method of
assessing blood
specimens.

with and without
diarrhea would
have been of
interest. One would
expect children with
diarrhea to have
higher rates of urine
test failure due to
contamination with
stool and to have
higher failure rates
using either
analytes due to
higher rates of
emesis.

The failure rate* for serum L:R
testing (20/197, 10%) was lower
than for urine testing (86/234, 37%)
(p<0.0001).

* Defined as emesis with
rhamnose/lactulose oral challenge
(same dose for urine and serum
testing), urine leakage or
contamination with stool, or plasma
quantity from blood draw of
insufficient quantity for analysis.

2003

Darwin,
Australia

Case-control

Urine Test:
Nitric Oxide (NO)*

n=318;
1-6 yr old
Increased nitric oxide Aboriginal and
n=169 cases with Blood Tests:
AD
production in acute
non-Aboriginal
• L:R
diarrhea is associated hospital inpatients. (154 Aboriginal) • Mean corpuscular
with abnormal gut
volume (MCV)
Kukuruzovic R et al.

The failure rate of
L:R blood testing
was significantly
lower than that of
urine testing.

Spot blood testing
might be more
feasible than timed
urine collections,
but HPLC might not
be feasible in
resource-poor
settings.

This study appears
to report on the
same population as
two other studies in
this review which
also assessed
serum L:R as a
marker of intestinal
permeability [43,
58].
NO among Aboriginal children with NO2 + NO3:Cr ratio, Positive stool RS
diarrhea was >3x higher than any
as a measure of
was defined as
other group and >5x higher than in endogenous nitric
>0.5%.
non-Aboriginal controls.
oxide production,
Abnormal L:R was
was used as a
• NO was >3x and >2x higher
defined as >7.6; no
marker of gut
among Aboriginal than nonreference or
Aboriginal children in the diarrhea permeability and
(p<0.001) and no infections groups inflammation, with derivation was

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest
permeability,
hypokalemia and
malnutrition in tropical
Australian aboriginal
children

Location and
Design and
Target Population Sample Size

Subjects were
n=149 controls:
grouped as
• 73 with non-GI
follows:
infections (49
1. Children with
Aboriginal)
AD
• 76 with no
2. Children with no infections (29
diarrhea but with Aboriginal)
Nitric oxide (NO) as a
non-GI
marker of intestinal
infectious
permeability and
conditions
inflammation, and
3. Children without
lactulose:rhamnose
ratio (L:R) as a marker GI or infectious
conditions
of intestinal
permeability and the
relationship between
NO and L:R, growth
parameters, mean
corpuscular volume
(as a surrogate of iron
deficiency), and stool
reducing substances
among children with
and without diarrhea

Biomarker

Results

Stool Test:
Reducing substances
(RS)**
(169 cases tested)
•

Reported results appear to have been adjusted for age and race.
Reported results were adjusted for age and race.
3
Reported results among children with diarrhea were adjusted for age and race.
2

Comments

(p<0.001), respectively, but there an attempt to identify provided for this
was no difference between them in how much more it
cut-point.
the non-GI infections group.
reflects as response
NO was >3x and ~2x higher in the to inflammation from Study population
appears to be the
GI vs. non-GI
diarrhea compared to the no
same as in another
infections.
infections group among
* NO is an unstable
Kukuruzovic, et al.
Aboriginals (p<0.001) and nonstudy also included
free radical and is
Aboriginals (p<0.03), respectively. Among nonconverted to nitrite
• NO was virtually the same among Aboriginal controls, in this review which
NO production was assessed serum
and nitrate. Urine
the Aboriginal non-GI infections
lactulose:rhamnose
nitrate (NO3)+ nitrite
and no infections groups, as well the same among
(NO2) was expressed as among the non-Aboriginal
those with diarrhea as a marker of
as a ratio with urine
intestinal
and non-GI
diarrhea and non-GI infections
permeability [58].
creatinine (NO2 +
infections (and
groups.
NO3:Cr) in order to
higher compared to
account for
112/152 (74%) and 31/169 (18%) of controls). NO was
differences in urine children with AD had abnormal L:R highest by far
1
concentration.
among Aboriginal
ratios and positive stool RS,
children with
respectively.
** Measured only
diarrhea compared
among children with NO and L:R were measured at
to any other group.
Authors suggest that
profuse diarrhea.
“convalescence” on Day 5 among
high basal
those with diarrhea: the mean
concentrations of
improvement in NO was 21.7%
NO among
compared with 54.6% for L:R
Aboriginal children
(p=0.01).
due to (clinically
NO and L:R were correlated (n=193, silent) enteropathy
1
could explain the
r=0.37, p<0.001) ; the correlation
concentrations seen
was stronger for lactulose (effect
among Aboriginal
ratio=1.47, p<0.001) than for
controls in this
rhamnose (effect ratio=0.80,
2
study.
p=0.02 ).
NO was not correlated with stool
3
RS or MCV, but was correlated with
lower WAZ score (effect ratio=0.88,
p=0.05).

1

Conclusion

NO appeared to
decrease
significantly more
slowly than L:R
among children

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

2002

Location and
Design and
Target Population Sample Size

Darwin, Australia

Kukuruzovic RH et al. Inpatient
Aboriginal children
Milk formulas in acute <3 yr old with AD
gastroenteritis and
and/or WAZ score
malnutrition: a
<-2.
randomized trial
60% of subjects
Lactulose:rhamnose had low WAZ
ratio (L:R) as a marker score and 90%
of intestinal
had diarrhea.
permeability among
children with diarrhea
and/or malnutrition
treated with milk
formulas of varying
composition and
osmolality

2002

Darwin, Australia

Kukuruzovic RH et al. Cases were
Aboriginal and
1
2

RCT

Biomarker

Blood Test:
L:R

n=177;
n=60 received
De-Lact formula

L:R testing was
repeated in 150
subjects at day 5:
n=65 received O- • De-Lact: n=48
Lac formula
• O-Lac: n=52
• Alfaré: n=50
n=52 received
Alfaré formula

Subjects were
treated with one
of three lowlactose formulas:
• De-Lact, lowosmolality
lactose-free
formula
• O-Lac, lactosefree formula
• Alfaré, partially
hydrolyzed
formula
Case-control

Blood Tests:
• Lactose
n=375 admissions • Lactulose 2
for 306 children; • Rhamnose

Geometric mean.
Lactulose and rhamnose results were expressed as % of dose administered.

Results

Conclusion

recovering from
diarrhea.
NO was found to
correlate with L:R.
NO was more
strongly correlated
with lactulose than
rhamnose.
1
Baseline mean L:R (CI) in De-Lact Authors noted that
group was 14.9 (10.4, 21.5), with no treatment with all of
difference between groups.
the low-lactose
formulas studied
The mean improvement* in L:R (CI) resulted in improved
was 13.0 (9.3, 16.6) with some
L:R among this
significant differences between the population at risk for
various formulas:
enteropathy and
• De-Lact: 18.6 (10.6, 26.6)
growth failure.
• O-Lac: 12.0 (7.5, 16.6), p=0.15
Improvement was
compared to De-Lact
most marked with
• Alfaré: 8.5 (2.1, 14.9), p=0.049
the low osmolality
compared to De-Lact
formula, De-Lact.

* Improvement in L:R was calculated
as baseline L:R minus repeat L:R.

27/75 (36%) of Aboriginal controls
and 0 non-Aboriginal controls had
abnormal L:R ratios.

Comments

Reported results
did not appear to be
harmonized with
the method
described for
calculating
improvement in
L:R.
Fully breastfed
children were
excluded.
The study did not
include a control
arm (of standard
care) to which
change in L:R could
be compared.

Authors reiterate
the advantages of
serum over timed
urine collection for
assessment of L:R
as discussed in
another publication
in this review [125].
Mean L:R ratios of Positive stool RS
Aboriginal children was defined as
were approximately >0.5%.
double those of non-

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest
Small bowel intestinal
permeability in
Australian Aboriginal
children

Location and
Design and
Target Population Sample Size

non-Aboriginal
children admitted n=285 case
admissions for
to hospital with
diarrhea. Controls AD (264
Aboriginal)
were Aboriginal
Serum lactulose:
and non-Aboriginal
rhamnose ratio (L:R), children admitted n=90 control
admissions with
without GI
serum lactose, and
no diarrhea (74
illnesses.
stool reducing
Aboriginal)
substances as
markers of intestinal
permeability among
Aboriginal and nonAboriginal children
with and without
diarrhea

1

Biomarker
• L:R
• Hemoglobin
• Mean corpuscular
volume (MCV)

Results
1

Mean L:R at baseline:
Cases:
• Aboriginal: 16.4
• Non-Aboriginal: 7.9, p=0.002
compared to Aboriginal cases
Controls:
• Aboriginal: 4.6
Stool Test:
Reducing substances • Non-Aboriginal: 2.5, p=0.02
compared to Aboriginal controls
(RS)*

Conclusion

Comments

Aboriginal children
both among those
with and without
diarrhea, consistent
with authors’
suggestion that
clinically silent
enteropathy is
prevalent among
Aboriginal children.

Abnormal L:R was
defined as >5.6,
derived from 2 SD
above the
arithmetic mean for
non-Aboriginal
controls in this
study. The rationale
for the choice of 2
SD above the
2
Mean improvement in L:R (CI) at
arithmetic, instead
day
5
among
those
with
repeat
of the geometric,
Mean
L:R
L:R testing was
testing:
mean is not clear.
significantly
repeated on day 5 for
•
Aboriginal
cases:
14.6
(11.2,
18.0)
Proportions of
improved
over
5
a subset of Aboriginal
• Aboriginal controls: -0.63 (-4.0,
cases with
days among
subjects:
abnormal
Aboriginal cases.
• 174/264 admissions 2.7)
Children with severe concentrations
for acute diarrhea
3
Mean lactulose recovery :
diarrhea had higher were not reported.
• 25/74 control
• Cases day 1: 0.085 (0.070–0.103) mean L:R.
admissions
• Cases day 5: 0.039 (0.033–0.046)
Analysis included
• Controls: 0.024 (0.019–0.029)
Higher case L:R was data for 69 children
All 3 values significantly differed
driven more by high with repeat
* Measured only
from
one
another.
lactulose than by low admissions; this
among children with
rhamnose.
might violate
profuse diarrhea
Mean
rhamnose
recovery:
Similarly,
independence
when “clinically
indicated." Number • Cases day 1: 0.479 (0.424–0.542) improvement in L:R assumptions for
tested not provided. • Cases day 5: 0.555 (0.498–0.616) among cases was their statistical
• Controls: 0.585 (0.500–0.685)
analysis methods.
primarily due to
These values did not significantly
decreased lactulose.
differ from one another.
Repeat L:R testing
Stool RS and serum was conducted on
Confidence intervals (CIs) in the
lactose were found controls of both
authors' graphical representation of in approximately
racial groups, but
mean L:R at admission did not
among cases it was
one-quarter and
overlap, and the difference in means one-third of
only conducted on
was particularly evident between
Aboriginal cases.
Aboriginal cases,
Aboriginal and non-Aboriginal
respectively. The
subjects.
This study appears
latter was weakly
associated with
to report on the

Geometric mean.
Improvement in L:R appears to have been calculated as baseline L:R minus repeat L:R, as described in another publication in this review; however, this was not expressly stated.
Reference 134. Kukuruzovic RH, Brewster DR. Milk formulas in acute gastroenteritis and malnutrition: a randomized trial. J Paediatr Child Health, 2002. 38(6):571-577.
3
Figures reported parenthetically after the mean percent recoveries of lactulose and rhamnose were not specified as ranges or CIs.
2

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

Factors associated with L:R among increased lactulose.
1
cases were :
• Acidosis (p=0.007)
• Hypokalemia (p=0.035)
• Diarrhea severity (p=0.001)
Age and malnutrition were not
associated with L:R.
38% and 27% of Aboriginal cases
had positive serum lactose and stool
RS, respectively. 12% of Aboriginal
and non-Aboriginal controls
combined had lactosemia.

2010

Fortaleza, Brazil

Lima AA et al.

2 mo-9 yr olds
n=79;
(mean 43 mo) from
an impoverished n=40 received
urban community, placebo
Stool Tests:
(tocopherol)
eligible if HAZ
• Lactoferrin
score was
• Cytokines:
<median for their n=39 received
• IFN-γ
vitamin A (retinyl
community.
• TNF-α
palmitate)
• IL-4
Subjects were
• IL-10
screened for
Subjects were
intestinal
treated every 4
parasites, and
mo.
longitudinal
anthropometrics
were assessed.

Effects of vitamin A
supplementation on
intestinal barrier
function, growth, total
parasitic, and specific
Giardia spp infections
in Brazilian children: a
prospective
randomized, doubleblind, placebocontrolled trial
L:M as a marker of
intestinal barrier
function, and stool
1

RCT

Urine Tests:
3
• Lactulose
• Mannitol
• L:M

Reported results were adjusted for confounding variables, unless otherwise noted.
Reported results were adjusted for severity of diarrhea, acidosis, hypokalemia, and age.
3
For lactulose and mannitol results, excretion measurement was not specified.
2

Comments
same population as
in the Kukuruzovic,
et al. 2003
reference also
included in this
review, which
assessed nitric
oxide excretion
[43].
Authors reiterate
the advantages of
serum over timed
urine collection for
assessment of L:R,
as discussed in
another publication
in this review [125].

Presence of lactosemia was
associated with L:R, adjusted
2
relative risk (CI)=1.06 (1.03, 1.10) .
Stool RS, anemia, and MCV were
not associated with L:R.
Median L:M at baseline was 0.089. Frequency of stool Authors did not
There was no significant change in lactoferrin varied
report testing for
L:M at 4 mo follow-up within either between 23%-32%. associations
treatment group.
between urinary
While vitamin A
markers of
No significant difference in L:M was supplementation
intestinal
observed between treatment groups. was associated with permeability and
concentrations of
reduced lactulose
Both median lactulose and mannitol excretion, it was also fecal cytokines, or
excretions decreased at 4 mo follow- associated with
between these
up among the vitamin A compared to reduced mannitol
markers and growth
the placebo group:
parameters or
excretion, with no
overall effect on L:M. parasitosis.
• Lactulose: 0.21 to 0.74, p=0.042
• Mannitol: 3.06 to 8.25, p=0.008
Vitamin A
Cut-point values for
lactoferrin positivity
Overall proportion of lactoferrin was supplementation
and abnormal L:M
was
not
associated
23% initially. At 1 mo follow-up, there
were not described.
with
presence
of
was no difference in prevalence
lactoferrin or
between vitamin A (33%) and

Evidence Table 2. Markers of permeability.
Reference and Study
Location and
Design and
Outcomes of
Target Population Sample Size
Diagnostic Interest
lactoferrin and specific
intestinal
immunological
cytokines as markers
of intestinal
inflammation among
nutritionally at-risk
children who received
either vitamin A or
placebo
2005
Fortaleza, Brazil RCT
Lima AA et al.
Intestinal barrier
function and weight
gain in malnourished
children taking
glutaminesupplemented enteral
formula
L:M as a marker of
intestinal permeability
and various stool tests
among children with
malnutrition or PD who
received either glycine
or glutamine
supplemented formula
or placebo

2-60 mo olds
hospitalized with
WAZ score <-2,
~70% of whom
had PD.

n=80;
n=53 received
supplemented
formula
• 27 with glycine
• 26 with
glutamine
n=27 received
nonsupplemented
formula

Biomarker

Results

Conclusion

Comments

placebo (31%) groups.

intestinal cytokine
response.

Exclusively
breastfed children
were excluded from
study participation
due to assessment
of stool lactoferrin.

Cytokine concentrations did not
significantly differ between placebo
and vitamin A groups.

Urine Tests*:
1
• Lactulose
• Mannitol
• L:M

Stool Tests**:
• Lactoferrin
• Leukocytes
• Occult blood
• Reducing
substances (RS)

* n=80 tested at
enrollment, n=65
tested at day 10.
** n=60 tested.

2

Mean L:M (SE):
L:M significantly
The relationship
• Glutamine group:
improved in the
between stool
markers and L:M
• Baseline: 0.31 (0.10) (similar in glutamine group
was not reported.
only.
all three groups)
• Day 10: 0.10 (0.02); significant
Data were not
>50% of subjects
decrease, (p=0.01)
stratified by history
• No significant decrease in L:M in had intestinal
of PD.
inflammation by
glycine and nonsupplemented
stool lactoferrin.
formula groups at day 10
Fecal fat was
Fecal leukocytes,
RS,
and
occult
blood
assessed, but
Mean lactulose (SE):
were
detected
in
results were not
• Glutamine group:
reported.
fewer
subjects
than
• Baseline: 0.97 (0.46) (similar in
lactoferrin.
all three groups)
Cut-off values for
• Day 10: NS decrease in all 3
lactoferrin positivity
groups
were not described.
Mean mannitol (SE):
Exclusively
• Glutamine group:
breastfed children
• Baseline: 3.42 (0.64) (similar in
were excluded from
all three groups)
study participation
• Day 10: NS decrease in all 3
due to assessment
groups
of stool lactoferrin.
Proportion of stool markers at
baseline among all subjects:
• Lactoferrin: 53.3%
• Leukocytes: 11.7%
• RS: 3.3%
• Occult blood: 5.0%

1
2

Lactulose and mannitol results were expressed as % of dose administered.
Type of mean not specified.

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest
2007

Location and
Design and
Target Population Sample Size
RCT

Lima NL et al.

Parque
Universitario,
Fortaleza, Brazil

Wasting and intestinal
barrier function in
children taking alanylglutaminesupplemented enteral
formula

6 mo-8 yr olds
(mean age 3.5 yr)
from an urban
setting with HAZ,
WAZ, or WHZ
scores <-1.

n=51 received
alanyl-glutamine
treatment

Jamalpur district,
northern
Bangladesh

RCT*

n=107;

Biomarker

Results

Conclusion

Urine Tests:
1
• Lactulose
• Mannitol
• L:M

L:M median (range) at baseline:
• Treatment: 0.0385 (0.8922 [sic])
• Placebo: 0.0302 (5.5812 [sic])

Even though
lactulose excretion
improved in the
treatment group,
mannitol excretion
worsened with
overall L:M not
changing.

n=56 received
glycine placebo

L:M as a marker of
intestinal permeability
in assessing alanylglutamine supplement
to improve intestinal
barrier function in
malnourished children
compared to glycinecontaining placebo
supplement

2001
Northrop-Clewes CA
et al.

2-5 yr olds from
Anthelmintic treatment poor rural villages,
of rural Bangladeshi
sampled randomly
children: effect on host from a larger
physiology, growth,
cohort study.
and biochemical status
1

n=109;

Blood Tests
• α 1antichymotrypsin
• Albumin
• Total protein

n=54 received
bimonthly empiric
antihelminthic
Urine Test:
treatment
L:M
n=55 received

Lactulose and mannitol results were expressed as % of dose administered.
Reported results were adjusted for age and season.
3
Reported results were adjusted for age and season.
4
Geometric mean.
2

Comments

Authors state that
L:M median and
range values were
within the
Lactulose and mannitol excretion
confidence interval
both significantly decreased in the
for values of
treatment group only (p=0.05 for
healthy children in
2
both sugars) . L:M did not change
the study
significantly within or across groups
community; no
days after treatment.
Lactulose, mannitol reference was
cited.
and L:M did not
Lactulose excretion was not
change significantly
associated with WHZ, WAZ or HAZ in the placebo
Although the
3
scores in either group . Mannitol
authors defined
group.
was not associated with growth
persistent and
parameters in the control group, but
chronic diarrhea in
2
was associated with WHZ (r =their methods, they
2
0.386, p=0.027) and WAZ (r =did not report data
0.385, p=0.027) scores in the
stratified according
supplemented group. Data for L:M
to these conditions.
and growth parameter association
was not provided.
Authors provide
2
negative R values
when reporting
Pearson’s
correlation analysis
results; these likely
actually represent r
values.
4
Mean L:M at baseline:
L:M ratios were high Baseline study data
overall and
were lost, so
• Treatment: 0.22
analysis began with
demonstrated
• Placebo: 0.25
seasonal variation. samples taken at
month 2.
Seasonal variation in L:M was
Intra-individual L:M
observed, with highest values
The relationship
values did not
following the monsoon season.
change significantly between the serum
Within-subject L:M analysis showed over time, nor were markers and
they associated with intestinal

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Stools were
placebo
L:M as a marker of
assessed for
intestinal permeability, helminthiasis and
and α 1giardiasis. Growth * Randomized at
the village level.
antichymotrypsin as a was followed
marker of inflammation longitudinally.
and immune activation
to treatment among
children randomized to
bimonthly
antihelminthics or
placebo.

2009

Kathmandu, Nepal Cohort

n=86;
3-18 mo olds in
two cohorts:
n=48 in squatter
Pathways leading to 1. All children in
target age range cohort
early growth faltering:
from four
An investigation into
n=38 in lower
squatter
the importance of
middle-class
settlements
mucosal damage and
cohort
immunostimulation in Randomly
selected, agedifferent sociomatched cohort
economic groups in
from lower middleNepal
class, periurban

Biomarker

Results

Conclusion

Comments

Among 93 subjects
with L:M at baseline:
• 46 received
treatment
• 47 received
placebo

no significant association with
intestinal helminthiasis and no
significant improvement in treatment
or placebo groups over 1 yr. L:M
was generally not associated with
giardiasis (with the exception of one
group at one study interval).

helminthiasis or
consistently
associated with
giardiasis.

permeability was
not reported.

Among 66 subjects
with repeated L:M
testing:
• 34 received
treatment
• 32 received
placebo

Urine Test:
Lactose:Cr

Panter-Brick C et al.

1

Geometric mean.

Blood Test:
Hemoglobin

L:M was inversely correlated with
∆HAZ and ∆WAZ scores at some of
the follow-up intervals (r=-0.22,
p<0.02 and r=-0.21, p<0.05,
respectively, at 12 mo follow-up
visit).

Inverse correlations
were seen between
L:M and growth
parameters.

Serum markers were
within normal range.
The only significant
change in these
markers was a
Mean serum ACT, albumin and total decrease in total
protein were within normal ranges
protein in the
and were not associated with growth treatment group
parameters. ACT and albumin
without concomitant
concentrations did not significantly change in albumin;
change with treatment, whereas total this suggested a
protein concentrations did (p<0.001). decrease in
globulins (not
directly measured),
perhaps due to
decreased
inflammation.
1
Mean Lactose:Cr (CI):
Authors speculate Specific sugar
• Squatter: 0.14 (0.12, 0.16)
that Lactose:Cr
excretion was
• Middle Class: 0.08 (0.07, 0.10)
accounted for less of normalized to
• Statistically significant difference the deterioration in urinary creatinine to
control for variation
between the 2 groups among the nutritional status
6-12 mo olds (p=0.007) and 18-24 among the squatter in renal function.
mo olds (p=0.002), but not among children because of
Authors suggest
12-18 mo olds.
several factors,
• For both SES groups, Lactose:Cr including poorer
that while
Lactose:Cr might
values decreased with increasing nutritional intake,
not be as accurate
age (p<0.001).
that impact the
nutritional status of as L:M, it might be
HAZ, WAZ, WHZ, and ∆WAZ scores children with lower a more field-friendly
were strongly associated with mean socio-economic
assessment of

Evidence Table 2. Markers of permeability.
Reference and Study
Location and
Design and
Outcomes of
Target Population Sample Size
Diagnostic Interest
Lactose:creatinine
households
ratio (Lactose:Cr) as a
marker of intestinal
permeability and
hemoglobin, albumin,
α-1-acid glycoprotein,
and IgG as markers of
immunostimulation.
The latter were also
assessed for their
relationship to
nutritional status.

2000
Quadro L et al.

Goncalves Dias
Cross-sectional
favela in Fortaleza,
Brazil
n =30

Biomarker

Conclusion

Lactose:Cr (p<0.001 each) as was status.
∆HAZ score (p=0.004); ∆WHZ score
was not. The strength and
magnitude of association between
∆WAZ score and Lactose:Cr was
most pronounced among the
wealthier cohort and there was no
association between ∆HAZ score
and Lactose:Cr among the squatter
children.
Hemoglobin concentrations were
inversely related to Lactose:Cr
2
(r =0.018, p<0.001).

Urine Tests:
1
• Lactulose
• Mannitol
• L:M

Retinol and retinol1-9 yr olds with
binding protein: gut
mild malnutrition
integrity and circulating selected from a
immunoglobulins
large cohort of
children from an
L:M as a marker of
urban slum. They
small intestinal
were recruited at
permeability, and its
birth and followed
correlation with serum longitudinally.
retinol among mildly
malnourished children 19 (63%) had
some degree of
vitamin A
deficiency—all of
1

Results

Lactulose and mannitol results were expressed as % of dose administered.

Comments
mucosal damage
compared to L:M,
requiring only spot
urine collection and
no substrate
dosing. However,
L:M was not
assessed in this
study; direct
comparison of the
two tests was not
possible.

While hemoglobin
concentration was
inversely related to
Lactose:Cr, testing
for associations of
other measured
blood markers (IgG,
AGP and albumin)
with Lactose:Cr
was not reported.
80% of subjects had abnormal L:M, Children with low
The L:M normal
defined as >=0.030.
serum retinol had
cutoff was defined
lower than for most
higher L:M,
Serum retinol was:
apparently mediated other L:M studies,
• Inversely correlated with L:M
as 0.030. The
by mannitol
authors reference
(r=0.46, p=0.012)
excretion.
• Directly correlated with mannitol
several studies
regarding use of
(r=0.66, p<0.01)
Not correlated with lactulose (data
this cut point.
not reported)

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

these had mild
deficiency, except
for 2 with
moderately low
concentrations.
2004
Dhaka,
RCT
Bangladesh
n=57;
Rabbani GH et al.
5-12 mo old males
Green banana and
n=19 received
admitted to the
green banana
pectin improve small hospital of the
and rice
intestinal permeability International
and reduce fluid loss in Centre for
Bangladeshi children Diarrhoeal Disease n=17 received
Research with PD pectin and rice
with persistent
but without other
diarrhea
n=21 received
concurrent
rice alone
L:M as a marker of
illnesses.
(placebo)
intestinal permeability
among infants with PD
who are treated with
green banana, pectin,
or rice diet

1

Biomarker

Results

Urine Tests:
1
• Lactulose
• Mannitol
• L:M

Mean L:M (SD) by treatment group,
pre- and post-treatment:
• Banana: pre=0.50 (0.14),
post=0.21 (0.12), p<0.01
• Pectin: pre=0.54 (0.17), post=0.23
(0.09), p<0.01
• Placebo: pre=0.41 (0.11),
post=0.45 (0.13), p>0.6

Lactulose and mannitol results were expressed as % of dose administered.

Conclusion

L:M values were
high at baseline
among the study
population of
inpatient young
children with PD.
Mean L:M
significantly
improved with the
Lactulose and mannitol excretion did green banana or
not differ between groups at
pectin intervention
baseline.
but were still above
normal range
Lactulose excretion was not
following 7 days of
significantly reduced after
treatment. The
intervention in the placebo group.
improvements in L:M
Mean (SD):
were driven by both
• Pre-treatment: 1.45 (0.12)
mannitol and
• Post-treatment: 1.35 (0.15)
lactulose, with the
latter having an
Both treatment groups had 70-80% impact of greater
reduced lactulose excretion following magnitude.
treatment (p<0.01).
Authors cite studies
Mannitol excretion increased in all
postulating that the
groups compared to their preeffectiveness of
treatment values, but only
green banana in
significantly so in the banana and
reducing diarrheal
pectin groups (p<0.05).
fluid loss is due to its
high content of
Mean mannitol % excretion (SD),
amylase-resistant
pre- vs. post-treatment:
starch, which
• Banana: 1.82 (0.13) vs. 3.21
undergoes
bacterial
(0.16)
• Pectin: 1.91 (0.12) vs. 3.2 (0.18) fermentation into
• Placebo: 2.10 (0.11) vs. 2.33
short-chain fatty

Comments

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results
(0.18)

2009

Darwin and
Adelaide, Australia

Ritchie BK et al.
13C-sucrose breath
test: novel use of a
noninvasive biomarker
of environmental gut
health

4 mo-5 yr old
Aboriginal children
admitted to
hospital with
diarrhea.

Two control
Sucrose breath test
groups:
(SBT) as a marker of 1. Aboriginal
controls
small bowel mucosal
admitted to
damage vis a vis
sucrase activity among hospital with
an Australian
non-GI
Aboriginal population.
symptoms (50%
had pneumonia)
Also compared SBT
2. Healthy, nonwith serum
Aboriginal
lactulose:rhamnose
controls
ratio (L:R)
recruited from
community

1

Geometric mean.

Conclusion

Comments

acids in the colon,
stimulating colonic
The banana and pectin groups
salt and water
stopped having diarrhea more often absorption. Pectin is
compared to controls (e.g. p<0.01 by thought to work by a
day 4). Among the banana and
similar mechanism.
pectin groups, stool reductions were Authors also
associated with percent change in
suggest that short
L:M before and after treatment
chain fatty acids
2
2
(R =0.84 for pectin and R =0.86 for might affect enterobanana; p<0.05 for each).
hormones and
growth factors,
resulting in the
observed changes in
intestinal
permeability [206].
Case-control
Blood Tests:
20/32 (63%) of Aboriginal children
SBT values were
Abnormal L:R ratios
had abnormal L:R ratios.
significantly lower
were defined as
• L:R
n=43;
and L:R values were >16; no reference
(32 Aboriginal cases
1
significantly higher or derivation was
and controls tested) Mean L:R (CI):
n=18 Aboriginal • C-reactive protein • Diarrhea cases: 31.8 (24.9, 40.7) among Aboriginal
provided for this
cases with AD
•
Aboriginal
controls
without
cut-point.
children
with
(CRP)
diarrhea
than
among
diarrhea:
11.4
(8.5,
15.5),
• Mean Corpuscular
n=25 controls:
significant difference (p<0.0001) those without GI
L:R test was not
Volume (MCV)
symptoms. SBT was conducted among
• 18 Aboriginal, • Hemoglobin
SBT Mean (CI):
also significantly
the non-Aboriginal
without diarrhea
• Diarrhea cases: 1.9% (0.9, 3.0),
controls.
lower among
• 7 nonp<0.0001 compared to nonAboriginal controls
Aboriginal,
Breath Test:
13
SBT/L:R correlation
Aboriginal controls and p=0.004 than among nonhealthy
C sucrose breath
analysis was based
compared
to
Aboriginal
controls
Aboriginal
children
test (SBT)
• Aboriginal controls: 4.1% (3.0,
on data for
without diarrhea.
Aboriginal cases
5.2), p=0.032 compared to non- This is consistent
with previous reports and controls
Aboriginal controls
• Non-Aboriginal controls: 6.1%
of high prevalence of combined; stratified
clinically silent TE in analysis was not
(4.8, 7.3)
Significant differences were
reported and could
this population.
observed between all three groups.
be of interest
SBT was
considering the
SBT results were not associated with significantly
large difference in
wasting or with patient age or
inversely correlated L:R observed
breastfeeding status.
with L:R.
between these

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

Comments
groups.

SBT and L:R were inversely
correlated (r=0.67; CI: 0.42, 0.62;
p<0.0001). L:R explained 45% of the
variance in SBT; diarrhea explained
28% of variance.

2001

Durban, South
Africa

Cohort
n=272

Rollins NC et al.
1, 6, and 14 wk old
infants born to
Feeding mode,
intestinal permeability, HIV-infected
mothers.
and neopterin
excretion: A
longitudinal study in
infants of HIV-infected
South African women

Urine Tests:
1
• Lactulose
• Mannitol
• L:M
• Neopterin

2000

A non-significant, positive trend in
neopterin excretion was observed
among HIV-infected infants.

Durban, South
Africa

1

RCT
n=139;

Rollins NC et al.
Vitamin A

6-60 mo old
inpatients or

n=66 received

Urine Tests:
3
• Lactulose
• Mannitol
• L:M
• Neopterin

Lactulose and mannitol results were expressed in mg.
Geometric mean.
3
For lactulose, mannitol, and neopterin results, excretion measurement was not specified.
4
Geometric mean.
2

SBT was associated with increased
MCV, relative risk (CI)=3.9 (2.8, 5.0).
SBT was not associated with
hemoglobin or CRP.
2
Mean L:M (CI):
L:M was generally Assessment of
normal (compared to association
• HIV-infected subjects:
UK values) for non- between L:M and
• 1 wk: 0.12 (0.06, 0.27)
HIV-infected infants, neopterin was not
• 6 wk: 0.24 (0.15, 0.38)
but significantly
reported.
• 14 wk: 0.24 (0.14, 0.44)
increased
among
• Uninfected subjects:
HIV-infected
• 1 wk: 0.13 (0.09, 0.19)
subjects, especially
• 6 wk: 0.08 (0.06, 0.11)
after 6 weeks.
• 14 wk: 0.09 ( 0.07, 0.13)
HIV-infection by 14 wk of age was
significantly associated with
increased L:M.

L:M as a marker of gut
mucosal integrity and
urinary neopterin
excretion as a marker
of cell-mediated
immunity in infants
with and without HIV
infection

Associations of
MCV, CRP, and
hemoglobin with
SBT after adjusting
for potentially
confounding
variables were not
reported.

4

Mean L:M:
• Group 1:
• Day 0: ~1.8
• Day 3: ~2.4
• Group 2:

The increased L:M
in HIV-infected
infants was primarily
driven by lactulose
rather than mannitol.
Higher neopterin
excretion by HIVinfected infants was
observed but this
was not statistically
significant.
Mean L:M ratios
Urine testing could
were very high
only be conducted
(~10x) (at baseline in the laboratory on
and at day 3 in both certain days; hence
groups) compared to only a subset of

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest
supplementation of
South African children
with diarrhea: optimum
timing for improving
biochemical and
clinical recovery and
subsequent vitamin A
status
L:M as a marker of
intestinal permeability
and urinary neopterin,
serum α-1 acid
glycoprotein, and Creactive protein as
markers of
inflammation among
children with severe
diarrhea

Location and
Design and
Target Population Sample Size
outpatients with
severe diarrhea.

Biomarker

vitamin A on
admission (group
1)
Blood Tests:
• C-reactive protein
n=73 received
(CRP)
vitamin A after
• α-1 acid
clinical
glycoprotein (AGP)
improvement
(group 2)
49 subjects received
urine testing:
• Group 1: n=25
Treatment
• Group 2: n=24
involved vitamin A
supplementation
either on the day Blood and urine were
of
tested on days 0 and
admission or after 3.
acute diarrheal
symptoms had
resolved.

Results
• Day 0: ~1.2
• Day 3: ~0.7

Conclusion

other studies in this
review. Study
authors suggested
There were no differences in mean (via personal
L:M between groups or within groups correspondence)
that this could have
between days 0 and 3, although
there was a significant difference in been due to the
paired analysis within individuals at severity of illness in
the sample
the two time points (data not
presented, and direction, magnitude population (children
hospitalized for
and degree of significance not
diarrhea).
reported).

Comments
subjects underwent
those tests.

Group 2 patients
had significantly
higher CRP, nonsignificantly higher
WBCs and AGP,
and lower retinol
and retinol-binding
protein
concentration
compared to group
1 at baseline.
Vitamin A
Lactulose and mannitol excretion
Authors note that
administration did
were assessed only in the paired
these parameters
not result in
analysis. Lactulose excretion
suggest that Group
significant
decreased between days 0 and 3
(magnitude of effect and degree of improvement in L:M, 2 patients might
neopterin, or AGP have been more ill
significance not reported), while
regardless of timing at baseline. For the
mannitol excretion showed no
subset of 49
of vitamin A
change.
patients undergoing
administration.
1
urine testing, the
Mean neopterin and AGP
mean L:M and
concentrations did not differ between
neopterin
groups or within groups on the
concentrations
different study days or in the paired
were lower among
analysis. When initial CRP (~2x
Group 2 than Group
higher in Group 2 compared to
1 subjects (NS).
Group 1, p<0.004) was taken into
However, baseline
account, mean CRP on day 3 did not
differences in acute
differ between the 2 groups.
phase and vitamin
However in the paired analysis, CRP
A markers at
concentrations were significantly
baseline were not
different between days 0 and 3.
reported separately
for these 49
subjects.
Data for lactulose
and mannitol
excretion were not

1

Geometric mean.

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

Comments
reported separately.
Rationale for
additional analyses
of these molecules
expressed as ratios
with creatinine was
not explained.

2000
Thurnham DI et al.

Orissa State, India

Subjects were
recruited from 2
Innate immunity, gut sources:
integrity, and vitamin A 1. Hospital-based
in Gambian and Indian infants admitted
infants
for “diarrheal or
respiratory
L:M as a marker of
disease,” mean
intestinal integrity
age 9 mo
among children
2. Clinic-based
receiving vitamin A
infants with
supplementation
“minor
ailments”, age
not specified

Authors suggest
that their 3-day
testing period
(based on their
previous work in a
different setting
[207] might have
been too short to
identify effect as
demonstrated by
McCullough et al. at
10 days after
presentation [208].
RCT
Urine Test:
Mean L:M was ~3-fold higher among Mean L:M values,
Precise numerical
L:M
hospitalized compared to clinic
including postvalues were not
n=174;
patients at baseline. Within the
intervention values, reported, rather L:M
allocation groups, mean baseline
results were
were 2-5 times
n=94 hospitalFor hospital-based
L:M did not differ for either the
portrayed in figures
higher than those
based
hospitalized or clinic subjects.
subjects, L:M was
observed in the UK with units
assessed at baseline,
expressed in mg,
[209].
• 31 received
Among the hospital cohort, mean
making it difficult to
vitamin A at day discharge from
hospital, and 10 or 30 L:M declined significantly in the two L:M reduction was compare these
1
days after discharge. vitamin A groups compared to the
accelerated among results to those of
• 32 received
placebo group, and remained lower vitamin Aother studies.
vitamin A at
at day 30 among the treatment
supplemented
discharge (up to For clinic-based
groups, but the difference was no
subjects, L:M was
children, but end-of- Information on
day 5)
assessed at baseline, longer significant compared to the
study mean values study design, such
• 31 received
4, and 8 wk.
placebo group.
as randomization
did not differ
placebo
statistically between scheme, was
Among the clinic cohort, mean L:M allocation groups in limited.
n=80 clinicreduction was accelerated in vitamin either the clinic or
based*
A-supplemented children. However, the hospital cohorts. The article also
mean L:M did not significantly differ
reported rebetween treatment groups at any
analyzed data from
Clinic-based
time point.
a 1991 report from
subjects were

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

randomized to
receive vitamin A
weekly for 8 wk or
placebo.

2009
Trehan I et al.
A randomized, doubleblind, placebocontrolled trial of
rifaximin, a
nonabsorbable
antibiotic, in the
treatment of tropical
enteropathy
L:M,
sucrose:lactulose, and
sucralose:lactulose as
markers of small
intestinal, gastric, and
colonic permeability,
respectively, among
those receiving
rifaximin or placebo

The Gambia [209].

The rate of decline in L:M was most
steep among the vitamin A-treated
hospitalized patients, in whom the
mean L:M value decreased by 63%
over 30 days, followed by placebo* Number of
treated hospitalized patients, with a
subjects in each
decrease of 38% over 30 days.
treatment group
Mean L:M decreased by 57% in the
was not specified.
vitamin A-treated clinic patients,
while there was no change in L:M
among the clinic placebo group.
Limela, Malawi
RCT
Urine Tests
At enrollment:
1
• Lactulose
• Mean mannitol (SD):
All 3-5 yr olds from n=144;
• Mannitol
• Treatment: 9.57 (5.24)
the village were
• Placebo: 10.29 (6.62)
• Sucrose (SUC)
n=72 received
recruited.
• Mean lactulose (SD):
• Sucralose (SCL)
2
rifaximin for 7
• L:M
• Treatment: 0.30 (0.18)
days
• Sucrose:lactulose
• Placebo: 0.34 (0.25)
ratio (SUC:L)
• Mean SUC (SD):
n=72 received
• Sucralose:lactulose
• Treatment: 0.062 (0.04)
placebo
ratio (SCL:L)
• Placebo: 0.074 (0.058)
•
Mean
SCL (SD):
It was presumed
•
Treatment:
0.51 (0.29)
that if SBBO is
Subjects were tested
•
Placebo:
0.58
(0.53)
the etiology for
before and after
•
Mean
L:M
(SD):
enteropathy,
treatment.
• Treatment: 0.18 (0.12)
treatment with
• Placebo: 0.17 (0.09)
rifaximin would
• Mean SUC:L (SD):
result in improved
intestinal integrity.
• Treatment: 0.50 (0.34)
• Placebo: 0.64 (0.90)
• Mean SCL:L (SD):
• Treatment: 0.42 (0.32)
• Placebo: 0.39 (0.23)
• For both groups combined:
• 76% had L:M >0.10
• 34% had L:M >0.20
No significant post- intervention

1
2

Lactulose, mannitol, SUC, and SCL results were expressed as % of dose administered.
Type of mean for sugar ratios not specified.

Comments

There was a high
proportion with
elevated L:M which
did not change with
rifaximin treatment.

Methodological
differences in
specimen collection
and testing, in
particular for SCL
excretion, might
Baseline L:M
account for some
differences in
measurements in
this study resembled values compared to
those of another
other studies.
Malawian population
in similar
This was the first
use of SCL for siteenvironmental
specific absorption
conditions [120].
testing in a
SCL excretion in this developing country
population was
setting.
similar to that found
in healthy American
children (0.4%),
while SCL:L was
comparatively lower
(0.8) and driven by
lactulose [210].
SCL:L might be a
better marker of
colonic permeability
[211-213]. Results

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

2008

Fortaleza, Brazil

Vieira MM et al.

n=102
2 mo-9 yr olds
(mean age 41 mo)
from an
impoverished
urban community,
eligible if HAZ
score <median
for their
community.

Carotenoids, retinol,
and intestinal barrier
function in children
from northeastern
Brazil
L:M as marker of
intestinal barrier
function, fecal
lactoferrin and
leukocytes as markers
of intestinal
inflammation, and
CRP and AGP as
acute phase reactants
among children with
varying vitamin A
1

Cross-sectional

Biomarker

Urine Tests:
1
• Lactulose
• Mannitol
• L:M
(97 tested)

Results

Conclusion

differences were observed in any
fractional sugar excretion or dual
sugar test, including among children
with elevated pre-intervention L:M.

from this study
potentially indicate
that colonic
permeability was
normal.

48.5% had abnormal L:M.
L:M and excretion of each sugar
separately did not vary with retinol
concentration.
L:M was associated with levels of
common dietary carotenoids,
primarily driven by lactulose.
However, the association was not
always statistically significant, and
the direction of association varied
depending on precursor.

Few data exist on
SUC excretion.
Results in this trial
are similar to those
found in another
Malawian population
(0.06% SUC
excretion) [120]
and high compared
to healthy older
children from
developed country
settings (0.020.03%) [210, 212].
Almost half of
subjects had
increased L:M, and
~40% of subjects
had increased
lactoferrin.

While serum retinol
concentrations were
not associated with
L:M, serum
carotenoids were;
authors suggest that
these retinol
Blood Tests:
40%
of
stool
samples
were
positive
precursors might be
• C-reactive protein
for lactoferrin.
more sensitive
(CRP)
predictors of
• α-1-acid
1%
of
stool
samples
were
positive
impaired intestinal
glycoprotein (AGP)
for fecal leukocytes.
function. However,
the reported
30% of stool samples were positive direction of
Stool Tests:
• Lactoferrin
(93 tested)
• Leukocytes

Lactulose and mannitol results were expressed as % of dose administered.

Comments

L:M threshold for
abnormal values
was defined as
>0.0864 [214]. Cutoff values for
lactoferrin positivity
were not described.
Relationships
between acute
phase proteins and
measures of
intestinal
permeability or
inflammation were
not reported.
Relationships
between L:M and
lactoferrin or fecal
leukocytes as well
as those between

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest
status

2007

Location and
Design and
Target Population Sample Size

West Kiang region, Cohort
Gambia
n=72
Williams EA et al.
4-10 mo olds from
Glutamine or
a rural area
A double-blind,
followed during the placebo of
placebo-controlled,
5-month rainy
nonessential
glutaminesupplementation trial season and for 6 amino acids was
months afterward. orally
in growth-faltering
administered
Gambian infants
twice daily during
rainy season; L:M
L:M and plasma
ratio was
immunoglobulins and
measured
acute phase reactant
monthly, and
proteins (albumin, Cplasma samples
reactive protein, and
were collected 3
alpha-1times.
antichymotrypsin) in
community-based
Gambian infants
enrolled in a glutamine
trial

Biomarker

Urine Tests:
1
• Lactulose
• Mannitol
• L:M
Blood markers
• C-reactive protein
(CRP)
• Alpha-1
antichymotrypsin
(ACT)
• IgA
• IgG
• IgM
• Albumin

Results

Conclusion

Comments

for parasites but this had no impact
on L:M results, lactoferrin, or acute
phase reactants.

association varied,
making
interpretation of
these results
unclear.

retinol or
carotenoids and
lactoferrin or fecal
leukocytes were not
reported.

2

Mean L:M (CI):
• Baseline:
• Glutamine group: 0.33 (0.25,
0.43)
• Placebo group: 0.33 (0.26,
0.41)
• Post-intervention:
• Glutamine group: 0.29 (0.23,
0.35)
• Placebo group: 0.26 (0.21,
0.32)
Mean excretion of lactulose (CI):
• Baseline:
• Glutamine group: 0.21 (0.16,
0.28)
• Placebo group: 0.20 (0.15,
0.26)
• Post-intervention:
• Glutamine group: 0.17 (0.13,
0.21)
• Placebo group: 0.14 (0.11,
0.18)
Mean excretion of mannitol (CI):
• Baseline:
• Glutamine group: 2.65 (2.02,

1
2

Lactulose and mannitol results were expressed as % of dose administered.
Geometric mean.

Exclusively
breastfed children
were excluded from
study participation
due to assessment
of stool lactoferrin.
L:M values were
The relationships
elevated in this
between L:M and
population, with no growth parameters,
significant change immuno-globulins,
and acute phase
after the
proteins were not
intervention.
None of the plasma reported.
markers differed
significantly between
treatment and
placebo groups,
either at baseline or
at the end of
supplementation.
Growth outcomes
did not differ
significantly across
treatment groups.

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results
3.48)
• Placebo group: 2.50 (1.87,
3.36)
• Post-intervention:
• Glutamine group: 2.48 (1.99,
3.11)
• Placebo group: 2.14 (1.62,
2.82)
L:M values did not differ significantly
between treatment groups before or
following intervention. However, a
repeated measures ANOVA showed
that during supplementation, L:M
values were borderline elevated
among the glutamine-supplemented
group relative to the placebo group
(p=0.05), counter to expectation.
Neither ACT, CRP, albumin, nor
immunoglobulins IgA, IgG, or IgM
differed significantly between
treatment and placebo groups, either
at baseline or at the end of
supplementation.
Mean levels of IgA and IgG
increased during the study (p
<0.001), while IgM levels did not.
Concentrations of each of these
immunoglobulins did not differ
between treatment and placebo
groups.
Plasma albumin, ACT, and CRP
values showed no change over the
course of the study.
Proportions of children with elevated
CRP ranged from 30-41% at
different collection time points. The
glutamine intervention had no effect
on proportion of children with

Conclusion

Comments

Evidence Table 2. Markers of permeability.
Reference and Study
Outcomes of
Diagnostic Interest

Location and
Design and
Target Population Sample Size

Biomarker

Results

Conclusion

Comments

elevated CRP.
Treatment and placebo groups
experienced decreases in WAZ,
HAZ, and MUAC coinciding with the
rainy season; however, there was no
significant difference observed
between the groups for any of these
parameters.

2000

Durban, South
Africa

Cross-sectional Urine Test:
L:M
analysis of
baseline data
Willumsen JF et al.
prior to
HIV-infected
randomization for
Subclinical mastitis as breastfeeding
mothers and their an RCT
a risk factor for
infants followed up
mother-infant HIV
n=104 mothers
to 14 wk of age.
transmission
L:M as a marker of
infant intestinal
permeability and its
relationship with
subclinical maternal
mastitis

Women recruited
from antenatal
clinic via a vitamin
A supplementation
trial to reduce
mother-to-child
HIV transmission.
Lima, Peru

2000

Treatment and placebo groups did
not differ in morbidity indices (i.e.
percentage of time reported with a
particular illness or illness overall).
There was no significant association Subclinical mastitis
between L:M and subclinical mastitis was not associated
as measured by milk Na/K.
with magnitude of
L:M.

n=108 infants (4
pairs of twins),
(26 were HIVinfected by 3 mo
of age)

Arithmetic mean.

Urine Test:
L:M

1

Mean L:M (SE) at day 1, day 20:
• Rotavirus only: 0.67 (0.38), 0.19
Zhang Y et al.
0-36 mo olds with n=36;
(0.09)
watery diarrhea
• Cryptosporidium only: 0.76 (0.43),
n=29 cases:
Enrollment and
Lactulose-mannitol
admitted to oral
0.28 (0.14)
convalescent (at day • Bacterial infection: ranged from
intestinal permeability rehydration unit of • 15 with C.
test in children with
hospital.
parvum alone 20) L:M ratios were
0.2-0.87, 0.11-0.99
diarrhea caused by
• 7 with rotavirus assessed.
• Unknown etiology: 0.26 (0.12),
rotavirus and
alone
0.29 (0.18)
Cryptosporidium
• 7 with bacteria
(alone or with
Mean L:M ratios significantly
1

Case-control

L:M ratios were
significantly
elevated in children
with rotavirus or
Cryptosporidium
infection compared
to those with
diarrhea not caused
by rotavirus,
Cryptosporidium, or
identifiable bacteria.

Actual L:M values
were not reported
but are found in a
companion study,
also included in this
review [119].The
study group in
Willumsen, et al.
represents a
subsample of the
study population
reported in the
companion study.

Evidence Table 2. Markers of permeability.
Reference and Study
Location and
Design and
Outcomes of
Biomarker
Target Population Sample Size
Diagnostic Interest
L:M as a marker of
rotavirus or
Cryptosporidium
intestinal permeability
)
in children with
diarrhea
n=7 controls with
unknown etiology

Results

Conclusion

Comments

differed between the unknown
etiology and both the rotavirus (p<
0.01) and Cryptosporidium groups
(p<0.05) at baseline, but not at day
20.

Mean L:M did not
change significantly
among those with
diarrhea of unknown
etiology, but did
Mean L:M ratios decreased between significantly
baseline and day 20 for both the
decrease among
rotavirus (p<0.001) and
those infected with
Cryptosporidium (p<0.05) groups.
rotavirus or
Cryptosporidium,
Among the group of subjects with
reaching ratios
enteric bacterial infections, the
similar to those with
causative agents identified and
diarrhea of unknown
mean L:M ratios (baseline, day 20) etiology.
were: Campylobacter jejuni and
rotavirus infection (0.86, 0.18), C.
jejuni and
Cryptosporidium infection (0.87,
0.53), Salmonella sp. (0.2, 0.11), C.
jejuni (0.69,
0.99), and Aeromonas sp. (0.38,
0.11). The L:M ratios of this group of
seven infants were not included in
the statistical analyses.

Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. Where these studies
did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s.
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting.
Further details on L:M studies can be found in Table 19.
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval,
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins,
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G,
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score),
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s)

5.3.1 The Urinary Lactulose:Mannitol Ratio (L:M)
The urine L:M test is the permeability test that has been most extensively used to
measure gut function in children in the literature identified for this review. This noninvasive test
involves oral administration of a dose of both sugars (i.e., lactulose and mannitol), followed by a
timed urine collection. As reviewed above, lactulose is a large sugar (a disaccharide) that is
minimally absorbed from an intact small intestine. However, if permeability is altered, this
disaccharide traverses intracellular spaces of the gut, is then cleared by glomerular filtration
without renal tubular reabsorption, and becomes measurable in the urine. Mannitol is a sugar
alcohol that is absorbed (via transcellular pathways) proportional to the small bowel absorptive
capacity (i.e. surface area). Shortened microvilli diminish uptake and subsequent urinary
excretion of mannitol, which, like lactulose, is filtered and not reabsorbed.

5.3.1.1 Technical Issues with the L:M Test
Prior to delving into the results of the L:M tests, it is important to note that all of the
biomarkers examined in this review have particular and general performance considerations,
perhaps none more so than the L:M test. These considerations for the L:M test are summarized
in Table 14, which demonstrates the tremendous variability in methods, citation of methods,
ranges of purported normal values of abnormal cutoff points, and the way that results were
reported across the 25 studies that we reviewed that used L:M as a marker.
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Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2004
Campbell DI et al.
Intestinal inflammation
measured by fecal neopterin in
Gambian children with
enteropathy

Population

Exclusion/
Inclusion
Criteria

Fasting

Loading
Doses of
Lactulose
and
2
Mannitol

2 mo olds from a
rural area followed
until 15 mo of age.

Not specified

1 hr after
A
loading dose

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval
5 hr

Central
Tendency
Measure for
L:M

Comparisons to
5
Other Studies

Enzymatic assay
Mean, type
per Northrop CA et not specified,
al. [215] and Lunn (CI)
PG et al. [216]

6

Normal value cut points : <0.10 based on UK norm. Campbell DI et al. cited Travis & Menzies et al. [201] but it was unclear if the citation was related to normal values
for lactulose and mannitol individually or also for L:M. Travis & Menzies did not report primary L:M data, but cited a mean (type not specified) of 0.016 (SEM 0.002), per
Juby et al. [217], as normal.
2003
Campbell DI et al.
Growth faltering in rural
Gambian infants is associated
with impaired small intestinal
barrier function

2-11 mo olds from
a rural village
followed up to 14
mo of age.

Not specified

2 hr after
A
loading dose

5 hr

Enzymatic assay
per Northrop CA et
al. [215] and Lunn
& Northrop-Clewes
[218]

Geometric
mean (CI,
range)

Gambian children
[209]

Normal value cut points: Based on UK norms, value was not specified, per Freeman JV et al. [219], Weaver [220], Lunn PG et al. [202], and Lunn [52]. Freeman JV et
al. [219] reported no data relevant to L:M. Weaver reported data for breastfed English infants and a derived median L:M from this data of ~0.2. Lunn PG et al. [202]
reported a mean (SEM) L:M for UK 3-15 mo olds of 0.12 (0.02) based on “data from [their] laboratory”, but did not portray the data or cite another reference. Text suggests
this was a geometric mean, but this was not clearly stated. Lunn [52] described L:M patterns, but not specific values.

1

Some titles are abbreviated.
A = 400 mg/kg of lactulose, 100 mg/kg of mannitol, B = not reported, C = 4 g lactulose, 1 g mannitol, D = 5 g lactulose, 1 g mannitol, E = 200 mg/kg of lactulose,
50 mg/kg of mannitol, F = 400 mg/kg of lactulose, 100 mg/kg of mannitol, G = 400 mg/kg of lactulose (maximum 4 g), 100 mg/kg of mannitol (maximum 1 g), H =
500 mg/kg of lactulose (maximum 5 g), 100 mg/kg of mannitol (maximum 1 g).
3
Where authors cited references for these parameters, they are provided.
4
Where authors cited references for these parameters, they are provided.
5
Other than studies presented within the “Normal value cut points” row.
6
Where authors cited references for normal value cut-points, they are provided along with the relevant information from those citations.
2

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2003
Campbell DI et al.
Chronic T cell-mediated
enteropathy in rural west African
children: relationship with
nutritional status and small
bowel function

Population

Exclusion/
Inclusion
Criteria

Fasting

Loading
Doses of
Lactulose
and
2
Mannitol

6 mo-3 yr old
malnourished inand out-patients
from rural areas.
Compared to wellnourished UK
children with GI
complaints other
than diarrhea.

Not specified

Not reported B

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval

Central
Tendency
Measure for
L:M

Comparisons to
5
Other Studies

5 hr

Not clearly
indicated

Asymptomatic
Gambian children
[209]

Enzymatic assay
per Sullivan PB et
al. [221] and Lunn
PG et al. [209]

Normal value cut points: <0.10 based on UK norms, per Fagundes-Neto U et al. [17] and Beattie RM et al. [222]. We were unable to obtain the article by Fagundes-Neto
U et al. to verify. No relevant L:M data were found in Beattie RM et al.

2002
2-60 yr olds from
rural communities.
Campbell DI et al.
Age-related association of small
intestinal mucosal enteropathy
with nutritional status in rural
Gambian children

Not specified

Not reported C

5 hr

Enzymatic assay
per Northrop CA et
al. [215], and Lunn
& Northrop-Clewes
[218]

Mean, type
Adults in UK &
not specified, tropics [57] and
(SE)
previous results in
Gambian & UK
subjects [202]

Normal value cut points: <0.10 based on UK norm per Freeman JV et al. [219] and Travis & Menzies [201]. Freeman JV et al. reported no relevant data. Travis &
Menzies cited a mean (type not specified) L:M ratio of 0.016 (SEM 0.002), per Juby LD et al. [217], as normal.
2003
2-97 mo olds from
an urban
Chen P et al.
shantytown.
Association of vitamin A and
zinc status with altered intestinal
permeability
Normal value cut points: Not reported.

Not specified

Not reported D

5 hr

HPLC
per Barboza MS et
al. [214]

Mean, type
not specified
(SD)

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2007
Darboe MK et al.
Effectiveness of an early
supplementation scheme of
high-dose vitamin A versus
standard WHO protocol in
Gambian mothers and infants

Population

Exclusion/
Inclusion
Criteria

Fasting

Loading
Doses of
Lactulose
and
2
Mannitol

0-12 mo olds from
a rural community.

Inclusion:
Not reported E
successfully
obtained cord
blood sample
Exclusion: birth
weight <2.2 kg,
<37 wk gestation,
congenital
anomalies or
severe
peripartum illness

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval

Central
Tendency
Measure for
L:M

5 hr

Geometric
mean

Enzymatic assay
per Lunn PG et al.

Comparisons to
5
Other Studies

[209]

Normal value cut points: <0.30, authors derived this from Lunn PG et al. [202] UK infants’ mean plus 2 SD. Lunn PG et al. stated a mean (type not specified) (SE) of
0.12 (0.02) based on “most recent data from this laboratory”, data not shown or cited.

2001
Filteau SM et al.
The effect of antenatal vitamin A
and (beta)-carotene
supplementation on gut integrity
of infants of HIV-infected South
African women

Infants of HIVNot specified
infected women
recruited from
antenatal clinic and
followed until 14 wk
of age.

Not reported A

5 hr

Enzymatic assay
per Lunn PG et al.
[209] and
Willumsen JF et al.
[207]

Geometric
mean (CI)

Normal value cut points: Based on norms, values not specified, per Catassi C et al. [223] and Lunn PG et al. [209]. Catassi C et al. reported data from 72 Italian infants.
Their L:M values were calculated in two ways: 1) absolute ratio of lactulose and mannitol in mg/dl with L:M mean (type not specified) (SD) ranging from 1.27 (0.73)-0.22
(0.21) and 2) ratio of lactulose and mannitol as percent dose ingested with L:M mean (type not specified) (SD) of 0.09 (0.08). Lunn PG et al. stated that UK infants’ norm
as a mean (type not specified) (SD) of 0.12 (0.09), but did not portray the related data or cite another reference for this UK norm.

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2005
Galpin L et al.
Effect of Lactobacillus GG on
intestinal integrity in Malawian
children at risk of tropical
enteropathy

Population

Exclusion/
Inclusion
Criteria

36-60 mo olds from Exclusion:
a rural community. evidence of
severe acute
malnutrition or
severe chronic
illness

Fasting

Loading
Doses of
Lactulose
and
2
Mannitol

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval

Overnight

D

3 hr

Central
Tendency
Measure for
L:M

Comparisons to
5
Other Studies

Cation-exchange
Arithmetic
column and
mean (SD)
refractometer by
modified method of
Catassi C et al.
[224] and Shulman
RJ et al. [225]

Normal value cut points: <0.10 based on developed world norms between 0.03-0.12, per Goto R et al. [205], van Elburg RM et al. [226], Campbell DI et al. [112]. Goto R
et al. reported data based on 158 Guatemalan infants aged 0-11 mo without diarrhea in preceding week; the L:M median ranged from 0.41-0.54. They also used 0.07 as a
cut point for normal L:M based on another reference by Ford RP et al. [227] which did not report data relevant to L:M. van Elburg RM et al. reported L:M based on 30
Dutch 0-16 yr olds. L:M was calculated in two ways: 1) absolute ratio of lactulose and mannitol in mmol/mol creatinine with L:M mean (type not specified) (SD) 0.043
(0.045) and 2) ratio of lactulose and mannitol as percent dose ingested with L:M mean (type not specified) (SD) 0.034 (0.033). Campbell DI et al. reported mean (type not
specified) (SE) L:M of 0.353 (0.022) based on 26 Gambian 2-5 yr olds without diarrhea. They also reference UK norms but do not report specific values (see above).

2008
Goto R et al.
Impact of anti-Giardia and
anthelminthic treatment on infant
growth and intestinal
permeability in rural Bangladesh

3-15 mo olds from
a rural community
followed over 9
mos. Malnutrition
was prevalent.

Not specified

Not reported A

Usually 3
hr, but up
to 5-6 hr if
no urine
output
within 3 hr
per Akram
S et al.
[228]

Enzymatic assay
per Lunn PG et al.
[216] and Northrop
CA et al. [215].

Geometric
mean (SD)

Gambian and
Bangladeshi
subjects per Lunn
PG et al. [209] and
Rousham EK et al.
[229]

Normal value cut points: < upper CI for UK infants, value not specified, per Lunn PG et al. [209]. Lunn PG et al. stated that UK infants’ norm as a mean (type not
specified) (SD) of 0.12 (0.09), but did not portray the related data or cite another reference for this UK norm.

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2008
Goto R et al.
Impact of intestinal permeability,
inflammation status and
parasitic infections on infant
growth faltering in rural
Bangladesh

Population

Exclusion/
Inclusion
Criteria

Fasting

Loading
Doses of
Lactulose
and
2
Mannitol

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval

Central
Tendency
Measure for
L:M

Comparisons to
5
Other Studies

3-15 mo olds from
a rural community
followed over 9
mos. Malnutrition
was prevalent.

Not specified

1 hr before
load

A

5 hr for
first exam.
Reduced
to 3 hr
subseque
ntly if
subject
voided
within first
90
minutes
per Akram
S et al.
[228]

Geometric
mean, mean
7
log L:M (SD
reported for
logged value)

Gambian and
Bangladeshi
subjects per Lunn
PG et al. [209] and
Rousham EK et al.
[229]

Enzymatic assay
per Lunn PG et al.
[216] and Northrop
CA et al. [215]

Normal value cut points: Geometric mean 0.12 for UK infants per Lunn PG et al. [209]. Lunn PG et al. stated that UK infants’ norm as a mean (type not specified) (SD)
of 0.12 (0.09), but did not portray the related data or cite another reference for this UK norm.

2002
Goto R et al.
Poor intestinal permeability in
mildly stunted Nepali children:
Associations with weaning
practices and Giardia lamblia
infection

0-5 yr olds from two Not specified
urban squatter
settlements.
Malnutrition was
prevalent.

1 hr after
A
load (with
the
exception of
breastfeedin
g)

5 hr

Enzymatic assay
per Lunn PG et al.
[216];
Northrop CA et al.
[215]; Blood et al.
[230]; Lunn &
Northrop-Clewes
[218]

Geometric
mean (range,
geometric
8
SE )

Bangladeshi
subjects per
Northrop-Clewes
CA et al. [150] and
Rousham EK et al.
[229]. Gambian
subjects per
Lunn PG et al. [202]
and Behrens RH et
al. [231].
Guatemalan
9
subjects per
Goto R et al. [205]

Normal value cut points: <0.12 based on UK geometric mean per Lunn PG et al. [202]. Lunn et al. stated that UK infants’ norm as a mean (type not specified) (SD) of
0.12 (0.09), but did not portray the related data or cite another reference for this UK norm.

7

Authors present positive log L:M values, however, logged values would be expected to be negative for ratios between 0-1 as is the case for L:M ratios.
Authors calculated the geometric standard error using the formula: antilog (mean + standard error of logged values) - geometric mean.
9
For this study, medians were reported rather than means.
8

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2010
Lima AA et al.
Effects of vitamin A
supplementation on intestinal
barrier function, growth, total
parasitic, and specific Giardia
spp infections in Brazilian
children

Population

Exclusion/
Inclusion
Criteria

2 mo-9 yr olds from Inclusion: HAZ
an impoverished
score
urban community.
<community
median
Exclusion:
exclusively
breast-fed,
participant in
another study in
past 2 yr, or
febrile illness at
enrollment

Fasting

Loading
Doses of
Lactulose
and
2
Mannitol

Not reported F

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval

Central
Tendency
Measure for
L:M

Per
Barboza
MS et al.
[214]

Per Lunn PG et al.
[216] and Northrop
CA et al. [215]

Median
10
(range )

5 hr

HPLC per Barboza
MS et al. [214]

Mean, type
not specified,
(SE)

Normal value cut points: Not reported.

2005
Lima AA et al.
Intestinal barrier function and
weight gain in malnourished
children taking glutaminesupplemented enteral formula

2-60 mo olds
hospitalized with
malnutrition, ~70%
of whom had PD.

Inclusion: history 3 hr before
of PD or WAZ
load
score <-2 and
consent to 10-day
hospital stay
Exclusion:
exclusively
breast-fed,
intolerant to
cow's milk,
participant in
another study in
past 2 yr, illness
at enrollment

G

Normal value cut points: Not reported.

10

Authors used the term "range," but for some of the L:M medians, only one value was reported, apparently the maximum L:M value observed.

Comparisons to
5
Other Studies

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2007
Lima NL et al.
Wasting and intestinal barrier
function in children taking alanylglutamine-supplemented enteral
formula

Population

Exclusion/
Inclusion
Criteria

Fasting

6 mo-8 yr olds from
an urban setting
with HAZ, WAZ, or
WHZ scores <-1.

Exclusion:
3 hr before
exclusively
load
breast-fed,
participant in
another study in
the past 2 yr,
sibling enrolled in
this study,
chronic or severe
or febrile illness
at enrollment

Loading
Doses of
Lactulose
and
2
Mannitol

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval

Central
Tendency
Measure for
L:M

D

5 hr

Median
i
(range )

HPLC per Barboza
MS et al. [214]

Comparisons to
5
Other Studies

Normal value cut points: Within the CI for values of healthy children in the community, values were not reported and no reference was provided.
2001
Northrop-Clewes CA et al.
Anthelmintic treatment of rural
Bangladeshi children: effect on
host physiology, growth, and
biochemical status

2-5 yr olds from
poor rural villages.

Not specified

2 hr before
and after
load

C

5 hr

Enzymatic assay
per Northrop CA et
al. [215], and Lunn
&
Northrop-Clewes
[218]

Geometric
mean, mean
log L:M (SE
reported for
logged value)

Bangladeshi
subjects per
Northrop CA et al.
[232]

Normal value cut points: <~0.15 based on UK norm per Lunn PG et al. [209]. Lunn PG et al. stated that UK infants’ norm as a mean (type not specified) (SD) of 0.12
(0.09), but did not portray the related data or cite another reference for this UK norm.
2000
Quadro L et al.
Retinol and retinol-binding
protein: gut integrity and
circulating immunoglobulins

1-9 yr olds with mild
malnutrition from an
urban slum. Vitamin
A deficiency was
prevalent.

Inclusion: no sign Overnight
of infection or
other obvious
illness

D

5 hr

HPLC
per Bao Y et al.
[233]

None
reported

Normal value cut points: <0.030 based on norms per Lima AA et al. [234], Deitch [235], Ukabam & Cooper [236],Wyatt J et al. [237], Pearson AD et al. [238], and Ford
RP et al. [227] Lima AA et al. reported mean L:M (type not specified) (SE) of 0.017 (0.002) based on data from 13 Brazilian adults without HIV infection. Deitch reported
mean L:M from 8 healthy American adult controls. Mean L:M was 1.7; SE was only presented graphically. L:M was expressed as lactulose/mannitol x 100 and the ratio
was calculated as units rather than % dose administered; type of mean was not otherwise specified. Baseline values of mannitol (from pre-test samples) were subtracted
from test samples. Ukabam & Cooper reported separate lactulose and mannitol excretion means for 25 healthy adult controls, presumably from the UK based on address
of corresponding author. They did not report data on the L:M ratio. Wyatt J et al. reported mean (type not specified) L:M (SE) of 0.018 (0.002) based on data from 30
healthy adults (presumably in Austria based on corresponding author’s address.) They defined a normal cutoff of 0.030 based on mean L:M + 2 SD. Pearson AD et al.
reported mean L:M (type not specified) (range) of 0.018 (0.005-0.028) based on data from 31 healthy 2-13 yr olds (presumably in UK based on corresponding author’s
address.) Ford RP et al. reported no data relevant to L:M.

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2004
Rabbani GH et al.
Green banana and pectin
improve small intestinal
permeability and reduce fluid
loss in Bangladeshi children with
persistent diarrhea

Population

Exclusion/
Inclusion
Criteria

Fasting

5-12 mo old males
admitted to hospital
with PD but without
other concurrent
illnesses.

Inclusion: male,
3 hr before
PD
load
Exclusion:
concurrent illness

Loading
Doses of
Lactulose
and
2
Mannitol

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval

Central
Tendency
Measure for
L:M

D

5 hr

Mean, type
not specified
(SD)

Enzymatic assay
per Behrens et al.
[239], and
Yamanaka [240]

Comparisons to
5
Other Studies

Normal value cut points: Based on norms, value not specified, per Lunn PG et al. [209], Barboza MS et al. [214], Behrens RH et al. [231], Roy SK et al. [241], Ford RP
et al. [227]. Lunn PG et al. stated that UK infants’ normal values are: mean (type not specified) (SD) 0.12 (0.09), but did not portray the related data or cite another
reference for this UK value. Barboza MS et al. reported mean L:M (type not specified) (SD) of 0.0394 (0.0235) based on 15 Brazilian under-5s from a low SES area
without diarrhea in the preceding 2 weeks. Behrens RH et al. reported mean L:M (type not specified) (+/-2SD) of 0.42 (0.2, 1.4) and 0.52 (0.2, 2.2) based on 255 tests on
60 healthy Gambian 0-18 mo olds with HFA >80% of NCHS median and 45 tests on 15 Gambian 0-18 mo olds with HFA between 60-80% of NCHS median. Roy SK et al.
reported geometric mean L:M (CI) of 0.13 (0.1, 0.16) based on 53 asymptomatic Bangladeshi controls. Ages of controls were not described but diarrheal cases were aged
3-24 mo. Ford RP et al. reported no data relevant to L:M.

2001
1, 6, and 14 wk old Not specified
infants born to HIVRollins NC et al.
infected mothers.
Feeding mode, intestinal
permeability, and neopterin
excretion: A longitudinal study in
infants of HIV-infected South
African women

Not reported A

5 hr

Enzymatic assay
Geometric
per Willumsen JF et mean (CI)
al. [207]

Normal value cut points: Based on norms, value not specified, per Catassi C et al. [223] and Behrens RH et al. [231]. Catassi C et al. reported mean L:M based on data
from 72 Italian infants. Their L:M values were calculated in two ways: 1) absolute ratio of lactulose and mannitol in mg/dl with L:M mean (type not specified) (SD) ranging
from 1.27 (0.73)-0.22 (0.21) and 2) ratio of lactulose and mannitol as percent dose ingested with L:M mean (type not specified) (SD) of 0.09 (0.08). Behrens RH et al.
reported mean L:M (type not specified) (+/-2SD) of 0.42 (0.2, 1.4) and 0.52 (0.2, 2.2) based on 255 tests on 60 healthy Gambian 0-18 mo olds with HFA >80% of NCHS
median and 45 tests on 15 Gambian 0-18 mo olds with HFA between 60-80% of NCHS median.

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2000
Rollins NC et al.
Vitamin A supplementation of
South African children with
diarrhea: optimum timing for
improving biochemical and
clinical recovery and subsequent
vitamin A status

Population

Exclusion/
Inclusion
Criteria

Fasting

Loading
Doses of
Lactulose
and
2
Mannitol

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval

Central
Tendency
Measure for
L:M

6-60 mo old in- or
out-patients with
severe diarrhea.
Intestinal
permeability tests
could be performed
only for a subset of
inpatients.

Exclusion:
children with
dysentery,
metabolic
acidosis,
circulatory
impairment,
severe
electrolyte
disturbances, or
inability to take
oral fluids

Not reported A

5 hr

Enzymatic assay
Geometric
per Willumsen JF et mean (CI)
al. [207]

Not reported B

5 hr

Not specified per
Lunn PG et al.
[209]

Comparisons to
5
Other Studies

Normal value cut points: Not reported.
2000
Thurnham DI et al.
Innate immunity, gut integrity,
and vitamin A in Gambian and
Indian infants

Inpatients with
Not specified
diarrheal or
respiratory disease,
mean age 9 mos.
And out-patients
with “minor
ailments”, age not
specified.

Mean, type
not specified
(SE)

Normal value cut points: <0.12 based on UK norm per Lunn PG et al. [209]. Lunn PG et al. stated that UK infants’ norm as a mean (type not specified) (SD) of 0.12
(0.09), but did not portray the related data or cite another reference for this UK norm.
2009
Trehan I et al.
A randomized, double-blind,
placebo-controlled trial of
rifaximin, a nonabsorbable
antibiotic, in the treatment of
tropical enteropathy

3-5 yr olds from a
rural village.

Exclusion:
Overnight
chronic
debilitating
illness, congenital
abnormalities, or
severe acute
malnutrition

D

4 hr

HPLC per Shulman Mean, type
RJ et al. [212] and not specified
Scarpignato C et al. (SD)
[242]

Normal value cut points: <0.10 based on norms of 0.03-0.12 per Campbell DI et al. [112], Goto R et al. [205], and Galpin L et al. [120]. Campbell DI et al. reported mean
(type not specified) (SE) L:M of 0.353 (0.022) based on 26 Gambian 2-5 yr olds without diarrhea. They also reference UK norms but do not report specific values (see
above). Goto R et al. reported L:M values based on 158 Guatemalan infants aged 0-11 mo without diarrhea in preceding week. L:M median ranged from 0.41-0.54. They
also used 0.07 as a cut point for normal L:M based on another reference by Ford RP et al. [227] which did not report data relevant to L:M. Galpin L et al. reported
arithmetic mean (SD) L:M of 0.18 (0.16) and 0.22 (0.20) based on 2 groups of 80 and 81 healthy Malawian 3-5 yr old children, respectively.

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

Population

2008
2 mo-9 yr olds from
an impoverished
Vieira MM et al.
urban community.
Carotenoids, retinol, and
intestinal barrier function in
children from northeastern Brazil

Exclusion/
Inclusion
Criteria

Fasting

Loading
Doses of
Lactulose
and
2
Mannitol

Inclusion: HAZ
score
<community
median
Exclusion:
exclusively
breast-fed,
participants in
another study in
past 2 yr or
febrile illness at
enrollment

1 hr after
H
load, fasted
prior as well,
but duration
not
specified.

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval

Central
Tendency
Measure for
L:M

5 hr

Mean
(SD);
however, only
the
proportion of
normal
values was
reported
rather than
the mean

HPLC per Bao Y et
al.
[233], Lima, et al.
[234], and Barboza
MS et al. [214]

Comparisons to
5
Other Studies

Normal value cut points: <0.0864, calculated as mean + 2SD based on data from Barboza MS et al. [214]: mean L:M (type not specified) (SD) of 0.0394 (0.0235) based
on 15 Brazilian under-5s from low SES area without diarrhea in preceding 2 weeks.
2007
Williams EA et al.
A double-blind, placebocontrolled, glutaminesupplementation trial
in growth-faltering Gambian
infants

4-10 mo olds from
a rural area
followed during the
5-month rainy
season and for 6
months afterward

All age-eligible
children in the
study villages
were included

None predose
(stating
ethical
considerations);
2 hr postdose
(exception
of water
allowed)

Inclusion:
breastfeeding

Not
B
reported

F

5 hr

Not specified.
Geometric
Williams et al. cited mean, (CI)
Travis and Menzies
[201] generally
regarding L:M
assessment of
intestinal
permeability; it was
unclear which
aspects of Travis
and Menzies’
methods were
being referenced.

Normal value cut points: Not reported.
2000
Willumsen JF et al.
Subclinical mastitis as a risk
factor for mother-infant HIV
transmission

Infants of HIVinfected
breastfeeding
mothers, followed
up to 14 wk of age.

Normal value cut points: Not reported.

Not
specified

Enzymatic assay
None
per Willumsen JF et reported
al. [207]

Table 14. Comparisons of L:M test study methods and reporting frameworks.
Reference

1

2000
Zhang Y et al.
Lactulose-mannitol intestinal
permeability test in children with
diarrhea caused by rotavirus
and Cryptosporidium

Population

Exclusion/
Inclusion
Criteria

Fasting

Loading
Doses of
Lactulose
and
2
Mannitol

0-36 mo olds with
watery diarrhea
admitted to a
hospital oral
rehydration unit.

Inclusion: watery Not reported A
diarrhea and
stool positive for
rotavirus or
Cryptosporidium
Exclusion:
dysentery, history
of renal disease,
or current
antibiotic use

Urine
Laboratory
Collection Analysis Method4
Post
Loading
Dose Time
3
Interval
5 hr

Central
Tendency
Measure for
L:M

Comparisons to
5
Other Studies

Enzymatic assay
Arithmetic
and
mean (SE).
spectrophotometer. Also reported
raw data
allowing for
further
analysis by
the reader.

Normal value cut points: Not reported.
Abbreviations: AIDS=Acquired immune deficiency syndrome, CI=95% confidence interval, GI=Gastrointestinal, HAZ=Height-for-age Z (score), HFA=Height-for-age,
HIV=Human immunodeficiency virus, HPLC=High performance liquid chromatography, hr=Hour(s), L=Lactulose, L:M=lactulose:mannitol, M=Mannitol, mo=Month(s),
PD=Persistent diarrhea, SD=Standard deviation, SE=Standard error, TB=Tuberculosis, UK=United Kingdom, WAZ=Weight-for-age Z (score), WFA=Weight-for-age,
WHZ=Weight-for-height Z (score), wk=Week(s), yr=Year(s)

An important initial methodological consideration is that administration of a loading dose
is required; dosing among the studies we reviewed varied. Ideally, the dosing should be related
to body mass, or at least to body weight, in view of the large range in body size and composition
of the subjects to whom it is administered. Such dosing was reported to have been performed in
only 13 of the 25 L:M studies we reviewed. It should be noted that either or both of these
molecules can cause diarrhea via their hyperosmolar properties, and that sometimes the load
causes vomiting. These side effects, although not serious, might be more prominent among
children with certain characteristics thus skewing results. Indeed, the hyperosmolar effect is
proposed to potentially interfere with absorption by causing solvent drag (retention of the
measured solute in the gut), and has prompted consideration of a liquid meal with which to
administer these exomolecular probes of intestinal absorption and permeability [184].
Because gastric emptying could delay kinetics of absorption, a standard and perhaps
prolonged fasting interval should be employed. This presents a challenge when testing infants
who cannot tolerate fasts of greater than 3-6 hours depending on age, especially if exclusively
breastfed since breastmilk is easily and relatively quickly digested. Furthermore, even a threehour fasting interval may not be tolerated among acutely malnourished children. However,
fasting is most important for assessment of individual component measurements. Twelve of the
25 reviewed studies reported that the children were fasted prior to challenge, but the duration of
fasting differed across studies.
There are additional theoretical concerns with hyperosmolar sugar absorption tests.
First, there is evidence in humans that intestinal permeability can be altered by the
administration of such solutes [243, 244]. Second, there is a small degree of endogenous
mannitol production and excretion [243]. Third, the use of lactulose can accelerate orocecal
transit time [245]. None of these factors were mentioned by any of these studies. These
potential technical limitations have also not received much attention outside of the field of
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environmental enteric dysfunction in the last two decades. Both the individual mannitol and
lactulose component measures provide unique information as mentioned above, and thus
should be reported separately; nearly three-quarters of the studies we reviewed did so. Ideally,
the individual components should be presented as percent of dose administered, and also as an
(ideally standardized) osmolarity of the ingested probe. Of the 18 studies reporting that
components were measured separately, 11 presented results as such. Indeed, the report of
Lima et al. exemplifies the merit of reporting such metadata, as a paradoxically inverse
relationship between mannitol uptake and poor growth was identified [139].
Five-hour timed urine collections are considered standard. Timed urine collection among
infants and young children presents a challenge in the best of circumstances and it can be even
more challenging when subjects have loose stools, as is often the case among the very cohort
of children for whom assessment of intestinal permeability is desired. Urine collection times
varied across the studies in this review, and two did not report the information. Additionally,
urinary bacteria, either representing clinical bacteriuria or contamination and replication prior to
freezing, could alter sugar concentrations [246].
Laboratory detection method varied as described in Table 14. Limits of normal results
have not been determined for populations in resource-limited settings. Comparisons are made
to those derived from developed-country settings. Table 14 demonstrates the various norms,
primarily from the United Kingdom (UK), that were cited and referenced within the studies that
we reviewed. Furthermore, the results were reported in varying ways. For example, L:M values
can change with age of the subject, and in the setting of low urinary flow, as in dehydration, the
impermeability of the proximal tubule has not been adequately assessed in children.
Stratification of results based on age was often non-existent or suboptimal for determining its
contribution to high L:M values. Also, it was difficult to compare the same age groups between
studies. Perhaps the most striking deficiency was the lack of standard reporting of central
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tendency measures, which were variably provided as medians or means. The latter were
calculated as arithmetic or geometric means; the geometric method is more appropriate for ratio
measures such as L:M. Some studies did not report central tendency measures but only the
proportion with abnormal results. Among the 25 L:M studies we reviewed, three reported no
central tendency values, two reported medians, and 20 reported means. Of the studies reporting
means, 10 reported the geometric mean, which is a mathematically preferred expression of a
mean for ratios, while two reported arithmetic means, and eight reported means without
specifying their type. Clearly, despite the relative abundance of recent L:M data, the wide
variation in study and reporting methods hamper our ability to make inter-study comparisons.

5.3.1.2 Range of L:M Values Reported
The majority of studies that we reviewed found elevated L:M values in their subjects,
consistent with reports from before the interval of publication of papers that we assessed for this
systematic review (i.e., studies published prior to 2000). These elevated L:M values were largely
compared to norms reported for Western (primarily from the UK) childhood values [201, 217,
220, 223, 226, 235, 237, 238] and less often related to presumed norms of children in
developing-country settings [112, 120, 205, 214, 231, 234, 241].
Delineation of normal values is a challenge for several reasons. Normative curves are
often established based on assessments among a small sample of children in a developed
country. Two standard deviations are frequently used as cutoff point to define normal/abnormal
levels. However, this may not always be an appropriate method for a variety of reasons. Genetic
factors might or might not influence test results. Marker response to environmental exposures
might, at least initially, reflect adaptive rather than pathologic responses.
As noted above, comparison of L:M values across the 25 studies that we reviewed was
also challenged by differences in the way the values were reported (see Table 14). Among
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studies reporting the ratio results as geometric means, the values (ratios) ranged from 0.08 to
2.4 and both extremes were published by the same author group in two different studies,
although among different populations. The lowest (i.e. least abnormal) values were reported
among HIV-negative South African infants under four months of age born to HIV-infected
mothers [160, 161], while the highest values were found in children aged six to 60 months
hospitalized with severe diarrhea, also in South Africa [161]. The fact that the highest values
were an order of magnitude higher than in other studies reviewed led us to speculate that L:M
values might have been expressed as a multiple for portrayal on the same graph with urinary
neopterin and serum retinol-binding data.
Among children in rural Bangladesh, one study found a geometric mean L:M value of
0.15 [123]. In two different rural Bangladesh intervention trials, baseline L:M values were 0.18 in
each of the anti-helminthic treatment groups and 0.16 in the placebo group in the same setting
[122], but were 0.22 and 0.25 in a different rural setting also among anti-helminthic treatment
and placebo groups, respectively [150].
In Nepal, the mean L:M value among mildly stunted children aged 0-60 months was
0.26, but did significantly differ between those infected with Giardia (0.43) vs. those without
evidence of giardiasis (0.25) [124]. A series of studies conducted in The Gambia reported L:M
geometric mean values of 0.169 [110], 0.353 [112], and 0.31 [15]. Another study demonstrated
similar results, ranging from 0.26 to 0.37 in placebo-treated children, depending on month of the
study [170]. These studies support the concept of widespread intestinal permeability issues
among children in developing settings with considerable variation between studies, generally
finding a greater degree of permeability in central African settings.
However, in contrast to the Asian and central African studies, some South African [119,
160] studies found L:M values that were similar to established norms (i.e., mean values from
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healthy children in developed settings). These apparent contradictions could reflect the
emergence of the economies in which these children reside, with concomitant improvement in
gut health. Three [119, 160, 161] of the four L:M studies from South Africa presented geometric
means (notably, each of these four studies were performed by the same investigator group).
The fourth study [171] presented a subset of data published by Filteau et al. [119]. Filteau et al.
[119] and Rollins et al. [160] assessed L:M among infants born to HIV-infected mothers and
generally found normal values that did not increase with age. Filteau et al. also noted no change
in L:M measures with increasing morbidity. However, in both studies the mean value of L:M for
the infants who became infected with HIV was increased; the Rollins et al. observational study
reported a mean of 0.24 and the Filteau et al. intervention trial reported a mean of almost 0.5
among those whose mothers had not received vitamin A supplementation.
Similarly, some South American [137, 139] studies found L:M values that were similar to
mean values for healthy children. Six L:M studies from Brazil were conducted by one team of
investigators [113, 137-139, 156, 169]. Three of the studies reported baseline L:M values but
did not classify them as normal or abnormal [113, 137, 138]. Two studies assessing similar
populations of mildly malnourished children from an impoverished urban community in Brazil
[156, 169] reported that a high proportion of their subjects had abnormal L:M values. L:M
median and range data collected a few years later in the same setting and with the same
inclusion criteria were noted by the authors to be within the confidence interval for values of
healthy children in the study community [139] (the reference for this confidence interval was not
cited).
Several studies measured the variability of L:M values between and within individuals.
Some of these identified wide ranges [122, 124], and Campbell et al. [112] found that L:M
showed significant intra-subject correlation between tests conducted 3.5 months apart. In
contrast, Northrop-Clewes et al. [150] observed that intra-individual L:M values in the placebo
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group of an anti-helminthic trial did not change significantly over 12 months. Of note, L:M values
might change with increasing age because of normal changes of physiologic maturation.
However, the studies that we reviewed rarely reported data stratified by age, thereby prohibiting
rigorous comparisons from one study to the next.
Very few studies investigated longitudinal change in a measure of central tendency of
L:M values for their study sample. Campbell et al. found a small but significant improvement in
mean L:M value between the two study time points (from 0.198 to 0.172, type of mean not
mentioned), driven by an improvement in mannitol recovery with no change in lactulose
excretion [112]. The interval between sampling was 3.5 months.
Three studies observed seasonal variation in L:M values. Two of these studies were
conducted in rural Bangladesh; the timing of peak L:M values differed slightly between them. In
one study [122], the highest values were observed during the monsoon season while in the
other [150], the peak followed the monsoon season. A study in The Gambia reported monthly
variation in geometric mean L:M values, ranging from 0.37 in July to 0.26 in October in placebotreated children [170].

5.3.1.3 Associations between L:M and Growth Outcomes
The L:M test has been used extensively to assess small intestinal function in relation to
nutritional status in children in resource-limited settings. Several studies have found inverse
relationships between L:M and growth parameters, while others have not (Table 15). Goto et al.
[123] and Campbell et al. [110] found that L:M was inversely associated with height-for-age Zscores (HAZ) and weight-for-age Z-scores (WAZ). A longitudinal study by Goto et al. [122]
found associations between change in L:M and changes in weight-for-age Z-scores (∆WAZ) and
weight-for-height Z-scores (∆WHZ),showing improvement in growth parameters with decreased
L:M values. A later study by Campbell et al. [15] found that long-term height gain was negatively

141

associated with mean L:M value. Northrop-Clewes et al. [150] observed that L:M was inversely
correlated with change in height-for-age Z- (∆HAZ) and ∆WAZ scores at 12 months of follow-up.
However, several studies did not find an association between L:M and growth
parameters. Goto et al. [124] reported no association between L:M values and growth status,
although they did not specify which of the assessed growth measures (HAZ and WAZ) were
used to evaluate this. A 2003 study by Campbell et al. similarly found no association between
L:M and grade of protein energy malnutrition [111]. The same group earlier demonstrated that
L:M was inversely associated with HAZ after correcting for age, gender, and study visit, but not
with WAZ or body mass index z-scores [112]. In these studies, the association with HAZ was
mainly attributed to the greater lactulose excretion in subjects with poorer HAZ scores and was
constant across all age groups. There was no significant association between L:M calculated as
the mean of the two data collection points and change in nutritional status parameters.
Several factors complicate comparison of the relationship between L:M and growth
parameters across studies. Anthropometric indices used in these assessments varied. Markers
were sometimes associated with different anthropometric measures within the same study. In
one instance [112], a relationship was identified between L:M and HAZ score but not WAZ
score. When the relationship between L:M values and growth parameters is not reported, it is
not clear if the anthropometric indicator was either not evaluated or whether a significant
relationship was not identified (i.e., only positive results were presented). One study assessed
association with single sugar excretion only, reporting no significant associations between HAZ,
WAZ, or weight-for-height Z- (WHZ) scores and lactulose, but significant associations with both
WAZ and WHZ scores and mannitol [139]. The article did not mention HAZ score when
reporting the results of mannitol analyses, leaving unspecified whether the relationship was
assessed and found to be nonsignificant, or not assessed at all.
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Table 15. Associations between anthropometric indicators and biomarkers of EED.
Data presented are from one study unless otherwise indicated in parentheses.

Anthropometric
Z- score

L:M

HAZ

Y (3)
N (1)

∆HAZ
WAZ

Y (2)
Y (2)
N (3)

∆WAZ
WHZ

Y (2)
Y

Lactulose Mannitol Lactose:creatinine
N

Y

N

Y

Y
Y

N

Y

Y
Y

Urine Intestinal
Stool
Stool
nitric maltase
lactoferrin neopterin
oxide activity

N

Intestinal
lactase
Histopathology
activity
Y
By 2 of 3 digital
morphometric
1
measures : Y

Y
N

N

Y

By 2 of 3 digital
morphometric
measures*: Y
Endoscopy: N
Histopathology:
N (2)
Y (1)

Y
By 2 of 3 digital
morphometric
1
measures : Y

∆WHZ
Y
BMI
N
Y=yes, a statistically significant relationship was found.
N=no, a statistically significant relationship was not found.

1

The three digital morphometry measures included enterocyte height, enterocyte brush border, and enterocyte nucleus height. The two measures
that were significantly associated with anthropometric indicators differed for each type of anthropometric indicator assessed.

5.3.1.4 Associations between L:M and Other Outcomes
Four studies assessed the potential association between L:M values and Giardia
infection. Two found no association [15, 123]. A Bangladeshi antihelmintic trial [150] found that
L:M and giardiasis were not associated overall; they only identified an association among the
treatment group in their intervention trial at a single time point over the course of the 12-month
study period. In the fourth study, the geometric mean L:M among mildly stunted Nepalese
children from urban squatter settlements aged five years and under was 0.26, but statistically
significantly differed between Giardia-infected and non-infected children (0.43 vs. 0.25,
respectively) [124].
Several studies investigated the relationship between subject age and L:M values; three
found no association [113, 119, 124]. Goto et al. demonstrated a decreasing L:M trend with age
among a cohort of Bangladeshi 3-15 month olds [123]. Campbell et al. [112] compared
Gambian 2-5 year olds with older children and found a significant association between age and
L:M values as well as a small but statistically significant improvement in mean L:M over 3.5
months driven by improved mannitol excretion without change in lactulose excretion. They later
[110] reported study results among another cohort of Gambian children that showed that L:M
values showed a large and statistically significant increase between 12 weeks and one year of
age, a change driven by both increasing lactulose and decreasing mannitol excretion. Darboe et
al. [115] observed that L:M values rose by about 50% from age two months to one year, but did
not analyze the trend statistically.
Various studies examined the L:M marker in the context of other conditions. No
association was found between L:M and diarrhea history [124] or helminthiasis [150, 205].
Associations were found between L:M and infection with HIV [119, 160] and Cryptosporidium
and rotavirus [172]. Two studies reported seasonal L:M variation in rural Bangladesh, with
peaks during [122] or following [150] monsoon season.
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5.3.1.5 Use of the L:M Test as an Endpoint for Intervention Trials
Multiple studies have used the L:M marker as an endpoint to assess intestinal
permeability in randomized, controlled trials. The specific interventions varied widely, including
micronutrient supplementation, probiotics, therapeutic diets, and antibiotic and anti-helminthic
drug administration.
Four studies utilized L:M as an outcome in vitamin A supplementation intervention trials
and found no association with L:M overall [115, 119, 137, 168] although Filteau et al. did identify
a significant reduction in L:M values among HIV-infected children treated with vitamin A [119].
While Darboe et al. noted that a vitamin A-supplemented group experienced a reduction in
lactulose uptake, they also observed an accompanying decrease in mannitol absorption;
therefore the ratio of the two sugars did not change [115]. This finding demonstrates the value
of reporting the absorption of the two sugars separately, in addition to reporting the ratio. In
contrast, Chen et al. observed improved L:M values after treating a cohort with persistent
diarrhea or low WAZ with a single dose of vitamin A and a two-week course of daily zinc [113].
Lima et al. conducted two studies using L:M as an outcome to assess the beneficial
effects of formulas of different compositions used in therapeutic rehabilitation of children with
persistent diarrhea and/or malnutrition. In the study assessing glycine-supplemented formula,
L:M values improved in the treatment group [138]. However in a trial in which this group
examined alanyl-glutamine-supplemented formula, even though lactulose excretion improved,
mannitol excretion worsened and therefore L:M values did not change after the intervention
[139]. In another trial of glutamine supplementation, conducted by Williams et al. in The
Gambia, the intervention did not improve L:M values; in fact, analysis by repeated measures
analysis of variance (ANOVA) indicated that L:M values were borderline elevated in the
glutamine-supplemented group (p=0.05), contrary to what was expected [170].
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Another dietary intervention trial examined the efficacy of green banana and pectin
among children with persistent diarrhea [157]. While post-intervention L:M values were still
elevated, both lactulose and mannitol excretion improved after treatment, with lactulose being
the primary driver of the improvements seen in the ratio of these two sugars.
Four other trials examined the degree to which L:M values improved as a result of
various interventions, with no effect observed: probiotics [120] and antibiotics (rifaximin) [13] to
target small bowel bacterial overgrowth as a potential cause of impaired intestinal integrity in
Malawi, and various anti-helminthic and anti-Giardia treatments in Bangladesh [122, 150].
Interestingly, a Brazilian vitamin A trial demonstrated reduced lactulose as well as mannitol
excretion, but an unchanged overall ratio [137], thereby highlighting the value of reporting
absorption of the sugars separately.
In many of these studies, power considerations were not addressed at all, or
incompletely addressed, and were often subordinated to study realities. Several examples
illustrate the issue. Goto et al. recruited 222 children, into two treatment groups and one
placebo group [122]. They estimated their sample size based on baseline recent Bangladeshi
infant data [247]. They calculated that to improve HAZ by 33%, a sample size of 68 was needed
(using an α of 0.05, and 80% power). For WAZ, the sample size needed was 73. So, after
allowing for attrition, they aimed to recruit approximately 100 infants in each group. The antiGiardia treatment used in this study, secnidazole, is unpalatable, so there was concern that
there might be more attrition in those receiving this treatment. Therefore the treatment groups
were increased by about 10% relative to the control group (n = 142, 141 and 127, respectively).
However, because of large loss of subjects to follow-up as well as other methodological issues,
including inaccurate dosing by many subjects and switching to analysis on actual treatment
received rather than on an "intent-to-treat" basis, the final group sizes were 75 (secnidazole &
albendazole), 59 (secnidazole only), and 88 (control). Hence, the size of the second group fell
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below sample size targets for adequate power, while the other groups were still of sufficient size
for projected HAZ and WAZ outcomes.
Northrop-Clewes et al. [150] did not report sample size calculations, indicating that their
target sample size of 120 was based on logistical reasons. They went on to state “the null effect
of deworming in this study could perhaps have stemmed from an inadequate sample size or
duration of follow-up. However, significant improvements were observed in studies with smaller
samples (e.g., n = 23, n = 55, and n = 72; 42, 10, 11) and of much shorter duration (seven and
nine weeks) [248-250]". This comparison draws attention to the potential role of publication bias
in any review of the literature.

5.3.1.6 Associations between L:M and Other Markers
Five of the 25 publications examined L:M results in relation to other potential markers of
intestinal dysfunction, including one study that found that it was not correlated with urinary
lactose or lactose:lactulose [124]. Two studies assessed L:M and markers of systemic
inflammation and found differing results [110, 123]. A fourth study found no correlation with stool
neopterin [15]. The only study that we reviewed that examined L:M in relation to intestinal tissue
reported a variety of intestinal tissue measurements by morphometry and reported positive
correlation with mucosal B-lymphocyte density, intraepithelial lymphocytes (IEL), and IELs
staining positive for perforin [111]. It is not clear if the other intestinal markers were not
correlated or merely not assessed for correlation.

5.3.2 The Lactulose:Rhamnose Ratio (L:R)
Similar to the L:M, the lactulose:rhamnose ratio (L:R) has been used as an index of gut
mucosal function. As in the L:M test, lactulose is used as the measure of barrier function, but
rhamnose replaces mannitol as the marker of absorptive capacity. L:M is performed on urine
samples and, as mentioned above, in timed collections, ranging from three to six hours. The L:R
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test had been performed on similarly timed urine specimens as well. To our knowledge, there
are no published data comparing rhamnose directly to mannitol in children with enteric
dysfunction, but in adults with inflammatory bowel disease the two sugars are absorbed
comparably [251].

5.3.2.1 The L:R Test as a Reflection of Issues in Serum or Urine Sugar
Testing in Children
Recent advances in high-performance liquid chromatography (HPLC) now permit
sensitive detection of lactulose, mannitol and rhamnose in the blood. While timed blood
specimens have been evaluated in animals and human adults [252-256], the invasiveness of
repeated phlebotomies presents practical and ethical challenges in pediatric research. However,
collection of urine over a period of time in young children, while less invasive, is not a trivial task
either. While application of urine “bag” collectors permits noninvasive capture of urine, loss of
urine because of leakage around the bag is common, as is contamination by stool, especially
among children with diarrhea. Indeed, it should be noted that the children in most need of
intestinal function testing often have diarrhea, and the ingestion of the sugar loads themselves
can lead to osmotic diarrhea.
Haase et al. compared the validity of L:R testing on one-time collections of blood to 5hour urine collections [125] in children. They found that blood L:R values were consistently
lower than urine L:R values by a geometric mean (95% confidence interval (CI)) of 1.09 (1.02,
1.16). There was substantial agreement between the two tests as measured by a kappa statistic
of concordance (95% CIs) of 0.71 (0.51, 0.92). Assuming urine L:R as a gold standard, Haase
et al. calculated sensitivity and specificity of blood L:R as 81% and 89% respectively.
As discussed above, test failure can occur for various reasons when tests rely on urine
samples, particularly timed samples. However, test failure can also occur with blood specimens
because of insufficient volumes collected to run the assay, and potentially from edema if blood
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is obtained by finger stick [257]. In addition, the assay cannot be performed using either analyte
if children vomit, or refuse to ingest, the sugars. Haase et al. defined test “failure” as emesis of
the sugar load, urine leakage or contamination with stool, or blood collection insufficient for
analysis (<0.25 mL of plasma). While they did not delineate the reasons for failure among the
blood vs. the urine collections, they did observe a significantly higher failure rate for the urine
(37%) compared to the blood assays (10%) (p<0.0001). Interestingly, a study published in 1999
(and therefore not included in the analysis of this systematic review) by the same authors also
reported a 37% failure rate for urine L:R testing and in this earlier study they specified the
proportions by cause of failure. They noted that the failure rate for a five-hour urine collection
varied between 47% (32 of 68) in girls with acute diarrhea to 17% (14 of 82) in non-diarrheal
controls. They also noted that causes of test failure consisted of vomiting or refusal to drink the
probe sugar solution in 21 (9%) of the tests [258].
The remaining four studies that used L:R as a marker of gut permeability measured
these ratios in blood specimens. We found that rates of technical failure of testing were not
often reported in the sugar absorption/permeability studies that we reviewed. Of the four studies
using serum L:R, two discussed failure to complete testing. One study specifically reported
difficulty with venipuncture in two of 34 subjects [159]. In the other study, L:R was measured at
baseline as well as following an intervention with specific milk formulas [134]. It was not entirely
clear, but it did seem that baseline L:R testing was successfully completed on all subjects while
there was a reported “failure” of post-intervention testing among 10 of 150 children. Reasons for
test failure in the second determination were not reported. Among the five studies that used Dxylose (either urine or serum) [136, 146, 147, 152, 155] no mention was made of lack of
completion of testing among the subjects enrolled. Only seven [124, 138, 139, 150, 161, 169,
172] of the 25 urinary L:M studies included in this review specifically mentioned the number of
children who completed L:M testing compared to the number recruited into the study. It was not
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always clear why incomplete L:M testing occurred, but it appears that in five of these studies
there was a failure in testing because of improper compounding of the sugar solution, inability to
collect urine during the testing period, urine leakage or stool contamination, or refusal to ingest
the sugar solution. Similar to the study that expressly measured and reported failure rates in L:R
testing [125], Goto et al. reported in 1999 (and therefore not included in this review) that the L:M
test failure rates were 32% [205].
It should be noted that each of the five L:R studies in this review was conducted by the
same researchers in Darwin, Northern Territories, Australia (one of their studies also included
subjects from Adelaide, South Australia, Australia). It appears that some of the studies might
represent data from overlapping cohorts of children. It should also be noted that while Australia
clearly falls within the classification of a high income country, our inclusion definition of children
in “developing-country setting” included marginalized or indigenous populations in a developed
country who are plausibly exposed to the same environmental and/or infectious risks for EED as
children in developed-country settings. In fact, research among Aboriginal populations in
Australia has contributed a great deal to the EED field [58, 258].

5.3.2.2 Range of L:R Values Reported and Associations with Growth
Outcomes
Many investigators report the L:R value multiplied by 100 for ease of reporting; this
convention was followed within the articles examined for this review. The geometric mean was
the measure of central tendency consistently used in these studies, facilitating comparison of
results. However, while the L:M studies referenced various ranges of normal standards, none of
the L:R studies cited such reference standards. Furthermore, the three studies that reported the
proportion of children with abnormal L:R results used different cutoff points and did not cite
references for these demarcations of normal and abnormal values that they employed. One
study defined an abnormal L:R value as >16, with 20 of 32 children (63%) exhibiting values
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above this threshold [159], another used 7.2 as their defined cutoff point with 112 of 152
subjects (74%) above that threshold [43], and a third explained the derivation of its cutoff point
of >5.6 as two standard deviations above the arithmetic mean for non-Aboriginal children
without diarrhea [58]. No citation was given for this standard value, implying that it might have
been derived from the data collected in this study. However, the authors reported that none of
the study’s non-Aboriginal children without diarrhea had abnormal permeability values,
suggesting that perhaps the cutoff point was derived from a different study. While their study
included Aboriginal children with diarrhea, they did not report proportions of children with L:R
values >5.6 for this group.
Three studies compared serum L:R values among primarily Aboriginal cases with
diarrhea and controls without this disorder. Baseline geometric means for L:R (95% CIs) in the
two studies ranged from 3.7 (2.8, 4.9) [134] to 5.9 (4.4, 7.8) [125] to 11.4 (8.5, 15.5) [159]
among controls and 9.4 (6.7, 13.1) [125] to 12.8 (10.3, 16.0) [134] to 31.8 (24.9, 40.7) [159]
among cases.
In a randomized trial of three different milk formulas in Aboriginal children with
malnutrition and/or diarrhea, baseline geometric mean L:R values (95% CIs) were 14.9 (10.4,
21.5) in one treatment group; baseline values were similar in the other groups [134]. Although
subjects were randomized to treatment groups, the study did not include a control arm of
standard care to which change in L:R could be compared. Mean improvement in L:R (95% CIs)
was 13.0 (9.3, 16.6) with some significant differences across treatment groups. This was the
only study in this review using L:R as an outcome measure in an intervention trial.
A similar study reported that mean L:R values among Aboriginal children were
approximately double those of non-Aboriginal children, whether examining across groups of
subjects either with or without diarrhea, consistent with the authors’ suggestion that clinically
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silent enteric dysfunction is prevalent among Aboriginal children [58]. Geometric mean L:R
among the children without diarrhea was 2.5 and 4.6 among non-Aboriginal and Aboriginals,
respectively (p=0.02). Geometric mean L:R among those with diarrhea was 7.9 and 16.4 among
non-Aboriginals and Aboriginals, respectively (p=0.002).
One study examined the relationship between L:R and growth and found no association
with nutritional status or age. Associations were, however, found between high L:R and acidosis
(p=0.007), hypokalemia (p=0.035) and diarrhea severity (p=0.001) among children with diarrhea
[58].

5.3.2.3 Associations between L:R and Other Markers
Serum L:R was compared to other biomarkers for EED in three of the other four studies.
Ritchie et al. found L:R to be significantly inversely correlated with the 13C sucrose breath test
(r=0.67; CI: 0.42, 0.62; p<0.0001) [159]. Kukuruzovic et al. studied urinary nitric oxide excretion
in relation to L:R in Aboriginal and non-Aboriginal in-patients with acute diarrhea, nongastrointestinal infections, or without infections or diarrhea [43]. They found that
NO2/NO3:creatinine and L:R were correlated (r=0.37, p<0.001), after adjusting for age and race.
The association was stronger for lactulose permeability, with an effect ratio (95% CIs) of 1.47
(1.29, 1.66), than it was for rhamnose malabsorption, with an effect ratio (95% CIs) of 0.80,
(0.67, 0.97). NO2/NO3 concentrations decreased significantly less rapidly than L:R values
among children recovering from diarrhea. Another study by Kukuruzovic et al. assessed the
association between L:R and red cell indices, stool reducing substances, and lactosemia and
identified an association only with the latter, but the degree of correlation was minimal [58].

5.3.2.4 Methodological Issues with the L:R Test
Overall, there were fewer issues with consistency in reporting of L:R results across
studies, perhaps because all of the L:R studies in our review were performed by the same group

152

of investigators. Four of the five studies reported a measure of central tendency for L:R and it
was consistently in the form of a geometric mean multiplied by 100. Dosing of the sugars was
the same across the studies. The timing for serum sampling was similar, with most using a
collection time of 90 minutes following administration of the dose; only one study differed
slightly, with testing occurring in a range between 90 to 120 minutes. HPLC was the test method
for the serum L:R throughout. However, in striking contrast to the L:M studies, reference
standards for L:R values were not cited. The three studies that reported proportions with
abnormal L:R values used markedly different cutoff values that were either not defined or given
insufficient explanation.
The urinary L:R test has disadvantages typical of any urinary method for dual-sugar
permeability testing; the serum method avoids these issues, and, indeed, Haase et al. found a
lower test failure rate with this method.

5.3.3 Serum and Urinary Lactose
As mentioned above, we assigned markers to categories based on their best fit,
recognizing that biomarkers could indicate derangement of more than one function. For
example, lactose is not normally absorbed across the intestine, but rather requires breakdown
to products that are absorbed, namely galactose and glucose. This digestion is catalyzed by
lactase, an intestinal brush border enzyme. While the presence of lactose in the serum or urine
would in most instances indicate a lack of lactase (as opposed to presence of lactose excessive
to lactase saturation), it also, and primarily, reflects a permeability defect, because even if
lactose is not broken down, its size should preclude traversing the mucosa unless a porosity
defect also exists.
We identified three studies that measured lactose in the blood (n=1) or urine (n=2) in the
context of putative intestinal injury. Kukuruzovic et al. tested markers of intestinal permeability,
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including serum lactose, among hospitalized Aboriginal and non-Aboriginal children with and
without diarrhea [58]. Circulating lactose was detected in 38% of Aboriginal cases and 12% of
controls (Aboriginal and non-Aboriginal combined). Lactosemia was weakly associated with an
abnormal L:R. Another study of children from two urban squatter settlements with high rates of
malnutrition primarily focused on identifying lactase deficiency via urinary lactose:lactulose,
finding that nearly half of subjects had low lactase activity [124]. Urinary lactose concentration,
as well as lactose:lactulose ratio, decreased with increasing age, but neither was associated
with the L:M. The authors noted that lactose concentrations and lactose:lactulose ratios were
significantly higher in breastfed subjects than those not breastfed, despite similar L:M values.
However, the paper did not specify the nature of the dietary lactose sources in the nonbreastfed babies. That is to say, if the bioavailability of the lactose or the quantity ingested is
low, mucosal function could appear to be inappropriately normal. The final study measured the
lactose:creatinine (L:Cr) ratio in Nepali children living either in squatter settlements or lower
middle-class periurban households [151]. Mean L:Cr was significantly higher among the
squatter compared to the lower-middle class group. For both SES groups, L:Cr values
decreased with increasing age (p<0.001). HAZ, WAZ, WHZ, and ∆WAZ scores were strongly
associated with mean L:Cr (p<0.001 for each parameter) as was ∆HAZ score (p=0.004); ∆WHZ
score was not. Interestingly, the strength and magnitude of association between ∆WAZ score
and L:Cr was most pronounced among the wealthier cohort and there was no association
between ∆HAZ score and L:Cr among the squatter children, perhaps because of poor diets
accounting for more of an effect among the squatter children.

5.3.4 Summary of Markers of Permeability
Despite logistical challenges, the L:M and L:R tests and other tests of permeability have
been utilized extensively to assess intestinal function in children in resource-limited settings.
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L:M values were often, but not always, elevated above published developed country
norms in community-based studies of asymptomatic children in resource-limited settings. The
other tests of permeability generally were not compared to a reference standard, limiting
comparison of results across studies and different settings.
The L:M test was more extensively studied than the other permeability markers and was
used more widely as an endpoint for intervention trials, including evaluation of micronutrient
supplementation, dietary interventions and probiotics, and anti-bacterial and anti-parasitic drug
treatments. L:R was used as an outcome measure for one intervention study. With new HPLC
laboratory methods that are sufficiently sensitive to detect lactulose, rhamnose and other
sugars, dual sugar tests might become more widely used.
While we identified two studies that compared serum L:R to serum lactose [58] and L:M
to urinary lactose and lactose:lactulose [124], we did not find comparisons of L:M and L:R test
results; a head-to-head comparison of the two most extensively used permeability tests would
be informative.
The relationship between L:M and age varied across studies; some observed an
association [110, 112, 115, 123], while others did not [113, 119, 124]. The single study that
investigated the relationship between L:R and age did not find an association [58]. Furthermore,
while most studies found an inverse association between L:M and anthropometric status, results
were mixed. One study investigated the relationship between L:R and growth, and did not
observe an association [58].
As with the D-xylose and endomolecular tests of absorption, lack of consistency in what
was used as a cutoff point for normal (or what was reported to have been used) in the dual
sugar permeability tests made it very difficult to compare results from one study to the next.
Across permeability tests, we found a wide spectrum of depth of reporting and insufficient
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details were often provided. The L:M studies best portrayed issues with methodology, reporting,
and poor comparability caused by wide differences in how the test was performed across
studies, differences in subject preparation and feeding mode, dosage of test sugars, and timing
of urine collection, all of which can influence test results. Further complicating comparability, the
measures of central tendency for reporting L:M varied.
While L:R tests have been conducted by evaluating the different biological sampling
media of urine or serum, the serum test was used much more widely in the last decade and
serum tests have been conducted in a much more standard manner than the urinary L:M test.
Urinary L:R has disadvantages typical of any urinary method for dual-sugar permeability testing;
the serum method avoids these, and Haase et al. [125] found fewer test failures with this
method.
We found only one example of the urinary lactose:creatinine test having been employed
in a pediatric population in a resource-limited setting [151]. The lactose in the urine is waste
from endogenous metabolism of ingested material, and the creatinine is also a waste product
naturally present in the urine. Testing endogenous metabolites eliminates the need for a loading
dose as well as a post-dose delay of multiple hours for sample collection, which are inherent
parameters of dual-sugar tests. These aspects of the L:Cr test could provide advantages
compared to dual-sugar tests in resource-limited settings. However, in comparing the tests, it
will be important to consider other parameters such as sample processing, as well as the
comparative accuracy and reproducibility of the different tests. Recent data on the use of the
L:Cr ratio to assess intestinal permeability in pediatric populations in resource-limited settings is
scarce. None of the studies from our review assessed both L:M and L:Cr ratios in the same
individuals, so it is not possible to compare the tests directly from the available data.
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It should be noted that many elements of this chapter, especially pertaining to the L:M
test, were published in 2014 [185].

5.4 Markers of Digestion
Twelve studies [43, 53, 58, 102, 109, 124, 132, 138, 147-149, 159] utilized a variety of
markers that reflect intestinal digestive function. The particular data relevant to this review are
listed for each of these studies in Evidence Table 3. Thirteen markers were assessed across the
studies: eleven and two were markers of carbohydrate and lipid digestion, respectively. Testing
for reducing substances in the stool was used in four studies as a marker of nonspecific poor
digestion of sugars [43, 58, 132, 138]. Two other studies used biopsied intestinal tissue to
measure specific disaccharidase activity or mRNA abundances [53, 109]. Three studies tested
exhaled breath to assess maldigestion of lactose or sucrose [102, 147, 159].
One study employed urine lactose:lactulose ratio as a marker of lactase function [124].
Lastly, two studies, both by the same investigators, assessed intestinal lipid digestive capacity
by measuring total triglyceride compared to fatty acids in the stool [148, 149].
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Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest
2002
Alves GM et al.
Nutritional status
and breath hydrogen
test with lactose and
lactulose in Terena
Indian children
Lactose hydrogen
breath test (HBT) as
a marker of lactase
activity, and
lactulose HBT as a
marker of SBBO
2003

Location and
Target Population

Design and
Sample Size

Limão Verde and
Cross-sectional
Córrego Seco, Mato
Grosso du Sul, Brazil n=264;
All children <10 yr
old were recruited
from these rural
villages.

Cochabamba,
Bolivia

Bustos M et al.
3-34 mo old
Disaccharidase
Amerindians
deficiency in Bolivian hospitalized with PD
children with
and moderate or
persistent diarrhea severe malnutrition
in an urban setting.
Jejunal biopsy and
disaccharidase
activities in children
with PD and different
forms of malnutrition

<5 yr old: n=145

Biomarker

Results

Conclusion

Comments

Breath Tests:
• Lactose HBT
(251 tested)
• Lactulose HBT
(252 tested)

Lactose HBT:
• Elevated: 27.1% among all
subjects
• Borderline: 43.0% among all
subjects
• 0% of subjects <4 yr had
elevated or borderline results

The prevalence of
lactase deficiency as
measured by lactose
HBT was >25%, but
non-existent among
those <4 yr of age.

Assessment of
association
between lactulose
and lactose
absorption was not
reported.

(However results
were provided by
<4 and >4 yr old
age groups.)

Cohort
n=42 cases with
PD and
malnutrition:
• 2 with
kwashiorkor
• 20 with
marasmus
• 20 with
marasmickwashiorkor

Lactulose HBT positive:
• 11.5% of all subjects
8.6% of subjects <4 yr

Jejunal tethered
capsule biopsy:
• Histopathology
• Disaccharidase
activity:
• Lactase
• SucroseIsomaltase
• Maltase

Most subjects had mild to
moderate (score of 2-3)
histological abnormalities, with
one kwashiorkor patient having
completely flat villi.

Second biopsy showed a trend
of improved mucosa, but
difference was not significant
based on histology score,
intraepithelial lymphocyte
Histology was scored density, or degree of infiltration
of lamina propria.
on a scale of 1
(normal) to 4 (severe
Percentages with enzymatic
Children were
morphological
activity below normal at
assessed on
damage or flat
baseline, discharge:
admission and at mucosa).
• Lactase: 64%, 59%
three weeks, after
• Sucrase-isomaltase: 97%,
diarrhea had
90%
resolved and
anthropometrics
• Maltase: 45%, 52%
were improving.
All changes were statistically
significant.
Lactase recovery was
associated with admission HAZ
(p=0.05) and WAZ (p=0.03)
scores.

Prevalence of SBBO as
assessed by lactulose
HBT was ~10%.

Patients had diminished
intestinal disaccharidase
activity and substantial
pathology on biopsy at
admission and at three
weeks, despite clinical
improvements and
tolerance of lactosecontaining formula.

Spanish language
article.
Values for
subnormal
disaccharidase
activity were not
provided.
The magnitude of
lactase inverse
association with
growth parameters
was not reported.
Authors did not
report whether they
had tested for
associations
between maltase or
sucrose-isomaltase
and growth
parameters.

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest

2002

Location and
Target Population

Kathmandu, Nepal

Design and
Sample Size

Cross-sectional

n=210
0-5 yr olds (mean
age 3.8 yr) from two
Poor intestinal
urban squatter
permeability in mildly settlements.
stunted Nepali
children:
37% and 33% of
Associations with
subjects were
weaning practices
stunted and
and Giardia lamblia underweight,
infection
respectively.
Goto R et al.

Biomarker

Lactulose and mannitol results were expressed as % of dose administered.
Lactose results were expressed in mg/L.
3
Geometric mean.
2

Conclusion

Despite continued high
disaccharidase deficiency
prevalence at discharge, all
children tolerated the lactosecontaining formula challenge.
L:M:
• 92% had values >UK norms
3
• Mean L:M (SD, range): 0.26
(0.21, 0.04-1.71).
• Giardia-infected versus
uninfected means: 0.43 vs.
0.25, p=0.014

L:M ratios were high
overall.

Urine Tests:
1
• Lactulose
• Mannitol
2
• Lactose
(168 tested)
• L:M
(158 tested)
• Lactose:lactulose
The duration of ingestion of solid
ratio
foods (with or without concurrent
(157 tested)
breastfeeding) was not
associated with L:M in
multivariate analysis.

L:M as a marker of
intestinal
permeability, and
assessment of
association with
giardiasis,
helminthiasis,
nutritional practices,
and growth status.

1

Results

Comments

Low lactase activity
was defined as
lactose:lactulose
Wide individual variation ratio >0.4.
was observed in L:M
Specific L:M data
ratios.
by WAZ and HAZ
L:M was associated with scores were not
reported, although
giardiasis but not
authors state that
helminthiasis.
L:M was not
associated with
Urinary lactose
“growth status.”
concentrations and
lactose:lactulose ratios
L:M was correlated with longer were significantly higher
in breastfed subjects
duration of breastfeeding
(r=0.27, p<0.019). Specifically, than in those that were
children who breastfed for >2 yr not breastfed, despite
similar intestinal
had higher L:M ratios than
permeability values.
children who breastfed for
shorter times (data not
There were some
provided).
unexpected findings: the
duration of
L:M was not associated with:
• History of diarrhea in the week breastfeeding, and not
the timing of introduction
preceding testing
of solid foods, was
• Helminthiasis
correlated with L:M, and
• Age
the correlation was
• WAZ or HAZ scores
direct, not inverse.
Lactulose excretion ranged from Authors speculate that
0.02–15.00. Mannitol excretion this could be due to
higher mean age of their
ranged from 0.5–15.00.

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

cohort compared to
47% showed low lactase activity. another study that
Lactose values and
demonstrated beneficial
lactose:lactulose ratios
effect of duration of
2
decreased with age (R =28%,
breastfeeding on
p<0.0001), but were not
reduced L:M in
associated with sex, ethnicity,
Guatemala [205].
and location nor were they
associated with L:M.
1

Mean urinary lactose
concentrations (mg/L) by feeding
mode:
• Breastfed: 172.5
• Non-breastfed: 44.5, p<0.0001
corrected for infant age
2

Mean lactose:lactulose ratio by
feeding mode:
• Breastfed: 2.76
• Non-breastfed: 0.31,
p<0.0001 corrected for infant
age
Mean L:M by feeding mode:
• Breastfed: 0.23
Non-breastfed: 0.28, nonsignificant, p-value not specified
2002
Port-au-Prince, Haiti Case-control
Stool Tests:
Proportion RS-positive:
Fecal lactoferrin was
identified most often in
• Reducing
• 33.3% cases
Kirkpatrick BD et al. <18 mo olds from a n=49;
children with diarrhea,
substances (RS) • 64.7% diarrhea controls
low SES setting
• Lactoferrin
• 46.7% healthy controls, (p=0.2) especially in those with
Cryptosporidium. While
n=17 cases with • Cytokines:
Cryptosporidiosis
recruited from the
Cryptosporidium
stimulates an
rehydration unit of
• TNF-α receptor Proportion lactoferrin-positive: some fecal cytokines
and diarrhea (5
inflammatory
GHESKIO HIV
were detected in as
• 83.3% cases
I
3
with PD)
intestinal response Center with
many as 40% of healthy
• 60.0% diarrhea controls
• IL-4
diarrhea and
in malnourished
controls and 70% of
• 28.6% healthy controls,
• IL-8
Cryptosporidium
n=32 controls
Haitian children
controls with diarrhea,
(p=0.01)
• IL-10
without
infection. Controls
they were generally
• IL-13
1

Geometric mean.
Geometric mean.
3
The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections.
2

Reported results
were not stratified
by persistent vs.
acute diarrhea
status.
Cut-off values for
lactoferrin positivity
were not described.
Stools from children

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest
Stool lactoferrin,
reducing
substances,
leukocytes and
cytokines as
markers of intestinal
inflammation of
children with and
without
Cryptosporidium
infection

Location and
Target Population

Design and
Sample Size

recruited from an
outpatient clinic
without
Cryptosporidium
infection included
those with and
without diarrhea.

Cryptosporidium;
• IFN- γ
• 17 with diarrhea
(5 with PD)
Blood Test:
• 15 healthy
WBC

Biomarker

Results

Conclusion

Comments

IFN-γ was not recovered in any associated with
who were
Cryptosporidium
stools.
breastfeeding were
infection. The other stool not tested for
All other fecal cytokines were
tests did not discriminate lactoferrin.
significantly associated with
by diarrhea or
Cryptosporidium cases
Cryptosporidium status.
compared to diarrhea and
healthy controls.
Additionally, TNF-α receptor I,
IL-8, IL-13 were found in
diarrhea and healthy controls,
while IL-4 and IL-10 were not.
Fecal lactoferrin was associated
with the presence of TNF-α
receptor I (point estimate not
provided, p=0.03).

Mean WBC counts were within
normal range in all 3 groups.
2003
Darwin,
Case-control
Urine Test:
NO among Aboriginal children
Australia
Nitric Oxide (NO)*
with diarrhea was >3x higher
n=318;
than any other group and >5x
Kukuruzovic R et al.
higher than in non-Aboriginal
1-6 yr old Aboriginal
controls.
Increased nitric
and non-Aboriginal n=169 cases with Blood Tests:
oxide production in hospital inpatients. AD
• L:R
• NO was >3x and >2x higher
(154 Aboriginal) • Mean corpuscular
acute diarrhea is
among Aboriginal than nonassociated with
Subjects were
Aboriginal children in the
volume (MCV)
abnormal gut
grouped as follows: n=149 controls:
diarrhea (p<0.001) and no
permeability,
1. Children with AD • 73 with non-GI
infections groups (p<0.001),
hypokalemia and
2. Children with no
infections (49 Stool Test:
respectively, but there was
malnutrition in
diarrhea but with
Aboriginal)
no difference between them
Reducing
tropical Australian
non-GI infectious • 76 with no
in the non-GI infections
substances (RS)**
aboriginal children
conditions
group.
infections (29 (169 cases tested)
3. Children without
• NO was >3x and ~2x higher
Aboriginal)
Nitric oxide (NO) as
GI or infectious
in the diarrhea compared to
a marker of intestinal conditions
the no infections group
* NO is an unstable
permeability and
among Aboriginals
free radical and is
inflammation, and
(p<0.001) and nonconverted to nitrite
lactulose:rhamnose
Aboriginals (p<0.03),
and nitrate. Urine
ratio (L:R) as a
respectively.
nitrate (NO3)+ nitrite
marker of intestinal
•
NO
was virtually the same
(NO2) was expressed

NO2 + NO3:Cr ratio, as a
measure of endogenous
nitric oxide production,
was used as a marker of
gut permeability and
inflammation, with an
attempt to identify how
much more it reflects as
response to
inflammation from GI vs.
non-GI infections.
Among non-Aboriginal
controls, NO production
was the same among
those with diarrhea and
non-GI infections (and
higher compared to
controls). NO was
highest by far among
Aboriginal children with
diarrhea compared to

Positive stool RS
was defined as
>0.5%.
Abnormal L:R was
defined as >7.6; no
reference or
derivation was
provided for this
cut-point.
Study population
appears to be the
same as in another
Kukuruzovic, et al.
study also included
in this review which
assessed serum
lactulose:rhamnose
as a marker of
intestinal
permeability [58].

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
permeability and the
relationship between
NO and L:R, growth
parameters, mean
corpuscular volume
(as a surrogate of
iron deficiency), and
stool reducing
substances among
children with and
without diarrhea

2002
Kukuruzovic RH et
al.
Small bowel
intestinal
permeability in
1

Darwin, Australia

Design and
Sample Size

Biomarker

Conclusion

Comments

as a ratio with urine
creatinine (NO2 +
NO3:Cr) in order to
account for
differences in urine
concentration.

among the Aboriginal non-GI any other group. Authors
infections and no infections suggest that high basal
groups, as well as among
concentrations of NO
the non-Aboriginal diarrhea among Aboriginal
and non-GI infections
children due to (clinically
groups.
silent) enteropathy could
explain the
112/152 (74%) and 31/169
** Measured only
concentrations seen
among children with (18%) of children with AD had
among Aboriginal
abnormal L:R ratios and positive controls in this study.
profuse diarrhea.
stool RS, respectively.
NO appeared to
NO and L:R were measured at decrease significantly
“convalescence” on Day 5
more slowly than L:R
among those with diarrhea: the among children
mean improvement in NO was recovering from
21.7% compared with 54.6% for diarrhea.
L:R (p=0.01).
NO was found to
correlate with L:R. NO
NO and L:R were correlated
was more strongly
1
(n=193, r=0.37, p<0.001) ; the correlated with lactulose
correlation was stronger for
than rhamnose.
lactulose (effect ratio=1.47,
p<0.001) than for rhamnose
2
(effect ratio=0.80, p=0.02 ).

Case-control

Blood Tests:
• Lactose
Cases were
n=375 admissions • Lactulose 4
Aboriginal and non- for 306 children; • Rhamnose
Aboriginal children
• L:R
admitted to hospital n=285 case
• Hemoglobin
with diarrhea.
admissions for
• Mean corpuscular
Controls were
AD (264

Reported results appear to have been adjusted for age and race.
Reported results were adjusted for age and race.
3
Reported results among children with diarrhea were adjusted for age and race.
4
Lactulose and rhamnose results were expressed as % of dose administered.
5
Geometric mean.
2

Results

NO was not correlated with stool
3
RS or MCV, but was correlated
with lower WAZ score (effect
ratio=0.88, p=0.05).
27/75 (36%) of Aboriginal
controls and 0 non-Aboriginal
controls had abnormal L:R
ratios.
5

Mean L:R at baseline:
Cases:
• Aboriginal: 16.4

Mean L:R ratios of
Aboriginal children were
approximately double
those of non-Aboriginal
children both among
those with and without
diarrhea, consistent with
authors’ suggestion that

Positive stool RS
was defined as
>0.5%.
Abnormal L:R was
defined as >5.6,
derived from 2 SD
above the

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest
Australian Aboriginal
children

Location and
Target Population

Design and
Sample Size

Aboriginal and non- Aboriginal)
Aboriginal children
admitted without GI n=90 control
Serum lactulose:
admissions with
illnesses.
no diarrhea (74
rhamnose ratio
Aboriginal)
(L:R), serum lactose,
and stool reducing
substances as
markers of intestinal
permeability among
Aboriginal and nonAboriginal children
with and without
diarrhea

Biomarker
volume (MCV)

Stool Test:
Reducing
substances (RS)*

Results

Conclusion

• Non-Aboriginal: 7.9, p=0.002

clinically silent
enteropathy is prevalent
among Aboriginal
children.

compared to Aboriginal cases
Controls:
• Aboriginal: 4.6
• Non-Aboriginal: 2.5, p=0.02
compared to Aboriginal
controls
1

L:R testing was
Mean improvement in L:R (CI)
repeated on day 5 for at day 5 among those with
a subset of Aboriginal repeat testing:
subjects:
• Aboriginal cases: 14.6 (11.2,
• 174/264 admissions 18.0)
for acute diarrhea • Aboriginal controls: -0.63 (4.0, 2.7)
• 25/74 control
admissions
2
Mean lactulose recovery :
• Cases day 1: 0.085 (0.070–
0.103)
* Measured only
•
Cases day 5: 0.039 (0.033–
among children with
0.046)
profuse diarrhea
• Controls: 0.024 (0.019–0.029)
when “clinically
indicated". Number All 3 values significantly differed
tested not provided. from one another.
Mean rhamnose recovery:
• Cases day 1: 0.479 (0.424–
0.542)
• Cases day 5: 0.555 (0.498–
0.616)
• Controls: 0.585 (0.500–0.685)
These values did not
significantly differ from one
another.
Confidence intervals (CIs) in the
authors' graphical representation
of mean L:R at admission did
not overlap, and the difference in

1

Comments

arithmetic mean for
non-Aboriginal
controls in this
study. The rationale
for the choice of 2
Mean L:R significantly SD above the
arithmetic, instead
improved over 5 days
among Aboriginal cases. of the geometric,
Children with severe
mean is not clear.
Proportions of
diarrhea had higher
cases with
mean L:R.
abnormal
concentrations
Higher case L:R was
were not reported.
driven more by high
lactulose than by low
Analysis included
rhamnose.
Similarly, improvement data for 69 children
in L:R among cases was with repeat
primarily due to
admissions; this
might violate
decreased lactulose.
independence
Stool RS and serum
assumptions for
their statistical
lactose were found in
analysis methods.
approximately onequarter and one-third of
Repeat L:R testing
Aboriginal cases,
respectively. The latter was conducted on
was weakly associated controls of both
with increased lactulose. racial groups, but
among cases it was
only conducted on
Aboriginal cases.
This study appears
to report on the
same population as
in the Kukuruzovic,
et al. 2003
reference also

Improvement in L:R appears to have been calculated as baseline L:R minus repeat L:R, as described in another publication in this review; however, this was not expressly stated.
Reference 134. Kukuruzovic RH, Brewster DR. Milk formulas in acute gastroenteritis and malnutrition: a randomized trial. J Paediatr Child Health, 2002. 38(6):571-577.
2
Figures reported parenthetically after the mean percent recoveries of lactulose and rhamnose were not specified as ranges or CIs.

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

means was particularly evident
between Aboriginal and nonAboriginal subjects.
Factors associated with L:R
1
among cases were :
• Acidosis (p=0.007)
• Hypokalemia (p=0.035)
• Diarrhea severity (p=0.001)
Age and malnutrition were not
associated with L:R.

Comments
included in this
review, which
assessed nitric
oxide excretion
[43].
Authors reiterate
the advantages of
serum over timed
urine collection for
assessment of L:R,
as discussed in
another publication
in this review [125]

38% and 27% of Aboriginal
cases had positive serum
lactose and stool RS,
respectively. 12% of Aboriginal
and non-Aboriginal controls
combined had lactosemia.

2005
Lima AA et al.

Fortaleza, Brazil

2-60 mo olds
hospitalized with
Intestinal barrier
WAZ score <-2,
function and weight ~70% of whom had
gain in malnourished PD.
children taking
glutaminesupplemented
enteral formula

RCT
n=80;
n=53 received
supplemented
formula
• 27 with glycine
• 26 with
glutamine
n=27 received

L:M as a marker of
1

Urine Tests*:
3
• Lactulose
• Mannitol
• L:M

Stool Tests**:
• Lactoferrin
• Leukocytes
• Occult blood
• Reducing
substances (RS)

Reported results were adjusted for confounding variables, unless otherwise noted.
Reported results were adjusted for severity of diarrhea, acidosis, hypokalemia, and age.
3
Lactulose and mannitol results were expressed as % of dose administered.
4
Type of mean not specified.
2

Presence of lactosemia was
associated with L:R, adjusted
relative risk (CI)=1.06 (1.03,
2
1.10) . Stool RS, anemia, and
MCV were not associated with
L:R.
4
Mean L:M (SE):
L:M significantly
• Glutamine group:
improved in the
glutamine group only.
• Baseline: 0.31 (0.10)
(similar in all three groups)
>50% of subjects had
• Day 10: 0.10 (0.02);
intestinal inflammation
significant decrease,
by stool lactoferrin.
(p=0.01)
• No significant decrease in L:M Fecal leukocytes, RS,
and occult blood were
in glycine and
detected in fewer
nonsupplemented formula
subjects than lactoferrin.
groups at day 10

The relationship
between stool
markers and L:M
was not reported.
Data were not
stratified by history
of PD.
Fecal fat was
assessed, but
results were not
reported.

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
intestinal
permeability and
various stool tests
among children with
malnutrition or PD
who received either
glycine or glutamine
supplemented
formula or placebo

Design and
Sample Size
nonsupplemented
formula

2002

Hermosillo, Sonora, Case-control
Mexico
n=13;
Moya-Camarena SY
3-6 yr olds in a
et al.
<5 yr old:
periurban setting
attending preschool n=5
Effects of
centers meeting
asymptomatic
Giardia intestinalis inclusion criteria of n=7
no GI symptoms, no asymptomatic
infection on
cases infected
antibiotics in the
carbohydrate
absorption in well- preceding 3 wk, and only with G.
intestinalis
nourished Mexican no SBBO by
lactulose HBT and
children
n=6 controls
Indican test.
without Giardia
Lactose hydrogen
breath test (HBT) as
a marker of lactose
Cases were
absorption, and
evaluated before
xylose breath test
and urinary excretion
and 3 wk after
as markers of xylose
treatment with
1

Biomarker

D-xylose results were expressed as % of dose administered.

* n=80 tested at
enrollment, n=65
tested at day 10.

Results

Conclusion

Mean lactulose (SE):
• Glutamine group:
• Baseline: 0.97 (0.46)
(similar in all three groups)
• Day 10: NS decrease in all
3 groups

Cut-off values for
lactoferrin positivity
were not described.
Exclusively
breastfed children
were excluded from
study participation
due to assessment
of stool lactoferrin.

** n=60 tested.
Mean mannitol (SE):
• Glutamine group:
• Baseline: 3.42 (0.64)
(similar in all three groups)
• Day 10: NS decrease in all
3 groups

Breath Tests*:
• Lactose HBT
• D-Xylose HBT**

Urine Test:
,1
D-xylose**

* Reported as parts
per million (ppm)
post-substrate
ingestion after
subtraction of
baseline, presubstrate H2
concentrations. A
positive HBT is
considered to be a
rise of >20ppm in
breath H2 above

Proportion of stool markers at
baseline among all subjects:
• Lactoferrin: 53.3%
• Leukocytes: 11.7%
• RS: 3.3%
Occult blood: 5.0%
Mean lactose HBT (SE):
• Cases pre-treatment: 3.6
(0.75) ppm
• Cases post-treatment: -0.85
(0.75) ppm (p<0.05 compared
to pre-treatment)
• Controls: 0.19 (0.81) ppm
(p<0.05 compared to pretreatment cases)
Mean xylose HBT (SE):
• Cases pre-treatment: 2.2
(0.69) ppm for infected group
• Cases post-treatment: -4.16
(0.69) ppm (p<0.05 compared
to pre-treatment)
• Controls: 1.13 (0.74) ppm (NS
compared to pre-treatment
cases)
Mean urinary excretion of xylose

Comments

Lactose HBT
concentrations were
normal according to
established cut-points
among all subjects.

Statistical methods
might not have
been adequate to
account for intrasubject correlation
when comparing
However, lactose HBT the same group of
was significantly higher subjects (cases)
among cases compared before and after
treatment.
to controls and there
was also a significant
decrease in lactose HBT Investigators
among cases after
wished to exclude
treatment. The clinical children with SBBO.
relevance of such mildly As such, inclusion
elevated HBT results in criteria restricted
participants to
asymptomatically
those with
infected children is
adequate
unclear.
production of H2
Results did not
following ingestion

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest
absorption in wellnourished children
with asymptomatic
giardiasis and noninfected controls

Location and
Target Population

Design and
Sample Size
tinidazole. Posttreatment stools
were verified for
absence of
parasites.

Biomarker
baseline H2
concentration.

Results

Conclusion

(SE) among cases pre-treatment demonstrate xylose
and post- treatment was 34% (3) malabsorption by either
and 46% (11), respectively (NS), urinary or breath
** Investigators did well above cut-offs indicative of measures among any
not specify the xylose malabsorption.
group. While urinary
enantiomer used,
results did not differ
however test
before and after
functionality
treatment, case xylose
characteristics lead
HBT was significantly
us to assume that it
lower after treatment;
was the dextrorotary
again the clinical
(D) enantiomer.
significance of such
results is not apparent.
2002
Kingston, Jamaica Case-series
Stool Tests:
Median total stool excretion of High concentrations of
13
13
C in phase 1 was 9% (range:
C (compared to
• Total and
13
n=24
1%-29%) and did not vary
Murphy JL et al.
5-23 mo olds
healthy UK children)
fractionated C
between TG groups.
admitted to the
[190] were observed in
following
13
Maldigestion and
Tropical Metabolism
ingestion of one Median C excretion dropped half of the subjects at
13
33%-99% in phase 2 and 86%- admission, reflecting
malabsorption of
Research Unit of the Subjects were
of three C
divided into 3
95% in phase 3 compared to
dietary lipid during University of the
impaired digestion or
labeled
groups of 8
severe childhood
West Indies with
absorption.
triglycerides (TG): phase 1 (p<0.05 each).
malnutrition
severe malnutrition. children, each
trilaurin, triolein,
group receiving a or trilinolein*
Over the study period, there
The differences in stool
13
different labeled • 13C stool assay
were significant associations
C were wide but not as
Stool recovery of
triglyceride.
between total lipid and the
extreme as in a previous
radiolabeled
following
13
amount of C labeled TGs in
study by same
products as markers
administration of
Data were
stool for some groups, but not
investigators (also
of lipid digestion and
labeled fatty acid
collected in three 13C glycocholate** for others.
examined in this review)
absorption, and bile
separate phases
using a different TG
salt deconjugation
13
as described
Median C in TG and FA was (tripalmitin) substrate
as a marker of
above in JL
similar across TG groups in all [149].
SBBO among
* To assess fat
Murphy et al.
children with severe
excretion as a % of phases. 13C FA recovery was
13
2001 [149].
C excretion did not
malnutrition
dose administered. similar and reduced by ~2/3
13
compared to Phase 1. C TG
significantly differ
Also assessed
13
proportion of C in was not detectable in Phases 2 between TG groups and
declined with improving
triglyceride (TG) and or 3. Statistical comparisons
between
phases
were
not
clinical course.
fatty acid (FA)
reported.
fractions to
Similar to their previous
distinguish excretion
13
C after radiolabeled
study, significantly more
caused impaired
13
digestion (presence glycocholate administration was C in stool was
detected in stool at quantities
recovered as FA than
of TG) vs. poor
TG, reflecting impaired
absorption (presence considered to be in excess of

Comments
of lactulose and
with minimal urinary
indoxyl sulfate
excretion. The
number of children
excluded due to
failure to meet
these criteria was
not reported.

Authors state that
the study was not
powered to
compare the
different TGs, but
they contend that
medium chain
trilaurin did not
appear to be
processed
differently than the
longer chain TGs
triolein and
trilinolein.
Authors did not
describe the
method used to
assign subjects to
different TG groups.
While it was noted
that some subjects
had positive stool
cultures, details
were not provided
on the nature of the
enteric infections.

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker
of FA).

Results

the 7% recovery of dose
administered upper limit of
** To assess bile salt normal in U.S. adults in [189]:
deconjugation in the • Phase 1: 13/24 (54%)
• Phase 2: 5/24 (20.8%)
bowel caused by
• Phase 3: 3/24 (12.5%)
SBBO; conducted
after the TG
assessment and a 3
day washout period.
2001
Kingston, Jamaica Case-series
Stool Tests:
Mean fecal fat (SD):
• Phase 1: 2.4 g/day (3.6) or
• Fecal fat*
7-23 mo olds with
n=8
Murphy JL et al.
5.9% (9.4) of dietary lipid
• Total and
13
malnutrition admitted
intake
fractionated C
Gastrointestinal
to the University of
• Phase 2: 1.7 (0.9) g/day, or
assay after
Data were
handling and
the West Indies.
3.3% (2.4) of intake
administration of
metabolic disposal of
collected in three 13C tripalmitin
• Phase 3: 0.9 (0.6) g/day, or
13
C-labelled
separate phases
1.4% (0.7) of intake
(TP)**
13
(each lasting 9
• Differences between phases
tripalmitin during
• C assay after
days):
were not statistically
rehabilitation from
administration of
1. Within 48 hours 13C glycocholate
significant.
childhood
of admission
malnutrition
(GCA)***
13
2. During early
Total excretion of C in stool
also varied widely across
Fecal fat, stool
rehabilitation
3. During late
patients (0%-44%) and did not
recovery of
Breath Tests:
13
differ between study phases.
rehabilitation
radiolabeled
• CO2 after
products, and breath
administration of
13
Correlation between fecal fat
tests as markers of
C glycocholate
13
and C (r=0.48; p<0.05) was
lipid digestion and
(GCA)***
13
observed.
absorption and bile
• CO2 after
salt deconjugation
administration of
13
Lack of lipid digestion and
as a marker of
C TP****
absorption were assessed by
SBBO among
measuring TG and FA fractions,
children with severe
13
respectively. Mean C TG
malnutrition
* In 72 hour stool
collection (measured recovery (SD) (% of
as total grams and as administered dose), number of
patients excreting TG:
% of dietary fat
• Phase 1: 0.7% (1.6), n=3
intake).
• Phase 2: 0.9% (2.8), n=1
• Phase 3: no recovery from
** To assess fat
any subjects, differences
excretion as a % of
between phases were NS
dose administered.
Also assessed

Conclusion

Comments

absorption over poor
lipid digestion/
hydrolysis. Unlike in their
previous study, there
was evidence of SBBO
as measured post13
ingestion of C
glycocholate.
Mean fecal fat was not
elevated compared to
published norms [191,
192] during any study
phase.

Statistical methods
might be
inappropriate for a
small sample.

All subjects were
There was wide variation treated with
in fecal fat at
antibiotics including
presentation, and wide metronidazole for
13
presumptive SBBO;
variations in stool C
across subjects. Authors this might have
indicate that this is the affected GCA
first such assessment in testing.
malnourished children;
previous studies on
healthy children from the
UK demonstrated
average excretion of 6%
[190].
The majority of excreted
13
C was in the form of
FA rather than TG.
Authors interpreted this
to reflect failure of lipid
absorption in the face of
adequate digestion/
hydrolysis. Each form
(FA and TG) was found
in decreasing values as
the study phases
progressed, suggesting
improved digestion and
absorption, although

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker
13

proportion of C in
triglyceride (TG) and
fatty acid (FA)
fractions to
distinguish excretion
caused by impaired
digestion (presence
of TG) vs. poor
absorption (presence
of FA).

2000

Sao Paulo, Brazil

Nichols B et al.

Cases were children n=33;
(mean age 9.9 mo,
SD 8.1) hospitalized n=24 cases
with malnutrition
refractory to dietary n=9 controls
rehabilitation.

Contribution of
villous atrophy to
reduced intestinal
maltase in infants
with malnutrition

Controls were

Case-control

Subjects were

Results

Conclusion

13

results did not differ
significantly.

C FA fraction in stool declined
during rehabilitation.
13
Mean C FA recovery (SD):
• Phase 1: 6.0% (7.3)
• Phase 2: 4.8% (3.7)
• Phase 3: 3.3% (3.8),
differences between phases
were NS

Comments

Fecal fat was correlated
with concentrations of
13
C in stool.
There was no evidence
of SBBO or bile acid
malabsorption.

Mean FA values were ~9x (NS),
13
5x (p<0.001), and 3x (p<0.05)
CO2 excretion following
13
higher than mean TG values in administration of C TP
*** To assess bile
salt deconjugation in Phases 1, 2, and 3, respectively. was minimal, suggesting
a propensity for
the bowel caused by
Following administration of
deposition in adipose
SBBO; conducted
13
labeled TP, absorbed C label tissues rather than
after the TG
oxidation for immediate
assessment and a 3 by breath analysis was ~5%
energy needs. The
day washout period. (range 0%-21.2%) and similar
across study phases.
authors report that this
breath test has not been
**** Expressed as a
Following the administration of widely used, but that
percentage of
absorbed label (dose labeled GCA, there was either healthy UK children
13
administered - label no or minimal recovery of C in have breath excretion
13
recovered in stool) to stool and CO2 on breath (as % values from 15%-43%
[190], compared to a
assess oxidation for of dose administered) in all
mean of 5% and range
acute energy needs. phases.
0%-21% in this cohort;
the latter findings were
more similar to results
from kwashiorkor
13
patients where Clabeled oleic acid was
used as substrate [193].
Jejunal capsule
Mean villous atrophy score (SD): The malnourished
Tissue from
biopsy:
• Cases: 2.6 (0.8)
children had significantly patients requiring
• Controls: 1.2 (0.5), p=0.006) greater villous atrophy
intestinal resection
• Histopathology*
as part of their
than
the
younger
• Maltase activity
WAZ
score
was
correlated
with
biliary atresia
controls.
• Intestinal
villous
atrophy
(r=0.65,
pvalue
management
messenger RNA
not reported).
Among the subset tested provides an
(mRNA)
for mRNA messages,
opportunity to
abundances:
13/25 [sic] cases and 0/5
maltase activity as well assess presumably
• Maltase“normal” intestinal
glucoamylase controls had subnormal (defined as the mRNA

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest
Jejunal biopsy,
maltase activity, and
enzyme messenger
RNAs among
malnourished and
well-nourished
children. Assessed
association between
maltase and villous
atrophy and other
mucosal intestinal
markers indicative of
loss of enterocytes
and enterocytic
function.

Location and
Target Population

Design and
Sample Size

children (mean age
3.6 mo, SD 1.0) with
HAZ and WAZ
scores >-2 and
normal intestinal
mucosa on biopsy,
hospitalized for
Kasai procedure for
biliary atresia.

matched on
height and
weight; ages
differed within
matched sets.

Biomarker

Results

(MGA)
as <94 U/g protein) of maltase
activity; mean maltase was 34%
• Sucraseisomaltase (SI) lower among cases (p=0.11).
Maltase activity did not appear
• Villin, a
to decrease with WAZ score
structural
(further details not provided).
protein
expressed only
in enterocytes However, in sub-analyses
among those samples with an
• Sodiumadequate β-actin, a
activated
housekeeping gene message,
luminal
(n=10 cases, n=9 controls),
glucosecases’ findings expressed as a
galactose
mean percent of controls' (SD)
transporter 1
included:
(SGLT), a
• Villous length (reciprocal of
functional
atrophy score): 38.9 (41.6),
protein
p=0.004
expressed only
in enterocytes • Maltase activity: 37.1 (23.2),
p=0.001
• β-actin
• MGA mRNA: 45.1 (36.4),
p=0.016
•
Villin mRNA: 52.5 (22.6),
* Mucosal atrophy
p=0.003
was scored on a
scale of 1 (absence • SGLT mRNA: 66.6 (23.1),
p=0.057
of atrophy compared
to an organ donor) to • β-actin: 88.2 (15.8), p=0.189
4 (similar to children
Both villous length and maltase
with active CD).
activity in a subset of cases
were less than 40% of control
Histology among
values.
controls was on
surgically resected
MGA, villin, and SGLT mRNA
tissue.
abundances were correlated
with villous atrophy score
(r=0.73), (r=0.76), and (r=0.54),
respectively (p-values not
1
reported) .
MGA mRNA abundance was

1

Villin and SGLT1 were assessed as a ratio with housekeeper gene β-actin.

Conclusion

Comments

abundances for MGA,
villin and SGLT were
significantly correlated
with case status and
were correlated with
villous atrophy.

architecture.
However, unless
they mocked up ex
vivo mucosal
biopsies in these
controls, resections
will have lower
While maltase deficiency proportions of
has been reported in
villous to
submucosa tissue
malnutrition in other
studies, authors assert compared to cases’
samples derived
that these are the first
from mucosal
results that directly
support the hypothesis biopsies. While this
probably doesn’t
that reductions in
maltase activity are due affect histology, it
to villous atrophy. This might affect
enterocyte
study also nicely
functional assays
correlates mRNA
relative abundance with and mRNA
determination, as
function.
transmural tissue
will bring in more
diverse populations
of cells; only some
of them might have
transcripts of
interest. However,
the bias is likely in a
direction that would
reduce effect size.
It was unclear if
control inclusion
criteria included
absence of atrophy
or if all potential
controls lacked
atrophy.
Statistical methods

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

correlated with maltase activity
(r=0.32).

2009

Blood Tests:
• L:R
n=43;
Ritchie et al.
(32 Aboriginal
4 mo-5 yr old
cases and controls
13C-sucrose breath Aboriginal children n=18 Aboriginal
tested)
test: novel use of a admitted to hospital cases with AD
• C-reactive protein
with diarrhea.
noninvasive
(CRP)
n=25 controls:
biomarker of
• Mean Corpuscular
Two control groups: • 18 Aboriginal,
environmental gut
Volume (MCV)
1. Aboriginal controls without diarrhea • Hemoglobin
health
admitted to
• 7 nonSucrose breath test
hospital with non- Aboriginal,
(SBT) as a marker of GI symptoms
healthy
Breath Test:
13
small bowel mucosal (50% had
C sucrose breath
1

Geometric mean.

Darwin and
Adelaide, Australia

Case-control

20/32 (63%) of Aboriginal
children had abnormal L:R
ratios.
1

Mean L:R (CI):
• Diarrhea cases: 31.8 (24.9,
40.7)
• Aboriginal controls without
diarrhea: 11.4 (8.5, 15.5),
significant difference
(p<0.0001)
SBT Mean (CI):
• Diarrhea cases: 1.9% (0.9,

Comments
might not have
adequately taken
into account the
small sample size
and matching
scheme.

SBT values were
significantly lower and
L:R values were
significantly higher
among Aboriginal
children with diarrhea
than among those
without GI symptoms.
SBT was also
significantly lower
among Aboriginal
controls than among
non-Aboriginal children
without diarrhea. This is

Subsets of subjects
were investigated
for various tests.
For example, 10
cases had mRNA
analyses based on
β-actin adequacy.
Another instance of
selected testing
was the subset of
22 and 15 cases
that had WAZ score
to histology and
mRNA correlation
analyses,
respectively.
Rationale for subset
selection was not
thoroughly
described.
Abnormal L:R ratios
were defined as
>16; no reference
or derivation was
provided for this
cut-point.
L:R test was not
conducted among
the non-Aboriginal
controls.
SBT/ L:R
correlation analysis

Evidence Table 3. Markers of digestion.
Biomarkers in bold are categorized as primarily markers of digestion.
Reference and
Location and
Design and
Study Outcomes of
Target Population
Sample Size
Diagnostic Interest
damage vis a vis
pneumonia)
sucrase activity
2. Healthy, nonamong an Australian Aboriginal controls
recruited from
Aboriginal
community
population. Also
compared SBT with
serum
lactulose:rhamnose
ratio (L:R)

Biomarker

Results

Conclusion

test (SBT)

3.0), p<0.0001 compared to
non-Aboriginal controls and
p=0.004 compared to
Aboriginal controls
• Aboriginal controls: 4.1% (3.0,
5.2), p=0.032 compared to
non-Aboriginal controls
• Non-Aboriginal controls: 6.1%
(4.8, 7.3)
Significant differences were
observed between all three
groups.

consistent with previous
reports of high
prevalence of clinically
silent TE in this
population.

SBT results were not associated
with wasting or with patient age
or breastfeeding status.
SBT and L:R were inversely
correlated (r=0.67; CI: 0.42,
0.62; p<0.0001). L:R explained
45% of the variance in SBT;
diarrhea explained 28% of
variance.

Comments

was based on data
for Aboriginal cases
and controls
combined; stratified
analysis was not
reported and could
be of interest
SBT was significantly
inversely correlated with considering the
large difference in
L:R.
L:R observed
between these
groups.
Associations of
MCV, CRP, and
hemoglobin with
SBT after adjusting
for potentially
confounding
variables were not
reported.

SBT was associated with
increased MCV, relative risk
(CI)=3.9 (2.8, 5.0). SBT was not
associated with hemoglobin or
CRP.
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects.
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s.
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting.
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval,
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins,
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G,
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score),
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s)

5.4.1 Sucrose and Lactose Breath Tests
Three studies used breath tests to detect the presence of lactose (n=2) [102, 147] or sucrose
(n=1) [159] in the intestines after administration of a loading dose activity. These disaccharides should, in
normal intestinal health, be split by the brush border enzymes lactase or sucrase to glucose and
galactose or fructose, respectively. While these breath tests also reflect intestinal capacity to absorb these
monosaccharides, we classified them as markers of digestive function first and foremost, because
enzymatic cleavage of the ingested sugars is a cardinal intestinal process required for absorption to take
place. Breath tests can measure various molecules in exhaled breath, most commonly hydrogen.
Normally, very little hydrogen is detected in breath after an overnight fast; however, hydrogen is produced
when undigested substances such as lactose are fermented by intestinal bacteria. The sucrose breath
test (SBT) assessed in this review measured exhaled CO2, a normal by-product of disaccharide
metabolism which will be found in reduced amounts if there is reduced sucrase activity. Because
genetically ordained age-associated lactose intolerance becomes common beyond infancy in many
populations irrespective of intestinal mucosal health, the possibility exists that sucrase activity might serve
as a better marker of overall intestinal function because such age-related decline in tolerances are not
known to be associated with sucrose.
CO2 exhalation in the SBT was significantly lower among Aboriginal children with diarrhea
compared to those without gastrointestinal symptoms, as well as among Aboriginal controls compared to
non-Aboriginal children without diarrhea. SBT results were not associated with age, breastfeeding status,
or wasting [159]. SBT results were significantly inversely correlated with L:R values (r=0.67), but this was
assessed among all Aboriginal subjects (cases and controls) combined. L:R values differed largely
between these groups; it would be useful to investigate the relationship between SBT and L:R stratified on
diarrhea status. SBT results were also associated with one other marker, mean corpuscular volume, but
were not associated with blood C-reactive protein, an index of systemic inflammation, or with hemoglobin,
concentrations of which can be reduced for a variety of reasons, including acute and chronic systemic
inflammation. While this study suggests that SBT is a promising diagnostic test for EED, this was the only
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publication that analyzed the SBT in children in a developing country setting or among marginalized
populations during the time period under review.
Two studies utilized hydrogen breath tests (HBT) to assess lactase function [102, 147]. Each study
also assessed either lactulose or D-xylose as substrates using the HBT. These two substrates for breath
hydrogen analyses are primarily used to identify small bowel bacterial overgrowth (SBBO) and
malabsorption, respectively, and as such they are discussed in those sections. Prevalence of abnormal
lactose absorption differed between these two studies. Lactose absorption among indigenous Brazilian
children with mild malnutrition was abnormal in more than one fourth of the subjects [102]. In wellnourished Mexican children, HBT values in cases with asymptomatic giardiasis were only mildly elevated
but remained below concentrations that have been used as criteria for lactose malabsorption [147]. Cases
had HBTs before and after anti-giardiasis treatment. The pre-treatment HBT excretion was significantly
higher compared to controls without giardiasis and to post-treatment values. The clinical relevance of
such mildly elevated HBT results in asymptomatically infected children remains unclear, however.
The discrepancy in results between the studies was unexpected, and the reason for it remains
unclear. Both studies used the same cutoff for normal values, but the proportions of children with lactase
deficiency were quite different. The differences might reflect numerous factors including differences in
age, nutritional status, and age-related lactose intolerance. Another potential contributing factor is the
exclusion of children with SBBO from the Mexican study but not from the Brazilian study, in which greater
than 10% of the subjects had SBBO by lactulose HBT. An additional complication in assessing mucosal
function, at least in children four years of age and older, is that there is a high prevalence of genetic
lactase deficiency in many of the populations at risk for enteropathy, including in Latin America, Africa and
Asia [259] and among Native Americans [260].
Neither of the HBT studies assessed the relationship of the test with growth outcomes in a
statistically interpretable manner. While the Mexican study found normal D-xylose absorption by breath
hydrogen testing in case (and control) subjects, neither this study nor the Brazilian study statistically
analyzed the association between growth and the lactose HBT.
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5.4.2 Stool Reducing Substances
Reducing substances are those that reduce copper salts in a hot solution to a chromogenic less
oxidized state. These substances include glucose, lactose, fructose, galactose, and pentose. Like breath
tests, reducing substances can indicate malabsorption, but also primarily identify maldigestion. This test
has been used for decades to differentiate diarrhea secondary to infection from that caused by
noninfectious intestinal dysfunction, particularly lactose intolerance. A condition of the test is that it must
be performed on liquid stool.
Four studies [43, 58, 132, 138] assessed the prevalence of stool reducing substances to
investigate digestive pathology. The proportion of positive tests for stool reducing substances among
subjects varied widely across studies. Only 3.3% of Brazilian children hospitalized with malnutrition or
persistent diarrhea had positive tests for stool reducing substances (definition of positive not provided)
[138]. In contrast, tests in Haitian children with and without diarrhea were positive for stool reducing
substances in one-third of those with diarrhea and cryptosporidiosis, in two-thirds of those with diarrhea
but no evidence of Cryptosporidium infection, and in nearly half of controls without diarrhea [132], though
the accuracy of this test on non-diarrheal stools is assumed to be inadequate because the non-absorbed
sugars reportedly partition to the aqueous phase [261]. Hence, finding these sugars in solid stools, while
unexpected, probably indicates of some degree of maldigestion. Again, cutoff points defining positivity
were not provided, and there was no statistical difference between groups for this parameter (p=0.2).
Two studies investigated reducing substances among Aboriginal and non-Aboriginal Australian
children with diarrhea; a positive result was defined as stool containing sugar concentrations >0.5 %. In
the first of these, one-quarter of Aboriginal diarrheal cases tested positive for stool reducing substances
[58]. In the subsequent study by the same authors almost one-fifth of children with profuse diarrhea tested
positive [43].
Only one study of reducing substances examined its association with clinical outcomes, and this
study found that the marker was associated with severity of diarrheal illness [58]. The same study found
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that among subjects with diarrhea, a positive test for reducing substances was associated with high L:R
by univariate analysis, but the association did not hold up in their multivariate model. Another study also
examined the association between reducing substances and urinary nitric oxide among Aboriginal and
non-Aboriginal children with acute diarrhea, but found none [43].

5.4.3 Intestinal Disaccharidases
Two studies assessed intestinal disaccharidase activity as a marker of digestive pathology on
jejunal specimens obtained by capsule biopsy--Bolivian children with persistent diarrhea and malnutrition
[109] and Brazilian children with refractory malnutrition [53]. Of note, the latter study utilized a unique
control group, children without severe malnutrition undergoing intestinal resection as part of the
management of their biliary atresia. Both studies assessed the proportion of children with maltase
activities that were below normal, and the Bolivian study also measured sucrase-isomaltase and lactase
activities. Both studies reported similar prevalences of abnormally low maltase activity in approximately
half of the subjects with enteric dysfunction, but only one of these studies provided a defined cut point for
abnormal (<94U/g protein) [53]. The deficiency in other disaccharidase activities was not as prevalent as
that of maltase. In addition to maltase activity, the Brazilian study also measured abundance of
messenger RNA for maltase-glucoamylase (MGA) and sucrase-isomaltase in small intestinal tissue, and
found that they were correlated with the activity of maltase at the messenger RNA abundance.
The Brazilian study found no association between WAZ score and tissue maltase activity (no other
details were provided), while the Bolivian study found that intestinal lactase concentrations were
significantly and positively associated with WAZ and less strongly associated with HAZ at admission.
Unfortunately, they did not detail the magnitude of these associations or report if they assessed maltase
and sucrase-isomaltase association with growth parameters. Because intestinal disaccharidase activity is,
by its nature, measured on intestinal tissue, it was relatively straightforward for these studies to assess
marker association with intestinal histopathology. Maltase-glucoamylase (MGA) mRNA abundances were
strongly correlated with both maltase activity and villous atrophy. The Bolivian study did not attempt to
correlate disaccharidase activity with histopathology.
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5.4.4 13C Assessment in Stool after Lipid Administration
Two studies by the same group of investigators in the same setting [148, 149] with a total sample
size of 32 severely malnourished children assessed digestion by administering radiolabeled lipids. They
then measured the amount of radiolabel excreted in the stool in the forms of triglyceride (TG) and fatty
acid (FA), with recovery of fatty acids interpreted to indicate adequate lipid breakdown but poor absorption
while recovery of triglycerides marked poor digestive function. Both studies found widely varying

13

C in

stool, although the variation was less marked in their later study; however the sample size was only eight
patients [148].
In both of these studies, the majority of excreted 13C was in the form of FA rather than TG,
reflecting a failure of lipid absorption in the face of adequate digestion. Each labeled lipid form (FA and
TG) was found in decreasing concentrations as the study progressed, suggesting improved digestion and
absorption, although concentrations did not differ significantly with time.
The two studies differed in their findings related to small bowel bacterial overgrowth; the first study
[149] found no evidence for bacterial overgrowth while the second [148] did, as measured by the recovery
of label in the stool after ingestion of 13C glycocholate.
The first of these studies [149] additionally investigated fecal fat as a marker and found that it was
associated with concentrations of 13C in stool.

5.4.5 Urinary Lactose:Lactulose Ratio
We considered serum and urinary lactose to be primarily measures of gut permeability, as
described above. As a large molecule, lactose should not enter the system unless there is a permeability
defect. It should be recognized, however, that presence of lactose in the serum or urine could be
complicated by lactase deficiency. However, lactase deficiency without a permeability defect would not be
expected to result in the presence of lactose in the blood or urine. When urinary lactose is normalized
against another marker for permeability, the lactose:lactulose ratio is primarily a marker of lactose
digestion. One study assessed this marker and found that nearly half of subjects had low lactase activity,
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defined as lactose:lactulose ratio >0.4 [124]. Urinary lactose and lactose:lactulose ratios significantly
decreased with age and were significantly elevated among breast-fed compared to non-breastfed infants,
adjusting for age, despite similar intestinal permeability values as measured by L:M. The markers were
not associated with sex, ethnicity, or location. Lactose and lactose:lactulose ratios were not associated
with L:M.

5.4.6 Summary of Markers of Digestion
A broad range of markers was used to assess digestive function in children in resource-limited
settings. Intestinal disaccharidases were affected in subjects with persistent diarrhea and/or malnutrition.
The sucrose and lactose HBTs showed varying degrees of digestive disturbance across studies with
subjects of differing health conditions. Results for maltase activities were consistent across the two
studies in which they were sought in intestinal tissues. Several different methods were used to assess
intestinal enzyme capacity, and results between methods were consistent where comparable.
Few markers of digestion were investigated in relation to biopsy or tests of intestinal permeability.
Breath tests in particular lacked comparison to other standard markers.
Varying associations were observed between markers of digestion and growth parameters. The
sucrose breath test was not associated with growth [159]. The studies of intestinal disaccharidases found
different results for different enzymes; one study found no association between maltase and wasting while
the other found an association between lactase and growth parameters [53, 109]. The relationship
between abnormal markers of digestion and growth outcomes was not reported for either hydrogen breath
tests or stool reducing substances.
The sucrose breath test results were significantly associated with the L:R; the concentration of
exhaled hydrogen was inversely associated with the L:R [159]. This test might be useful as a noninvasive
marker of enteric dysfunction, although replication of these results is needed before a judgment as to their
value can be made.
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5.5 Markers of Intestinal Inflammation and Intestinal
Immune Activation
Eighteen studies utilized a variety of markers that reflect intestinal inflammation or immune
activation among children in resource-limited settings. The data relevant to this review are listed for each
of these studies in Evidence Table 4. Eight types of markers were assessed across the studies, most of
which were examined in stool. Lactoferrin was the most commonly assessed marker among these
reports; nine studies utilized it to assess intestinal inflammation. Additionally, fecal cytokines, leukocytes,
and neopterin were measured in five [101, 131, 132, 137, 140], four [104, 138, 158, 169], and one [15]
studies, respectively. Two studies by the same group of investigators assessed fecal IgE [142, 143].
Intestinal tissue cytokines, immune and inflammatory cell markers, and duodenal aspirate
immunoglobulins were investigated in one study apiece.
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Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
2003
Fortaleza,
Brazil
Alcantara CS et al.
3-43 mo olds
Interleukin-8, tumor recruited from a
shantytown
necrosis factorcommunity who
alpha, and
were screened for
lactoferrin in
immunocompetent enteric pathogens.
hosts with
There was a high
experimental and
prevalence of
Brazilian children
malnutrition among
with acquired
the cases.
cryptosporidiosis
Fecal cytokines and
lactoferrin as
markers of intestinal
inflammation among
children with and
without
Cryptosporidium
parvum.

(Adults
experimentally
exposed to C.
parvum by
ingestion were also
studied; these data
were not included
in this review.)

Design and
Sample Size

Biomarker

Stool tests:
• Lactoferrin
n=32;
(17 cases and 15 controls
tested)
n=17 cases with C. • IL-8
parvum:
(13 cases and 15 controls
• 4 with no
tested)
diarrhea
• TNF-α
• 10 with AD
(10 cases and 0 controls
• 3 with PD
tested)
Case-control

n=15 controls with
no diarrhea or
enteric pathogens
and comparable
HAZ and WAZ
scores to cases

Results

Conclusion

Comments

Lactoferrin positive:
• 12/17 cases
• 1/4 cases without
diarrhea
• 8/10 AD cases
• 3/3 PD cases
• 3/15 controls (p=0.006
compared to cases)

The proportion of
children who tested
positive for fecal
lactoferrin was
greater in those
with
cryptosporidiosis,
especially those
symptomatic with
diarrhea, than in
uninfected controls,
although 20% of
the control group
tested positive.

Direct comparisons
between various
stool tests were
not reported.

IL-8 detectable:
• 3/13 all cases
• 0/2 cases without
diarrhea
• 3/10 AD cases
• 0/1 PD cases
• 6/16 controls (p=0.435
compared to cases)

Fecal IL-8 did not
differ between
those with and
without
TNF-α detectable:
Cryptosporidium
• 0/10 cases
infection. TNF-α
was not elevated
among children
with
Cryptosporidium
infection.
2009
Lusaka, Zambia
Case-control
Endoscopic duodenal
Biopsy findings among the
Mucosal
biopsy:
Zambian compared to the UK architecture was
12.2-19.8 mo olds n=41*;
markedly abnormal
Amadi B et al.
children:
• Histopathology
with PD and
compared to UK
•
Villous
height
reduced
• Densities in lamina propria
controls but did not
Reduced production malnutrition
n=41 cases with
• Crypt depth increased
and crypt epithelium:
admitted to the
vary between
of sulfated
PD and
• Cell proteins:
• ~50% reduction in
marasmus and
glycosaminoglycans malnutrition ward of malnutrition:
crypt:villous ratio
• Glycosaminoglycan
occurs in Zambian a teaching hospital. • 18 with
(GAG)
• Values for lamina propria cell kwashiorkor
children with
marasmus
densities were not reported presentations of
• Enterocyte heparan
malnutrition.
kwashiorkor but not
• 8 with marasmic
sulfate proteoglycan
for UK subjects
marasmus
kwashiorkor
(HSPG)
Inflammatory cell
• 15 with
• Syndecan-1
No significant differences in
Duodenal biopsy
densities were
kwashiorkor
• Inflammatory cell
crypt or villous measures or
generally higher
including
markers:
lamina propria cell densities
compared to UK
assessments of
n=19 healthy
• CD3 IEL
were observed between
children and
intestinal markers in
control children
• Ki67
nutritional groups or after
children with PD and
showed different
from UK
• Human leukocyte
nutritional rehabilitation.

Lactoferrin results
were graded based
on agglutination
reaction positivity
with increasing
dilution and were
considered
negative if there
was no reaction at
1:25.
Four subjects were
breastfed and were
tested for
lactoferrin.

27 subjects were
HIV positive;
incidence was
lower in the
kwashiorkor group.

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
different forms of
malnutrition

Design and
Sample Size

Biomarker
antigen DR-1 (HLADR)

Results

Conclusion

Comments

patterns across the
Intestinal markers:
malnutrition
* UK subjects are
• Inflammatory markers were presentations.
presented in this
seen in higher densities
table due to
compared to the UK children. Tissue
concentrations of
comparisons of
There were significant
HSPG and GAG
interest made in
differences between the
the review.
different nutritional groups in were reduced
However we do not
especially amongst
the specific types of
include these
children with
inflammatory markers.
kwashiorkor.
subjects in the
• There was a significant
sample size for this
reduction in GAGs and HSPG Intestinal protein
review.
markers did not
in the kwashiorkor group
compared to UK children, but differ amongst the
malnutrition groups.
no significant differences
between kwashiorkor and
other presentations of
malnutrition.
• There was no difference in
epithelial syndecan-1 protein
expression between the
malnutrition groups (data not
available for UK controls).
2000
Dhaka, Bangladesh Case-control
Blood tests:
WBC total and differential,
Some immune and The number of
immunoglobulin
subtypes,
inflammatory
controls was
• IFN-γ
7-12 mo olds with n=136;
markers
were
relatively small and
Azim T et al.
cytokines,
transferrin,
and
• TNF-α
6-8 days of watery
associated
with
their nutritional
albumin
did
not
differ
between
• WBC (total and differential)
Immune response of diarrhea attending n=38 cases with
acute
and/or
status was not
cases
with
diarrhea
or
controls,
• IgA
Bangladeshi
the International
persistent
diarrhea.
reported.
PD
nor
did
stool
leukocyte
or
• IgG
children with acute Centre for Diarrheal
erythrocyte counts.
• IgM
Disease Research. n=98 controls:
The only marker
diarrhea who
• Transferrin
The percentages of neutrophils that was
subsequently have
• 85 with AD
• Albumin
significantly
that polarized in response to
persistent diarrhea Cases were those • 13 with no
• Immune function tests:
who went on to
associated with
stimulation
were
significantly
diarrhea
• Neutrophil polarization
progression to PD
Immune activation develop PD,
higher in subjects with AD or
response to chemotactic PD compared to those without was a negative
controls were those
tests, as well as
factor
who did not.
DTH response to
transferrin and
diarrhea; there was no
•
Neutrophil opsonization difference between the two
tuberculin antigen
albumin as markers
to yeast
(odds ratio=3.8, CI:
of nutritional status An additional group
diarrhea groups.
• Mononuclear cell
1.4, 9.9). This was
among children with of subjects without
proliferation,
diarrhea were
calculated from a
and without PD
Opsonization did not vary
spontaneous and in
recruited from a
logistic regression
between any groups.
response to stimuli with
nutrition follow-up
analysis that only

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
unit.

Design and
Sample Size

Prevalence of
malnutrition was
high in all groups.

2007

Goncalves Dias
Cohort
favela in Fortaleza,
Brazil
Bushen OY et al.
n=42
(41 tested)
Heavy
All newborns from
an urban
cryptosporidial
infections in children shantytown were
Stools were
in northeast Brazil: recruited at birth
collected at regular
and followed for up intervals as well as
comparison of
Cryptosporidium
to 4 yr.
during episodes of
hominis and
diarrhea.
Cryptosporidium
This study included
parvum
only children testing
positive for
Fecal lactoferrin as Cryptosporidium.
a marker of
intestinal
inflammation in
children with
Cryptosporidium

Biomarker
mitogens

Results

Conclusion

Comments

Monocyte spontaneous
included children
proliferation counts were less with diarrhea.
than half among children with
no diarrhea compared to those
with AD (p<0.001) or with PD
(p=0.011); there was no
difference between the two
diarrhea groups.

Skin Test:
• Delayed-type
hypersensitivity response
(DTH) to tuberculin,
tetanus, diphtheria,
Streptococcus, Proteus,
Candida, and Trichophyton Monocyte proliferation in
response to stimulation did not
differ between the 3 groups.
Stool tests:
The proportion with DTH
• Leukocytes
responses differed among the
• Red blood cells
three groups only in response
to tuberculin (p=0.021). More
PD subjects had a negative
tuberculin response than did
subjects with AD (p=0.024).
Stool Test:
68.3% were lactoferrinLactoferrin
positive; there were no
differences in positivity
between subjects with C.
hominis and C. parvum spp.
67.9% of lactoferrin-positive
subjects had very high titers.

Lactoferrin was
correlated with
younger age and
symptomatic
infection among
those infected with
C. parvum.

Lactoferrin results
were graded based
on agglutination
reaction positivity
with increasing
dilution and were
considered
negative if there
Lactoferrin did not was no reaction at
significantly predict 1:50 and highly
growth outcomes. positive at >1:400.

Younger children were more
often lactoferrin-positive
(p=0.03). The difference was
mediated by C. parvum; 87.5% Cryptosporidium
of ≤1 year olds compared to
species-specific
40.0% of older children with C. differences were
parvum were lactoferrinobserved in
positive (p=0.04). There was no lactoferrin results.
In contrast to C.
difference among those
parvum, there was
infected with C. hominis.
no association
Lactoferrin was correlated with between lactoferrin
symptomatic infection among and symptomatic/
those with C. parvum: 78.6% of asymptomatic C.

Data were part of a
larger study;
similar data on
lactoferrin in
Giardia-infected
children was
published by A.
Kohli, et al. (also
included in this
review), using a
slightly different

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest

Design and
Sample Size

Biomarker

Results

Conclusion

hominis infection
(p=0.231). In
addition, similar
proportions of
asymptomatic
Lactoferrin was not correlated children with C.
with degree of oocyst shedding hominis had high
fecal lactoferrin
(p=0.28).
titers as had
Lactoferrin was correlated with undetectable
∆HAZ score among those with results.
C. parvum, although this
observation was not statistically
significant (r=-0.39, p=0.13).
symptomatic children
compared to no asymptomatic
children had a positive test
1
(r=0.67, p=0.004 ).

2004

Keneba, Gambia

Cohort

2 mo olds from
n=72
rural area followed
until 15 mo of age.
Intestinal
Subjects were
inflammation
evaluated with
measured by fecal
twice-weekly
neopterin in
questionnaire to
Gambian children
determine diarrhea
with enteropathy:
morbidity, clinic
association with
growth failure,
assessments of
Giardia lamblia, and
growth, and
screening
intestinal
laboratory tests
permeability
every 2 mo.
Fecal neopterin and
L:M as markers of
intestinal
inflammation and
permeability,
respectively, and
their correlation with
growth status and

Stool Test:
Neopterin

Campbell DI et al.

1

Urine Tests:
2
• Lactulose
• Mannitol
• L:M

Reported results were adjusted for confounding variables, unless otherwise noted.
Lactulose and mannitol results were expressed as % of dose administered.
3
Geometric mean.
2

Comments

grading scale for
reporting
lactoferrin results
[133]. Rather than
exclude breastfed
children, Bushen et
al. stratified results
on breastfeeding
status and found
no difference in
positive/ negative
results, including
when examined
among younger
and older children.
Mean neopterin concentration L:M and mean fecal Study population
was negatively correlated with neopterin
might have some
concentration were overlap with that of
long-term height (r=-0.29,
Campbell et al.
p<0.009) and weight (r=-0.36, not correlated.
also included in
p<0.007) gain, but not with
Mean L:M in the
this review [110].
giardiasis.
Gambian children
3
was substantially
Mean L:M (CI): 0.31 (0.26,
higher than normal
0.34).
values in children in
the UK. These high
Mean excretion of lactulose
L:M ratios appear
(CI): 0.20 (0.18, 0.23).
to be driven by
mannitol excretion.
Mean excretion of mannitol
(CI): 3.0 (2.8, 3.2).
Mean L:M was negatively
correlated with long-term height
gain (r value not provided,
p<0.0001), but was not
correlated with presence of
Giardia.
L:M and fecal neopterin were

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Design and
Study Outcomes of
Target Population Sample Size
Diagnostic Interest
Giardia recovery in
the stool
2003
Fajara and Sibanar, Case-control
The Gambia
Campbell DI et al.
n=40 cases:
6 mo-3 yr old
• Group 1: n=4
Chronic T cellhospital- and clinic- • Group 2: n=11 (7
based cases from
mediated
with diarrhea)
enteropathy in rural rural communities. • Group 3: n=25
west African
(18 with
children: relationship Case groups based diarrhea)
with nutritional
on differences in
nutritional status: n=34 with case
status and small
bowel function
• WAZ score >-2,
tissue samples
with GI
sufficient for
complaints other cytokine
L:M as a marker of
than diarrhea
immunoreactivity
intestinal
• Grade I protein
tests:
permeability, small
energy
• Group 1: n=3
bowl biopsy with
malnutrition
• Group 2: n=8
assessment of
(PEM) (WAZ
• Group 3: n=23
intestinal immune
score -2 to -4)
markers, and
and
computerized
unresponsive to
morphometric
nutritional
analysis among rural supplements,
Gambian children
with or without
with differing
diarrhea
degrees of
• Grade II PEM
malnutrition and
(WAZ score <-4)
compared to wellwith or without
nourished UK
diarrhea
children
Controls from UK*
who were well
nourished children
with GI complaints
other than diarrhea
and with normal
endoscopy results
1
2

Biomarker

Results

Conclusion

Comments

not correlated (p=0.11).
Endoscopic
small bowel biopsy, site not
specified:
• Histopathology
• Morphometric assessment
by computer analysis*
• Intestinal tissue cytokines
and immune markers:
• CD-3
• CD-4
• CD-8
• CD-19
• CD-25
• HLA-DR
• Perforin
• γδ T-cell receptor
• Syndecan-1
• TNF-α
• IFN-γ
• TGF-β
• IL-10

Urine Tests:
1
• Lactulose
• Mannitol
• L:M

* Biopsy involved
morphometric assessment
by computer analysis of
villous height, crypt depth,
villous:crypt ratio, and
intraepithelial lymphocyte
(IEL) density (per 100
epithelial cells).

Lactulose and mannitol results were expressed as % of dose administered.
These figures are presumed to represent IEL means; however, this was not explicitly stated.

Crypt-hyperplasia and villous
atrophy were observed among
all Gambian subjects, and the
degree of histopathology did
not differ among cases with
differing nutritional status, nor
was there a correlation with
diarrhea.

All Gambian
Statistical
subjects had
methodology was
evidence of
not sufficiently
enteropathy with
detailed to
crypt-hyperplasia determine what
and villous atrophy, was compared
and mean IELs >2 (e.g. type of central
SD above UK
tendency measure
norms, independent and variance
2
of nutritional status calculations for
IEL means were ~3-fold
and diarrhea
L:M not stated).
higher in Gambian than UK
history.
children.
Duration of
Elevation of cellMedian CD3, CD4, CD8,
diarrhea not
mediated intestinal specified, but
CD19, and CD25 cell counts
were significantly higher (2-5x markers and
assumed to be
mucosal
higher) among each case
persistent.
proinflammatory
group compared to the UK
cytokines was
controls.
Mucosal
present across the lymphocyte
IEL, γδ, syndecan-1, HLA-DR, 3 Gambian groups, densities, cytokine
variably correlated immunoreactivity,
and perforin were detected
among the Gambian children in with nutritional
and L:M results
varying degrees but were not status.
were not stratified
reported for UK controls.
by history of
L:M ratios were
Syndecan, CD3, and CD8
diarrhea.
elevated in all
displayed a gradient
Gambian groups,
proportional to malnutrition
without apparent
severity.
correlation to host
nutritional status.
All Gambian groups showed
higher lamina propria cytokineimmunoreactive mononuclear
2
cell density (~200-450/mm )
2
than UK controls (30-80/mm ).
Among subjects with elevated
cytokines, similar densities

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Design and
Study Outcomes of
Target Population Sample Size
Diagnostic Interest
were also studied.

Biomarker

Results

Conclusion

Comments

Differences in
immunoglobulin
concentrations
were limited among
children with PD
infected with
Giardia compared
to children without
such conditions.

The number of
controls was small
due to constraints
in obtaining
duodenal aspirate
from children
without GI
symptoms.

were seen for both proinflammatory (IFN-γ and TNFα) and putative regulatory (IL10 and TGF-β) cytokines.
Epithelial expression of TGF-β
was also enhanced compared
to UK controls, but subjects
with poorer nutritional status
had lower densities of mucosal
TGF-β+ cells, with median
densities of 420 and 250
2
cells/mm in the grade I and
grade II PEM groups,
respectively.

* UK subjects are
presented in this
table due to
comparisons of
interest made in the
review. However
we do not include
these subjects in
the sample size for
this review.

1

L:M values :
• Group 1: 0.53 (0.4-1.3)
• Group 2: 0.47 (0.02-2.20)
• Group 3: 0.73 (0.14-2.2)
• Not assessed among the UK
controls
Nutritional status was not
associated with L:M, recoveries
of lactulose or mannitol.

2001

New Delhi, India

Kapoor S et al.

<12 yr olds
n=40;
admitted to hospital
with PD and
n=30 cases with
Giardia.
PD and Giardia

Giardiasis--clinical
and diagnostic
perspective
Immunoglobulin
concentrations in
1

Case-control

Controls had no
n=10 controls
diarrhea and were without diarrhea
hospitalized for

Duodenal secretion
aspirates:
• IgG
• IgM
• IgA

Blood Tests:
• IgG
• IgM

Not clearly indicated if these figures represent mean (CI) or another measure of central tendency.

L:M was correlated with
mucosal B lymphocyte density
(r=0.57, p<0.05), IEL (r=0.51,
p<0.02), and perforin+ IEL (r=0.64, p<0.03).
Higher mean concentrations of
IgM were found in duodenal
aspirates of cases compared to
controls (p<0.05).
Mean concentrations of
duodenal IgA and IgG did not
differ between cases and
controls.

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
duodenal fluid and non-GI conditions.
serum among
children with PD and Most cases were
Giardia infection
<7 yr old, with n=19
compared to those <3 yr old. Ages of
controls were not
without diarrhea
specified.
2006
Port-au-Prince,
Haiti
Kirkpatrick BD et al.
<36 month olds
recruited from
Childhood
cryptosporidiosis is GHESKIO HIV
1
Center with
associated with a
persistent systemic Cryptosporidium
infection and
inflammatory
healthy controls.
response
Fecal cytokines and
lactoferrin as
markers of intestinal
mucosal
inflammation among
children with and
without
Cryptosporidium
infection

Subjects were
followed-up at 6
and 9 months after
infection resolved.

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

• IgA

Cohort
n=73;
n=42 cases with
diarrhea and
Cryptosporidium
infection
(18 with PD)

Stool Tests:
• Lactoferrin
• Cytokines:
• IFN-γ
• TNF-α
• TGF-β
• IL-4
• IL-8
• IL-10

n=31 healthy
controls without
diarrhea and
Cryptosporidiumnegative

HIV status of
subjects varied.
There was a high
prevalence of
malnutrition in the
study population.

Proportion lactoferrin-positive
at enrollment:
• Cases: 51.2%
• Controls: 4.0%

Lactoferrin was
present among half
of subjects with
cryptosporidiosis
and uncommon
among those
Cases had higher
concentrations of TNF-α than without such
controls at enrollment (p=0.04), infection.
but no difference was observed
Fecal TNF-α was
at follow-up.
higher among
Controls had almost 2x higher cases at enrollment
but did not persist
fecal IFN-γ at enrollment
when infection
(p=0.1); the magnitude of
difference increased (to almost resolved.
3x) and was statistically
Paradoxically,
significant at the 6- and 9controls’
month follow-up (p=0.01 and
comparatively
p=0.03, respectively).
higher fecal IFN-γ
increased in both
No differences in fecal
concentrations of TGF-β, IL-8, magnitude and
degree of statistical
IL-4, or IL-10 were noted
significance at
between groups.
follow-up.

Cut-off values for
lactoferrin positivity
were not provided.
Breastfed children
(>85% of cases
and controls) were
included in testing.
Proportions at
follow-up were not
reported.
The association of
fecal cytokines and
lactoferrin with
growth
parameters, history
of PD, and HIV
status were not
reported, nor was
their association
with each other.

Various markers of
systemic
inflammation,
Of the remaining
including serum
fecal cytokines
cytokines, were
assessed, there
measured but their
were no differences relationship with
between cases and markers of
controls.
intestinal
inflammation was
not reported.

1

The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections.

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest

Design and
Sample Size

2002

Case-control

Port-au-Prince,
Haiti

Kirkpatrick BD et al.
<18 mo olds from a
low SES setting
Cryptosporidiosis
recruited from the
stimulates an
rehydration unit of
inflammatory
intestinal response GHESKIO HIV
1
Center with
in malnourished
diarrhea and
Haitian children
Cryptosporidium
infection. Controls
Stool lactoferrin,
recruited from an
reducing
outpatient clinic
substances,
without
leukocytes and
Cryptosporidium
cytokines as
markers of intestinal infection included
those with and
inflammation of
without diarrhea.
children with and
without
Cryptosporidium
infection

n=49;
n=17 cases with
Cryptosporidium
and diarrhea (5
with PD)

Biomarker

Results

Stool Tests:
• Reducing substances (RS)
• Lactoferrin
• Cytokines:
• TNF-α receptor I
• IL-4
• IL-8
• IL-10
• IL-13
• IFN- γ

Proportion RS-positive:
• 33.3% cases
• 64.7% diarrhea controls
• 46.7% healthy controls,
(p=0.2)

n=32 controls
without
Cryptosporidium;
• 17 with diarrhea Blood Test:
(5 with PD)
• WBC
• 15 healthy

Conclusion

Comments

Fecal lactoferrin
Reported results
was identified most were not stratified
often in children
by persistent vs.
with diarrhea,
acute diarrhea
especially in those status.
with
Proportion lactoferrin-positive: Cryptosporidium. Cut-off values for
While some fecal lactoferrin positivity
• 83.3% cases
cytokines were
were not
• 60.0% diarrhea controls
detected
in
as
described.
• 28.6% healthy controls,
many as 40% of
(p=0.01)
healthy controls
Stools from
and
70%
of
controls
children who were
IFN-γ was not recovered in any
with
diarrhea,
they
breastfeeding were
stools.
were generally
not tested for
associated
with
lactoferrin.
All other fecal cytokines were
Cryptosporidium
significantly associated with
infection. The other
Cryptosporidium cases
stool tests did not
compared to diarrhea and
discriminate by
healthy controls.
diarrhea or
Additionally, TNF-α receptor I, Cryptosporidium
IL-8, and IL-13 were found in status.
diarrhea and healthy controls,
while IL-4 and IL-10 were not.
Fecal lactoferrin was
associated with the presence of
TNF-α receptor I (point
estimate not provided, p=0.03).

2008

Goncalves Dias
Cohort
favela in Fortaleza,
Brazil
Kohli A et al.
n=108 stool
samples from 47
Giardia duodenalis All newborns from children
assemblage, clinical an urban
presentation and
shantytown were
Stools were
1

Stool Test:
Lactoferrin

The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections.

Mean WBC counts were within
normal range in all 3 groups.
Proportion of positive
lactoferrin results decreased
with each new Giardia
infection, p=0.015:
st
1.1 infection: 74.0% (15.2% of
those testing positive had
high titers)

Increased
concentrations of
lactoferrin were
observed more
frequently with first
time Giardia
infections.

Lactoferrin results
were graded based
on agglutination
reaction positivity
with increasing
dilution; the
following scale was

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
markers of intestinal
inflammation in
Brazilian children

Location and
Target Population

recruited at birth
and followed for up
to 4 yr. Those with
Giardia recovered
Fecal lactoferrin as from stools were
included in this
a marker of
study.
intestinal
inflammation in
Giardia-infected
children and its
association with
persistence of
diarrhea

Design and
Sample Size

Biomarker

Results
nd

collected at regular
intervals as well as
during episodes of
diarrhea.

2.2 infection: 40.0% (5.3% of
those testing positive had
high titers)
rd
3.3 infection: 1 (20.0%) tested
positive (at a high titers)
Increasing titers of lactoferrin
were associated with longer
duration of diarrhea, p=0.017:
• Negative: 2.2 days
• Low: 9.7 days
• High: 14.6 days
Lactoferrin results did not differ
between symptomatic and
asymptomatic children at first
infection, but those with
symptoms had positive results
with recurrent infections with
greater frequency (75.0% vs. 0
in asymptomatic repeat
infections, p=0.017.)

2010

Fortaleza, Brazil

RCT

2 mo-9 yr olds
n=79;
(mean 43 mo) from
Effects of vitamin A an impoverished
n=40 received
supplementation on urban community, placebo
eligible if HAZ
intestinal barrier
(tocopherol)
score was <median
function, growth,
total parasitic, and for their community. n=39 received
specific Giardia spp
vitamin A (retinyl
Lima AA et al.

1

Urine Tests:
1
• Lactulose
• Mannitol
• L:M

Median L:M at baseline was
0.089. There was no significant
change in L:M at 4 mo followup within either treatment
group.

Stool Tests:
• Lactoferrin
• Cytokines:
• IFN-γ

No significant difference in L:M
was observed between
treatment groups.

For lactulose and mannitol results, excretion measurement was not specified.

Conclusion

Comments

Concentrations
used:
were associated
• High = positive
with longer duration at 1:400-1:3200
of diarrhea,
dilution
although these
• Low = positive at
results were not
1:25-1:200
presented
• Negative = no
separately for first
reaction at 1:25
and recurrent
infections.
Stools from
children who were
Stool lactoferrin
breastfeeding were
might be useful in not tested.
predicting duration
of diarrheal illness Data were part of a
in G. duodenalis- larger study;
infected children. similar data on
lactoferrin in
Cryptosporidiuminfected children
were published by
O.Y. Bushen, et al.
(also included in
this review);
however, Bushen
et al. used a
slightly different
grading scale for
reporting
lactoferrin results
[108].
Frequency of stool Authors did not
lactoferrin varied
report testing for
between 23%-32%. associations
between urinary
While vitamin A
markers of
supplementation
intestinal
was associated
permeability and
with reduced
concentrations of
lactulose excretion, fecal cytokines, or
it was also
between these

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
infections in
Subjects were
Brazilian children: a screened for
intestinal parasites,
prospective
randomized, double- and longitudinal
anthropometrics
blind, placebowere assessed.
controlled trial

Design and
Sample Size
palmitate)
Subjects were
treated every 4
mo.

Biomarker
• TNF-α
• IL-4
• IL-10

Results

Conclusion

Comments

Both median lactulose and
mannitol excretions decreased
at 4 mo follow-up among the
vitamin A compared to the
placebo group:
• Lactulose: 0.21 to 0.74,
p=0.042
• Mannitol: 3.06 to 8.25,
p=0.008

associated with
reduced mannitol
excretion, with no
overall effect on
L:M.

markers and
growth parameters
or parasitosis.

Cut-point values
for lactoferrin
Vitamin A
positivity and
L:M as a marker of
supplementation
abnormal L:M were
was not associated not described.
intestinal barrier
with presence of
function, and stool
Exclusively
lactoferrin and
Overall proportion of lactoferrin lactoferrin or
intestinal
cytokine
breastfed children
specific intestinal
was 23% initially. At 1 mo
response.
were excluded
immunological
follow-up, there was no
from study
cytokines as
difference in prevalence
participation due to
markers of intestinal
between vitamin A (33%) and
assessment of
inflammation among
placebo (31%) groups.
nutritionally at-risk
stool lactoferrin.
children who
Cytokine concentrations did not
received either
significantly differ between
vitamin A or placebo
placebo and vitamin A groups.
2
2005
Fortaleza, Brazil
RCT
Urine Tests*:
Mean L:M (SE):
L:M significantly
The relationship
1
improved in the
between stool
• Lactulose
• Glutamine group:
2-60 mo olds
glutamine group
markers and L:M
Lima AA et al.
n=80;
• Mannitol
• Baseline: 0.31 (0.10)
hospitalized with
only.
was not reported.
(similar in all three
• L:M
WAZ score <-2,
Intestinal barrier
n=53 received
groups)
>50% of subjects Data were not
function and weight ~70% of whom had supplemented
• Day 10: 0.10 (0.02);
gain in malnourished PD.
had intestinal
stratified by history
formula
Stool Tests**:
significant decrease,
children taking
inflammation by
of PD.
• 27 with glycine • Lactoferrin
(p=0.01)
stool lactoferrin.
glutamine• 26 with glutamine • Leukocytes
• No significant decrease in
Fecal leukocytes, Fecal fat was
supplemented
L:M in glycine and
• Occult blood
RS, and occult
assessed, but
enteral formula
n=27 received
nonsupplemented
formula
• Reducing substances (RS)
blood
were
results were not
nonsupplemented
groups at day 10
detected in fewer reported.
L:M as a marker of
formula
subjects than
intestinal
* n=80 tested at enrollment, Mean lactulose (SE):
lactoferrin.
Cut-off values for
permeability and
• Glutamine group:
n=65 tested at day 10.
lactoferrin positivity
various stool tests
• Baseline: 0.97 (0.46)
were not
among children with
(similar in all three
** n=60 tested.
described.
malnutrition or PD
groups)
who received either
• Day 10: NS decrease in
Exclusively
glycine or glutamine
all 3 groups
1
2

Lactulose and mannitol results were expressed as % of dose administered.
Type of mean not specified.

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
supplemented
formula or placebo

2006

Mexico City,
Mexico

Long KZ et al.
The effect of vitamin
A supplementation
on the intestinal
immune response in
Mexican children is
modified by
pathogen infections
and diarrhea
Fecal cytokines as
markers of intestinal
mucosal immune
activation in children
with and without GI
pathogens receiving
vitamin A or placebo

1

All 5-15 mo olds
within a periurban
community were
eligible to be
screened for
participation.

Design and
Sample Size

Biomarker

Results

Conclusion

Mean mannitol (SE):
• Glutamine group:
• Baseline: 3.42 (0.64)
(similar in all three
groups)
• Day 10: NS decrease in
all 3 groups

RCT

Stool Tests:
Cytokines:
• IL-4
n=505 stool
samples from 127 • IL-6
• IFN-γ
children;
n=243 stool
samples from 57
who received
vitamin A
supplementation
n=262 stool
samples from 70
who received
placebo

Participants were
followed regularly;
diarrhea history
was tracked and
stool samples were
tested.

Proportion of stool markers at
baseline among all subjects:
• Lactoferrin: 53.3%
• Leukocytes: 11.7%
• RS: 3.3%
• Occult blood: 5.0%
Positive tests for fecal
cytokines:
• IL-4: ~55%
• IFN-γ: ~50%
• IL-6: ~40%

Differences in fecal
cytokine
concentrations due
to vitamin A
supplementation
were observed only
in the subset of
There were no significant
subjects with GI
differences in proportions of
these fecal cytokines between infection or
diarrhea.
vitamin A-supplemented and
placebo subjects.
Vitamin A-supplemented
children with diarrhea had
lower median IFN-γ
concentrations (odds
1
ratio =0.51; CI: 0.26, 0.99) and
higher IL-4 concentrations
(odds ratio=2.14; CI: 0.94,
4.87) compared to children with
diarrhea in the placebo group
in a nonrandomized analysis.
IL-6 concentrations did not
differ in this analysis. There
were no differences between
the two groups among those

Comments
breastfed children
were excluded
from study
participation due to
assessment of
stool lactoferrin.

Pre-intervention
fecal cytokine
concentrations
were not reported.
Differences in fecal
cytokines between
all subjects with
and without GI
infections or
history of diarrhea
were not directly
reported; all
differences were
described in terms
of vitamin A
interaction.

The odds ratios represent odds that a cytokine (categorized into three levels: undetectable, <median, >median) will have a higher value among vitamin A-supplemented children.

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

without diarrhea.

2001

Bilbeis, Egypt

Nested caseStool Test:
IgE
control within a
Mahmud MA et al. Newborns recruited cohort study
at birth from a rural
Sociodemographic, village and followed n=392 episodes of
environmental and for the first year of diarrhea (including
41 episodes of PD)
clinical risk factors life.
among 152
for developing
infants* )
persistent diarrhea Surveillance of
among infants in a diarrhea symptoms
rural community of identified 392
episodes of
* Stool samples
Egypt
diarrhea, 41 (11%) from each PD
of which were
episode were
Stool IgE as a
persistent.
counted as a case
marker of
for analysis and
gastrointestinal
compared to
allergy and its
randomly selected
association with
AD episodes and
persistent vs. acute
to non-diarrheal
diarrhea
samples.

2001

Bilbeis, Egypt

Mahmud MA et al.

Newborns recruited n=152
at birth from a rural followed for 29,036

1

Cohort

Stool Test:
IgE

Reported results were adjusted for confounding variables, unless otherwise noted.

Differences in median
concentrations of fecal
cytokines by types of enteric
pathogens were also observed.
Fecal IgE was detected more
frequently in stools from
episodes of PD compared to
episodes of AD: odds ratio
1
(CI) =3.3 (1.0, 10.9).

Fecal IgE was
Sampling was
detected 3 times
based on episodes
more frequently
of diarrhea within a
during episodes of cohort of infants;
PD than AD and 5 individual infants
times more
could have
Fecal IgE was detected more frequently in PD
contributed more
stools than in stools than one diarrheal
frequently in stools from
episodes of PD than in stools from those without episode.
Additionally, it
from children without diarrhea: diarrhea.
appears that an
odds ratio (CI)=4.84 (1.1, 21.7).
individual could
also have been
included as a case
of PD, a control
with AD, or a nondiarrhea stool
within the same
analysis.

Overall incidence of fecal IgE: Substantial
0.39/child-year
incidence of fecal
IgE was observed
By age group:
in this setting in

Study population
appears to be the
same as in another
Mahmud, et al.
study also included
in this review
which reported the
prevalence of fecal
IgE by gender and
age within the
cohort [143].
Study population
appears to be the
same population
as in another

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
Increased fecal IgE village and followed
among infants in a for the first year of
rural community of life.
Egypt: an analysis of
associated risk
factors
Fecal IgE as a
marker of intestinal
inflammation among
children with
diarrhea
2001
Dhaka,
Bangladesh
Rabbani GH et al.
2-6 yr olds with
Increased nitrite and cholera or
nitrate
shigellosis admitted
to the hospital.
concentrations in
sera and urine of
patients with cholera Controls were
or shigellosis
recruited from the
healthy attendants
To assess and
of patients or from
compare nitric oxide children of hospital
staff.
as a marker of
intestinal
inflammation among Mean age (SD) in
children with cholera yr:
or shigellosis or
• Shigellosis
healthy controls.
cases: 3.8 (1.2)
Evaluated to assess • Cholera cases:
4.2 (1.4)
nitric oxide
• Controls: 4.7
production during
(1.8)
infection of small
bowel without
inflammatory lesion
(e.g., cholera) and
during infection
causing colon
inflammation (e.g.,
shigellosis).

Design and
Sample Size

Biomarker

infant days
Stools were
collected during
episodes of
diarrhea.

Case-control

n=18 healthy
controls

Samples were
collected from
cases on
admission
and upon
discharge (after 710 days of
treatment).

Conclusion

Comments

•
•
•
•

infants.

Mahmud, et al.
reference also
included in this
review which
assessed the
relationship
between fecal IgE
and PD [142].

< 3 mo: 0.28/child-yr
3-6 mo: 0.42/child-yr
6-9 mo: 0.16/child-yr
>9 mo: 0.12/child-yr

IgE incidence
peaked at 3-6 mo
of age.

Relative risks (CI):
• 3-6 compared to >9 mo olds: Male gender was
associated with
3.28 (1.03, 13.60)
fecal IgE.
• Male gender: 1.82 (0.83,
4.18)
Urine Test:
Nitric Oxide (NO)*

n=63;
n=45 cases:
• 24 with cholera
• 21 with
shigellosis

Results

Blood Tests:
• Nitrite (NO2)
• Nitrate (NO3)
• WBC

Stool Test:
Leukocytes

* Nitric oxide (NO) is an
unstable free radical that is
converted to nitrite and
nitrate. Urine NO2 + NO3
were expressed as a ratio
with urine creatinine in order
to account for differences in
urine concentration.

In children with shigellosis,
median serum NO was ~8x
higher at baseline than in
controls and significantly
differed from convalescent
concentrations (p<0.01).
Concentrations declined by
52% of baseline during the
recovery period but did not
return to values found in the
controls (measure of statistical
significance not reported).
In children with cholera,
median serum NO
concentrations at baseline
were ~4x higher than in control
subjects. Recovery
concentrations decreased 52%
from baseline (p<0.01);
convalescent values did not
differ from the values in
controls (p<0.4).
Median urinary NO ratios were
similar among those with
Shigella and V. cholerae
infection, both upon admission
and discharge. Initial values
were ~2x higher than upon
discharge (p<0.05 and 0.01,

NO as measured
by both serum and
urinary NO2 and
NO3 concentrations
was significantly
elevated at
presentation during
acute illness
compared to 7-10
days after
hospitalization in
both cholera and
shigellosis.

Some values
reported in table
format conflict with
the text; columns
of data appear to
be transposed.

Assessment for
NO correlation with
fecal leukocyte
counts was not
reported, nor was
the correlation
between urinary
Median serum NO NO and total blood
concentrations in WBC.
cholera patients
were ~half of those
with shigellosis
both upon
admission and
upon discharge and
concentrations
were much higher
in cases than in
controls, Such
striking differences
were not observed
for urinary NO
results.

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest

Design and
Sample Size

Biomarker

Results

Conclusion

respectively). Control median
NO was of an intermediate
concentration between cases’
admission and discharge
median concentrations; the
difference between control and
case admission values was
NS.

Serum NO
concentrations
correlated with total
blood WBC in
shigellosis cases.

Comments

Mean blood WBC counts (SD):
• Shigellosis: 19.6 (3.3)
• Cholera: 8.3 (2.8)
• Controls: 7.1 (1.8)
Mean fecal WBC/high power
field (SD):
• Shigellosis: 38 (17)
• Cholera: 5 (2)
• Controls: 3 (1)

2006

Vhembe, South
Africa

Cross-sectional

n=26 <5 yr old:
0.1-88 yr olds from • 22 hospitalCryptosporidium
semi-urban
based subjects
species: preliminary community included • 4 school-based
subjects
descriptions of the patients
hospitalized with
prevalence and
genotype distribution diarrhea or other GI
among school
complaints as well
Samie A et al.

Stool Test:
Lactoferrin

Serum NO correlated with
blood WBC count in shigellosis
2
cases at baseline (r =0.92,
p<0.01), but only to a slight
degree upon discharge
2
(r =0.26, no p-value reported)
and there was no correlation
among the cholera cases.
Serum NO correlated with stool
volume at presentation
2
(r =0.85, statistically significant
per authors, p-value not
reported).
16/22 patients and 0/4 students Lactoferrin
Among the entire
were lactoferrin positive.
prevalence was
study cohort of all
high among
ages, lactoferrin
While examination of lactoferrin children
results were similar
association with history of
hospitalized with
among
diarrhea or other GI hospitalized
diarrhea or with
Cryptosporidium infection was symptoms,
patients regardless
of Cryptosporidium
regardless of
not reported, only 3/22 and
status (influence of
16/22 hospitalized patients and Cryptosporidium
2/4 and 3/4 school children
status.
HIV infection was

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
children and hospital as students
patients in the
attending nearby
schools.
Venda region,
Limpopo Province,
South Africa

Design and
Sample Size

Biomarker

were positive for
Cryptosporidium and had a
history of diarrhea,
respectively.

Stool lactoferrin as a
marker of intestinal
inflammation among
hospitalized patients
and school children

2008

Fortaleza, Brazil

Cross-sectional

2 mo-9 yr olds
n=102
(mean age 41 mo)
Carotenoids, retinol, from an
and intestinal barrier impoverished urban
function in children community, eligible
if HAZ score
from northeastern
<median
Brazil
for their community.
L:M as marker of
intestinal barrier
function, fecal
lactoferrin and
leukocytes as
Vieira MM et al.

1

Results

Urine Tests:
1
• Lactulose
• Mannitol
• L:M
(97 tested)

Stool Tests:
• Lactoferrin
(93 tested)
• Leukocytes

lood Tests:
• C-reactive protein (CRP)

Lactulose and mannitol results were expressed as % of dose administered.

Conclusion

Lactoferrin was not
found among
school-recruited
children, most of
whom did have a
history of diarrhea.
Two of the four
school children
were
Cryptosporidiumpositive.

Comments
not reported).
Among school
children, lactoferrin
was more
frequently found to
be positive among
those infected with
Cryptosporidium;
statistical testing
was not reported.
Lactoferrin results
were graded based
on agglutination
reaction positivity
with increasing
dilution and was
considered
negative if there
was no reaction at
1:25.

Some subjects
were breastfed and
were tested for
lactoferrin.
48.5% had abnormal L:M.
Almost half of
L:M threshold for
subjects had
abnormal values
increased L:M, and was defined as
L:M and excretion of each
sugar separately did not vary ~40% of subjects >0.0864 [214]. Cuthad increased
off values for
with retinol concentration.
lactoferrin.
lactoferrin positivity
L:M was associated with levels
were not
of common dietary carotenoids, While serum retinol described.
primarily driven by lactulose.
concentrations
Relationships
However, the association was were not
associated with
between acute
not always statistically
phase proteins and
significant, and the direction of L:M, serum
association varied depending carotenoids were; measures of
authors suggest
intestinal
on precursor.
that these retinol
permeability or

Evidence Table 4. Markers of intestinal inflammation and intestinal immune activation.
Biomarkers in bold are primarily markers of gut inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
markers of intestinal
inflammation, and
CRP and AGP as
acute phase
reactants among
children with varying
vitamin A status

Design and
Sample Size

Biomarker

Results

Conclusion

• α-1-acid glycoprotein
(AGP)

40% of stool samples were
positive for lactoferrin.

precursors might be inflammation were
more sensitive
not reported.
predictors of
Relationships
impaired intestinal between L:M and
function. However, lactoferrin or fecal
the reported
leukocytes as well
direction of
as those between
association varied, retinol or
making
carotenoids and
interpretation of
lactoferrin or fecal
these results
leukocytes were
unclear.
not reported.

1% of stool samples were
positive for fecal leukocytes.
30% of stool samples were
positive for parasites but this
had no impact on L:M results,
lactoferrin, or acute phase
reactants.

Comments

Exclusively
breastfed children
were excluded
from study
participation due to
assessment of
stool lactoferrin.
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects.
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s.
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting.
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval,
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins,
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G,
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score),
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s)

5.5.1 Fecal Lactoferrin
Fecal lactoferrin reflects infiltration of intestinal mucosa by polymorphonuclear
neutrophils. The lactoferrin test might be more sensitive than assays for detection of leukocytes
in stool because the former does not rely on the detection of whole cells, or on visualizing
technology and trained observers. Its usefulness as a marker is enhanced by its relative stability
in feces at room temperature.
We reviewed nine studies that utilized stool lactoferrin as a measure of intestinal
inflammation. Populations in two of these studies appear to overlap [108, 133].

5.5.1.1 Prevalence of Fecal Lactoferrin
The proportion of lactoferrin-positive stools varied widely across publications whose
study populations also varied in terms of nutritional status and health conditions such as
diarrhea symptoms and infection with enteric parasites. The proportion of subjects whose stools
tested positive for lactoferrin ranged from 13 to 74% [132, 133].
Two studies assessed stools of children whose HAZ scores were below the median and
found that 23 to 40% were lactoferrin-positive [137, 169]. Another study found that 53% of
subjects with malnutrition or persistent diarrhea had lactoferrin in their stools [138]. Samie et al.
measured lactoferrin in 26 stools of children hospitalized with diarrhea or other gastrointestinal
complaints and in stools of four primary school children, three of whom had diarrhea at the time
of testing [162]. None of the schoolchildren and 73% of the inpatients had lactoferrin in their
stools.
Several studies measured stool lactoferrin in children with parasitic infections. The
proportion of Brazilian children infected with Giardia whose stools tested lactoferrin-positive
decreased with each subsequent infection [133]. At first infection, 74% of subjects’ stools were
lactoferrin positive, 15% of which had high lactoferrin concentrations, defined as 1:400-1:3200
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dilution in an agglutination reaction. At second infection, 40% were positive, of which 5% had
high concentrations of this marker. At third infection, 20% tested positive, all of which had a high
concentration of lactoferrin. Interestingly, lactoferrin results did not differ between symptomatic
and asymptomatic children at first colonization by these parasites, but those with symptoms
were more likely to produce stools that tested positive with recurrent infections. In a study
among children from an impoverished Brazilian community with HAZ scores less than the
median, nearly one-third of stools were positive for parasites, but parasitic infection was not
associated with presence of stool lactoferrin [169].
Four studies measured stool lactoferrin in children with Cryptosporidium infection. One
study tested stool lactoferrin in infants and children with Cryptosporidium parvum diarrhea,
controls with diarrhea of different etiology, and healthy controls [132]. Lactoferrin was detected in
60% of stools from C. parvum-infected cases, 35% of diarrhea control stools, and 13% of
healthy control stools. This difference across groups was statistically significant. Two other
studies also found that the proportion of subjects with lactoferrin-positive stools was about 50
percentage points higher among cases compared to controls [101, 131]. Bushen et al. reported
lactoferrin results only on Cryptosporidium-infected children; 68% were positive for lactoferrin
and 68% of these subjects tested positive at a high titer, defined as positive at >1:400 dilution
[108]. There were no differences in prevalence of lactoferrin-positivity between subjects with C.
hominis and C. parvum spp.

5.5.1.2 Associations between Fecal Lactoferrin and Growth or Other
Outcomes
Fecal lactoferrin did not significantly predict growth outcomes in the one study that
assessed this relationship [108]. This was also the only study to assess the marker’s relationship
to breastfeeding and age. While there was no association with breastfeeding, younger subjects’
stools were significantly more likely to be lactoferrin-positive. This difference, however, was
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mediated by C. parvum; there was no age-associated difference among those infected with C.
hominis.
Three studies found significant associations between fecal lactoferrin and
cryptosporidiosis [101, 131, 132]. A fourth study reported a high proportion of positive stools
from infected subjects but did not enroll uninfected children, so assessment of association with
presence of infection was not possible [108]. That study did, however, test the relationship of
fecal lactoferrin with oocyst shedding and found no association. A fifth study that had a small
proportion of subjects infected with Cryptosporidium species did not report examining for
association with fecal lactoferrin and infection, but based on the numerical data presented such
an association was not mathematically possible [162].
Fecal lactoferrin was used as an outcome measure in one intervention trial testing the
efficacy of vitamin A supplementation on intestinal barrier function, growth, and intestinal
parasite infections [137]. No difference was observed in fecal lactoferrin results among treatment
and placebo groups.

5.5.1.3 Association between Fecal Lactoferrin and Other Markers
Despite the number of studies that utilized fecal lactoferrin, only one study examined the
association between fecal lactoferrin and another biomarker and found that fecal lactoferrin was
significantly associated with the presence of tumor necrosis factor-α receptor I (TNF-αRI).
Although the investigators also tested for other fecal cytokines, leukocytes and reducing
substances, they did not report attempts to associate lactoferrin presence or concentration and
these other markers in these subjects [132].

5.5.1.4 Methodological Issues with the Fecal Lactoferrin Test
The stool lactoferrin assay was generally performed with commercial kits. Methods
described were similar across studies and results graded based on agglutination reaction
positivity with increasing dilution. Six studies did not clearly report their cutoff for a positive test
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[131, 132, 137, 138, 162, 169]. Two studies defined a positive threshold as a titer of >1:50 [101,
108], another as >1:25 [133]. Two studies defined high titers of positivity to be values >1:400
[108, 133].
Ingestion of breast milk might cause lactoferrin to be detected in the stool, in the absence
of intestinal inflammation. Most of the lactoferrin studies in this review did not discuss this
potential issue within the context of their research. One study that tested a wide age range of
subjects did not mention the breastfeeding status of those being tested [162]. Five of the studies
excluded breastfeeding subjects from lactoferrin testing [132, 133, 137, 138, 169]. Several
studies, however, tested fecal lactoferrin in subjects known to be breast feeding [101, 108, 131],
and one of these studies assessed the association between breastfeeding and stool lactoferrin
but found none [108].

5.5.2 Fecal Cytokines
Five studies [101, 131, 132, 137, 140] measured concentrations of stool cytokines as
indicators of intestinal inflammation; four of these studies investigated fecal cytokines in relation
to gastrointestinal infection [101, 131, 132, 140]. The most commonly measured fecal cytokines
were IFN-γ, TNF-α or TNF-αRI, and IL-4; each was assessed in four studies. IL-8 and IL-10
were each measured in three studies, while TGF-β, IL-6 and IL-13 were each measured in one.

5.5.2.1 Prevalence of Fecal Cytokines
Three of the five studies of fecal cytokines reported the proportion of subjects with
positive tests. The proportion of samples with detectable cytokines in stool varied widely by
cytokine and by study, ranging from 3% for IL-4 [132] to 55%, also for IL-4 [140]. In a study of
children with and without gastrointestinal pathogens, about half of the stool samples were
positive for IL-4, IFN-γ, and/or IL-6, respectively [140]. In contrast, in a study that measured a
panel of cytokines in the stools of children with and without diarrhea, IFN-γ was not recovered in
any stools and IL-4 was only detected in 3% of samples [132]. Only IL-13 and TNF-αRI were
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detected in a substantial proportion of these subjects’ stools; the former was detected in 32%
and the latter in 52%. IL-8 was detected in 15% and IL-10 in 12% of stools. At 4-month follow-up
in a subset of subjects, IL-8 was found in 6% and IFN-γ, IL-4, and IL-10 were not found in any
stools. Among subjects in whom TNF-αRI was detected in stool during acute infection, this
cytokine persisted at lower concentrations in stools of 50% of cases but was not detected in
stools of controls. Some subjects previously negative for fecal TNF-αRI were positive at followup. In a study of fecal IL-8 and TNF-α in children with or without C. parvum infection, IL-8 was
detectable in 31% of subjects without significant differences based on infection status [101].
TNF-α was only investigated in infected children and was detected in stools of 40%, all of whom
had acute diarrhea; however, none had high fecal concentrations of the cytokine.

5.5.2.2 Associations between Fecal Cytokines and Growth or Other
Outcomes
None of the studies of fecal cytokines reported assessment of their relationship to growth
outcomes in the children studied.
Three studies investigated the relationship between fecal cytokines and Cryptosporidium
infection. While IFN-γ was not identified in any stools in a Haitian study, fecal TNF-αRI, IL-8, IL13, IL-4 and IL-10 were significantly associated with C. parvum infection [132]. Interestingly,
some of these cytokines (TNF-αRI, IL-8, IL-13) were found in children with non-Cryptosporidium
diarrhea and in children without diarrhea while other cytokines (IL-4 & IL-10) were not. Fecal
cytokines were not associated with presence of co-pathogens in the stool. A subsequent study
by the same investigators measured concentrations of IFN-γ, TNF-α, TGF-β, IL-4, IL-8, and IL10 at multiple time points over nine months in stools of children with and without
Cryptosporidium infection [131]. In contrast to their previous study, there were no differences in
fecal concentrations of TGF-β, IL-8, IL-4 or IL-10 between those children with and without
Cryptosporidium infection. Also, in contrast to their previous study, IFN-γ was detected and
concentrations in stools of controls were almost double those of cases at enrollment, but this
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difference was not statistically significant. At six- and nine-month follow-up, however,
concentrations in stools of controls increased to almost triple that of cases and the difference
was significant. Fecal TNF-α was only assessed in the second study; those with
cryptosporidiosis had significantly higher concentrations at enrollment, but this did not persist at
follow-up, i.e., after infection had resolved. A Brazilian study only measured TNF-α among 10 C.
parvum-infected children and found no samples with elevated concentrations. IL-8 was
measured among those with and without C. parvum infection, but the proportions of those with
detectable serum concentrations did not differ between the groups [101].
Two randomized, controlled trials of vitamin A supplementation used fecal cytokines as
outcome measures [137, 140]. In one, IL-4, IL-6 and IFN-γ were measured as the primary
endpoints of the intervention in children with and without gastrointestinal pathogens [140].
Overall no significant difference was observed in stool cytokine concentrations between vitamin
A-supplemented and placebo subjects. However the relationship between fecal cytokine
concentrations and vitamin A supplementation was modified by both gastrointestinal infection
and diarrhea. Similarly in the second study, vitamin A supplementation was not associated with
an intestinal cytokine response [137].

5.5.2.3 Associations between Fecal Cytokines and Other Markers
Fecal cytokines were compared to other markers in only one of these studies, finding that
TNF-αRI was significantly associated with fecal lactoferrin [132].

5.5.3 Fecal Leukocytes
Four studies collected data on stool leukocytes. Two of these studies reported the
proportion of tests positive for the presence of leukocytes. These values ranged from 1% among
children with HAZ scores below the local median [169] to 11.7% among children hospitalized
with malnutrition or persistent diarrhea [138]. Two studies compared fecal leukocytes across
subject groups with different gastrointestinal conditions. In one study, where neither proportions
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of positive nor fecal leukocyte counts were reported, the investigators found that fecal leukocytes
did not differ between children with acute diarrhea, some of whom went on to develop persistent
diarrhea, and controls without diarrhea [104]. The second of these two studies found that mean
fecal leukocyte counts were nearly eight times higher in shigellosis cases than in cholera cases
and nearly 13 times higher in shigellosis than in healthy controls [158].

5.5.4 Fecal Neopterin
One study measured fecal neopterin as an indicator of intestinal inflammation, following
subjects from 2-15 months of age [15]. No association was observed between L:M and fecal
neopterin. Mean neopterin concentrations were negatively associated with long-term height gain,
but were not associated with Giardia recovery in stools.

5.5.5 Fecal IgE
Two studies assessed fecal IgE as a marker of intestinal inflammation; both appear to
have been conducted on the same population. The first was a community-based cohort study
that investigated incidence of fecal IgE by gender and age group [143]. The incidence of fecal
IgE was substantial, at 0.39/child-years, and peaked at 3-6 months of age. The second study
assessed the relationship between stool IgE and persistent and/or acute diarrhea [142]. Fecal
IgE was detected greater than three times more frequently among stools from episodes of
persistent diarrhea compared to stool from episodes of acute diarrhea (OR (95% CIs) =3.3 (1.0,
10.9)) and nearly five times more frequently in persistent diarrhea stools than in stools from
those without diarrhea (OR (95% CIs) =4.8 (1.07, 21.7)).

5.5.6 Inflammatory Intestinal Cell Markers
One study assessed inflammatory cell markers in intestinal tissue [103]. Densities of cell
proteins and inflammatory markers in the lamina propria and crypt epithelium in Zambian
children with persistent diarrhea and different forms of malnutrition were compared across
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groups and to those in healthy controls from the UK. Immunohistochemistry was performed on
intestinal tissue obtained by endoscopic biopsy. The intestinal cell proteins studied were
glycosaminoglycans (GAG), heparan sulfate proteoglycan (HSPG), and syndecan-1. The
inflammatory cell markers measured were CD3+ intraepithelial lymphocytes (IEL), human
leukocyte antigen DR-1 (HLA-DR), and Ki67, a crypt epithelial nuclear proliferative marker.
Inflammatory markers were observed at higher concentrations in the Zambian subjects
than in the UK controls. There were significant differences in specific types of inflammatory
markers across malnutrition groups. There was a significant reduction in intestinal GAG and
HSPG in the kwashiorkor group compared to UK children, but there were no significant
differences in these values between the children with kwashiorkor and those with other types of
malnutrition. There was no difference in epithelial syndecan-1 protein expression between the
malnutrition groups; data for this marker were not reported for the UK controls.
These markers were not compared to other types of markers of intestinal function.

5.5.7 Intestinal Tissue Cytokines and Immune Markers
While scintigraphy and counts of intraepithelial white blood cells (WBCs) and leukocyte
presence in the lamina propria provide assessments of intestinal inflammation, scintigraphy can
be used more broadly to study intestinal pathology and as such is listed in section VII on
nonspecific markers of intestinal injury. Because WBCs are sought in biopsies along with
assessments of intestinal architecture, histopathology, including assessment of WBC infiltration,
is listed in section VII as well.
Only one study assessed intestinal tissue cytokines and immune markers. Markers were
compared between rural Gambian children with differing degrees of malnutrition and UK control
subjects with normal endoscopic results [111]. They assessed cytokine immunohistochemistry of
intestinal tissue using antibodies against syndecan-1, perforin, γδ T-cell receptor, CD-3, CD-4,
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CD-8, CD-19, CD-25, HLA-DR, TNF-α, IFN-γ, TGF-β, and IL-10. Median CD3+, CD4+, CD8+,
CD19+, and CD25+ cell counts were 2-5 times higher among each case group compared to the
UK controls; these differences were statistically significant. IEL, γδ, syndecan-1, HLA-DR, and
perforin were detected among the Gambian children in varying degrees but were not reported for
UK controls. Syndecan, CD3, and CD8 displayed a gradient proportional to malnutrition severity.
All Gambian groups had greater density of cytokine-immunoreactive mononuclear cells in the
lamina propria than UK controls. Among subjects with elevated cytokines, similar densities were
seen for both pro-inflammatory (IFN-γ and TNF-α) and putative regulatory (IL-10 and TGF-β)
cytokines. Epithelial expression of TGF-β in Gambian subjects was also enhanced compared to
UK controls, but subjects with poorer nutritional status had lower densities of mucosal TGF-β+
cells. A marker of intestinal permeability, L:M was significantly associated with mucosal B
lymphocyte, IEL, and perforin-positive IEL densities.

5.5.8 Duodenal Aspirates for Immunoglobulins
One study measured immunoglobulin concentrations in duodenal fluid as a marker of
intestinal inflammation [128]. Concentrations of duodenal immunoglobulin were compared in
hospitalized children with both persistent diarrhea and Giardia infection and controls without
diarrhea or gastrointestinal infection. Significantly higher mean concentrations of IgM were found
in duodenal aspirates of cases compared to controls. Mean concentrations of duodenal IgA and
IgG did not differ between cases and controls, however.

5.5.9 Summary of Markers of Intestinal Inflammation
A variety of markers were assessed with a preponderance of studies using fecal
lactoferrin. Lactoferrin was measured among study populations with varying characteristics.
Lactoferrin results varied considerably as did results of other measures of intestinal
inflammation.
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Of note, among studies that met our review inclusion criteria, there was a complete
absence of research utilizing fecal calprotectin (a protein produced by neutrophils and
monocytes). This marker has been found in stools of patients with inflammatory bowel diseases
in developed country settings during the time period of this review [262-264], but we found no
analyses of its prevalence and potential role as a diagnostic tool in children with EED.
A threshold for normal for tests of intestinal inflammation was often not defined by
authors. Generally data on these markers were not collected longitudinally so it is not clear how
much intra-individual variation exists. Only one study statistically compared markers of intestinal
inflammation to each other, and found a relationship between TNF-αR1 and lactoferrin [132].
None of the intestinal inflammation studies compared these markers to biopsy results or to other
tests of intestinal dysfunction such as permeability or absorption.
An important consideration in evaluating these tests is the overall feasibility of performing
them, especially in resource-limited settings. For example, stool is a somewhat easier analyte to
obtain than blood (especially non-capillary assessments) and even urine among young children.
Duodenal aspirates are, of course, more invasive tests and examination of intestinal tissue can
only be performed on biopsy specimens, limiting their feasible use. Nonetheless, stool is an
imperfect analyte. Production of sample cannot be scheduled, and the mechanics of obtaining
the specimen are sometimes challenging, necessitating using adhesive bags or collection from
diapers. In addition, stool is probably more biohazardous than blood, and certainly more than
urine, and often elicits handling concerns by laboratory staff and couriers.

5.6 Markers of Systemic Inflammation and Systemic
Immune Activation
Markers of systemic immune function and inflammatory response might provide
informative indirect evidence of precursors to, or consequences of, small intestinal injury.
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Indeed, the hypothesis that local inflammation could be reflected in systemic markers is
intriguing. There is precedent for associations between markers of organ-specific inflammation
and systemic inflammation, with the best studied being coronary artery and inflammatory bowel
diseases. The atherosclerotic lesion in coronary artery disease and the small and/or large bowel
inflammation in Crohn’s disease and ulcerative colitis are characterized by acute and chronic
inflammatory changes, and, as such, could be analogous to the lesions found in EED. By
extension, there is ample evidence of an association between systemic markers of inflammation
and acute coronary artery events, including myocardial infarction, sudden cardiac death, and
cerebrovascular accidents, and of intestinal disease activity in inflammatory bowel diseases.
Concentrations of circulating C-reactive protein (CRP) have, indeed, emerged as strong
predictors of such events in adults, and complement the use of lipid profiles, which are a more
specific biomarker of coronary artery disease [265-267]. Systemic CRP or erythrocyte
sedimentation rates are indices of inflammatory bowel disease activity [268, 269].
In the case of EED, there is justification for seeking evidence of systemic inflammation as
a biomarker, based on the precedent of coronary artery disease and inflammatory bowel
diseases. However, there are additional justifications: the pathophysiology of environmental
enteric dysfunction might result in, or be associated with, a hyperpermeable gut. Such increased
bowel permeability would expose the host to a variety of injurious substances, most particularly
microbial inflammatory drivers, and the host response could either be a surrogate for
inflammation, or reflect the process that leads to enteric dysfunction. For example, one or more
bacterial molecules could be absorbed, leading to a pro-inflammatory host response, as
manifested by elevated CRP, but such a response could be an appropriate reaction to the gut
that enables the molecules to be absorbed.
To hone in on assessments of systemic inflammation and immune function that could be
helpful as markers of enteric dysfunction, we reviewed those studies that examined the markers
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among children with presentations such as persistent diarrhea, or investigations of the markers
in relationship to markers of intestinal inflammation or dysfunction.
It should be noted that there can be considerable overlap between the primary
assignment of many of these markers of systemic inflammation and nutrient testing (e.g., serum
albumin, total protein, hemoglobin, and blood counts.) For example, while hypoalbuminemia,
hypo- or hypergammaglobulinemia, and impaired erythropoiesis are indicators of nutritional
status, they can also reflect systemic immune activation [270-273]; as such, they were assigned
to this section. For purposes of this review, if a test could be related to inflammatory activation
and measured the product of a nutrient (such as hemoglobin) and not the nutrient itself (such as
iron), then we included the test in our review.
We identified a diverse set of markers from 23 studies that we assigned to the category
of systemic inflammation but which could serve as biomarkers for intestinal inflammation.
Relevant data for each of the studies in this category can be found in Evidence Table 5. The
most commonly employed markers were CRP, albumin, hemoglobin, transferrin, and varying
total and immunoglobulin class concentrations. Additional markers included circulating cytokines
and/or chemokines, total oxidant status, circulating α-1-acid glycoprotein (AGP), serum
mannose-binding lectin, and urinary neopterin. Three studies assessed nitric oxide [43, 158] and
plasma endotoxin and IgG endotoxin-core antibody [110], which are markers that could reflect
systemic inflammation driven by intestinal processes. One study also included data on multiple
markers of cellular, as well as humoral, immunity [104].
Although we did not systematically seek studies that assessed systemic marker
association with nutritional status, among the studies that used markers of systemic
inflammation or immune activation that were included in this review, seven assessed systemic
inflammatory markers in relation to anthropometric indices [43, 110, 122, 123, 130, 150, 151].
The relationships varied widely across markers and sometimes across different growth
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parameters for the same marker. Some data associated circulating markers of systemic
inflammation and stunting; the markers with the strongest associations were albumin and α-1acid glycoprotein, each in an inverse relationship [123].
Six studies investigated association of systemic markers with persistent diarrhea [104,
106, 107, 114, 130, 166]. Those identified at significantly lower concentrations in children with
persistent diarrhea relative to children without diarrhea included: serum total protein [106, 107],
hemoglobin [106, 166], mean corpuscular volume (MCV) and mean corpuscular hemoglobin
(MCH) [166], lymphocyte counts [166], and anti-oxidant concentrations [107]. Albumin
concentrations were also lower in children with persistent diarrhea; this relationship was
statistically significant in one study [106] but not in another [166]. Sample size differences could
explain the effect discrepancy with six 6-24 month olds with persistent diarrhea in the latter [166]
compared to 96 6-36 month olds in the former [106]. While albumin concentrations are known to
increase with increasing age, the slightly older cohort in the study that found an association is
unlikely to explain the discrepancy in results.
Markers found at higher levels in children with persistent diarrhea compared to those with
no diarrhea were total oxidant status, thiobarbituric reactive substances, and DNA damage
[107]. In addition, assays of neutrophil polarization and monocyte spontaneous proliferation
showed increased responsiveness in children with acute or persistent diarrhea relative to those
without diarrhea [104]. A negative delayed-type hypersensitivity response to tuberculin antigen
was also associated with progression from acute to persistent diarrhea [104].
Only one study utilizing markers of systemic inflammation investigated both growth
outcomes and persistent diarrhea; this was in relation to serum mannose-binding lectin [130],
which was not significantly associated with either.
Five studies investigated the relationship of systemic inflammatory markers to gut
permeability. Associations were found between IgG, IgA, IgM, and IgG endotoxin core antibody
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and intestinal function as measured by the L:M ratio [110] and between hemoglobin
concentration and the lactose:creatinine ratio [151]. Additionally a correlation was observed
between urinary nitric oxide and the serum L:R ratio [43]. In contrast, anemia and mean
corpuscular volume (MCV) were not associated with serum L:R [58], and associations were not
found between the L:M ratio and other markers such as α-1-acid glycoprotein (AGP), total IgG,
albumin, or hemoglobin concentrations [123]. Furthermore, only one of these studies included
biopsy, but the authors did not report assessing the relationship between markers of systemic
inflammation and histology [146].

208

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
2000

Location and
Target Population

Design and
Sample Size

Dhaka, Bangladesh Case-control

Azim T et al.

7-12 mo olds with 68 days of watery
Immune response of diarrhea attending
Bangladeshi children the International
with acute diarrhea Centre for Diarrheal
who subsequently
Disease Research.
have persistent
Cases were those
diarrhea
who went on to
develop PD, controls
Immune response
were those who did
tests, as well as
not.
transferrin and
albumin as markers
of nutritional status An additional group
among children with of subjects without
diarrhea were
and without PD
recruited from a
nutrition follow-up
unit.
Prevalence of
malnutrition was high
in all groups.

n=136;
n=38 cases with
PD
n=98 controls:
• 85 with AD
• 13 with no
diarrhea

Biomarker

Results

Conclusion

Comments

Blood tests:
WBC total and differential,
Some immune and The number of
immunoglobulin subtypes, cytokines, inflammatory
controls was
• IFN-γ
transferrin, and albumin did not differ markers were
relatively small and
• TNF-α
between
cases
with
diarrhea
or
their nutritional
associated
with
• WBC (total and
controls,
nor
did
stool
leukocyte
or
status was not
acute
and/or
differential)
erythrocyte
counts.
reported.
persistent
diarrhea.
• IgA
• IgG
The percentages of neutrophils that The only marker that
• IgM
polarized in response to stimulation was significantly
• Transferrin
were significantly higher in subjects associated with
• Albumin
with AD or PD compared to those
progression to PD
• Immune function
without diarrhea; there was no
was a negative DTH
tests:
difference between the two diarrhea response to
• Neutrophil
groups.
tuberculin antigen
polarization
(odds ratio=3.8, CI:
response to
Opsonization did not vary between 1.4, 9.9). This was
chemotactic factor any groups.
calculated from a
• Neutrophil
logistic regression
opsonization to Monocyte spontaneous proliferation analysis that only
yeast
counts were less than half among
included children
• Mononuclear cell children with no diarrhea compared with diarrhea.
proliferation,
to those with AD (p<0.001) or with
spontaneous and PD (p=0.011); there was no
in response to
difference between the two diarrhea
stimuli with
groups.
mitogens
Monocyte proliferation in response to
stimulation did not differ between the
Skin Test:
3 groups.
• Delayed-type
hypersensitivity The proportion with DTH responses
response (DTH) differed among the three groups only
to tuberculin,
in response to tuberculin (p=0.021).
tetanus,
More PD subjects had a negative
diphtheria,
tuberculin response than did
Streptococcus, subjects with AD (p=0.024).
Proteus,
Candida, and
Trichophyton
Stool tests:
• Leukocytes
• Red blood cells

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
2003

Location and
Target Population

Design and
Sample Size

Kampala and Mpigi, Case-control
Uganda
n=192;
Bitarakwate E et al.
6-36 mo olds with
Serum zinc status of PD, recruited from n=96 cases with
hospital, and healthy PD
children with
persistent diarrhoea controls recruited
mainly from the local n=96 healthy
admitted to the
controls
population.
diarrhoea
management unit of
Mulago Hospital,
Uganda
Serum protein,
albumin, and
hemoglobin among
children with and
without PD
2010
Bukhari AS et al.
DNA damage and
plasma
homocysteine
concentrations are
associated with
serum metabolites
and mineral
constituents' profiles
in children with
persistent diarrhea
Serum proteins,
metabolites, and
levels of DNA
damage among
children with and
without PD

Faisalabad, Pakistan Case-control
3-6 yr olds admitted n=72;
to hospital with PD
and healthy controls. n=36 cases with
PD
n=36 healthy
controls

Biomarker

Results

Conclusion

Blood Tests:
• Albumin
• Total protein
• Hemoglobin

PD cases:
7.47.9% low serum protein
8.69.7% low serum albumin
9.Low mean hemoglobin (10.5 g/dL)

Decreased albumin,
serum total protein
and hemoglobin
concentrations were
associated with PD.

Comments

For controls, means of all three
laboratory values were within normal
range; percent of subjects with
abnormal values are not reported.
All three test results were
significantly lower in children with PD
than in controls (p< 0.01 for each
comparison).

Blood Tests:
Mean values significantly higher
Serum proteins and among PD cases than in healthy
controls:
metabolites:
10.LDL
• Albumin
11.Homocysteine
• Globulin
12.TOS
• Homocysteine
13.TBARs
• Total protein
• Total cholesterol, 14.DNA damage
HDL, LDL,
Mean values significantly lower
triglycerides
among PD cases than in healthy
• AST, ALT
controls:
• T3, T4
15.Total protein
• Total oxidant
16.T4
status (TOS), Total
17.TAS
anti-oxidant status
(TAS), and
thiobarbituric
reactive
substances
(TBARS)
• DNA damage to
lymphocytes

Multiple serum
markers were
associated with PD,
especially DNA
damage to
lymphocytes
(p=0.0001).

Control recruitment
strategy was not
well described.
TOS, TBARS and
TAS were
incompletely
defined.

The authors
speculate that zinc Some values
differed by gender
deficiency, more
commonly found in in both the case
the children with PD, and control groups:
might be responsible 18.Triglycerides
for increased
19.Total cholesterol
20.HDL
homocysteine
concentrations and 21.T3
play an important
Multiple markers
role in mediating
studied; analyses
DNA damage.
did not appear to
address potential
confounding.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
2003

Location and
Target Population

Design and
Sample Size

Keneba, The
Gambia

Cohort

Campbell DI et al.
All 2-11 mo olds
Growth faltering in were recruited from
this rural village and
rural Gambian
infants is associated followed up to 14 mo
with impaired small of age.
intestinal barrier
function, leading to
endotoxemia and
systemic
inflammation
L:M as a marker of
intestinal
permeability and its
relationship with
various inflammatory
markers and
endotoxin

n=71

Biomarker

Results

Conclusion

Comments

Urine Tests:
1
• Lactulose
(53 tested)
• Mannitol
(52 tested)
• L:M
(52 tested)

At 8 wk of age:
2
• Mean L:M: 0.169 (CI: 0.145,
0.198; range: 0.058-0.657)
• Mean lactulose recovery: 0.202
(SD=0.159; range: 0.009-0.640)
• Mean mannitol recovery: 3.80
(SD=2.35; range: 0.52-8.58)

Mean L:M ratios
were elevated at 8
weeks of age, and
more than doubled
in the first year of
life.

Presence of malaria
parasites was
assessed by blood
smear at each
study visit; the only
parameter
associated with
malaria was CRP.
Authors did not
report investigating
relationships
between certain
serum parameters
(blood counts, CRP
concentrations) and
L:M.

Blood tests:
• Albumin
• CBC
• C-reactive
protein (CRP)
• IgA
• IgM
• IgG
• Plasma endotoxin
• IgG endotoxincore antibody

L:M more than doubled between 12
wk-1 yr of age (r=0.44, p<0.001) and
was driven by both increasing
lactulose (r=0.18, p<0.001) and
decreasing mannitol (r=-0.14,
p<0.01) excretion with age.
WAZ and HAZ scores were
negatively correlated with L:M (r=0.41, p<0.001), and primarily driven
by lactulose excretion (r=-0.39,
p<0.001).
Laboratory values were consistent
with chronic, low level
immunostimulation:
• 50% of platelet and 39% of
leukocyte counts were elevated,
especially mean lymphocyte
counts which were almost twice
expected values [198].
3
• While the mean CRP was within
the normal range, 25% of values
were above the upper limit of
normal (5 mg/L), and 17% were
>10 mg/L [198].
• Mean IgG, IgA and IgM
concentrations were near normal
at 8 wk of age, but increased
rapidly; all three were elevated
above expected values in all other

1

For lactulose and mannitol results, excretion measurement was not specified.
Geometric mean.
3
Geometric mean.
2

Many markers of
inflammation and
endotoxin release
were significantly
correlated with L:M
and lactulose
recovery.
Poor growth was
significantly
correlated with L:M
ratios, primarily due
to lactulose
excretion.
Authors postulate
that while general
markers of
inflammation cannot
be specifically
ascribed to a gut
source, endotoxin
and its related core
antibody are
potentially a direct
measure of intestinal
inflammation due to
gut gram negatives
as a primary source
of endotoxin release
among subjects
without sources of

Study population
might have overlap
with that of
Campbell et al.
2004 also included
in this review [15].

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

age groups [198, 199].
extra-intestinal gram
1
negative infection.
• Mean free plasma endotoxin
concentration was twice the upper
limit of normal [200] and IgG
endotoxin-core antibody
concentrations were also elevated
[198].
• However, mean albumin
concentrations (and
concentrations within SD) were
generally within normal range
[198].
L:M was correlated with
IgG and IgA (r=0.41 and 0.41,
respectively, p<0.001), and IgM
(r=0.28, p<0.02).
IgG and IgA were also correlated
with lactulose recovery (r=0.26 and
0.25, respectively, p<0.02).
IgG endotoxin core antibody
concentration was correlated with
L:M and driven by lactulose
recovery, (r=0.35, p<0.005 for both).

2002

Kampala, Uganda

Cohort

n=225
9 mo old HIVinfected children
Risk factors and
followed at Mulago
cumulative incidence hospital until 36 mo
of anaemia among of age.
human
More than 40% were
immunodeficiency
stunted and/or
virus-infected
children in Uganda underweight at
Clark TD et al.

1

Geometric mean.

Blood Test:
Hemoglobin

Endotoxin concentrations were
correlated with lactulose recovery
(r=0.36, p<0.02) only.
While chronic diarrhea was
While there was a
associated with moderate anemia in high prevalence of
a univariate analysis (odds ratio=2.5, anemia (<11 g/dL)
CI: 1.0, 6.3), it was either not
and moderate
associated with moderate anemia
anemia (<9 g/dL)
(hemoglobin <9 g/dL) in a
(92% and 35% at 9
multivariate model or not included in months,
the model
respectively) among
this cohort of HIVinfected children,
chronic diarrhea

The association
between chronic
diarrhea and other
assessed
hematologic
markers (any
degree of anemia,
mean corpuscular
volume, and mean
corpuscular
hemoglobin

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

enrollment.
Association of
chronic diarrhea with
moderate anemia in
HIV-infected children

2008

Dhamrai Upazila,
Bangladesh

L:M as a marker of
intestinal
permeability, IgG as
a marker of chronic
immune stimulation,
and α-1-acid
glycoprotein as an
acute phase reactant
among children
undergoing antiparasitic
presumptive
treatment vs.
placebo. Also
assessed markers’
associations with
1

Geometric mean.

Urine Test:
L:M

n=222*

Goto R et al.
Impact of antiGiardia and
anthelminthic
treatment on infant
growth and intestinal
permeability in rural
Bangladesh: a
randomised doubleblind controlled
study

RCT

3-15 mo olds from a
rural area were
enrolled and
followed in a 9-mo
trial.
There was a high
prevalence of
malnutrition in the
study population.

n=75 received
anti-Giardia and
anthelminthic
treatment
n=59 received
anti-Giardia
treatment only
n=88 received
placebo

* Those who fully
participated and
for whom data
were analyzed
are included in
this review.

Blood Tests:
• α-1-acid
glycoprotein
(AGP)
• IgG
• Albumin

Results

Conclusion

Comments

appears to have not concentration) was
been associated
not reported.
with anemia in the
multivariate analysis.
However, the text
did not specifically
state whether
chronic diarrhea was
tested in the
multivariate model.
1
Mean L:M (SD) at baseline was
High L:M ratios
High L:M ratios
0.18 (0.24) in treatment groups, with overall with
were defined as
no significant difference in placebo substantial seasonal greater than the
group or in testing post-intervention. and within-infant
upper CI for UK
infants.
variability.
Proportion with elevated L:M at any
study time point varied between
Interventions did not Same study
58%-74%. >57% consistently
impact L:M or serum population as
elevated L:M ratios.
immune markers.
reported by this
group in another
Seasonal variation in L:M was
study also included
There was
observed (p <0.001), with highest
in this review [123].
improvement in
mean values in the monsoon
weight with better
season.
L:M values, the
degree to which this
L:M was associated with ∆WAZ and occurred was not
∆WHZ scores at 24 weeks (p=0.001 reported.
and p<0.001, respectively, point
estimates not provided.)
Serum immune marker values were
similar in all groups and did not
change substantially with
interventions.
AGP concentrations were negatively
associated with ∆WAZ score at 24
weeks (p=0.004, point estimate not
provided), and were associated with
∆WHZ score at 12 weeks but not at
24 weeks.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
growth parameters.
2008
Dhamrai Upazila,
Bangladesh
Goto R et al.
3-15 mo olds from a
Impact of intestinal rural area were
enrolled and
permeability,
inflammation status followed in a 9-mo
trial.
and parasitic
infections on infant
There was a high
growth faltering in
prevalence of
rural Bangladesh
malnutrition in the
L:M as a marker of study population.
intestinal
permeability, IgG as
a marker of chronic
immune stimulation,
and α-1-acid
glycoprotein as an
acute phase
reactant. Also
assessed laboratory
values’ associations
with giardiasis and
growth parameters.

2007

Delhi, India

Design and
Sample Size

Biomarker

Longitudinal data Urine Test:
extracted from an L:M
RCT [123]
n=298

Blood Tests:
• α-1-acid
glycoprotein
(AGP)
Urine and blood
• IgG
samples were
collected every 3 • Albumin
• Hemoglobin
mo and
anthropometric
measurements
were collected
monthly.

Case-control

Children (ages
n=80;
unspecified)
Fecal occult blood admitted with severe n=50 cases with
screening in children malnutrition and age- severe
malnutrition
matched healthy
with severe
controls recruited
malnutrition
n=30 healthy
from an
Fecal occult blood immunization clinic. controls

Stool Test:
Occult blood

Jain S et al.

1

Geometric mean.

Blood Test:
Hemoglobin

Results
1

Mean L:M: 0.15
L:M showed a decreasing trend with
age (p=0.003), and was associated
with female gender (p=0.004), HAZ
score (p=0.039), and WAZ score
(p=0.019), but not with giardiasis or
any of the serum immune markers.

Conclusion

Comments

Mean L:M was
elevated. L:M was
not associated with
any of the tested
serum markers of
inflammation or with
giardiasis.

Helminthiasis
prevalence was
very low; testing for
association with
markers was not
performed.

Giardiasis was
IgG rose with
defined as
IgG, AGP, and albumin were
increasing age at the presence of a
Giardia-specific IgM
associated with giardiasis, but
rate expected
hemoglobin was not.
response.
(compared to UK
norms) [199] but at
Mean circulating albumin
Same study
higher
concentration was normal for age
population as
concentrations
[203]. Compared to UK age-matched across all ages.
reported by this
reference [199], rate of rise in IgG
group in another
with increasing age was similar, but
study also included
concentrations were consistently
in this review [122].
~3g/L higher.
Cut-off values
IgG was not associated with growth
representing
parameters. Albumin was associated
elevated
with HAZ score only (p=0.016). AGP
concentrations
was inversely associated with HAZ
have not been
(p=0.011) and WAZ (p=0.005)
determined for
scores
AGP. UK norms for
10 mo olds-adults
are 0.88 g/L mean
(0.21 SD) [204].
Fecal occult blood test was positive A high proportion of Among cases, half
in 30/50 (60%) cases and 0/30
severely
had a presenting
controls.
complaint of
malnourished
diarrhea (duration
children had a
Among cases positive for fecal
positive fecal occult not specified), but
occult blood, 20 (66.7%) were found blood test,
the authors did not
to have hemoglobin <8 g/dL.
report results
compared with no
stratified by
positives among
Enteric infections:
diarrhea duration.
healthy controls.
• Parasitic infections were detected

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
among severely
malnourished
children compared to
healthy controls

Design and
Sample Size

2001

New Delhi, India

Kapoor S et al.

<12 yr olds admitted n=40;
to hospital with PD
and Giardia.
n=30 cases with
PD and Giardia
Controls had no
diarrhea and were n=10 controls
hospitalized for non- without diarrhea
GI conditions.

Giardiasis--clinical
and diagnostic
perspective
Immunoglobulin
concentrations in
duodenal fluid and
serum among
children with PD and
Giardia infection
compared to those
without diarrhea
2006

Case-control

Most cases were <7
yr old, with n=19 <3
yr old. Ages of
controls were not
specified.
Port-au-Prince, Haiti Case-control

Kirkpatrick BD et al. <36 mo old inner-city n=99;
residents recruited
Serum mannosefrom the rehydration n=49 cases with
Cryptosporidium
binding lectin
unit at the State

Biomarker

Duodenal secretion
aspirates:
• IgG
• IgM
• IgA

Blood Tests:
• IgG
• IgM
• IgA

Blood Test:
Mannose-binding
lectin (MBL)

Results

Conclusion

Comments

in 14/50 (28%) of cases, 12
Malnourished
Authors did not
(85.7%) of whom tested positive for children with
provide differences
fecal occult blood.
in proportions of
identifiable
occult blood among
• Bacterial infections were detected pathogens more
often tested positive those with and
in 18/50 (36%) of cases, 13
without specific
(72.2%) of whom tested positive for for fecal occult
enteric pathogens.
blood, although
fecal occult blood.
• Of the remaining 18 for whom an approximately 25%
of those without an Statistical analysis
enteric pathogen was not
identified, 5 (27.8%) tested positive identifiable pathogen was not provided;
also tested positive. data were reported
for fecal blood.
as proportions only.
Presence
of
fecal
Among the 30 cases with fecal
occult blood, 16 were breastfed, 11 blood did not appear Matching scheme
was not defined.
were fed cow’s milk, and 3 were fed to vary by feeding
mode (e.g. breast
formula.
milk, cow’s milk, or
formula), although
data presented were
limited.
Higher mean concentrations of IgM Differences in
The number of
were found in duodenal aspirates of immunoglobulin
controls was small
cases compared to controls
concentrations were due to constraints
(p<0.05).
in obtaining
limited among
duodenal aspirate
children with PD
infected with Giardia from children
Mean concentrations of duodenal
IgA and IgG did not differ between compared to
without GI
cases and controls.
symptoms.
children without
such conditions.

Serum MBL concentrations were
lower in cases than in healthy
controls (p=0.002) and diarrhea
controls (p=0.045).
Percentage MBL-deficient:

While
MBL deficiency was
cryptosporidiosis
defined as
was associated with concentrations <70
ng/mL.
MBL deficiency,
MBL concentrations
were not significantly

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
deficiency is
associated with
cryptosporidiosis in
young Haitian
children
Mannose-binding
lectin as a marker of
innate immune
activation among
children with and
without
Cryptosporidium
infection

2002

Location and
Target Population

Design and
Sample Size

University Hospital
or from GHESKIO
1
HIV Center .

infection
(22 with PD)

All subjects were
HIV-negative.

Biomarker

n=9 diarrhea
controls negative
for
Cryptosporidium
n=41 healthy
controls without
diarrhea and
Cryptosporidiumnegative

Stool Tests:
• Reducing
Kirkpatrick BD et al. <18 mo olds from a n=49;
substances (RS)
low SES setting
• Lactoferrin
n=17 cases with • Cytokines:
Cryptosporidiosis
recruited from the
Cryptosporidium
stimulates an
rehydration unit of
• TNF-α receptor
and diarrhea (5
inflammatory
GHESKIO HIV
I
3
with PD)
intestinal response Center with
• IL-4
diarrhea and
in malnourished
• IL-8
Cryptosporidium
n=32 controls
Haitian children
• IL-10
without
infection. Controls
• IL-13
Cryptosporidium;
recruited from an
Stool lactoferrin,
• IFN-γ
• 17 with
outpatient clinic
reducing
diarrhea (5 with
without
substances,
Cryptosporidium
PD)
leukocytes and
Blood Test:
• 15 healthy
infection included
cytokines as
• WBC
markers of intestinal those with and
without diarrhea.
inflammation of
children with and
without
1

Port-au-Prince, Haiti Case-control

The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections.
Reported results were adjusted for confounding variables, unless otherwise noted.
3
The Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections.
2

Results

Conclusion

• 36.7% cases
• 9.8% healthy controls
• 0 diarrhea controls

associated with
mean duration of
diarrhea or history of
PD.

Comments

Cryptosporidiosis was associated
with MBL deficiency (odds
2
ratio=22.4; CI: 3.1, 160.8 ).
Among cases, the proportion of
those with PD was nearly double
among those with MBL deficiency
compared to those without MBL
deficiency, but these results were
not significant (p=0.13). MBL
deficiency was not associated with
duration of diarrhea (p=0.37) among
those with cryptosporidiosis nor with
anthropometric status among either
cases or controls.
Proportion RS-positive:
• 33.3% cases
• 64.7% diarrhea controls
• 46.7% healthy controls, (p=0.2)

Fecal lactoferrin was Reported results
identified most often were not stratified
by persistent vs.
in children with
diarrhea, especially acute diarrhea
status.
in those with
Cryptosporidium.
Proportion lactoferrin-positive:
Cut-off values for
While some fecal
• 83.3% cases
lactoferrin positivity
cytokines
were
• 60.0% diarrhea controls
were not described.
detected
in
as
many
• 28.6% healthy controls, (p=0.01)
as
40%
of
healthy
IFN-γ was not recovered in any
controls and 70% of Stools from children
stools.
who were
controls with
diarrhea, they were breastfeeding were
All other fecal cytokines were
generally associated not tested for
significantly associated with
lactoferrin.
Cryptosporidium cases compared to with
Cryptosporidium
diarrhea and healthy controls.
infection. The other
Additionally, TNF-α receptor I, IL-8, stool tests did not
discriminate by
IL-13 were found in diarrhea and
healthy controls, while IL-4 and IL-10 diarrhea or

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
Cryptosporidium
infection

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

were not.

Cryptosporidium
status.

Comments

Fecal lactoferrin was associated with
the presence of TNF-α receptor I
(point estimate not provided,
p=0.03).

2003

Darwin,
Australia

Kukuruzovic R et al.
Increased nitric
oxide production in
acute diarrhea is
associated with
abnormal gut
permeability,
hypokalemia and
malnutrition in
tropical Australian
aboriginal children

1-6 yr old Aboriginal
and non-Aboriginal
hospital inpatients.

Subjects were
grouped as follows:
• Children with AD
• Children with no
diarrhea but with
non-GI infectious
conditions
• Children without GI
Nitric oxide (NO) as
or infectious
a marker of intestinal conditions
permeability and
inflammation, and
lactulose:rhamnose
ratio (L:R) as a
marker of intestinal
permeability and the
relationship between
NO and L:R, growth
parameters, mean
corpuscular volume
(as a surrogate of
iron deficiency), and
stool reducing
substances among
children with and
without diarrhea

Mean WBC counts were within
normal range in all 3 groups.
Case-control
Urine Test:
NO among Aboriginal children with
Nitric Oxide (NO)* diarrhea was >3x higher than any
n=318;
other group and >5x higher than in
non-Aboriginal controls.
n=169 cases with Blood Tests:
• NO was >3x and >2x higher
AD
• L:R
among Aboriginal than non(154 Aboriginal) • Mean
Aboriginal children in the
corpuscular
diarrhea (p<0.001) and no
volume (MCV)
n=149 controls:
infections groups (p<0.001),
respectively, but there was no
• 73 with non-GI
infections (49
difference between them in the
Stool Test:
Aboriginal)
non-GI infections group.
Reducing substances • NO was >3x and ~2x higher in
76 with no
(RS)**
infections (29
the diarrhea compared to the no
(169 cases tested)
Aboriginal)
infections group among
Aboriginals (p<0.001) and nonAboriginals (p<0.03),
respectively.
* NO is an unstable
• NO was virtually the same
free radical and is
among the Aboriginal non-GI
converted to nitrite
infections and no infections
and nitrate. Urine
groups, as well as among the
nitrate (NO3)+ nitrite
non-Aboriginal diarrhea and
(NO2) was expressed
non-GI infections groups.
as a ratio with urine
creatinine (NO2 +
NO3:Cr) in order to 112/152 (74%) and 31/169 (18%) of
children with AD had abnormal L:R
account for
differences in urine ratios and positive stool RS,
respectively.
concentration.
NO and L:R were measured at
** Measured only
among children with “convalescence” on Day 5 among
those with diarrhea: the mean
profuse diarrhea.
improvement in NO was 21.7%

NO2 + NO3:Cr ratio, Positive stool RS
as a measure of
was defined as
>0.5%.
endogenous nitric
oxide production,
Abnormal L:R was
was used as a
defined as >7.6; no
marker of gut
reference or
permeability and
inflammation, with derivation was
an attempt to identify provided for this
how much more it
cut-point.
reflects as response
to inflammation from Study population
appears to be the
GI vs. non-GI
same as in another
infections.
Kukuruzovic, et al.
Among nonstudy also included
Aboriginal controls, in this review which
NO production was assessed serum
lactulose:rhamnose
the same among
those with diarrhea as a marker of
intestinal
and non-GI
permeability [58].
infections (and
higher compared to
controls). NO was
highest by far
among Aboriginal
children with
diarrhea compared
to any other group.
Authors suggest that
high basal
concentrations of
NO among
Aboriginal children

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

compared with 54.6% for L:R
(p=0.01).

2002
Kukuruzovic RH et
al.

Darwin, Australia

Cases were
Aboriginal and nonAboriginal children
Small bowel
admitted to hospital
intestinal
with diarrhea.
permeability in
Controls were
Australian Aboriginal Aboriginal and nonchildren
Aboriginal children
admitted without GI
Serum lactulose:
illnesses.
rhamnose ratio
(L:R), serum lactose,
and stool reducing
substances as
markers of intestinal
1

due to (clinically
silent) enteropathy
could explain the
NO and L:R were correlated (n=193, concentrations seen
1
r=0.37, p<0.001) ; the correlation
among Aboriginal
was stronger for lactulose (effect
controls in this
ratio=1.47, p<0.001) than for
study.
rhamnose (effect ratio=0.80,
2
p=0.02 ).
NO appeared to
decrease
NO was not correlated with stool
significantly more
3
RS or MCV, but was correlated with slowly than L:R
lower WAZ score (effect ratio=0.88, among children
p=0.05).
recovering from
diarrhea.
NO was found to
correlate with L:R.
NO was more
strongly correlated
with lactulose than
rhamnose.
Case-control
Blood Tests:
27/75 (36%) of Aboriginal controls
Mean L:R ratios of
and 0 non-Aboriginal controls had
Aboriginal children
• Lactose
abnormal L:R ratios.
were approximately
n=375 admissions • Lactulose 4
double those of nonfor 306 children; • Rhamnose
5
Mean L:R at baseline:
Aboriginal children
• L:R
Cases:
both among those
n=285 case
• Hemoglobin
with and without
admissions for
• Mean corpuscular • Aboriginal: 16.4
diarrhea, consistent
AD (264
• Non-Aboriginal: 7.9, p=0.002
volume (MCV)
with authors’
Aboriginal)
compared to Aboriginal cases
suggestion that
Controls:
clinically silent
n=90 control
1.Aboriginal:
4.6
Stool Test:
enteropathy is
admissions with Reducing substances 2.Non-Aboriginal: 2.5, p=0.02
no diarrhea (74 (RS)*
compared to Aboriginal controls prevalent among
Aboriginal children.
Aboriginal)
1
Mean improvement in L:R (CI) at
Mean L:R
day 5 among those with repeat
L:R testing was
significantly
testing:

Comments

Reported results appear to have been adjusted for age and race.
Reported results were adjusted for age and race.
3
Reported results among children with diarrhea were adjusted for age and race.
4
Lactulose and rhamnose results were expressed as % of dose administered.
5
Geometric mean.
2

Positive stool RS
was defined as
>0.5%.
Abnormal L:R was
defined as >5.6,
derived from 2 SD
above the
arithmetic mean for
non-Aboriginal
controls in this
study. The rationale
for the choice of 2
SD above the
arithmetic, instead
of the geometric,
mean is not clear.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
permeability among
Aboriginal and nonAboriginal children
with and without
diarrhea

Design and
Sample Size

Biomarker

Results

repeated on day 5 for • Aboriginal cases: 14.6 (11.2,
a subset of Aboriginal
18.0)
subjects:
• Aboriginal controls: -0.63 (-4.0,
• 174/264 admissions
2.7)
for acute diarrhea
2
Mean lactulose recovery :
• 25/74 control
admissions
• Cases day 1: 0.085 (0.070–
0.103)
• Cases day 5: 0.039 (0.033–
* Measured only
0.046)
among children with
• Controls: 0.024 (0.019–0.029)
profuse diarrhea
All 3 values significantly differed
when “clinically
from one another.
indicated." Number
tested not provided. Mean rhamnose recovery:
• Cases day 1: 0.479 (0.424–0.542)
• Cases day 5: 0.555 (0.498–0.616)
• Controls: 0.585 (0.500–0.685)
These values did not significantly
differ from one another.

Conclusion

Comments

improved over 5
days among
Aboriginal cases.
Children with severe
diarrhea had higher
mean L:R.

Proportions of
cases with
abnormal
concentrations
were not reported.

Analysis included
Higher case L:R was data for 69 children
driven more by high with repeat
lactulose than by low admissions; this
rhamnose.
might violate
Similarly,
independence
improvement in L:R assumptions for
among cases was their statistical
analysis methods.
primarily due to
decreased lactulose.
Repeat L:R testing
Stool RS and serum was conducted on
lactose were found controls of both
racial groups, but
in approximately
among cases it was
one-quarter and
only conducted on
one-third of
Confidence intervals (CIs) in the
Aboriginal cases.
Aboriginal cases,
authors' graphical representation of
respectively. The
mean L:R at admission did not
This study appears
latter was weakly
overlap, and the difference in means
to report on the
associated with
was particularly evident between
increased lactulose. same population as
Aboriginal and non-Aboriginal
in the Kukuruzovic,
subjects.
et al. 2003
reference also
Factors associated with L:R among
included in this
3
cases were :
review, which
• Acidosis (p=0.007)
assessed nitric
• Hypokalemia (p=0.035)
oxide excretion
• Diarrhea severity (p=0.001)
[43].
Age and malnutrition were not
associated with L:R.

1

Authors reiterate
the advantages of
serum over timed

Improvement in L:R appears to have been calculated as baseline L:R minus repeat L:R, as described in another publication in this review; however, this was not expressly stated.
Reference 134. Kukuruzovic RH, Brewster DR. Milk formulas in acute gastroenteritis and malnutrition: a randomized trial. J Paediatr Child Health. 2002. 38(6):571-577.
2
Figures reported parenthetically after the mean percent recoveries of lactulose and rhamnose were not specified as ranges or CIs.
3
Reported results were adjusted for confounding variables, unless otherwise noted.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results
38% and 27% of Aboriginal cases
had positive serum lactose and stool
RS, respectively. 12% of Aboriginal
and non-Aboriginal controls
combined had lactosemia.

2001

New Delhi,
India

Case-series

n=94;
(38 with repeat
0-15 yr old
biopsies)
Tropical sprue in
gastroenterology
north Indian children clinic patients with
<5 yr old: n=44
PD.
D-xylose and
duodenal biopsy as Those with abnormal
morphology on
markers of TS
biopsy, abnormal Dxylose test, and
clinical response to
antibiotics were
diagnosed as having
TS.
Mittal SK et al.

Those with abnormal
morphology and
response to glutenfree diet were
diagnosed with CD.
We include data on
these subjects for
comparative
reasons.

Comments
urine collection for
assessment of L:R,
as discussed in
another publication
in this review [125].

Presence of lactosemia was
associated with L:R, adjusted
1
relative risk (CI)=1.06 (1.03, 1.10) .
Stool RS, anemia, and MCV were
not associated with L:R.
Duodenal biopsy,
36 (38.3%) were diagnosed with TS More than half of the Biopsy results were
method not specified: including 14/44 (31.8%) who were
GI clinic patients
not provided for
Histopathology
under 5 years of age.
with PD had some patients without TS
or CD.
degree of villous
18 (19.1%) were diagnosed with CD. atrophy.
Blood Tests:
It was unclear if
• Hemoglobin
Degree of villous atrophy among TS More than one-third there were patients
• D-xylose*
vs. CD patients:
and almost one-fifth with abnormal Dxylose and
of subjects were
• Mild in 8/36 (22.2%) vs. 0
histology who did
diagnosed
with
TS
• Moderate in 23/36 (63.9%) vs. 4/18
* Not specified
not respond to
and
CD,
(22.2%)
whether from urine or • Severe in 5/36 (13.9%) vs. 14/18 respectively.
antibiotic therapy
serum, and units of
and therefore were
(77.8%)
measurement not
By study diagnostic not diagnosed with
TS.
provided.
definition, all TS
Mean hemoglobin concentration
(range) among TS patients was 8.3 patients improved
Cut-off points used
g/dL (5.5-11) and did not differ from with treatment.
Among
those
who
to define abnormal
values of those with CD.
had repeat biopsies, D-xylose tests were
not provided.
almost threeAmong the 22 TS patients, repeat
quarters showed
biopsies showed:
normalization of
• 16 with normalization
histology, while 23%
• 5 with improvement
• 1 worsened despite marked clinical had partial
improvement and 1
improvement
patient had
The D-xylose test was abnormal in worsened pathology.
all TS patients by diagnostic
definition.

1

Conclusion

Reported results were adjusted for severity of diarrhea, acidosis, hypokalemia, and age.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
2001

Location and
Target Population

Design and
Sample Size

Jamalpur district,
RCT*
northern Bangladesh
Northrop-Clewes CA
n=109;
et al.
2-5 yr olds from poor
rural villages,
n=54 received
Anthelmintic
sampled randomly bimonthly empiric
treatment of rural
from a larger cohort antihelminthic
treatment
Bangladeshi
study.
children: effect on
n=55 received
Stools were
host physiology,
placebo
assessed for
growth, and
biochemical status helminthiasis and
giardiasis. Growth
* Randomized at
L:M as a marker of was followed
the village level.
longitudinally.
intestinal
permeability, and α
1-antichymotrypsin
as a marker of
inflammation and
immune activation to
treatment among
children randomized
to bimonthly
antihelminthics or
placebo.

2009

Kathmandu, Nepal

Cohort

Panter-Brick C et al. 3-18 mo olds in two n=86;
1
2

Geometric mean.
Geometric mean.

Biomarker

Results

Blood Tests:
• α 1antichymotrypsin
(ACT)
• Albumin
• Total protein

Mean L:M at baseline:
• Treatment: 0.22
• Placebo: 0.25

1

Seasonal variation in L:M was
observed, with highest values
following the monsoon season.

Conclusion

Comments

L:M ratios were high
overall and
demonstrated
seasonal variation.

Baseline study data
were lost, so
analysis began with
samples taken at
month 2.

Intra-individual L:M
The relationship
values did not
change significantly between the serum
Within-subject L:M analysis showed over time, nor were markers and
Urine Test:
they associated with intestinal
no significant association with
L:M
permeability was
helminthiasis or
intestinal helminthiasis and no
not reported.
consistently
significant improvement in treatment
associated
with
Among 93 subjects or placebo groups over 1 yr. L:M
giardiasis.
with L:M at baseline: was generally not associated with
giardiasis
(with
the
exception
of
one
• 46 received
Inverse correlations
group at one study interval).
treatment
were seen between
• 47 received
L:M and growth
L:M was inversely correlated with
placebo
∆HAZ and ∆WAZ scores at some of parameters.
Among 66 subjects the follow-up intervals (r=-0.22,
Serum markers were
p<0.02 and r=-0.21, p<0.05,
with repeated L:M
within normal range.
respectively,
at
12
mo
follow-up
testing:
The only significant
visit).
• 34 received
change in these
treatment
markers was a
Mean
serum
ACT,
albumin
and
total
• 32 received
decrease in total
protein
were
within
normal
ranges
placebo
and were not associated with growth protein in the
treatment group
parameters. ACT and albumin
concentrations did not significantly without concomitant
change with treatment, whereas total change in albumin;
protein concentrations did (p<0.001). this suggested a
decrease in
globulins (not
directly measured),
perhaps due to
decreased
inflammation.
2
Urine Test:
Mean Lactose:Cr (CI):
Authors speculate Specific sugar
Lactose:Cr
• Squatter: 0.14 (0.12, 0.16)
that Lactose:Cr
excretion was
• Middle Class: 0.08 (0.07, 0.10)
accounted for less of normalized to

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

cohorts:
Pathways leading to • All children in
n=48 in squatter
early growth
target age range cohort
faltering: An
from four squatter
n=38 in lower
investigation into the settlements
• Randomly
middle-class
importance of
cohort
selected, agemucosal damage
matched cohort
and
from lower middleimmunostimulation
class, periurban
in different sociohouseholds
economic groups in
Nepal

Biomarker

• Statistically significant difference

Blood Test:
Hemoglobin

Lactose:creatinine
ratio (Lactose:Cr) as
a marker of intestinal
permeability and
hemoglobin,
albumin, α-1-acid
glycoprotein, and
IgG as markers of
immunostimulation.
The latter were also
assessed for their
relationship to
nutritional status.

2001

Results

the deterioration in
nutritional status
among the squatter
children because of
several factors,
including poorer
nutritional intake,
that impact the
nutritional status of
HAZ, WAZ, WHZ, and ∆WAZ scores children with lower
were strongly associated with mean socio-economic
Lactose:Cr (p<0.001 each) as was status.
∆HAZ score (p=0.004); ∆WHZ score
was not. The strength and
magnitude of association between
∆WAZ score and Lactose:Cr was
most pronounced among the
wealthier cohort and there was no
association between ∆HAZ score
and Lactose:Cr among the squatter
children.
between the 2 groups among the
6-12 mo olds (p=0.007) and 18-24
mo olds (p=0.002), but not among
12-18 mo olds.
• For both SES groups, Lactose:Cr
values decreased with increasing
age (p<0.001).

Hemoglobin concentrations were
inversely related to Lactose:Cr
2
(r =0.018, p<0.001).

Dhaka,
Bangladesh

Case-control

n=63;
2-6 yr olds with
Increased nitrite and cholera or shigellosis n=45 cases:
admitted to the
nitrate
• 24 with cholera
hospital.
concentrations in
• 21 with
sera and urine of
shigellosis
patients with cholera Controls were

Urine Test:
Nitric Oxide (NO)*

Rabbani GH et al.

Blood Tests:
• Nitrite (NO2)
• Nitrate (NO3)
• WBC

Conclusion

Comments
urinary creatinine to
control for variation
in renal function.
Authors suggest
that while
Lactose:Cr might
not be as accurate
as L:M, it might be
a more field-friendly
assessment of
mucosal damage
compared to L:M,
requiring only spot
urine collection and
no substrate
dosing. However,
L:M was not
assessed in this
study; direct
comparison of the
two tests was not
possible.

While hemoglobin
concentration was
inversely related to
Lactose:Cr, testing
for associations of
other measured
blood markers (IgG,
AGP and albumin)
with Lactose:Cr
was not reported.
In children with shigellosis, median NO as measured by Some values
serum NO was ~8x higher at
both serum and
reported in table
baseline than in controls and
urinary NO2 and NO3 format conflict with
significantly differed from
concentrations was the text; columns of
convalescent concentrations
significantly elevated data appear to be
(p<0.01). Concentrations declined by at presentation
transposed.
52% of baseline during the recovery during acute illness
period but did not return to values
Assessment for NO
compared to 7-10
found in the controls (measure of
days after
correlation with

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
or shigellosis
To assess and
compare nitric oxide
as a marker of
intestinal
inflammation among
children with cholera
or shigellosis or
healthy controls.
Evaluated to assess
nitric oxide
production during
infection of small
bowel without
inflammatory lesion
(e.g., cholera) and
during infection
causing colon
inflammation (e.g.,
shigellosis).

Location and
Target Population

Design and
Sample Size

recruited from the
n=18 healthy
healthy attendants of controls
patients or from
children of hospital
Samples were
staff.
collected from
Mean age (SD) in yr: cases on
• Shigellosis cases: admission
and upon
3.8 (1.2)
• Cholera cases: 4.2 discharge (after
7-10 days of
(1.4)
• Controls: 4.7 (1.8) treatment).

Biomarker

Results

Conclusion

statistical significance not reported). hospitalization in
both cholera and
shigellosis.
In children with cholera, median
serum NO concentrations at
Median serum NO
baseline were ~4x higher than in
concentrations in
* Nitric oxide (NO) is control subjects. Recovery
an unstable free
concentrations decreased 52% from cholera patients
were ~half of those
radical that is
baseline (p<0.01); convalescent
converted to nitrite
values did not differ from the values with shigellosis both
upon admission and
and nitrate. Urine
in controls (p<0.4).
upon discharge and
NO2 + NO3 were
expressed as a ratio Median urinary NO ratios were
concentrations were
with urine creatinine similar among those with Shigella
much higher in
in order to account
and V. cholerae infection, both upon cases than in
for differences in
controls, Such
admission and discharge. Initial
urine concentration. values were ~2x higher than upon
striking differences
were not observed
discharge (p<0.05 and 0.01,
for urinary NO
respectively). Control median NO
was of an intermediate concentration results.
between cases’ admission and
Serum NO
discharge median concentrations;
the difference between control and concentrations
correlated with total
case admission values was NS.
blood WBC in
shigellosis cases.
Mean blood WBC counts (SD):
• Shigellosis: 19.6 (3.3)
• Cholera: 8.3 (2.8)
• Controls: 7.1 (1.8)
Stool Test:
Leukocytes

Mean fecal WBC/high power field
(SD):
• Shigellosis: 38 (17)
• Cholera: 5 (2)
• Controls: 3 (1)
Serum NO correlated with blood
WBC count in shigellosis cases at
2
baseline (r =0.92, p<0.01), but only
to a slight degree upon discharge
2
(r =0.26, no p-value reported) and
there was no correlation among the
cholera cases. Serum NO correlated
with stool volume at presentation

Comments
fecal leukocyte
counts was not
reported, nor was
the correlation
between urinary NO
and total blood
WBC.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

2

2009

Darwin and
Adelaide, Australia

Case-control

(r =0.85, statistically significant per
authors, p-value not reported).
20/32 (63%) of Aboriginal children
had abnormal L:R ratios.

Blood Tests:
• L:R
n=43;
Ritchie BK et al.
(32 Aboriginal
1
4 mo-5 yr old
cases and controls Mean L:R (CI):
13C-sucrose breath Aboriginal children n=18 Aboriginal
• Diarrhea cases: 31.8 (24.9,
tested)
test: novel use of a admitted to hospital cases with AD
40.7)
• C-reactive protein
with diarrhea.
noninvasive
(CRP)
• Aboriginal controls without
n=25 controls:
biomarker of
diarrhea: 11.4 (8.5, 15.5),
• Mean Corpuscular
Two control groups: • 18 Aboriginal,
environmental gut
Volume (MCV)
• significant difference
health
• Aboriginal controls without diarrhea • Hemoglobin
(p<0.0001)
admitted to
• 7 nonSucrose breath test
hospital with non- Aboriginal,
SBT Mean (CI):
(SBT) as a marker of GI symptoms
healthy
Breath Test:
• Diarrhea cases: 1.9% (0.9,
13
small bowel mucosal (50% had
C sucrose breath
3.0), p<0.0001 compared to
damage vis a vis
pneumonia)
test (SBT)
non-Aboriginal controls and
sucrase activity
Healthy, nonp=0.004 compared to
among an Australian Aboriginal controls
Aboriginal controls
Aboriginal
recruited from
• Aboriginal controls: 4.1%
population. Also
community
(3.0, 5.2), p=0.032
compared SBT with
compared to non-Aboriginal
serum
controls
lactulose:rhamnose
• Non-Aboriginal controls:
ratio (L:R)
6.1% (4.8, 7.3)
• Significant differences were
observed between all three
groups.
SBT results were not associated with
wasting or with patient age or
breastfeeding status.
SBT and L:R were inversely
correlated (r=0.67; CI: 0.42, 0.62;
p<0.0001). L:R explained 45% of the
variance in SBT; diarrhea explained
28% of variance.
SBT was associated with increased
MCV, relative risk (CI)=3.9 (2.8, 5.0).
1

Geometric mean.

SBT values were
Abnormal L:R ratios
significantly lower
were defined as
and L:R values were >16; no reference
significantly higher or derivation was
provided for this
among Aboriginal
cut-point.
children with
diarrhea than among
those without GI
L:R test was not
symptoms. SBT was conducted among
also significantly
the non-Aboriginal
controls.
lower among
Aboriginal controls
SBT/L:R correlation
than among nonAboriginal children analysis was based
on data for
without diarrhea.
Aboriginal cases
This is consistent
with previous reports and controls
of high prevalence of combined; stratified
clinically silent TE in analysis was not
reported and could
this population.
be of interest
considering the
SBT was
large difference in
significantly
inversely correlated L:R observed
between these
with L:R.
groups.
Associations of
MCV, CRP, and
hemoglobin with
SBT after adjusting
for potentially
confounding
variables were not
reported.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

2001

Durban, South Africa Cohort

Rollins NC et al.

1, 6, and 14 wk old n=272
infants born to HIVinfected mothers.

Feeding mode,
intestinal
permeability, and
neopterin excretion:
A longitudinal study
in infants of HIVinfected South
African women

Biomarker

Urine Tests:
1
• Lactulose
• Mannitol
• L:M
• Neopterin

L:M as a marker of
gut mucosal integrity
and urinary
neopterin excretion
as a marker of cellmediated immunity
in infants with and
without HIV infection

Results
SBT was not associated with
hemoglobin or CRP.
2
Mean L:M (CI):
• HIV-infected subjects:
• 1 wk: 0.12 (0.06, 0.27)
• 6 wk: 0.24 (0.15, 0.38)
• 14 wk: 0.24 (0.14, 0.44)
• Uninfected subjects:
• 1 wk: 0.13 (0.09, 0.19)
• 6 wk: 0.08 (0.06, 0.11)
• 14 wk: 0.09 ( 0.07, 0.13)
HIV-infection by 14 wk of age was
significantly associated with
increased L:M.
A non-significant, positive trend in
neopterin excretion was observed
among HIV-infected infants.

Conclusion

Comments

L:M was generally Assessment of
normal (compared to association
UK values) for non- between L:M and
HIV-infected infants, neopterin was not
reported.
but significantly
increased among
HIV-infected
subjects, especially
after 6 weeks.
The increased L:M
in HIV-infected
infants was primarily
driven by lactulose
rather than mannitol.

Higher neopterin
excretion by HIVinfected infants was
observed but this
was not statistically
significant.
4
2000
Durban, South Africa RCT
Urine Tests:
Mean L:M:
Mean L:M ratios
Urine testing could
3
were very high
only be conducted
• Group 1:
• Lactulose
n=139;
Rollins NC et al.
6-60 mo old
(~10x) (at baseline in the laboratory on
• Day 0: ~1.8
• Mannitol
inpatients or
and at day 3 in both certain days; hence
• Day 3: ~2.4
• L:M
n=66 received
groups) compared to only a subset of
Vitamin A
outpatients with
• Group 2:
• Neopterin
vitamin A on
other studies in this subjects underwent
supplementation of severe diarrhea.
• Day 0: ~1.2
admission (group
those tests.
review. Study
South African
• Day 3: ~0.7
1)
authors
suggested
children with
Blood Tests:
Group 2 patients
diarrhea: optimum
• C-reactive protein There were no differences in mean (via personal
n=73 received
had significantly
correspondence)
timing for improving
(CRP)
L:M between groups or within groups
vitamin A after
higher CRP, nonthat
this
could
have
biochemical and
between days 0 and 3, although
• α-1 acid
clinical
significantly higher
been
due
to
the
clinical recovery and
there was a significant difference in
glycoprotein
improvement
WBCs and AGP,
severity
of
illness
in
subsequent vitamin
paired
analysis
within
individuals
at
(AGP)
(group 2)
and lower retinol
the
sample
A status
the two time points (data not
1

Lactulose and mannitol results were expressed in mg.
Geometric mean.
3
For lactulose, mannitol, and neopterin results, excretion measurement was not specified.
4
Geometric mean.
2

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
L:M as a marker of
intestinal
permeability and
urinary neopterin,
serum α-1 acid
glycoprotein, and Creactive protein as
markers of
inflammation among
children with severe
diarrhea

Location and
Target Population

Design and
Sample Size

Biomarker

49 subjects received
urine testing:
Treatment
• Group 1: n=25
involved vitamin A • Group 2: n=24
supplementation
either on the day
of admission or Blood and urine were
after acute
tested on days 0 and
diarrheal
3.
symptoms had
resolved.

Results

Conclusion

Comments

presented, and direction, magnitude population (children and retinol-binding
and degree of significance not
hospitalized for
protein
reported).
concentration
diarrhea).
compared to group
Lactulose and mannitol excretion
1 at baseline.
Vitamin A
were assessed only in the paired
Authors note that
administration did
analysis. Lactulose excretion
these parameters
not result in
decreased between days 0 and 3
suggest that Group
significant
(magnitude of effect and degree of improvement in L:M, 2 patients might
significance not reported), while
neopterin, or AGP have been more ill
mannitol excretion showed no
regardless of timing at baseline. For the
change.
subset of 49
of vitamin A
patients undergoing
administration.
1
Mean neopterin and AGP
urine testing, the
2
concentrations did not differ between
mean L:M and
groups or within groups on the
neopterin
different study days or in the paired
concentrations
analysis. When initial CRP (~2x
were lower among
higher in Group 2 compared to
Group 2 than Group
Group 1, p<0.004) was taken into
1 subjects (NS).
account, mean CRP on day 3 did not
However, baseline
differ between the 2 groups.
differences in acute
However in the paired analysis, CRP
phase and vitamin
concentrations were significantly
A markers at
different between days 0 and 3.
baseline were not
reported separately
for these 49
subjects.
Data for lactulose
and mannitol
excretion were not
reported separately.
Rationale for
additional analyses
of these molecules
expressed as ratios
with creatinine was
not explained.

1
2

Geometric mean.
Geometric mean.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

2003
Soliman SM et al.

Location and
Target Population

Cairo, Egypt

6-24 mo olds with
diarrhea were
Role of micronutrient recruited from Almixture in acute and Sahel teaching
persistent diarrhea in hospital malnutrition
infants and its
clinic.
impact on nutritional
status
5/6 PD cases and
10/14 AD cases had
Blood cell and
some degree of
albumin markers
malnutrition.
among infants with
acute, persistent or Infants with PD had
no diarrhea, and
significantly lower
effects on these
vitamin A and zinc
markers after 10
stores compared to
days of
controls. Those with
supplementation
AD had significantly
with micronutrient
lower vitamin A
mixture (containing stores.
vitamin A, zinc and
other micronutrients)
among subjects with
and without diarrhea

Design and
Sample Size

Case-control
n=30;
n=20 cases:
• 6 with PD
• 14 with AD
n=10 healthy
controls*

* Controls were
age- and sexmatched to
cases.

Biomarker

Results

Conclusion

Comments

Authors suggest
that their 3-day
testing period
(based on their
previous work in a
different setting
[207] might have
been too short to
identify effect as
demonstrated by
McCullough et al. at
10 days after
presentation [208].
Blood Tests:
Mean baseline hemoglobin was
Albumin and many Information on
• Complete blood
significantly lower in infants with AD hematologic markers control recruitment
count and
and PD (p<0.05 for each group) than were low at baseline and
differential
in controls
among infants with anthropometrics
• Red cell measures:
diarrhea, especially were not specified.
Mean MCV and MCH were lower in in those with PD,
• Mean
those with AD (p<0.025 and p<0.01, compared to those Sample size was
corpuscular
small when
without diarrhea;
volume (MCV) respectively) and PD (p<0.01 for
both
markers)
compared
to
controls.
stratified by
some
of
these
• Mean
case/control
differences were
corpuscular
Mean lymphocyte counts among PD statistically
groups, especially
hemoglobin
cases were low compared to those significant.
for PD cases (n=6).
(MCH)
of controls (p<0.01).
Controls were
Parameters
• Mean
generally normalized reported to have
corpuscular
Other markers did not vary
after micronutrient been matched to
hemoglobin
significantly
at
baseline.
However,
cases, yet there
supplementation.
concentration
among
infants
with
PD,
mean
were half the
(MCHC)
albumin
was
abnormally
low,
number of controls
• Transferrin
although
it
was
not
significantly
than cases and
saturation
different compared to controls or
statistical testing
• Albumin
those with AD.
(student’s t-test)
Mean albumin (g/dL) (SE):
was not
commensurate with
• PD: 2.9 (0.27)
matched case• AD: 3.29 (0.25)
control
• Controls: 3.37 (0.21)
methodology.
Following micronutrient
supplementation, mean hemoglobin,
MCV, lymphocyte counts and
albumin increased in both diarrhea

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

2008

Location and
Target Population

Fortaleza, Brazil

Design and
Sample Size

Cross-sectional

2 mo-9 yr olds
n=102
(mean age 41 mo)
Carotenoids, retinol, from an
and intestinal barrier impoverished urban
function in children community, eligible if
HAZ score <median
from northeastern
for their community.
Brazil
Vieira MM et al.

L:M as marker of
intestinal barrier
function, fecal
lactoferrin and
leukocytes as
markers of intestinal
inflammation, and
CRP and AGP as
acute phase
reactants among
children with varying
vitamin A status

Biomarker

Results

Conclusion

groups to concentrations on par with
control baseline concentrations
(albeit increases were NS except
within the PD group). MCH improved
to concentrations on par with the
control group only among the infants
with AD.
Urine Tests:
48.5% had abnormal L:M.
Almost half of
1
• Lactulose
subjects had
• Mannitol
L:M and excretion of each sugar
increased L:M, and
• L:M
separately did not vary with retinol ~40% of subjects
concentration.
(97 tested)
had increased
lactoferrin.
L:M was associated with levels of
Stool Tests:
common dietary carotenoids,
While serum retinol
primarily driven by lactulose.
concentrations were
• Lactoferrin
However, the association was not
not associated with
(93 tested)
always statistically significant, and L:M, serum
• Leukocytes
the direction of association varied
carotenoids were;
depending on precursor.
authors suggest that
these retinol
Blood Tests:
40%
of
stool
samples
were
positive
precursors might be
• C-reactive protein
for
lactoferrin.
more sensitive
(CRP)
predictors of
• α-1-acid
1% of stool samples were positive
impaired intestinal
glycoprotein
for fecal leukocytes.
function. However,
(AGP)
the reported
30% of stool samples were positive direction of
for parasites but this had no impact association varied,
on L:M results, lactoferrin, or acute making
phase reactants.
interpretation of
these results
unclear.

Comments

L:M threshold for
abnormal values
was defined as
>0.0864 [214]. Cutoff values for
lactoferrin positivity
were not described.
Relationships
between acute
phase proteins and
measures of
intestinal
permeability or
inflammation were
not reported.
Relationships
between L:M and
lactoferrin or fecal
leukocytes as well
as those between
retinol or
carotenoids and
lactoferrin or fecal
leukocytes were not
reported.
Exclusively
breastfed children
were excluded from
study participation
due to assessment
of stool lactoferrin.

1

Lactulose and mannitol results were expressed as % of dose administered.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest
2007

Location and
Target Population

Design and
Sample Size

West Kiang region,
Gambia

Cohort

Biomarker
Urine Tests:
1
• Lactulose
• Mannitol
• L:M

Results
2

Mean L:M (CI):
• Baseline:
n=72
Williams EA et al.
• Glutamine group: 0.33 (0.25,
4-10 mo olds from a
0.43)
A double-blind,
rural area followed Glutamine or
• Placebo group: 0.33 (0.26,
placebo-controlled, during the 5-month placebo of
Blood markers
0.41)
glutaminerainy season and for nonessential
• C-reactive protein • Post-intervention:
supplementation trial 6 months afterward. amino acids was
(CRP)
• Glutamine group: 0.29 (0.23,
in growth-faltering
orally
0.35)
• Alpha-1 antiadministered
Gambian infants
chymotrypsin
• Placebo group: 0.26 (0.21,
twice daily during
(ACT)
0.32)
rainy season; L:M • IgA
L:M and plasma
ratio was
immunoglobulins
Mean excretion of lactulose (CI):
• IgG
measured
and acute phase
• Baseline:
• IgM
monthly, and
reactant proteins
• Glutamine group: 0.21 (0.16,
• Albumin
plasma samples
(albumin, C-reactive
0.28)
were collected 3
protein, and alpha-1• Placebo group: 0.20 (0.15,
times.
antichymotrypsin) in
0.26)
community-based
•
Post-intervention:
Gambian infants
• Glutamine group: 0.17 (0.13,
enrolled in a
0.21)
glutamine trial
• Placebo group: 0.14 (0.11,
0.18)
Mean excretion of mannitol (CI):
• Baseline:
• Glutamine group: 2.65 (2.02,
3.48)
• Placebo group: 2.50 (1.87,
3.36)
• Post-intervention:
• Glutamine group: 2.48 (1.99,
3.11)
• Placebo group: 2.14 (1.62,
2.82)
L:M values did not differ significantly
between treatment groups before or
following intervention. However, a
1
2

Lactulose and mannitol results were expressed as % of dose administered.
Geometric mean.

Conclusion

Comments

L:M values were
elevated in this
population, with no
significant change
after the
intervention.

The relationships
between L:M and
growth parameters,
immuno-globulins,
and acute phase
proteins were not
reported.

None of the plasma
markers differed
significantly
between treatment
and placebo groups,
either at baseline or
at the end of
supplementation.
Growth outcomes
did not differ
significantly across
treatment groups.

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results
repeated measures ANOVA showed
that during supplementation, L:M
values were borderline elevated
among the glutamine-supplemented
group relative to the placebo group
(p=0.05), counter to expectation.
Neither ACT, CRP, albumin, nor
immunoglobulins IgA, IgG, or IgM
differed significantly between
treatment and placebo groups, either
at baseline or at the end of
supplementation.
Mean levels of IgA and IgG
increased during the study
(p<0.001), while IgM levels did not.
Concentrations of each of these
immunoglobulins did not differ
between treatment and placebo
groups.
Plasma albumin, ACT,
and CRP values showed no change
over the course of the study.
Proportions of children with elevated
CRP ranged from 30-41% at
different collection time points. The
glutamine intervention had no effect
on proportion of children with
elevated CRP.
Treatment and placebo groups
experienced decreases in WAZ,
HAZ, and MUAC coinciding with the
rainy season; however, there was no
significant difference observed
between the groups for any of these
parameters.
Treatment and placebo groups did
not differ in morbidity indices (i.e.

Conclusion

Comments

Evidence Table 5. Markers of systemic inflammation and systemic immune activation.
Biomarkers in bold are primarily markers of systemic inflammation and/or immune activation.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

percentage of time reported with a
particular illness or illness overall).
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects.
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s.
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting.
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval,
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins,
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G,
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score),
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s)

5.7 Markers of Microbial Drivers
Markers of microbial environments, such small bowel bacterial overgrowth (SBBO), were
reviewed, while markers for specific enteric organisms were beyond the scope of this review. The
data from each of the studies relevant to this review are listed in Evidence Table 6.
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Evidence Table 6. Markers of microbial drivers.
Biomarkers in bold are primarily markers of microbial drivers.
Reference and
Study Outcomes of
Diagnostic Interest
2002
Alves GM et al.
Nutritional status
and breath hydrogen
test with lactose and
lactulose in Terena
Indian children

Location and
Target Population

Limão Verde and
Cross-sectional
Córrego Seco, Mato
Grosso du Sul, Brazil n=264;
All children <10 yr
old were recruited
from these rural
villages.

Lactose hydrogen
breath test (HBT) as
a marker of lactase
activity, and
lactulose HBT as a
marker of SBBO
2000
Sao Paulo, Brazil
Fagundes-Neto U et 2-10 mo olds with
al.
PD and protein
calorie malnutrition
Studies of the small consecutively
bowel surface by
admitted to Sao
scanning electron
Paulo Hospital.
microscopy in infants
with persistent
diarrhea
Scanning electron
microscope (SEM)
and light microscope
(LM) analyses of
small intestinal
biopsy among
infants with PD with
and without SBBO

Design and
Sample Size

<5 yr old: n=145

Biomarker

Results

Conclusion

Breath Tests:
• Lactose HBT
(251 tested)
• Lactulose HBT
(252 tested)

Lactose HBT:
• Elevated: 27.1% among all
subjects
• Borderline: 43.0% among all
subjects
• 0% of subjects <4 yr had elevated
or borderline results

The prevalence of Assessment of
lactase deficiency as association
measured by lactose between lactulose
HBT was >25%, but and lactose
non-existent among absorption was not
those <4 yr of age. reported.

(However results
were provided by
<4 and >4 yr old
age groups.)

Case-series
n=16

Jejunal secretions
aspirate:
Bacterial
concentrations

Lactulose HBT positive:
• 11.5% of all subjects
• 8.6% of subjects <4 yr

Prevalence of SBBO
as assessed by
lactulose HBT was
~10%.

68.7% had bacterial overgrowth
4
(concentration >10 colonies/mL): 3
had enteropathogenic E. coli while
the rest had colonic microflora.

Histological
abnormalities were
noted in all subjects
by LM and SEM.

All small intestine specimens had
Jejunal tethered
morphological abnormalities on LM:
capsule biopsy:
• 43.7% moderate villous atrophy
Histopathology by LM • 56.3% subtotal villous atrophy
and SEM
SEM revealed abnormalities of
varying intensity:
Rectal tethered
• Among the 11 with SBBO, villous
capsule biopsy:
atrophy ranged from Grade II
Histopathology
(n=4), Grade III (n=2), to Grade IV
(n=3).
• For the 5 subjects without SBBO,
villous atrophy ranged from Grade
I (n=1) to Grade 2 (n=4).
• A mucous-fibrinoid pseudomembrane over enterocytes was
noted in 7 of the 11 with SBBO
and none of the others.
• Other abnormalities noted on

SEM included:
• Mucus and debris covered large

Comments

Inconsistent
reporting of
proportions of
histopathologic
findings among all
Degree of villous
subjects and by
SBBO status;
atrophy noted on
SEM seemed to be assessment of
potential
correlated with
SBBO (no statistical relationship with
tests were reported). SBBO between
different histologic
Authors speculate findings was not
possible.
that the mucousfibrinoid pseudomembrane partially
covering enterocytes
is consistent with a
malabsorptive
process, with the
findings of fat
droplets on
enterocytes
surfaces, and with
the state of
malnutrition of the
subjects.

Evidence Table 6. Markers of microbial drivers.
Biomarkers in bold are primarily markers of microbial drivers.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

areas of the villous surface
• Derangement of the enterocytes

(in some cases cell borders were
not clearly defined)
• Reduced height and number (or
absence in some places) of
microvilli
• Lymphocytes and fat droplets
were observed over the surface of
1
enterocytes (18%)
10 subjects had colitis on rectal
biopsy; this was not associated with
SBBO or degree of small intestinal
pathology on SEM.
13
2002
Kingston, Jamaica Case-series
Stool Tests:
Median total stool excretion of C in
phase 1 was 9% (range: 1%-29%)
• Total and
13
n=24
and did not vary between TG
Murphy JL et al.
5-23 mo olds
fractionated C
admitted to the
following ingestion groups.
13
13
Maldigestion and
Tropical Metabolism
of one of three C Median C excretion dropped 33%malabsorption of
Research Unit of the Subjects were
labeled triglycerides 99% in phase 2 and 86%-95% in
divided into 3
phase 3 compared to phase 1
dietary lipid during University of the
(TG): trilaurin,
groups of 8
(p<0.05 each).
severe childhood
West Indies with
triolein, or
malnutrition
severe malnutrition. children, each
trilinolein*
group receiving a • 13C stool assay
Over the study period, there were
different labeled
significant associations between
Stool recovery of
following
13
triglyceride.
radiolabeled
administration of total lipid and the amount of C
products as markers
labeled fatty acid labeled TGs in stool for some
13
Data were
of lipid digestion and
C glycocholate** groups, but not for others.
collected in three
absorption, and bile
13
separate phases
Median C in TG and FA was
salt deconjugation
as described
similar across TG groups in all
as a marker of
* To assess fat
above in JL
SBBO among
excretion as a % of phases. 13C FA recovery was
Murphy et al.
children with severe
dose administered. similar and reduced by ~2/3
13
2001 [149].
compared to Phase 1. C TG was
malnutrition
Also assessed
13
proportion of C in not detectable in Phases 2 or 3.
triglyceride (TG) and Statistical comparisons between
phases were not reported.
fatty acid (FA)
fractions to
13
distinguish excretion C after radiolabeled glycocholate
1 These SEM results were not presented separately for those with and without SBBO.

High concentrations Authors state that
13
of C (compared to the study was not
healthy UK children) powered to
[190] were observed compare the
in half of the
different TGs, but
they contend that
subjects at
admission, reflecting medium chain
impaired digestion or trilaurin did not
absorption.
appear to be
processed
differently than the
The differences in
13
stool C were wide longer chain TGs
but not as extreme triolein and
trilinolein.
as in a previous
study by same
investigators (also Authors did not
describe the
examined in this
method used to
review) using a
assign subjects to
different TG
different TG groups.
(tripalmitin)
substrate [149].
While it was noted
13
C excretion did not that some subjects
had positive stool
significantly differ
between TG groups cultures, details

Evidence Table 6. Markers of microbial drivers.
Biomarkers in bold are primarily markers of microbial drivers.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker
caused impaired
digestion (presence
of TG) vs. poor
absorption (presence
of FA).

Results

administration was detected in stool
at quantities considered to be in
excess of the 7% recovery of dose
administered upper limit of normal in
U.S. adults in [189]:
• Phase 1: 13/24 (54%)
** To assess bile salt • Phase 2: 5/24 (20.8%)
deconjugation in the • Phase 3: 3/24 (12.5%)
bowel caused by
SBBO; conducted
after the TG
assessment and a 3
day washout period.

Conclusion

Comments

and declined with
improving clinical
course.

were not provided
on the nature of the
enteric infections.

Similar to their
previous study,
significantly more
13
C in stool was
recovered as FA
than TG, reflecting
impaired absorption
over poor lipid
digestion/ hydrolysis.
Unlike in their
previous study, there
was evidence of
SBBO as measured
13
post-ingestion of C
glycocholate.
2001
Kingston, Jamaica Case-series
Stool Tests:
Mean fecal fat (SD):
Mean fecal fat was Statistical methods
might be
• Fecal fat*
• Phase 1: 2.4 g/day (3.6) or 5.9% not elevated
7-23 mo olds with
n=8
inappropriate for a
Murphy JL et al.
compared
to
(9.4)
of
dietary
lipid
intake
• Total and
13
small sample.
malnutrition admitted
fractionated C
• Phase 2: 1.7 (0.9) g/day, or 3.3% published norms
Gastrointestinal
to the University of
[191, 192] during
assay after
(2.4) of intake
Data were
All subjects were
handling and
the West Indies.
administration of
• Phase 3: 0.9 (0.6) g/day, or 1.4% any study phase.
metabolic disposal of
collected in three 13C tripalmitin
treated with
(0.7)
of
intake
13
C-labelled
separate phases
antibiotics including
(TP)**
• Differences between phases were There was wide
13
(each lasting 9
tripalmitin during
variation in fecal fat metronidazole for
• C assay after
not statistically significant.
days):
rehabilitation from
at presentation, and presumptive SBBO;
administration of
• Within 48 hours 13C glycocholate Total excretion of 13C in stool also
this might have
childhood
wide variations in
13
of admission
C
across
affected GCA
malnutrition
stool
(GCA)***
varied widely across patients (0%• During early
testing.
subjects.
Authors
44%) and did not differ between
Fecal fat, stool
rehabilitation
indicate that this is
Breath Tests:
study phases.
13
• During late
recovery of
the first such
• CO2 after
rehabilitation
radiolabeled
administration of Correlation between fecal fat and 13C assessment in
13
products, and breath
malnourished
C glycocholate (r=0.48; p<0.05) was observed.
tests as markers of
children; previous
(GCA)***
13
lipid digestion and
studies on healthy
Lack of lipid digestion and
• CO2 after
children
from the UK
absorption and bile
absorption were assessed by
administration of
13
demonstrated
salt deconjugation
measuring TG and FA fractions,
C TP****
13
as a marker of
respectively. Mean C TG recovery average excretion of
6% [190].
SBBO among
(SD) (% of administered dose),
children with severe
number of patients excreting TG:
* In 72 hour stool

Evidence Table 6. Markers of microbial drivers.
Biomarkers in bold are primarily markers of microbial drivers.
Reference and
Study Outcomes of
Diagnostic Interest
malnutrition

Location and
Target Population

Design and
Sample Size

Biomarker

Results

collection (measured •
as total grams and as •
% of dietary fat
•
intake).

Conclusion

The majority of
13
excreted C was in
the form of FA rather
than TG. Authors
interpreted this to
** To assess fat
reflect failure of lipid
excretion as a % of 13C FA fraction in stool declined
absorption in the
dose administered. during rehabilitation.
face of adequate
13
Also assessed
digestion/hydrolysis.
Mean
C
FA
recovery
(SD):
13
proportion of C in • Phase 1: 6.0% (7.3)
Each form (FA and
triglyceride (TG) and • Phase 2: 4.8% (3.7)
TG) was found in
fatty acid (FA)
decreasing values
• Phase 3: 3.3% (3.8),
fractions to
differences between phases were as the study phases
distinguish excretion
progressed,
NS
suggesting improved
caused by impaired
digestion (presence Mean FA values were ~9x (NS), 5x digestion and
absorption, although
of TG) vs. poor
(p<0.001), and 3x (p<0.05) higher
absorption (presence than mean TG values in Phases 1, results did not differ
significantly.
of FA).
2, and 3, respectively.
*** To assess bile
salt deconjugation in
the bowel caused by
SBBO; conducted
after the TG
assessment and a 3
day washout period.

Phase 1: 0.7% (1.6), n=3
Phase 2: 0.9% (2.8), n=1
Phase 3: no recovery from any
subjects, differences between
phases were NS

Following administration of labeled Fecal fat was
13
correlated with
TP, absorbed C label by breath
of
analysis was ~5% (range 0%-21.2%) concentrations
13
C
in
stool.
and similar across study phases.
There was no
evidence of SBBO
Following the administration of
labeled GCA, there was either no or or bile acid
13
minimal recovery of C in stool and malabsorption.

**** Expressed as a 13CO on breath (as % of dose
2
percentage of
administered) in all phases.
absorbed label (dose
administered - label
recovered in stool) to
assess oxidation for
acute energy needs.

13

CO2 excretion
following
13
administration of C
TP was minimal,
suggesting a
propensity for
deposition in
adipose tissues
rather than oxidation
for immediate
energy needs. The
authors report that
this breath test has
not been widely

Comments

Evidence Table 6. Markers of microbial drivers.
Biomarkers in bold are primarily markers of microbial drivers.
Reference and
Study Outcomes of
Diagnostic Interest

Location and
Target Population

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

used, but that
healthy UK children
have breath
excretion values
from 15%-43%
[190], compared to a
mean of 5% and
range 0%-21% in
this cohort; the latter
findings were more
similar to results
from kwashiorkor
13
patients where Clabeled oleic acid
was used as
substrate [193].
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects.
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s.
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting.
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval,
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins,
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G,
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score),
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s)

5.7.1 Lactulose Hydrogen Breath Test (HBT)
Alves et al. utilized the lactose hydrogen breath test (HBT) to measure of lactose absorption
and the lactulose HBT as a measure of SBBO in a community-based study of indigenous children in
Brazil [102]. Prevalence of SBBO in the study subjects was 12% among subjects below four years of
age, and overall 9% had SBBO. The authors did not report on the relationship between lactulose and
lactose absorption.
In a study of intestinal function among well-nourished children with asymptomatic giardiasis
and healthy controls in Mexico, Moya-Camarena et al. utilized the lactulose HBT and the indican test
to exclude subjects with SBBO. No further data were reported on results of the lactulose HBT;
therefore we did not include this study in this section of our review [147].

5.7.2 13CO2 in Breath or Stool after Administration of
13
C Glycocholate as Marker for SBBO
Murphy et al. [149] assessed gastrointestinal function by stool tests with [149] or without [148]
breath tests in children hospitalized for rehabilitation of malnutrition. The 13CO2 breath test was
performed after administering 13C glycocholate (GCA) to assess bile salt deconjugation in the bowel
caused by SBBO. The test was conducted after a similar assessment with triglyceride and a
subsequent 3-day washout period. Results were expressed as percent of administered dose. In their
initial study, following the administration of labeled GCA, there was no or minimal recovery of 13C in
stool and 13CO2 on breath in all study phases. The authors interpreted these results to indicate that
the GCA was not malabsorbed and that the subjects did not show evidence of bile salt
deconjugation. In the subsequent larger study, however, 13C from labeled GCA was recovered in the
stool in more than one-third of the children, indicating the presence of SBBO [148].
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5.7.3 Intestinal Aspirates for Bacterial Concentrations
Fagundes-Neto et al. analyzed jejunal aspirates and small intestinal biopsies of hospitalized
infants with persistent diarrhea and malnutrition by scanning electron microscopy (SEM) and light
microscopy [118]. Based on bacterial concentration in jejunal aspirates, more than two-thirds of
subjects had bacterial overgrowth (concentration >104 colonies/mL), and three were infected with
enteropathogenic E. coli while the rest had colonic microflora in their small bowel. Histological
abnormalities were noted in all subjects by light microscopy and SEM. The degree of villous atrophy
noted on SEM seemed to correlate with SBBO, but statistical testing was not provided.
Fagundes-Neto et al. also reported a mucous-fibrinoid pseudo-membrane that partially
covered enterocytes [118]. They speculated that it could indicate a malabsorptive process, based on
the findings of fat droplets on enterocyte surfaces and the malnourished condition of the subjects.
Reporting of proportions of histopathologic findings among all subjects and by SBBO status,
as well as statistical assessment of potential correlation with SBBO between different histologic
findings, would have benefitted the analysis.

5.8 Markers of Nonspecific Intestinal Injury
The matter of small bowel biopsies and EED is complex. From initial investigations nearly five
decades ago, the histopathologic appearance of the small bowel defined the entity. Sentinel papers
from Southeast Asia and elsewhere formed the basis of our understanding of the entity on which we
have focused in this review [274, 275]. Also, there is an extensive tradition of pathological
assessments of the bowel and other organs in a variety of syndromes and diseases, and histological
assessment is often considered the gold standard to which biomarkers are compared. Histology
certainly can inform the nature of lesions. In the digestive system, microscopic evaluation of tissue
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can often help differentiate infectious from noninfectious inflammations, assess the degree of allergic
reaction if present, suggest the principal effector cells, and identify malignant potential (rare in these
subjects). Specific diagnoses can also be made by histologic evaluation of the small bowel; wellknown examples are celiac disease and Crohn’s disease.
In view of the potential value of relating biopsies to biomarkers, we sought to find any relation
between this putatively definitive test (small bowel biopsy) and any laboratory test or abnormality.
The data relevant to this review are listed for each of these 18 biopsy studies in Evidence Table 7.
We also include other markers of non-specific intestinal injury in Evidence Table 7, including three
studies utilizing fecal occult blood or red blood cells and one employing Tc-99m dextran scintigraphy.
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Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
2009
Lusaka, Zambia

Design and
Sample Size
Case-control

Biomarker

Results

Conclusion

Comments

Endoscopic duodenal
Biopsy findings among the
Mucosal
27 subjects were
biopsy:
Zambian compared to the UK
architecture was
HIV positive;
children:
Amadi B et al.
12.2-19.8 mo olds n=41*;
markedly abnormal incidence was
• Histopathology
with PD and
compared to UK
lower in the
• Villous height reduced
• Densities in lamina
n=41 cases with
Reduced production malnutrition
controls
but
did
not
kwashiorkor group.
propria and crypt
• Crypt depth increased
PD and
of sulfated
admitted to the
vary
between
epithelium:
• ~50% reduction in crypt:villous
glycosaminoglycans malnutrition ward of malnutrition:
marasmus and
ratio
• Cell proteins:
occurs in Zambian a teaching hospital. • 18 with
• Glycosaminoglyca • Values for lamina propria cell kwashiorkor
children with
marasmus
n (GAG)
densities were not reported for presentations of
kwashiorkor but not
malnutrition.
• 8 with marasmic
• Enterocyte heparan UK subjects
marasmus
kwashiorkor
sulfate
• 15 with
No significant differences in crypt Inflammatory cell
proteoglycan
Duodenal biopsy
densities were
kwashiorkor
or villous measures or lamina
(HSPG)
including
generally higher
propria cell densities were
• Syndecan-1
assessments of
compared to UK
n=19 healthy
observed between nutritional
• Inflammatory cell
intestinal markers in
children and
control children
groups
or
after
nutritional
markers:
children with PD and
showed different
from UK
rehabilitation.
• CD3 IEL
different forms of
patterns across the
• Ki67
malnutrition
malnutrition
Intestinal
markers:
• Human leukocyte
presentations.
* UK subjects are
antigen DR-1 (HLA- • Inflammatory markers were
presented in this
seen in higher densities
DR)
table due to
compared to the UK children. Tissue
concentrations of
comparisons of
There were significant
HSPG and GAG
interest made in
differences between the
were reduced
the review.
different nutritional groups in
especially amongst
However we do not
the specific types of
children with
include these
inflammatory markers.
kwashiorkor.
subjects in the
• There was a significant
sample size for this
reduction in GAGs and HSPG Intestinal protein
markers did not
review.
in the kwashiorkor group
compared to UK children, but differ amongst the
malnutrition groups.
no significant differences
between kwashiorkor and other
presentations of malnutrition.
• There was no difference in
epithelial syndecan-1 protein
expression between the
malnutrition groups (data not
available for UK controls).
2000
Dhaka, Bangladesh Case-control
Blood tests:
WBC total and differential,
Some immune and The number of
immunoglobulin subtypes,
inflammatory
controls was
• IFN-γ
cytokines, transferrin, and
relatively small and
Azim T et al.
7-12 mo olds with 6- n=136;
markers were
• TNF-α
albumin did not differ between
their nutritional
8 days of watery
associated with
• WBC (total and

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
Immune response of diarrhea attending
Bangladeshi children the International
with acute diarrhea Centre for Diarrheal
who subsequently Disease Research.
have persistent
Cases were those
diarrhea
who went on to
Immune activation develop PD,
tests, as well as
controls were those
transferrin and
who did not.
albumin as markers
of nutritional status An additional group
among children with of subjects without
and without PD
diarrhea were
recruited from a
nutrition follow-up
unit.

Design and
Sample Size
n=38 cases with
PD
n=98 controls:
• 85 with AD
• 13 with no
diarrhea

Prevalence of
malnutrition was
high in all groups.

Biomarker

Delhi, India

1-18 yr olds with a
presentation
Celiac disease with consistent with CD
mild to moderate
(combination of
histological changes chronic diarrhea,
Bhatnagar S et al.

Case-series
n=107

Conclusion

Comments

differential)
cases with diarrhea or controls, acute and/or
status was not
nor did stool leukocyte or
persistent diarrhea. reported.
• IgA
erythrocyte counts.
• IgG
The only marker
• IgM
The
percentages
of
neutrophils
that was
• Transferrin
that
polarized
in
response
to
significantly
• Albumin
stimulation
were
significantly
associated with
• Immune function tests:
higher
in
subjects
with
AD
or
PD
progression to PD
• Neutrophil polarization
compared
to
those
without
was a negative
response to
diarrhea;
there
was
no
difference
DTH response to
chemotactic factor
between
the
two
diarrhea
tuberculin antigen
• Neutrophil opsonization
groups.
(odds ratio=3.8, CI:
to yeast
1.4, 9.9). This was
• Mononuclear cell
Opsonization did not vary
calculated from a
proliferation,
between any groups.
logistic regression
spontaneous and in
analysis that only
response to stimuli with
Monocyte spontaneous
included children
mitogens
proliferation counts were less
with diarrhea.
than half among children with no
diarrhea compared to those with
Skin Test:
AD (p<0.001) or with PD
• Delayed-type
(p=0.011); there was no
hypersensitivity
difference between the two
response (DTH) to
diarrhea groups.
tuberculin, tetanus,
diphtheria,
Monocyte proliferation in
Streptococcus, Proteus,
response to stimulation did not
Candida, and
differ between the 3 groups.
Trichophyton

Stool tests:
• Leukocytes
• Red blood cells

2005

Results

Endoscopic duodenal
biopsy:
Histopathology

The proportion with DTH
responses differed among the
three groups only in response to
tuberculin (p=0.021). More PD
subjects had a negative
tuberculin response than did
subjects with AD (p=0.024).
70 had normal histology (defined
as crypt:villous ratio 1:2-3,
absence of lymphoid lamina
propria infiltration, and minimal
intraepithelial lymphocytes (IEL).

More than one
quarter of children
with chronic
diarrhea had
normal small
intestinal mucosa;
37 had mild changes (defined as at follow-up their

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Study Outcomes of
Diagnostic Interest
is a common cause
of chronic diarrhea
in Indian children

Location and
Target Population

Design and
Sample Size

abdominal
distension, and
growth failure),
recruited from a
Duodenal biopsy
pediatric
among children with gastroenterology
chronic diarrhea
clinic.
Subjects negative
for CD-specific
antibodies were of
interest for this
review.

2003

Cochabamba,
Bolivia

Results

Conclusion

mild blunting of villi with
crypt:villous ratio of 1:1*). A
specific etiology was identified in
only n=5:
• 2 with giardiasis
• 1 with lymphangiectasia
• 2 with chronic pancreatitis

growth had
improved and their
diarrhea had
resolved.

Only children with CD had
moderate or severe histologic
changes.

Cohort

n=42 cases with
3-34 mo old
PD and
Disaccharidase
malnutrition:
Amerindians
deficiency in Bolivian hospitalized with PD • 2 with
children with
and moderate or
kwashiorkor
persistent diarrhea severe malnutrition • 20 with
in an urban setting.
marasmus
Jejunal biopsy and
• 20 with
disaccharidase
marasmicactivities in children
kwashiorkor
with PD and different
forms of malnutrition
Children were
assessed on
admission and at
three weeks, after
diarrhea had
resolved and
anthropometrics
were improving.
Bustos M et al.

Biomarker

* Along with increased IEL and
lymphocytic lamina propria
infiltration.
Jejunal tethered capsule Most subjects had mild to
biopsy:
moderate (score of 2-3)
histological abnormalities, with
• Histopathology
• Disaccharidase activity: one kwashiorkor patient having
completely flat villi.
• Lactase
• Sucrose-Isomaltase
Second biopsy showed a trend
• Maltase
of improved mucosa, but
difference was not significant
Histology was scored on a based on histology score,
intraepithelial lymphocyte
scale of 1 (normal) to 4
density, or degree of infiltration
(severe morphological
damage or flat mucosa). of lamina propria.

Comments

No definitive
diagnosis was
reached for 86% of
subjects with
abnormal histology
(albeit most had
mild findings).

Patients had
Spanish language
diminished
article.
intestinal
Values for
disaccharidase
subnormal
activity and
disaccharidase
substantial
activity were not
pathology on
biopsy at admission provided.
and at three weeks,
despite clinical
The magnitude of
improvements and lactase inverse
tolerance of
association with
lactose-containing growth parameters
formula.
was not reported.
Percentages with enzymatic
Authors did not
activity below normal at baseline,
report whether they
discharge:
had tested for
associations
• Lactase: 64%, 59%
between maltase
• Sucrase-isomaltase: 97%, 90%
or sucrose• Maltase: 45%, 52%
isomaltase and
All changes were statistically
growth parameters.
significant.
Lactase recovery was
associated with admission HAZ
(p=0.05) and WAZ (p=0.03)
scores.

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest

Design and
Sample Size

Biomarker

2003

Fajara and Sibanar, Case-control
Endoscopic
The Gambia
small bowel biopsy, site
n=40 cases:
not specified:
Campbell DI et al.
6 mo-3 yr old
• Histopathology
• Group 1: n=4
Chronic T cellhospital- and clinic- • Group 2: n=11 (7 • Morphometric
mediated
based cases from
assessment by
with diarrhea)
enteropathy in rural rural communities. • Group 3: n=25
computer analysis*
west African
(18 with diarrhea) • Intestinal tissue
children: relationship Case groups based
cytokines and immune
with nutritional
on differences in
n=34 with case
markers:
status and small
nutritional status:
tissue samples
• CD-3
bowel function
1. WAZ score >-2,
sufficient for
• CD-4
with GI complaints
cytokine
• CD-8
other than diarrhea
immunoreactivity
• CD-19
L:M as a marker of 2. Grade I protein
tests:
• CD-25
intestinal
energy malnutrition • Group 1: n=3
• HLA-DR
permeability, small (PEM) (WAZ score - • Group 2: n=8
• Perforin
bowl biopsy with
2 to -4) and
• Group 3: n=23
• γδ T-cell receptor
assessment of
unresponsive to
•
Syndecan-1
intestinal immune
nutritional
•
TNF-α
markers, and
supplementation,
•
IFN-γ
computerized
with or without
• TGF-β
morphometric
diarrhea
• IL-10
analysis among rural 3. Grade II PEM
Gambian children
(WAZ score <-4)
with differing
with or without
Urine Tests:
degrees of
diarrhea
1
• Lactulose
malnutrition and
• Mannitol
Controls from UK*
compared to well• L:M
who were well
nourished UK
nourished children
children
with GI complaints
* Biopsy involved
other than diarrhea
morphometric assessment
and with normal
by computer analysis of
endoscopy results
1
2

Lactulose and mannitol results were expressed as % of dose administered.
These figures are presumed to represent IEL means, however, this was not explicitly stated.

Results
Despite continued high
disaccharidase deficiency
prevalence at discharge, all
children tolerated the lactosecontaining formula challenge.
Crypt-hyperplasia and villous
atrophy were observed among
all Gambian subjects, and the
degree of histopathology did not
differ among cases with differing
nutritional status, nor was there
a correlation with diarrhea.
2

IEL means were ~3-fold higher
in Gambian than UK children.
Median CD3, CD4, CD8, CD19,
and CD25 cell counts were
significantly higher (2-5x higher)
among each case group
compared to the UK controls.
IEL, γδ, syndecan-1, HLA-DR,
and perforin were detected
among the Gambian children in
varying degrees but were not
reported for UK controls.
Syndecan, CD3, and CD8
displayed a gradient proportional
to malnutrition severity.
All Gambian groups showed
higher lamina propria cytokineimmunoreactive mononuclear
2
cell density (~200-450/mm ) than
2
UK controls (30-80/mm ).
Among subjects with elevated
cytokines, similar densities were
seen for both pro-inflammatory

Conclusion

Comments

All Gambian
Statistical
subjects had
methodology was
evidence of
not sufficiently
enteropathy with
detailed to
crypt-hyperplasia determine what
and villous atrophy, was compared
and mean IELs >2 (e.g. type of central
tendency measure
SD above UK
norms, independent and variance
of nutritional status. calculations for L:M
not stated)
Elevation of cellmediated intestinal Duration of
diarrhea not
markers and
specified, but
mucosal
assumed to be
proinflammatory
persistent.
cytokines was
present across the
3 Gambian groups, Mucosal
variably correlated lymphocyte
densities, cytokine
with nutritional
immunoreactivity,
status.
and L:M results not
stratified by history
L:M ratios were
of diarrhea.
elevated in all
Gambian groups,
without apparent
correlation to host
nutritional status.

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
were also studied.

Design and
Sample Size

* UK subjects are
presented in this
table due to
comparisons of
interest made in the
review. However we
do not include these
subjects in the
sample size for this
review.

Biomarker

Results

Conclusion

villous height, crypt depth,
villous:crypt ratio, and
intraepithelial lymphocyte
(IEL) density (per 100
epithelial cells).

(IFN-γ and TNF-α) and putative
regulatory (IL-10 and TGF-β)
cytokines. Epithelial expression
of TGF-β was also enhanced
compared to UK controls, but
subjects with poorer nutritional
status had lower densities of
mucosal TGF-β+ cells, with
median densities of 420 and 250
2
cells/mm in the grade I and
grade II PEM groups,
respectively.

Comments

1

L:M values :
• Group 1: 0.53 (0.4-1.3)
• Group 2: 0.47 (0.02-2.20)
• Group 3: 0.73 (0.14-2.2)
• Not assessed among the UK
controls
Nutritional status was not
associated with L:M, recoveries
of lactulose or mannitol.

2006

Riyadh, Saudi
Arabia

Retrospective
case-series

El Mouzan MI et al.
n=241 cases:
1.5 mo-18 yr olds
referred to hospital • 102 with PD
for endoscopy with • 116 with
duodenal biopsy.
unexplained
short stature
78% of subjects
Duodenal biopsy
• 11 with refractory
among children with were <12 yr old;
rickets
suspected intestinal results not
• 12 with other
presented by age.
disease
conditions
Endoscopic
duodenal biopsy in
children

1

Endoscopic duodenal
biopsy:
• Gross endoscopic
visualization
• Histopathology

Not clearly indicated if these figures represent mean (CI) or another measure of central tendency.

L:M was correlated with mucosal
B lymphocyte density (r=0.57,
p<0.05), IEL (r=0.51, p<0.02),
and perforin+ IEL (r=-0.64,
p<0.03).
14% had abnormalities on
endoscopic visualization:
• 1% had esophagitis
• 6% had gastritis, 7 (47%) of
which were H. pylori positive
• 7% had duodenitis
Biopsy results:
• PD:
• 26% normal
• 29% chronic non-specific
duodenitis

Villous atrophy was Specific results for
identified not only the 2 patients with
among 40% of
protein losing
children with PD, enteropathy were
but also among
not reported.
22%, 9%, and 17%
of those with short For 27% of cases,
stature, rickets, and the only
other conditions,
histopathology
finding was chronic
respectively.
non-specific
Authors argue that duodenitis; the

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest

Design and
Sample Size

Biomarker

Results
• 40% villous atrophy
• 5% other*

(including 2 with
protein losing
enteropathy)

• Short stature:
• 56% normal
• 22% chronic non-specific
duodenitis
• 22% villous atrophy
• Rickets:
• 55% normal
• 36% chronic non-specific
duodenitis
• 9% villous atrophy
• Other:
• 25% normal
• 50% chronic non-specific
duodenitis
• 17% villous atrophy
• 8% other*

2000

Sao Paulo, Brazil

Case-series

Fagundes-Neto U et 2-10 mo olds with n=16
al.
PD and protein
calorie malnutrition
Studies of the small consecutively
bowel surface by
admitted to Sao
scanning electron
Paulo Hospital.
microscopy in
infants with
persistent diarrhea
Scanning electron
microscope (SEM)
and light microscope
(LM) analyses of

Jejunal secretions
aspirate:
Bacterial concentrations

Jejunal tethered capsule
biopsy:
Histopathology by LM
and SEM

Rectal tethered capsule
biopsy:
Histopathology

* 3 lymphangiectasia, 2 Giardia,
1 Mycobacterium avium
intracellulare. Findings were
reported according to presenting
symptoms.
68.7% had bacterial overgrowth
4
(concentration >10
colonies/mL): 3 had
enteropathogenic E. coli while
the rest had colonic microflora.

Conclusion

Comments

endoscopic biopsy diagnostic,
is superior to “blind” prognostic, and
capsule biopsy in therapeutic utility of
developing country identification is
settings and allows unclear.
for visualization of
the intestine.
Endoscopic
visualization results
were not reported
by condition nor in
relation to
histopathology
results; it is difficult
to assess the value
added compared to
biopsy alone.

Histological
Inconsistent
abnormalities were reporting of
noted in all subjects proportions of
by LM and SEM.
histopathologic
findings among all
Degree of villous
subjects and by
All small intestine specimens
atrophy noted on SBBO status;
had morphological abnormalities SEM seemed to be assessment of
on LM:
correlated with
potential
SBBO (no
relationship with
• 43.7% moderate villous
statistical tests
SBBO between
atrophy
different histologic
• 56.3% subtotal villous atrophy were reported).
findings was not
Authors
speculate
possible.
SEM revealed abnormalities of
that
the
mucousvarying intensity:
fibrinoid pseudo• Among the 11 with SBBO,

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
small intestinal
biopsy among
infants with PD with
and without SBBO

Design and
Sample Size

Biomarker

Results

Conclusion

villous atrophy ranged from
Grade II (n=4), Grade III (n=2),
to Grade IV (n=3).
• For the 5 subjects without
SBBO, villous atrophy ranged
from Grade I (n=1) to Grade 2
(n=4).
• A mucous-fibrinoid pseudomembrane over enterocytes
was noted in 7 of the 11 with
SBBO and none of the others.

membrane partially
covering
enterocytes is
consistent with a
malabsorptive
process, with the
findings of fat
droplets on
enterocytes
surfaces, and with
the state of
malnutrition of the
subjects.

Other abnormalities noted on
SEM included:
• Mucus and debris covered
large areas of the villous
surface
• Derangement of the
enterocytes (in some cases cell
borders were not clearly
defined)
• Reduced height and number
(or absence in some places) of
microvilli
• Lymphocytes and fat droplets
were observed over the
1
surface of enterocytes (18%)

2001

Brasilia, Brazil

Cross-sectional

Jejunal capsule biopsy:
Histopathology

6 mo-13 yr olds with n=31
acute, persistent or
chronic diarrhea,
Antiendomysial
and/or malnutrition
antibody test
reliability in children being seen at the
pediatric
with frequent
Gandolfi L et al.

1

These SEM results were not presented separately for those with and without SBBO.

10 subjects had colitis on rectal
biopsy; this was not associated
with SBBO or degree of small
intestinal pathology on SEM.
30/31 (96.8%) had abnormal
histopathology:
• Suggesting non-specific
inflammatory abnormalities in
27 (87.1%) subjects.
• Demonstrating grade 3
mucosal abnormalities in all
malnourished 1 yr olds

Comments

The vast majority of Biopsies of interest
children with
were not provided
clinically severe
in subject-specific
diarrhea and/or
detail (e.g.
malnutrition had
characteristics of
the 27 children with
some degree of
non-specific
abnormality on
inflammation were
jejunal biopsy.

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Study Outcomes of
Diagnostic Interest
diarrhea and
malnutrition: is it
celiac disease

Location and
Target Population

Design and
Sample Size

gastroenterology
service of a
university hospital
and determined to
Jejunal biopsy
have disease
among children with severity warranting
PD and/or
biopsy.
malnutrition
Subjects negative
for CD-specific
antibodies were of
interest for this
review.
2000
Islamabad, Pakistan Case-series
2 mo-12 yr olds
n=41;
• 28 with PD
referred from
An audit of pediatric various hospitals to • 9 with FTT
• 4 with short
KRL Hospital
upper
stature
Islamabad for
gastrointestinal
abdominal pain, PD,
endoscopies
short stature, FTT,
GI bleeding, or
Duodenal biopsy
among children with anemia. The
subjects of interest
PD or growth
for this review were
problems
those with PD or
growth problems.
Hafeez A et al.

2007

Delhi, India

Case-control

Jain S et al.

Children (ages

n=80;

Biomarker

Results

Conclusion

negative for enteric parasites.

Endoscopic duodenal
Biopsy:
• Gross endoscopic
visualization
• Histopathology

Stool Test:
Occult blood

Positive histopathologic findings
were identified in:
• 21/28 with PD
• 7/9 with FTT
• 3/4 with short stature

Comments
not detailed (e.g.
presence of
parasites, degree
of malnutrition
and/or diarrhea).

75% of the PD and
77% and the short
stature/FTT
patients had
abnormalities by
endoscopy.

There was possible
bias in the manner
of selection for
endoscopy. 14
biopsies were
unable to be
analyzed (from 100
More abnormalities were found
endoscopies).
Authors
assert
the
via histology than visualization,
importance
of
and findings did not necessarily
Authors did not
biopsies among
correlate.
report the
children with
endoscopic
indications for
endoscopy, due to appearance of the
lack of correlation mucosa.
between them and
Histology findings
increased
were reported by
identification of
specimen (with
abnormalities by
multiple specimens
biopsy.
from some
patients), not by
condition or by
patient, so specific
results could not be
interpreted in
regards to this
review.
Fecal occult blood test was
A high proportion of Among cases, half
positive in 30/50 (60%) cases
severely
had a presenting
and 0/30 controls.
malnourished
complaint of

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
unspecified)
Fecal occult blood admitted with
screening in children severe malnutrition
with severe
and age-matched
malnutrition
healthy controls
recruited from an
Fecal occult blood immunization clinic.
among severely
malnourished
children compared
to healthy controls

Design and
Sample Size

Biomarker

n=50 cases with
Blood Test:
severe malnutrition Hemoglobin
n=30 healthy
controls

Results

Conclusion

Comments

Among cases positive for fecal
occult blood, 20 (66.7%) were
found to have hemoglobin <8
g/dL.

children had a
positive fecal occult
blood test,
compared with no
positives among
healthy controls.

diarrhea (duration
not specified), but
the authors did not
report results
stratified by
diarrhea duration.

Enteric infections:
• Parasitic infections were
detected in 14/50 (28%) of
cases, 12 (85.7%) of whom
tested positive for fecal occult
blood.
• Bacterial infections were
detected in 18/50 (36%) of
cases, 13 (72.2%) of whom
tested positive for fecal occult
blood.
• Of the remaining 18 for whom
an enteric pathogen was not
identified, 5 (27.8%) tested
positive for fecal blood.

Malnourished
children with
identifiable
pathogens more
often tested
positive for fecal
occult blood,
although
approximately 25%
of those without an
identifiable
pathogen also
tested positive.

Authors did not
provide differences
in proportions of
occult blood among
those with and
without specific
enteric pathogens.

Presence of fecal
blood did not
appear to vary by
feeding mode (e.g.
breast milk, cow’s
milk, or formula),
although data
presented were
limited.
Abnormal Tc-99m dextran
Scintigraphy might
uptake was positive in one child be a useful,
found to have subtotal villous
noninvasive
atrophy on biopsy and another method for
thought to have abdominal
detecting intestinal
tuberculosis.
pathology.
Among the 30 cases with fecal
occult blood, 16 were breastfed,
11 were fed cow’s milk, and 3
were fed formula.

2002

New Delhi, India

Case-series

2-12 yr olds
n=3 <5 yr old
selected from
Detecting protein
hospitalized patients
losing enteropathy with symptoms
by Tc-99m dextran suspicious for
scintigraphy: A novel protein-losing
experience
enteropathy
(hypoalbuminemia
Tc-99m dextran
and edema).
scintigraphy as a
marker of proteinKapoor, S et al.

Tc-99m dextran
scintigraphy

The child with the negative scan
had marasmus and partial villous
atrophy on biopsy.

Statistical analysis
was not provided;
data were reported
as proportions
only.
Matching scheme
was not defined.

This pilot study had
a small sample
size of 8 children,
and only 3 were
younger than 5
years.

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
losing enteropathy
or intestinal
inflammation
2004
Sfax, Tunisia
Laadhar A et al.
Determination of
antitransglutaminase
antibodies in the
diagnosis of celiac
disease in children:
results of a five year
prospective study

Children admitted
for endoscopic
biopsy for
symptoms of CD
(not specified).

Design and
Sample Size

Case-control
n=99

Biomarker

Results

Conclusion

Comments

Endoscopic duodenal
biopsy:
Histopathology

Of 99 subjects not meeting
diagnostic criteria for CD,
endoscopic biopsies revealed:
• 76 had normal morphology of
the intestinal mucosa
• 7 had elevated densities of
intraepithelial lymphocytes
• 10 had partial villous atrophy
(Marsh stage 2)
• 6 had various other conditions
such as giardiasis or gastritis

Among 169
children with
symptoms of CD,
41% had subtotal
or total villous
atrophy, 10% had
partial villous
atrophy or
inflammatory
findings, and 45%
had normal
biopsies.

Article in French.

Subjects of interest
for this review were
those who tested
negative for CDspecific serology
and who did not
Duodenal biopsy
among patients with meet the study
diagnostic criteria
suspected CD
for CD--subtotal or
total villous atrophy
consistent with
Marsh stages 3 or 4.
Controls were aged
3 mo-17 yr (mean
4.5 yr).

2006
Leite CA et al.

Sao Paulo, Brazil

5 mo-12 yr old
(median 24 mo)
Functional,
HIV-infected
microbiological and subjects recruited
morphological
from a hospital and
intestinal findings
clinic.
among human
immunodeficiency All subjects had
virus infected
some degree of
children
protein-energy
malnutrition.

Cohort
n=11;

Blood Test:
D-xylose
(9 tested)

n=5 patients with
current or recent Biopsy of small intestine
episode of diarrhea by tethered capsule or
endoscopy:
n=6 patients with Histopathology
no diarrhea in the (10 tested)
30 days preceding
enrollment
Rectal biopsy:

Prevalence of CD
antibodies did not
clearly align with
case/control
designation.
Because of the
way the results
were reported, we
could not extract
data on those who
tested negative for
CD-specific
serology and who
had Marsh stages
3 or 4
histopathology.

Methods section
described obtaining
duodenal biopsies,
while results and
conclusion sections
specify that jejunal
specimens were
obtained.
100% had low D-xylose
There was a high Portuguese
absorption:
prevalence (100%) language article.
of abnormal D• Mean: 15.6 mg/dL
D-xylose <25
xylose results
• SD: 5
among HIV-infected mg/dL was defined
• Range: 8.9-24.4
children, regardless as indicative of
• Median: 14.2
of diarrhea status. malabsorption.
This value is higher
Small intestinal biopsy:
than what some
All
patients
also
• 100% had some degree of
references have
had
cellular
villous atrophy based on a I-IV
noted as a cutinfiltration
of
the
grading system:
point [186].
lamina
propria
and
• Grade I: 3
varying
degrees
of
• Grade I/II: 2

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
Small intestinal and
rectal biopsy to
assess morphology
and D-xylose as a
marker of
malabsorption
among HIV-infected
children

2005
Lima AA et al.

Fortaleza, Brazil

2-60 mo olds
hospitalized with
Intestinal barrier
WAZ score <-2,
function and weight ~70% of whom had
gain in malnourished PD.
children taking
glutaminesupplemented
enteral formula
L:M as a marker of
intestinal
permeability and
various stool tests
among children with
malnutrition or PD
who received either
glycine or glutamine
1
2

Design and
Sample Size

Biomarker
Histopathology
(6 tested)

RCT
n=80;

Urine Tests*:
1
• Lactulose
• Mannitol
• L:M

n=53 received
supplemented
formula
Stool Tests**:
• 27 with glycine • Lactoferrin
• 26 with glutamine • Leukocytes
• Occult blood
n=27 received
• Reducing substances
nonsupplemented
(RS)
formula

Results
•
•
•
•

Grade II: 1
Grade II/III: 1
Grade III/IV: 1
2 samples were too
superficial to assess
• Intraepithelial lymphocytes
were increased in half of the
biopsies.
• Lymphocytic and
polymorphonuclear (PMN)
infiltration of the lamina
propria were present in 10/10
and 7/10 biopsies,
respectively.
Rectal biopsy:
• 100% had normal architecture
• Lymphocytic and PMN
infiltration were present in 6/6
and 4/6, respectively.
2
Mean L:M (SE):
• Glutamine group:
• Baseline: 0.31 (0.10)
(similar in all three groups)
• Day 10: 0.10 (0.02);
significant decrease,
(p=0.01)
• No significant decrease in L:M
in glycine and
nonsupplemented formula
groups at day 10

Mean lactulose (SE):
• Glutamine group:
• Baseline: 0.97 (0.46)
* n=80 tested at
(similar in all three groups)
enrollment, n=65 tested at
• Day 10: NS decrease in all
day 10.
3 groups
** n=60 tested.

Lactulose and mannitol results were expressed as % of dose administered.
Type of mean not specified.

Conclusion

Comments

villous atrophy.

Investigators used
a well-articulated
There was no
system of grading
correlation between villous atrophy.
D-xylose and
degree of villous
Results were not
atrophy on biopsy. presented by
diarrhea status,
perhaps due to
small sample size.

L:M significantly
improved in the
glutamine group
only.

The relationship
between stool
markers and L:M
was not reported.

>50% of subjects
had intestinal
inflammation by
stool lactoferrin.
Fecal leukocytes,
RS, and occult
blood were
detected in fewer
subjects than
lactoferrin.

Data were not
stratified by history
of PD.
Fecal fat was
assessed, but
results were not
reported.
Cut-off values for
lactoferrin positivity
were not
described.
Exclusively

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
supplemented
formula or placebo

Design and
Sample Size

Results

Conclusion

Mean mannitol (SE):
• Glutamine group:
• Baseline: 3.42 (0.64)
(similar in all three groups)
• Day 10: NS decrease in all
3 groups

2001

Varanasi, India

Mishra OP et al.

1-5 yr olds with PD n=30 with
selected randomly endoscopy
from an outpatient performed
population in a
urban setting.

Endoscopic and
histopathological
evaluation of
preschool children
with chronic diarrhea A high proportion of
the children had
Duodenal biopsy
varying degrees of
among patients with protein energy
chronic diarrhea
malnutrition.

Biomarker

Case-series

Endoscopic duodenal
biopsy:
• Gross endoscopic
visualization
• Histopathology

breastfed children
were excluded
from study
participation due to
assessment of
stool lactoferrin.

Proportion of stool markers at
baseline among all subjects:
• Lactoferrin: 53.3%
• Leukocytes: 11.7%
• RS: 3.3%
• Occult blood: 5.0%
7 (23.3%) had grossly abnormal
endoscopic findings:
• 5 (16.7%) with chronic
duodenitis
• 1 with duodenitis with multiple
erosions
• 1 with duodenitis with
hemorrhagic gastritis

Grossly abnormal
endoscopic
appearance was
found in onequarter of children
with chronic
diarrhea assessed
by endoscopy.
Three-quarters had
abnormal histology.
22 (73.3%) had abnormal
More than half had
histopathology:
1. 17 (56.7%) with villous atrophy villous atrophy with
mononuclear cell
with mononuclear cell
infiltration; these
infiltration
• 1 (3.3%) with villous atrophy patients had >1
month longer
and eosinophilic infiltration
• 2 (6.7%) with villous atrophy duration of diarrhea
than those with
and mononuclear and
either normal
eosinophilic infiltration
histology or
• 2 (6.7%) with only
mononuclear cell
mononuclear cell infiltration
infiltration without
Mean duration of diarrhea (SD) villous atrophy.
was not associated with gross
endoscopic findings but did vary
by histopathology:
• Normal histopathology: 9.0 wk
(6.0), n=8
• Mononuclear cell infiltration:
9.0 wk (6.0), n=2

Comments

Age,
enteropathogen
recovery, and
degree of
malnutrition were
not associated with

Authors do not
report assessing
relationship
between gross
endoscopic
findings and
histopathology.
Number of patients
with villous atrophy
and both
mononuclear and
eosinophilic
infiltration was very
small (n=2), yet
authors report a
significant
difference in their
duration of diarrhea
relative to those
with normal
histopathology.

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

gross endoscopic
• Villous atrophy with
mononuclear cell infiltration: or histopathological
findings.
14.9 wk (5.3), n=17, p<0.02
compared to normal
histopathology
• Villous atrophy with
mononuclear and eosinophilic
infiltration: 21.5 wk (2.1), n=2,
p<0.02 compared to normal
histopathology
• Villous atrophy with
eosinophilic infiltration: 6.0 wk,
n=1

2001

New Delhi,
India

Case-series

n=94;
(38 with repeat
0-15 yr old
Tropical sprue in
biopsies)
gastroenterology
north Indian children clinic patients with
<5 yr old: n=44
PD.
D-xylose and
duodenal biopsy as Those with
markers of TS
abnormal
morphology on
biopsy, abnormal Dxylose test, and
clinical response to
antibiotics were
diagnosed as
having TS.
Mittal SK et al.

Those with
abnormal
morphology and
response to gluten-

No consistent pattern was
observed between gross
endoscopic findings or
histopathological lesions and
age, WFA, or type of
enteropathogen recovered in
stools.
Duodenal biopsy, method 36 (38.3%) were diagnosed with More than half of Biopsy results were
not specified:
TS including 14/44 (31.8%) who the GI clinic
not provided for
Histopathology
were under 5 years of age.
patients without TS
patients with PD
had some degree or CD.
18 (19.1%) were diagnosed with of villous atrophy.
Blood Tests:
CD.
It was unclear if
• Hemoglobin
More than one-third there were patients
• D-xylose*
Degree of villous atrophy among and almost one-fifth with abnormal DTS vs. CD patients:
of subjects were
xylose and
diagnosed with TS histology who did
• Mild in 8/36 (22.2%) vs. 0
* Not specified whether
not respond to
• Moderate in 23/36 (63.9%) vs. and CD,
respectively.
from urine or serum, and
antibiotic therapy
4/18 (22.2%)
units of measurement not • Severe in 5/36 (13.9%) vs.
and therefore were
By
study
diagnostic
provided.
not diagnosed with
14/18 (77.8%)
definition, all TS
TS.
Mean hemoglobin concentration patients improved
Cut-off points used
(range) among TS patients was with treatment.
Among those who to define abnormal
8.3 g/dL (5.5-11) and did not
D-xylose tests
differ from values of those with had repeat
were not provided.
biopsies,
almost
CD.
three-quarters
showed
Among the 22 TS patients,

Evidence Table 7. Markers of non-specific intestinal injury.
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Reference and
Location and
Design and
Study Outcomes of
Target Population Sample Size
Diagnostic Interest
free diet were
diagnosed with CD.
We include data on
these subjects for
comparative
reasons.

Biomarker

Results
repeat biopsies showed:
• 16 with normalization
• 5 with improvement
• 1 worsened despite marked
clinical improvement

Conclusion

Comments

normalization of
histology, while
23% had partial
improvement and 1
patient had
worsened
The D-xylose test was abnormal pathology.
in all TS patients by diagnostic
definition.
2000
Sao Paulo, Brazil
Case-control
Jejunal capsule biopsy:
Mean villous atrophy score (SD): The malnourished Tissue from
• Histopathology*
children had
patients requiring
• Cases: 2.6 (0.8)
Cases were children n=33;
• Maltase activity
Nichols B et al.
• Controls: 1.2 (0.5), p=0.006) significantly greater intestinal resection
(mean age 9.9 mo,
• Intestinal messenger
villous atrophy than as part of their
SD 8.1) hospitalized n=24 cases
RNA (mRNA)
Contribution of
biliary atresia
WAZ score was correlated with the younger
with malnutrition
abundances:
villous atrophy to
management
villous atrophy (r=0.65, p- value controls.
refractory to dietary n=9 controls
reduced intestinal
provides an
• Maltasenot reported).
Among the subset opportunity to
rehabilitation.
maltase in infants
glucoamylase (MGA)
assess presumably
tested for mRNA
with malnutrition
• Sucrase-isomaltase 13/25 [sic] cases and 0/5
Controls were
Subjects were
controls had subnormal (defined messages, maltase “normal” intestinal
(SI)
Jejunal biopsy,
children (mean age matched on height
as <94 U/g protein) of maltase activity as well as architecture.
• Villin, a structural
However, unless
maltase activity, and 3.6 mo, SD 1.0) with and weight; ages
activity; mean maltase was 34% the mRNA
protein expressed
they mocked up ex
differed within
enzyme messenger HAZ and WAZ
abundances for
only in enterocytes lower among cases (p=0.11).
vivo mucosal
matched sets.
scores >-2 and
RNAs among
Maltase activity did not appear to MGA, villin and
• Sodium-activated
biopsies in these
malnourished and normal intestinal
SGLT were
decrease with WAZ score
luminal glucosecontrols, resections
mucosa on biopsy,
well-nourished
significantly
(further details not provided).
galactose
will have lower
children. Assessed hospitalized for
correlated
with
transporter 1
proportions of
association between Kasai procedure for
case
status
and
However,
in
sub-analyses
(SGLT), a functional
villous to
maltase and villous biliary atresia.
were
correlated
among
those
samples
with
an
protein expressed
atrophy and other
with villous atrophy. submucosa tissue
only in enterocytes adequate β-actin, a
compared to cases’
mucosal intestinal
housekeeping gene message,
• β-actin
markers indicative of
While maltase
samples derived
(n=10 cases, n=9 controls),
loss of enterocytes
cases’ findings expressed as a deficiency has been from mucosal
and enterocytic
biopsies. While this
mean percent of controls' (SD) reported in
* Mucosal atrophy was
malnutrition
in
other
function.
probably doesn’t
included:
scored on a scale of 1
studies,
authors
affect histology, it
• Villous length (reciprocal of
(absence of atrophy
assert
that
these
might affect
atrophy
score):
38.9
(41.6),
compared to an organ
are
the
first
results
enterocyte
p=0.004
donor) to 4 (similar to
that
directly
support
functional assays
•
Maltase
activity:
37.1
(23.2),
children with active CD).
the hypothesis that and mRNA
p=0.001
reductions in
determination, as
Histology among controls • MGA mRNA: 45.1 (36.4),
maltase
activity
are
transmural tissue
was on surgically resected p=0.016
due
to
villous
will bring in more
tissue.
• Villin mRNA: 52.5 (22.6),
diverse populations
atrophy.
This
study
p=0.003
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Study Outcomes of
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Diagnostic Interest

Design and
Sample Size

Biomarker

Results

Conclusion

Comments

• SGLT mRNA: 66.6 (23.1),
p=0.057
• β-actin: 88.2 (15.8), p=0.189

also nicely
correlates mRNA
relative abundance
with function.

of cells; only some
of them might have
transcripts of
interest. However,
the bias is likely in
a direction that
would reduce effect
size.

Both villous length and maltase
activity in a subset of cases were
less than 40% of control values.
MGA, villin, and SGLT mRNA
abundances were correlated with
villous atrophy score (r=0.73),
(r=0.76), and (r=0.54),
respectively (p-values not
1
reported) .
MGA mRNA abundance was
correlated with maltase activity
(r=0.32).

It was unclear if
control inclusion
criteria included
absence of atrophy
or if all potential
controls lacked
atrophy.
Statistical methods
might not have
adequately taken
into account the
small sample size
and matching
scheme.
Subsets of subjects
were investigated
for various tests.
For example, 10
cases had mRNA
analyses based on
β-actin adequacy.
Another instance of
selected testing
was the subset of
22 and 15 cases
that had WAZ
score to histology
and mRNA
correlation
analyses,

1

Villin and SGLT1 were assessed as a ratio with housekeeper gene β-actin.
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Design and
Sample Size

Biomarker

Results

Conclusion

Comments
respectively.
Rationale for
subset selection
was not thoroughly
described.

2003

Porto Alegre, Brazil Cross-sectional,
retrospective
Pires AL et al.
6 mo-5 yr old
inpatients from an n=65
Digital morphometric urban setting who
and stereologic
underwent biopsy
analysis of small
as part of a work-up
intestinal mucosa in for PD.
well-nourished and
malnourished
There was a high
children with
proportion of
persistent diarrhea children with
malnutrition in this
Computerized
study population.
morphometric and
stereologic
assessments in
proximal small
intestine biopsy in
subjects with PD

2008
Poddar U et al.

Chandigarh, India

<14 yr (mean age
6.9 yr) presenting
Is tissue
with symptoms
transglutaminase
consistent with CD
autoantibody the
(PD, FTT, and/or
best for diagnosing pallor)
celiac disease in
children of
Subjects negative
developing countries for CD were of
interest for this

Small intestinal biopsies, Computerized mucosal
Enterocyte
site and method not
measures were similar to those measures show
specified*:
by micrometer and were not
some correlation
• Mucosal morphometric associated with nutritional status. with WAZ and WHZ
scores, but not with
assessment by computer
Digitally assessed enterocyte
HAZ score.
analysis (62 tested):
height, enterocyte brush border, However, surface
• Villous height
and enterocyte nucleus height
area and
• Crypt depth
correlations:
villous:crypt ratios
• Villous:crypt ratio
were not correlated
•
WAZ
score:
r=0.25
(p=0.038),
• Mucosal thickness
with any growth
r=0.26
(p=0.03),
and
r=0.24,
• Digital assessment (500x
parameter.
(p=0.05),
respectively
magnification) (65
•
WHZ
score:
r=0.29
(p=0.02),
tested):
r=0.27 (p=0.03), and r=0.16
• Enterocyte height
• Enterocyte nucleus (p=0.19), respectively
• HAZ score: r=0.16 (0.18),
height
r=0.23 (p=0.06), r=0.23 (0.06)
• Brush border
height
• Stereological analysis There was no correlation
between mucosal surface area
to assess mucosal
surface area (62 tested) and growth parameters.

* From stored specimens
previously assessed by
micrometer.
Case-control
Endoscopic duodenal
Duodenal biopsy of those with
biopsy:
giardiasis showed nonspecific
Histopathology
n=28 controls;
chronic inflammation of lamina
propria; there was no evidence
• 22 with giardiasis
of villous atrophy.
• 1 with TS
• 5 with SBBO

Duodenal biopsy
demonstrated
histological
changes
accompanying
Giardia infection.

Authors did not
report the biopsy
findings in the TS
or SBBO patients.

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
Duodenal biopsies in review.
controls with
giardiasis, TS, and
SBBO
2002
Chandigarh, India
Poddar U et al.
Celiac disease in
India: Are they true
cases of celiac
disease
Duodenal biopsy, Dxylose, and fecal fat
in children with
symptoms of CD but
normal mucosal
biopsy results

Design and
Sample Size

Case-control

n=47
18 mo-14 yr olds
with PD, FTT, or
pallor from a
hospital pediatric
gastroenterology
unit.
Subjects with
normal crypt:villous
ratio on biopsy were
of interest for this
review.

Biomarker

Results

Conclusion

Comments

Endoscopic duodenal
biopsy:
Histopathology

38% had chronic inflammatory
cell infiltrates in the lamina
propria.

Among controls
with normal
mucosal
architecture by
biopsy, more than
one-third had PD.

Relationships
between fecal fat,
D-xylose and
biopsy results were
not reported.

Stool Tests:
• Fecal fat*
• D-xylose**

* In 72-hour stool
collection.

55% had abnormal D-xylose
concentrations.

20% had abnormal fecal fat test. D-xylose and fecal
fat might not
No results beyond proportion
correlate well with
positive were reported for any of duodenal biopsy
the above markers.
results.

While 38% of
controls had PD,
results for the
markers studied
were not stratified
by PD for this
group.
Seven children with
biopsies consistent
with CD did not
respond to glutenfree diet and were
excluded from the
study.

** Not specified whether
from urine or serum, and
units of measurement not
provided.

Cut-off points used
to define abnormal
D-xylose tests
were not provided.
2008

Aligarh, India

Cross-sectional

1-12 yr olds (mean n=19
age 51.2 mo) from
Prevalence of iron an urban setting
deficiency anemia in with PD recruited
chronic diarrhoea
from pediatric
and celiac disease - outpatient and
A western UP
inpatient units.
experience
Those with negative
Duodenal biopsy in CD work-up were
Sherwani K et al.

Duodenal biopsy, method Six patients had partial villous
not specified:
atrophy and non-specific
Histopathology
duodenitis by biopsy.

Biopsy identified
abnormal
histopathology in
approximately 1/3
of patients who did
not have CD, but
did not identify PD
etiology in the
remainder who did
not have CD.

The 6 children with
partial villous
atrophy were
thought to have
SBBO as they
recovered after
treatment with
broad spectrum
antibiotics.

Evidence Table 7. Markers of non-specific intestinal injury.
Biomarkers in bold are primarily markers of non-specific intestinal injury.
Reference and
Location and
Design and
Study Outcomes of
Target Population Sample Size
Diagnostic Interest
patients with PD
subjects of interest
for this review.
2003
Santiago, Chile
Cross-sectional
0-12 yr old (median n=11
9 mo) HIV-infected
Gastrointestinal
children treated in
diseases in children hospital. A high
infected with the
proportion had PD.
human
immunodeficiency
virus
Tassara O et al.

Biomarker

Results

Endoscopic
upper GI biopsy including
esophagus, stomach,
and/or duodenum:
• Gross endoscopic
visualization
• Histopathology

Macroscopic inflammatory
changes were observed on
endoscopy in the esophagus,
stomach or duodenum in 2
subjects.

Conclusion

Biopsy results
might show
inflammatory
damage in cases
with no
macroscopic
Biopsies of esophagus, stomach damage visible.
or duodenum showed
inflammatory changes of varying
degree in all 11 subjects.

Comments

Spanish language
article.
Inflammatory
changes identified
in the digestive
system were not
specified by site
(i.e. esophagus,
stomach or
duodenum).

Endoscopy and
biopsy among HIVinfected children

Results were not
stratified by
presenting
symptoms,
including PD.
Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects.
Where these studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s.
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting.
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval,
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins,
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G,
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score),
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s)

Our findings indicate a profound lack of enteric histologic data on pediatric populations in
resource-limited settings. Specifically, only 18 of the 77 studies that we reviewed contained any
biopsy materials, and only three of these 18 publications also included any non-intestinal tissue
candidate biomarkers [111, 136, 155]. Furthermore, only two [111, 136] of these three studies
attempted to statistically relate the less invasive, non-intestinal markers to histologic findings;
the only significant association reported was between L:M and intestinal tissue inflammation on
histopathology. Moreover, only 718 subjects aged 0-18 years were represented among the 18
biopsy studies. Ages were mixed in many studies, such that it was impossible to discern which
subjects were in the age range of maximal interest in this review (i.e., under five years of age),
and indications for the biopsies were quite diffuse (e.g., diarrhea, poorly specified abdominal
symptoms). Therefore, the subject population and data availability were suboptimal for the
purposes of this review. In addition, none of the studies that included biopsies related the
findings to the outcome of most considerable interest, i.e., stunting.
Prospectively collected small bowel biopsies may provide useful data, guide biomarker
development and validation, and reveal information about the cause(s) and pathophysiology of
EED. Appropriate conditions are necessary for biopsy studies to be illuminating. For example,
the context in which subjects and controls are selected is vital. Regarding cases, a rigorous
clinical case definition must be established that defines growth faltering and minimal extent of
intestinal functional abnormalities. Exclusion criteria should also be established for disorders
that might mimic EED, such as celiac disease or inflammatory bowel disease. The pathology
associated with these disorders, however, could inform biomarker association with intestinal
dysfunction not specific to, but nevertheless relevant to and sensitive for EED. Such markers
could be part of a set of markers used to diagnose EED. However, the usefulness of a biopsy to
guide biomarker development and validation depends on several factors. Ideally, the lesion
should be from treatment-naïve hosts; this does bring up an ethical dilemma, however. For
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example, placement of a patient on gluten free diet, even briefly, or treating a patient with
possible inflammatory bowel disease, prior to biopsies can obscure findings and render the
histopathologic evaluation less valuable. Second, biopsies obtained under protocol must take
into account the distribution of the lesion, so as to confirm the negative predictive value of any
set of biopsies. Two disorders provide some guidance in this realm. For celiac disease, the
lesion is surprisingly non-uniform [276-279], and multiple biopsies must be sought to avoid beta
error. A similar situation applies to gastric biopsies for Helicobacter pylori detection [280-286]. A
comparison group is also necessary, and to date, most “normal” or “control” tissues were from
children in developed country settings. Hence, the abnormalities noted in children’s biopsies
cannot be attributed to the disease process (enteropathy), or its consequences (stunting, most
particularly), rather than to residence in an area in which such disorders are common. In other
words, biopsy association with disease is, based on the available literature, no more strong than
EED association with geography.
A case could be made that biopsies are part of a routine evaluation of a child with failure
to thrive, and a recent publication from North America suggests that this diagnostic modality is
commonly employed in the evaluation of stunting disorders [287]. However, the precise
diagnostic yield of a biopsy is not stated in this publication, nor are the data weighted by the
symptoms or the age of the children. At this time, it remains uncertain how generalizable the
utility of these recommendations is in settings where EED is common.
The safety of a biopsy also needs to be considered in pondering the value of tissue
assessment, or of biomarker discovery or validation. If a biopsy is obtained as part of an
evaluation of poor growth, then the small risk of the biopsy usually is less than the potential
benefit. However, this calculus assumes that substantial pre-procedure and post-procedure care
is available to mitigate the likelihood of complications. The use of anesthesia in inpatient or
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outpatient settings is safe, but should conform to the highest grade of safety [288]. An additional
concern is that endoscopy of the duodenum carries a risk of causing intramural hematomas,
estimated at 0.08% of upper endoscopic procedures in the United States [289, 290]. This
complication results in small bowel obstruction, severe pain, and Ampulla of Vater obstruction
and requires management involving prolonged hospitalization and total parenteral nutrition
and/or or naso-enteral feeds. Coagulopathies such as von Willebrand Disease, other platelet
disorders, and vitamin K deficiency (the risk of which is increased in chronic diarrhea and
malabsorption) [291, 292] are thought to contribute to approximately half of endoscopy-related
duodenal hematomas [289, 290, 293-307]. Among von Willebrand Disease variants, only severe
(type 3) disease can be readily identified by available screening tests (prothrombin time)
although such assessments can be used to pre-endoscopically identify treatment-responsive
vitamin D deficiency.
If biopsies are obtained as part of a research protocol to identify markers that predict
clinically consequential EED (and even if biopsies are only used for clinical care), it is necessary
to assemble a panel of individuals whose tissues are evaluated in parallel, but who do not have
the most consequential of the complications of putative enteropathy, namely, stunting
(assuming this remains the outcome of greatest concern). It would not be possible to recruit
healthy control children for biopsies, because the procedure would offer limited benefit—
especially in relation to potential harm. However, some surrogate controls might arise as
adventitiously obtained tissue becomes available either during operations or other endoscopic
procedures, and the use of small bowel obtained at time of portoenterostomy is a particularly
inspired choice [53].
Caveats must be attached to any histologic assessment of the guts in children being
evaluated for enteropathy as part of a care plan. It is very unlikely that intestinal biopsies would
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be used as a diagnostic procedure at the beginning of an evaluation for malnutrition or poor
growth. More likely, it would be a procedure of last resort, after less invasive evaluation failed to
establish an etiology, and after attempts at nutritional and intestinal rehabilitation are undertaken
and prove unsuccessful. However, as noted above, the empiric treatment of consequential
intestinal dysfunction might change the pathology, and thereby diminish the diagnostic value of
the procedure. Also, if biopsies are obtained, and subjected to analysis, it is critical that the
materials be handled in a systematic manner, and processed per protocol, so as to maximize
the data that they generate.
In summary, there is no evidence to date that biopsies have been used to define the
entity of childhood EED, because inadequate controls have been studied (children without
evidence of functional impairment of gut function living in the same environment). There is no
evidence that the biopsies relate to the outcome of greatest concern, namely, stunting. The data
obtained from biopsies could be falsely normal, because of attempts at intestinal rehabilitation
that will presumably precede the endoscopy. This negative assessment does not mean that
biopsies are without worth, only that their value as providing case-defining information, or
guiding biomarker discovery or validation, has yet to be made. However, if biopsies are
obtained, it is critical that they be performed in a rigorous, disciplined and ethical manner, and
that the data to be obtained are maximized.

5.9 Markers of Extra-Small Intestinal Function
We included markers of non-small intestinal organ function as these might provide
important indirect assessments of precursors to or resultants of small intestinal injury. We
reviewed those markers that were examined among children with presentations potentially
consistent with enteropathy, such as persistent diarrhea, or were examined in relationship to
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markers of intestinal inflammation or dysfunction. The data relevant to this review are listed for
each of these studies in Evidence Table 8.
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Evidence Table 8. Markers of extra-small intestinal function.
Biomarkers in bold are primarily markers of extra-small-intestinal function.
Reference and
Location and
Design and
Study Outcomes of
Target Population
Sample Size
Diagnostic Interest
2010
Faisalabad, Pakistan Case-control

Biomarker

Results

Blood Tests:
Mean values significantly higher
Serum proteins and
among PD cases than in healthy
3-6 yr olds admitted n=72;
Bukhari AS et al.
metabolites:
controls:
to hospital with PD
• LDL
• Albumin
and healthy controls. n=36 cases with • Globulin
DNA damage and
• Homocysteine
PD
plasma
• Homocysteine
• TOS
homocysteine
• TBARs
• Total protein
n=36 healthy
concentrations are
• Total cholesterol, • DNA damage
controls
associated with
HDL, LDL,
serum metabolites
triglycerides
Mean values significantly lower
and mineral
among PD cases than in healthy
• AST, ALT
constituents' profiles
controls:
• T3, T4
in children with
• Total oxidant status • Total protein
persistent diarrhea
• T4
(TOS), Total antioxidant status (TAS), • TAS
Serum proteins,
and thiobarbituric
metabolites, and
reactive substances
levels of DNA
(TBARS)
damage among
DNA damage to
children with and
lymphocytes
without PD

2000

Sao Paulo, Brazil

Fagundes-Neto U et 2-10 mo olds with
PD and protein
al.
calorie malnutrition
Studies of the small consecutively
admitted to Sao
bowel surface by
Paulo Hospital.
scanning electron
microscopy in infants
with persistent
diarrhea
Scanning electron
microscope (SEM)
and light microscope
(LM) analyses of
small intestinal
biopsy among
infants with PD with
and without SBBO

Case-series
n=16

Jejunal secretions
aspirate:
Bacterial
concentrations

68.7% had bacterial overgrowth
4
(concentration >10 colonies/mL): 3
had enteropathogenic E. coli while
the rest had colonic microflora.

All small intestine specimens had
Jejunal tethered
morphological abnormalities on LM:
capsule biopsy:
• 43.7% moderate villous atrophy
Histopathology by LM • 56.3% subtotal villous atrophy
and SEM
SEM revealed abnormalities of
varying intensity:
Rectal tethered
• Among the 11 with SBBO, villous
capsule biopsy:
atrophy ranged from Grade II
Histopathology
(n=4), Grade III (n=2), to Grade IV
(n=3).
• For the 5 subjects without SBBO,
villous atrophy ranged from Grade
I (n=1) to Grade 2 (n=4).
• A mucous-fibrinoid pseudo-

Conclusion

Comments

Multiple serum
markers were
associated with PD,
especially DNA
damage to
lymphocytes
(p=0.0001).

Control recruitment
strategy was not
well described.
TOS, TBARS and
TAS were
incompletely
defined.

The authors
speculate that zinc Some values
deficiency, more
differed by gender
commonly found in in both the case
the children with PD, and control groups:
might be
• Triglycerides
responsible for
• Total cholesterol
increased
• HDL
homocysteine
• T3
concentrations and
play an important
Multiple markers
role in mediating
studied; analyses
DNA damage.
did not appear to
address potential
confounding.
Histological
Inconsistent
abnormalities were reporting of
noted in all subjects proportions of
by LM and SEM.
histopathologic
findings among all
Degree of villous
subjects and by
atrophy noted on
SBBO status;
SEM seemed to be assessment of
correlated with
potential
SBBO (no statistical relationship with
tests were reported). SBBO between
different histologic
Authors speculate findings was not
that the mucouspossible.
fibrinoid pseudomembrane partially
covering
enterocytes is
consistent with a
malabsorptive

Evidence Table 8. Markers of extra-small intestinal function.
Biomarkers in bold are primarily markers of extra-small-intestinal function.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest

Design and
Sample Size

Biomarker

Results
membrane over enterocytes was
noted in 7 of the 11 with SBBO
and none of the others.
Other abnormalities noted on SEM
included:
• Mucus and debris covered large
areas of the villous surface
• Derangement of the enterocytes
(in some cases cell borders were
not clearly defined)
• Reduced height and number (or
absence in some places) of
microvilli
• Lymphocytes and fat droplets
were observed over the surface of
1
enterocytes (18%)

2005
Galpin L et al.
Effect of
Lactobacillus GG on
intestinal integrity in
Malawian children at
risk of tropical
enteropathy
L:M and sucrose:
lactulose ratio
(SUC:L) as markers
of intestinal and
gastric permeability,
respectively, in
1

Mwenye, Malawi

RCT

Urine Tests:
2
• Lactulose
36-60 mo olds
n=164;
• Mannitol
recruited from a rural
• Sucrose (SUC)
community,
n=81 received
• L:M
excluding children Lactobacillus GG • SUC:L
with severe acute
(80 completed the
malnutrition or
study)
severe chronic
illnesses.
n=83 received
placebo
Subjects were
(81 completed the
considered at risk for study)
EED due to
residence in a
location with high
Subjects received
prevalence of EED. 30-days of

These SEM results were not presented separately for those with and without SBBO.
Lactulose, mannitol, and sucrose results were expressed as % of dose administered.
3
Arithmetic mean.
2

10 subjects had colitis on rectal
biopsy; this was not associated with
SBBO or degree of small intestinal
pathology on SEM.
At enrollment:
• 73% had L:M >0.10
• 40% had L:M >0.20
3
• Mean L:M (SD):
• Treatment: 0.18 (0.16)
• Placebo: 0.22 (0.20)
• Mean lactulose (SD) in treatment
group: 0.25 (0.17)
• Mean mannitol (SD) in treatment
group: 8.0 (4.5)
• Mean SUC:L (SD):
• Treatment: 0.58 (0.64)
• Placebo: 0.60 (0.64)
Mean excretion of sucrose (SD)
increased from 0.057 (0.042) to
0.078 (0.058) in the treatment group

Conclusion

Comments

process, with the
findings of fat
droplets on
enterocytes
surfaces, and with
the state of
malnutrition of the
subjects.

A high baseline
prevalence of
abnormal L:M was
observed, with no
change after
intervention.
High mannitol
excretion (relative to
UK norms) drove
the abnormal L:M.
There was little
effect on SUC:L with
intervention;
sucrose excretion
increased in both

Difficult to interpret
sucrose tests
because there are
limited data on
laboratory values
for these tests in
young children.

Evidence Table 8. Markers of extra-small intestinal function.
Biomarkers in bold are primarily markers of extra-small-intestinal function.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
asymptomatic
Presumed that if
children presumed at SBBO is etiology for
risk of EED
EED, treatment with
Lactobacillus will
result in improved
gut integrity.
2006
Sao Paulo, Brazil

Design and
Sample Size

Lactobacillus GG
or placebo. Only
the 161 subjects
who completed
the study had
repeat testing.
Cohort
Blood Test:
D-xylose
n=11;
(9 tested)

5 mo-12 yr old
(median 24 mo) HIVinfected subjects
Functional,
n=5 patients with
microbiological and recruited from a
current or recent
hospital and clinic. episode of
morphological
intestinal findings
diarrhea
All subjects had
among human
immunodeficiency some degree of
n=6 patients with
protein-energy
virus infected
no diarrhea in the
malnutrition.
children
30 days
preceding
Small intestinal and
enrollment
rectal biopsy to
assess morphology
and D-xylose as a
marker of
malabsorption
among HIV-infected
children
Leite CA et al.

2003

Santiago, Chile

Cross-sectional

0-12 yr old (median n=11
9 mo) HIV-infected
Gastrointestinal
children treated in
diseases in children hospital. A high
infected with the
proportion had PD.
Tassara O et al.

Biomarker

Results

Conclusion

Comments

(p=0.01), but similar results were
treatment and
observed in the placebo group.
control groups.
Otherwise there were no changes in
lactulose, mannitol, L:M, or SUC:L
after treatment or placebo.
100% had low D-xylose absorption:
• Mean: 15.6 mg/dL
• SD: 5
• Range: 8.9-24.4
• Median: 14.2

There was a high
prevalence (100%)
of abnormal Dxylose results
among HIV-infected
children, regardless
of diarrhea status.

Portuguese
language article.

Biopsy results might
show inflammatory
damage in cases
with no macroscopic
damage visible.

Spanish language
article.

D-xylose <25
mg/dL was defined
Biopsy of small
as indicative of
intestine by tethered Small intestinal biopsy:
malabsorption. This
capsule or endoscopy: • 100% had some degree of villous
value is higher than
Histopathology
atrophy based on a I-IV grading All patients also had what some
cellular infiltration of references have
(10 tested)
system:
the lamina propria noted as a cut-point
• Grade I: 3
and varying degrees [186].
• Grade I/II: 2
Rectal biopsy:
of villous atrophy.
• Grade II: 1
Histopathology
Investigators used
• Grade II/III: 1
There
was
no
(6 tested)
a well-articulated
• Grade III/IV: 1
correlation
between
system
of grading
• 2 samples were too superficial
D-xylose
and
villous
atrophy.
to assess
• Intraepithelial lymphocytes were degree of villous
increased in half of the biopsies. atrophy on biopsy. Results were not
presented by
• Lymphocytic and
diarrhea status,
polymorphonuclear (PMN)
perhaps due to
infiltration of the lamina propria
small sample size.
were present in 10/10 and 7/10
biopsies, respectively.
Rectal biopsy:
• 100% had normal architecture
Lymphocytic and PMN infiltration
were present in 6/6 and 4/6,
respectively.
Endoscopic
Macroscopic inflammatory changes
upper GI biopsy
were observed on endoscopy in the
including esophagus, esophagus, stomach or duodenum
stomach, and/or
in 2 subjects.
duodenum:
• Gross endoscopic Biopsies of esophagus, stomach or
visualization
duodenum showed inflammatory

Inflammatory
changes identified
in the digestive
system were not

Evidence Table 8. Markers of extra-small intestinal function.
Biomarkers in bold are primarily markers of extra-small-intestinal function.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest
human
immunodeficiency
virus
Endoscopy and
biopsy among HIVinfected children

2009

Limela, Malawi

Trehan I et al.

All 3-5 yr olds from
the village were
recruited.

A randomized,
double-blind,
placebo-controlled
trial of rifaximin, a
nonabsorbable
antibiotic, in the
treatment of tropical
enteropathy
L:M,
sucrose:lactulose,
and
sucralose:lactulose
as markers of small
intestinal, gastric,
and colonic
permeability,
respectively, among
those receiving
rifaximin or placebo

1

Design and
Sample Size

Biomarker

Results

• Histopathology

changes of varying degree in all 11
subjects.

Conclusion

Comments
specified by site
(i.e. esophagus,
stomach or
duodenum).

Results were not
stratified by
presenting
symptoms,
including PD.
RCT
Urine Tests
At enrollment:
There was a high
Methodological
1
proportion with
differences in
• Lactulose
• Mean mannitol (SD):
elevated
L:M
which
specimen collection
n=144;
• Mannitol
• Treatment: 9.57 (5.24)
did
not
change
with
and testing, in
• Sucrose (SUC)
• Placebo: 10.29 (6.62)
rifaximin
treatment.
particular for SCL
n=72 received
• Sucralose (SCL)
• Mean lactulose (SD):
excretion, might
rifaximin for 7
• L:M
• Treatment: 0.30 (0.18)
Baseline
L:M
account for some
days
• Sucrose:lactulose
• Placebo: 0.34 (0.25)
measurements
in
differences in
ratio (SUC:L)
• Mean SUC (SD):
this
study
resembled
values compared to
n=72 received
• Sucralose:lactulose
• Treatment: 0.062 (0.04)
those
of
another
other studies.
placebo
ratio (SCL:L)
• Placebo: 0.074 (0.058)
Malawian population
• Mean SCL (SD):
It was presumed
in similar
This was the first
• Treatment: 0.51 (0.29)
environmental
that if SBBO is
use of SCL for siteSubjects were tested
• Placebo: 0.58 (0.53)
conditions
[120].
the etiology for
specific absorption
before and after
• Mean L:M (SD):
enteropathy,
testing in a
treatment.
• Treatment: 0.18 (0.12)
SCL excretion in this developing country
treatment with
• Placebo: 0.17 (0.09)
population was
rifaximin would
setting.
• Mean SUC:L (SD):
result in improved
similar to that found
intestinal integrity.
in healthy American
• Treatment: 0.50 (0.34)
children (0.4%),
• Placebo: 0.64 (0.90)
while SCL:L was
• Mean SCL:L (SD):
comparatively lower
• Treatment: 0.42 (0.32)
(0.8) and driven by
• Placebo: 0.39 (0.23)
lactulose [210].
• For both groups combined:
SCL:L might be a
• 76% had L:M >0.10
better marker of
• 34% had L:M >0.20
colonic permeability
[211-213]. Results
No significant post- intervention
from this study
differences were observed in any
potentially indicate
fractional sugar excretion or dual
sugar test, including among children that colonic

Lactulose, mannitol, SUC, and SCL results were expressed as % of dose administered.

Evidence Table 8. Markers of extra-small intestinal function.
Biomarkers in bold are primarily markers of extra-small-intestinal function.
Reference and
Location and
Study Outcomes of
Target Population
Diagnostic Interest

Design and
Sample Size

Biomarker

Results

Conclusion

with elevated pre-intervention L:M.

permeability was
normal.

Comments

Few data exist on
SUC excretion.
Results in this trial
are similar to those
found in another
Malawian population
(0.06% SUC
excretion) [120] and
high compared to
healthy older
children from
developed country
settings (0.020.03%) [210, 212].

Notes: Some studies included subjects ≥5 yr of age. Where these studies provided data separately for children <5 yr, we present results for only those subjects. Where these
studies did not stratify results by age, but did report the number of children <5 yr included in the study, we provide a breakdown of under-5s.
All studies reporting lactulose:rhamnose ratio results presented values multiplied by a factor of 100 for ease of reporting.
Abbreviations: AD=acute diarrhea, ALT=alanine aminotransferase, AST=aspartate aminotransferase, CBC=complete blood count, CD=celiac disease, CI=95% confidence interval,
Cr=creatinine, ∆=change in, EED=environmental enteric dysfunction, FTT=failure to thrive, GI=gastrointestinal, HAZ=height-for-age Z-(score), HDL=high density lipoproteins,
HIV=human immunodeficiency virus, HLA=human leukocyte antigen, IEL=intraepithelial lymphocytes, IgA=immunoglobulin A, IgE=immunoglobulin E, IgG=immunoglobulin G,
IgM=immunoglobulin M, IL=interleukin, IFN=interferon, LDL=low density lipoproteins, L:M=lactulose:mannitol ratio, mo=month(s), NS=not statistically significant, PD=persistent
diarrhea, RCT=randomized controlled trial, SBBO=small bowel bacterial overgrowth, SD=standard deviation, SE=standard error, SES=socioeconomic status, Tc-99m=technetium
99, T3=triiodothyronine, T4=thyroxine, TE=tropical enteropathy, TGF=transforming growth factor, TNF=tumor necrosis factor, TS=tropical sprue, WAZ=weight-for-age Z-(score),
WBC=white blood cell count, WFA=weight-for-age, WHZ=weight-for-height Z-(score), wk=week(s), yr=year(s)

One study assessed markers of liver and thyroid function among hospitalized persistent
diarrhea cases and healthy controls [107]. These authors found that thyroid hormones were
significantly lower in children with diarrhea than in controls. Liver tests showed associations in
conflicting directions.
The remaining five studies examined tests related to segments of the gastrointestinal
tract outside of the small bowel [13, 118, 120, 136, 167]. Three of these performed endoscopy
and/or biopsy on the esophagus, stomach, and/or rectum [118, 136, 167]. In a study of 11 HIVinfected malnourished children rectal biopsy tissue uniformly demonstrated normal architecture,
but increased lymphocytic and neutrophilic infiltration. Duodenal biopsies were also infiltrated
with these cells but all subjects had additionally some degree of abnormal architecture [136].
Another case series found macroscopic inflammatory changes in 18% of endoscopies and
100% of biopsies of the upper gastrointestinal tract in eight children with HIV infection, many of
whom had persistent diarrhea [167]. However, the investigators did not report whether these
findings were identified in the esophagus, stomach and/or duodenum. A third study in this
category found that nearly two-thirds of subjects had evidence of colitis based on rectal biopsy;
this was not associated with small bowel bacterial overgrowth or degree of small intestinal
pathology observed by scanning electron microscope [118].
Tests of small intestinal permeability have been described in a previous section (5.3),
but certain dual-sugar permeability tests are more specific for evaluating colonic or gastric
function. These markers include urinary sucrose, urinary sucralose, the urinary
sucrose:lactulose ratio (SUC:L), and the urinary sucralose:lactulose ratio (SCL:L). Sucrose
excretion and sucrose:lactulose (SUC:L) were components of a panel of urinary excretion tests
that comprised the clinical endpoints as measures of gastric permeability for two communitybased intervention studies, one of which additionally tested sucralose excretion and
sucralose:lactulose (SCL:L) as measures of colonic permeability. The first of these studies was

269

a randomized, controlled trial of Lactobacillus GG [120]. The mean excretion of sucrose
increased in the treatment group following treatment, but similar results were observed in the
placebo group. Following the intervention, there was no change in the mean SUC:L in either
group. The second of these studies was a randomized, controlled trial that assessed L:M,
SUC:L, and SCL:L responses to treatment with rifaximin, a nonabsorbable antibiotic. The
investigators hypothesized that if small bowel bacterial overgrowth played an etiologic role in
enteropathy, treatment with the antibiotic would result in improvements in measurements of
permeability [13]. Sucralose excretion in this population was similar to that found in healthy
American children while SCL:L was comparatively lower and driven by lactulose [210]. These
results were similar to those found in another Malawian population [120] in where excretion
values were 2-3 fold greater than those excreted by healthy older children from developed
countries [210, 212]. No significant post-intervention differences were observed for any of these
markers. The authors asserted that this was the first use of sucralose for site-specific absorption
testing in a developing country setting. Few data exist on sucrose excretion, but overall values
for sucrose excretion were similar across the two studies.

5.10 Relationships between Markers of EED,
Including Histopathology
Biomarkers provide, by definition, “read-outs” or values that are related to one or more
host processes. Here we review inter-marker relationships, independent of host outcomes
(which are reviewed below).
Only four studies included assessments of “noninvasive” biomarkers (i.e., those not
requiring the introduction of an endoscope or tube into the small bowel (e.g., for visualization, to
obtain duodenal fluid or biopsy tissue) as well as intestinal histopathology [111, 136, 155]; only
two of these studies compared histopathology to less invasive markers. Leite et al. assessed
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the relationship of D-xylose and the degree of villous blunting and found no association [136].
Campbell et al. found that L:M was associated with various findings on scanning electronic
microscopy (SEM) and was correlated with mucosal B lymphocyte density, intraepithelial
lymphocyte (IEL) density, and the presence of perforin-positive IELs [111].
An additional three studies compared endoscopic visualization or markers in intestinal
tissue obtained by biopsy to standard light microscopic histopathology [53, 118, 126]. Neither
endoscopic [126] nor SEM [118] findings were associated with histopathology on light
microscopy. However, intestinal maltase activity, as well as intestinal mRNA abundances for
maltase-glucoamylase and the enterocyte-specific proteins villin and sodium-activated luminal
glucose-galactose transporter 1, were correlated with villous atrophy [53].
Twelve studies [15, 43, 58, 110, 123-125, 132, 149, 151, 158, 159] compared 15
different non-intestinal tissue markers to each other. Four of these studies assessed serum L:R
to other markers and found relationships with sucrose breath values [159], serum lactose [58],
urinary nitrites [43], and urinary L:R [125], but did not demonstrate associations with stool
reducing substances [58] or serum red blood cell markers [58]. Three other studies assessed
urinary L:M to other markers and found no associations with fecal neopterin [15], urinary lactose
or lactose:lactulose [124], or a variety of systemic immune/inflammatory markers including AGP,
total IgG, albumin, and hemoglobin [123]. However, one additional study did find that L:M was
associated with not only total serum IgM and IgA levels, but also IgG [110]. This study also
found a correlation between L:M values and IgG endotoxin core antibody concentrations, and
additionally found urinary lactulose excretion to correlate with circulating IgG endotoxin core
antibody and endotoxin concentrations. Other studies found that urinary lactose:creatinine was
inversely related to hemoglobin [151] and that fecal lactoferrin was related to TNF-α receptor I
[132]. Others found no relationship between urinary nitrite and stool reducing substances [43] or
between sucrose breath test and hemoglobin or C-reactive protein [159].
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5.11 Relationships between EED Biomarkers and
Growth or Other Outcomes of Interest
We sought to find biomarkers of processes relevant to consequential outcomes in the
host. In the context of EED, the outcome of greatest proximate interest is growth failure,
specifically linear growth failure, but other potential injuries (e.g., persistent diarrhea) and distal
consequences (e.g., delayed cognitive development) were also considered.
Eight studies attempted to associate various markers with persistent diarrhea, six of
which found such an association. In five of the six studies, these were systemic markers such
as serum proteins or indices of serum white or red blood cells [106, 107, 142, 166, 308]. A sixth
study found that concentrations of immunoglobulin in duodenal aspirates were associated with
persistent diarrhea among children infected with Giardia [128]. A study of mannose-binding
lectin (MBL) found that while a deficiency of the marker was associated with cryptosporidiosis,
MBL concentrations were not significantly associated with either duration of diarrhea or
persistent diarrhea [130]. While the eighth study did assess for hemoglobin association with
persistent diarrhea, it was not clear from the reporting of their multivariate results if there was an
association [114].
Fourteen studies [101, 103, 111, 113, 117, 121, 126, 131-133, 138, 154, 155, 167]
included subjects with and without persistent diarrhea but did not statistically assess
relationships between markers and this outcome, although five of these studies [101, 103, 117,
126, 155] did present data stratified by the outcome of persistent diarrhea.
While acute diarrhea is not a cardinal EED symptom, we included it as an outcome of
interest when looking at studies that sought its association with biomarkers of enteric
dysfunction. Our rationale was that intestinal damage or pathophysiology resulting from acute
enteric processes might still provide meaningful insights into the utility of various markers in
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representing pathologic gut processes. Eight studies [43, 58, 116, 124, 125, 159, 166, 308]
investigated the relationship between markers and acute diarrhea. It should be noted that some
of these studies included children with persistent diarrhea, but did not stratify results according
to acute or persistent presentations; we include all of these studies under the heading “acute
diarrhea”. Most of these studies found associations between acute diarrhea and the markers
investigated. One of these studies [125] found a relationship between acute diarrhea and both
urinary and serum L:R while another [58], a study limited to serum L:R testing, found
associations between diarrhea and serum L:R and lactulose. However, Goto et al. [124] did not
find an association between the L:M ratio and acute diarrhea.
Studies also found associations between acute diarrhea and other tests specific for
intestinal function, such as the sucrose breath test [159], and fecal fat [116]. Association was
also observed for two markers of innate immunity, neutrophil polarization in response to a
chemotactic factor and monocyte spontaneous proliferation assays [104], as well as nitric oxide
production [43]. While one study found associations between acute diarrhea and various red
blood cell parameters [166], another [104] found a lack of association between acute diarrhea
and other systemic markers such as white blood cells, transferrin, serum albumin, cytokines,
and immunoglobulin subtypes.
Sixteen [15, 101, 108, 121, 130-134, 136, 140, 152, 158, 162, 168, 172] studies had
subjects with and without acute diarrhea but did not statistically analyze the relationship
between markers and acute diarrhea, although three [101, 152, 162] presented data stratified by
acute diarrhea status. In two studies [101, 162], a high proportion of those with acute diarrhea
were lactoferrin positive. One of these studies [101] also found that a low proportion of cases
with acute diarrhea were positive for stool IL-8, but all of the individuals positive for stool IL-8
had acute diarrhea. The study [152] utilizing the D-xylose test found that of the eight children
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with abnormal results, one had diarrhea and of 19 children with diarrhea, only one had an
abnormal result for D-xylose.
Thirteen studies included children with symptomatic or clinically silent giardiasis [15,
105, 116, 117, 122-124, 128, 133, 137, 147, 150, 154]; diagnostic methods to identify Giardia
varied between microscopy and antigen testing. Seven of these studies investigated the
relationship between markers and giardiasis [15, 116, 123, 124, 128, 147, 150] and five found
an association between at least one marker and the infection [116, 123, 124, 128, 147],
although the studies commonly reported associations between one biomarker and not others.
Some studies found serum total IgG and AGP [123], and lactose hydrogen breath test results
[147] were significantly higher in asymptomatic, Giardia-infected children than in uninfected
controls. Significantly higher mean concentrations of total IgM were found in duodenal aspirates
of Giardia cases with persistent diarrhea compared to controls without diarrhea [128]. In a study
that included subjects with and without diarrhea, giardiasis was associated with the presence of
fecal fat, and this association held across four testing methods [116]. In contrast, a study of a
fecal marker of inflammation, neopterin, did not find an association with Giardia infection [15].
The relationship between Giardia infection and a urinary marker of intestinal permeability
differed across studies. While Goto et al. found an association between giardiasis and mean
urinary L:M value in one study [124], they did not find this association in a subsequently
published study [123]. Campbell et al. did not find an association between Giardia infection and
urinary L:M [15], and another report found that urinary L:M was not consistently associated with
giardiasis [150]. The relationship between circulating markers and Giardia infection varied by
marker; specifically, an association was observed between infection and serum albumin but not
hemoglobin concentrations [123]. Six studies [105, 117, 122, 133, 137, 154] that included both
infected and uninfected subjects did not statistically investigate the relationship between Giardia
infection and these markers, although two [105, 117] of these studies did present data stratified
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by infection status and a third [154] provided a general description of the histopathology in
infected subjects. These three studies investigated cases with intestinal symptoms consistent
with celiac disease and referred for duodenal biopsy. Among the children that were not
diagnosed as having celiac disease, the studies reported widely varying percentages of subjects
with Giardia infection: 0.8% [117], 5.4% [105], and 78.6% [154].
Eight studies presented data on children with asymptomatic and/or symptomatic
cryptosporidiosis. Five of these [101, 130-132, 172] tested the association of Cryptosporidium
infection with various markers, three of which were conducted in Haiti by the same group [130132]. Fecal lactoferrin [101, 132] serum mannose-binding lectin deficiency [130], and mean
urinary L:M [172] were associated with cryptosporidiosis. A sixth study tested longitudinally
collected stools of Brazilian children for Cryptosporidium and presented the results for the
children with infection, finding that stool lactoferrin was strongly associated with symptomatic
infection in children with C. parvum but not C. hominis [108].
In the three cryptosporidiosis studies that included testing for various fecal cytokines,
results were mixed. For example, two studies found no association between infection and IL-8
[101, 131], IL-4 [131], or IL-10 [131], while associations were identified with each of these
cytokines, as well as with IL-13, in one of the studies from Haiti [132]. One of the studies from
Haiti found an association between fecal IFN-γ and control status rather than among those with
Cryptosporidium infection [131], while the other did not detect IFN-γ in the stools of any subjects
[132].
In two additional studies of subjects with and without Cryptosporidium infection,
abnormal D-xylose results were found more often among infected children [152], while fecal
lactoferrin did not appear to be related to infection status based on the numbers reported in the
study, although statistical testing of the relationship was not described [162].
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Sixteen studies assessed the association of markers of intestinal function with nutritional
status outcomes [15, 43, 53, 108-112, 122-124, 139, 145, 150, 151, 153]. The anthropometric
assessments used in these investigations varied, and the results for given measures were
mixed. We describe the results of the eight studies that measured the relationship between L:M
and anthropometrics above (see Table 15) [15, 110-112, 122-124, 150].
Urinary lactose:creatinine [151], stool neopterin [15], and intestinal lactase activity [109]
were associated with all anthropometric indices investigated while stool lactoferrin [108] and
intestinal maltase activity were not [53]. Results for urinary nitric oxide and WAZ correlation
were of borderline statistical significance (effect ratio 0.88, p=0.05) [43].
Four studies examined the association between histopathology and growth parameters
[53, 111, 145, 153]; two studies identified no relationship between weight-for-age measures
[111, 145], while one reported that WAZ score was correlated with degree of villous atrophy
[53]. Examination of tissue by digital morphometry in another study produced ambiguous results
[153]. One of these studies also examined the relationship of weight-for-age with endoscopic
visualization of the intestine and found no association [145]. Campbell et al. found varying
results when assessing the relationship of different intestinal tissue cytokines and immune
markers with WAZ score [111].
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